SynGap Missense Server

Table of SynGAP1 Isoform α2 (UniProt Q96PV0-1) Missense Variants.

c.dna Variant SGM Consensus Domain IUPred2 ANCHOR2 AlphaFold MobiDB ClinVar gnomAD ESM1b AlphaMissense REVEL PSMutPred FoldX Rosetta Foldetta PremPS PROVEAN PolyPhen-2 HumDiv PolyPhen-2 HumVar FATHMM SIFT PAM Physical SASA Normalized B-factor backbone Normalized B-factor sidechain SynGAP Structural Annotation DOI
Score Prediction Score Prediction pLDDT disorder disorder Clinical Status Review Subm. ID Allele count Allele freq. LLR score Prediction Pathogenicity Class Optimized Score Prediction IP RF SP RF Prediction Average ΔΔG Prediction StdDev ΔΔG Prediction ΔΔG Prediction ΔΔG Prediction Score Prediction pph2_prob Prediction pph2_prob Prediction Nervous System Score Prediction Prediction Status Conservation Sequences PAM250 PAM120 Hydropathy Δ MW Δ Average Δ Δ StdDev Δ StdDev Secondary Tertiary bonds Inside out GAP-Ras interface At membrane No effect MD Alert Verdict Description
c.694G>T
A232S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A232S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Across the evaluated in‑silico predictors, all tools except AlphaMissense‑Default converge on a benign interpretation: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all predict benign. AlphaMissense‑Default is uncertain, while AlphaMissense‑Optimized predicts benign. No tool predicts pathogenicity. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.254060Structured0.307228Uncertain0.8780.3050.000-3.264Likely Benign0.344AmbiguousLikely Benign0.378Likely Benign0.27770.53000.23Likely Benign0.1-0.23Likely Benign0.00Likely Benign-0.20Likely Benign0.54Neutral0.057Benign0.025Benign5.95Benign1.00Tolerated11-2.616.00
c.695C>A
A232D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A232D is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus. Uncertain or inconclusive results are reported for Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as pathogenic, while Foldetta remains uncertain. Overall, the majority of available predictions support a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.254060Structured0.307228Uncertain0.8780.3050.000-13.956Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.725Likely Pathogenic0.20660.28960.14Likely Benign0.21.55Ambiguous0.85Ambiguous0.77Ambiguous-2.50Deleterious0.845Possibly Damaging0.348Benign5.78Benign0.02Affected0-2-5.344.01
c.695C>G
A232G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A232G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the change as benign include REVEL, FoldX, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. Those that predict pathogenicity are polyPhen‑2 HumDiv and AlphaMissense‑Default. Uncertain or inconclusive results come from Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a benign effect; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.254060Structured0.307228Uncertain0.8780.3050.000-4.924Likely Benign0.835Likely PathogenicAmbiguous0.453Likely Benign0.20120.47240.43Likely Benign0.11.43Ambiguous0.93Ambiguous0.53Ambiguous-1.39Neutral0.608Possibly Damaging0.172Benign5.81Benign0.11Tolerated10-2.2-14.03
c.695C>T
A232V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A232V is catalogued in gnomAD (ID 6‑33435546‑C‑T) but has no ClinVar entry. Functional prediction tools show mixed results: benign calls come from FoldX, Rosetta, Foldetta, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas pathogenic calls are reported by REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, and the Foldetta stability assessment predicts benign. premPS is inconclusive and therefore not considered. Overall, the majority of independent predictors lean toward pathogenicity, but the stability‑based Foldetta suggests a benign effect. With no ClinVar classification to contradict, the variant is most likely pathogenic according to the prevailing computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.254060Structured0.307228Uncertain0.8780.3050.0006-33435546-C-T21.24e-6-9.418Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.539Likely Pathogenic0.12020.60270.40Likely Benign0.10.23Likely Benign0.32Likely Benign0.55Ambiguous-2.99Deleterious0.608Possibly Damaging0.240Benign5.85Benign0.06Tolerated3.4014002.428.05
c.778G>A
V260I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260I missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome, while ESM1b is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts benign. Overall, the consensus of the majority of tools, including the high‑accuracy methods, points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-7.525In-Between0.104Likely BenignLikely Benign0.404Likely Benign0.05590.3704-0.16Likely Benign0.10.27Likely Benign0.06Likely Benign-0.14Likely Benign-0.85Neutral0.994Probably Damaging0.970Probably Damaging5.83Benign0.19Tolerated430.314.03
c.778G>C
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, Rosetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar) and ESM1b. The high‑accuracy assessment shows AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, and Foldetta predicts a benign effect on protein stability. No prediction is missing or inconclusive. Overall, the evidence points to a benign effect for V260L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign0.532Likely Pathogenic0.07300.4360-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated21-0.414.03
c.778G>T
V260L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the aggregate predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-8.785Likely Pathogenic0.416AmbiguousLikely Benign0.532Likely Pathogenic0.07300.4360-0.26Likely Benign0.10.15Likely Benign-0.06Likely Benign0.25Likely Benign-1.84Neutral0.994Probably Damaging0.970Probably Damaging5.90Benign0.11Tolerated21-0.414.03
c.779T>A
V260E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V260E is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a benign impact on protein stability. Overall, the majority of computational evidence points toward a pathogenic interpretation, and this conclusion is not contradicted by the ClinVar status. Thus, the variant is most likely pathogenic, and this conclusion is not contradicted by the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.254060Structured0.382651Uncertain0.8880.2590.250-9.516Likely Pathogenic0.667Likely PathogenicLikely Benign0.848Likely Pathogenic0.08460.1636-0.02Likely Benign0.10.32Likely Benign0.15Likely Benign1.10Destabilizing-3.66Deleterious0.999Probably Damaging0.991Probably Damaging5.79Benign0.09Tolerated-2-2-7.729.98
c.779T>C
V260A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260A missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, the SGM‑Consensus (majority vote), and Foldetta. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Two tools (premPS and AlphaMissense‑Default) give uncertain results. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta—all indicate a benign outcome. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.254060Structured0.382651Uncertain0.8880.2590.250-3.271Likely Benign0.407AmbiguousLikely Benign0.487Likely Benign0.26760.19030.38Likely Benign0.00.02Likely Benign0.20Likely Benign0.81Ambiguous-1.41Neutral0.994Probably Damaging0.970Probably Damaging5.87Benign0.33Tolerated00-2.4-28.05
c.779T>G
V260G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V260G missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FATHMM and AlphaMissense‑Optimized, while the majority of tools (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. FoldX, Rosetta, and Foldetta are uncertain and therefore not considered evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans pathogenic (3 pathogenic vs. 1 benign). Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for V260G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.254060Structured0.382651Uncertain0.8880.2590.250-9.300Likely Pathogenic0.644Likely PathogenicLikely Benign0.817Likely Pathogenic0.18440.19491.00Ambiguous0.31.86Ambiguous1.43Ambiguous1.40Destabilizing-4.20Deleterious0.991Probably Damaging0.999Probably Damaging5.76Benign0.00Affected-1-3-4.6-42.08
c.1426T>A
F476I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant F476I has no ClinVar entry and is not reported in gnomAD. Functional prediction tools fall into two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, and FATHMM; pathogenic predictions come from FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—remains inconclusive and is treated as unavailable. With seven tools indicating pathogenicity versus five indicating benign, and two high‑accuracy tools supporting pathogenicity, the evidence points to a likely pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.617Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.239Likely Benign0.13830.22023.90Destabilizing0.13.09Destabilizing3.50Destabilizing0.39Likely Benign-1.23Neutral0.997Probably Damaging0.989Probably Damaging3.50Benign0.37Tolerated101.7-34.02
c.1426T>C
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No other tools provide definitive evidence. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.196Likely Benign0.16530.29161.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.4022201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1426T>G
F476V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F476V variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM. Those that agree on a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and Foldetta. Tools with uncertain or mixed outputs are Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a pathogenic impact. Overall, the majority of evidence points toward a pathogenic effect. The variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.329Likely Pathogenic0.918Likely PathogenicAmbiguous0.353Likely Benign0.14780.22513.01Destabilizing0.21.90Ambiguous2.46Destabilizing0.64Ambiguous-1.63Neutral0.996Probably Damaging0.993Probably Damaging3.49Benign0.53Tolerated-1-11.4-48.04
c.1427T>A
F476Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta predicts a benign outcome. Overall, the balance of evidence leans toward a benign impact for F476Y, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-9.707Likely Pathogenic0.576Likely PathogenicLikely Benign0.169Likely Benign0.11090.15680.50Ambiguous0.20.30Likely Benign0.40Likely Benign1.10Destabilizing-1.10Neutral0.965Probably Damaging0.919Probably Damaging3.46Benign0.90Tolerated73-4.116.00
c.1427T>C
F476S
2D
AIThe SynGAP1 missense variant F476S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields an equal split of pathogenic and benign signals. Overall, the balance of evidence favors a pathogenic effect for F476S, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-12.675Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.278Likely Benign0.33870.05583.02Destabilizing0.94.07Destabilizing3.55Destabilizing1.23Destabilizing-2.33Neutral1.000Probably Damaging1.000Probably Damaging3.56Benign0.44Tolerated-3-2-3.6-60.10
c.1427T>G
F476C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476C is catalogued in gnomAD (ID 6‑33438459‑T‑G) but has no ClinVar entry. Functional prediction tools split in two groups: benign predictions come from REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, seven tools predict pathogenicity versus six predicting benign, with no ClinVar evidence to contradict this assessment. Thus, the variant is most likely pathogenic based on the current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.0006-33438459-T-G-9.270Likely Pathogenic0.745Likely PathogenicLikely Benign0.280Likely Benign0.20510.12512.05Destabilizing0.12.62Destabilizing2.34Destabilizing-0.30Likely Benign2.69Neutral1.000Probably Damaging0.999Probably Damaging3.46Benign0.83Tolerated3.4022-2-4-0.3-44.04
c.1428C>A
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. No other tools provide definitive evidence. Overall, the majority of predictions (five pathogenic vs. four benign) lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.180Likely Benign0.16530.29161.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.4022201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1428C>G
F476L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F476L is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33438460‑C‑G). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, SIFT, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that returned uncertain results—FoldX, Rosetta, Foldetta, and premPS—do not contribute to the assessment. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, with two pathogenic and two benign calls; Foldetta also reports an uncertain stability change. Overall, the balance of evidence favors a pathogenic effect for F476L, which contrasts with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.397815Uncertain0.8210.2500.000Uncertain 26-33438460-C-G42.48e-6-10.109Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.180Likely Benign0.16530.29161.00Ambiguous0.11.04Ambiguous1.02Ambiguous0.75Ambiguous-1.10Neutral0.997Probably Damaging0.978Probably Damaging3.53Benign0.60Tolerated3.4022201.0-34.02235.916.10.00.1-0.20.0XPotentially BenignIn the WT simulations, the phenyl ring of Phe476, located at the end of an α-helix (res. Ala461-Phe476), packs with the hydrophobic side chains of Leu482 and Ile483. Additionally, Phe476 stacks with the Arg475 side chain on the preceding α-α loop connecting the two α-helices (res. Ala461-Phe476 and res. Leu489-Glu519) near the GAP-Ras interface.In the variant simulations, Leu476 can maintain hydrophobic packing with neighboring residues, although not as efficiently as the phenylalanine in the WT system. The absence of Phe476/Arg475 stacking weakens the integrity of the α-helix end in the variant simulations. Nonetheless, no large-scale adverse effects are observed in the simulations. Lastly, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1441C>A
H481N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H481N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Two tools—Rosetta and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current predictive data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.257454Structured0.430977Uncertain0.7640.2470.000-8.229Likely Pathogenic0.381AmbiguousLikely Benign0.205Likely Benign0.12050.16310.16Likely Benign0.10.54Ambiguous0.35Likely Benign0.09Likely Benign-4.11Deleterious1.000Probably Damaging0.999Probably Damaging3.68Benign0.57Tolerated21-0.3-23.04
c.1441C>G
H481D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H481D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two consensus groups: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further support a pathogenic signal: the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign stability. Uncertain results from AlphaMissense‑Optimized, Foldetta, premPS, and Rosetta are treated as unavailable. Overall, the preponderance of evidence points to a pathogenic effect for H481D, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-11.822Likely Pathogenic0.812Likely PathogenicAmbiguous0.273Likely Benign0.21090.1058-0.09Likely Benign0.10.54Ambiguous0.23Likely Benign0.70Ambiguous-5.41Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.50Tolerated1-1-0.3-22.05
c.1441C>T
H481Y
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H481Y is listed in ClinVar as benign (ClinVar ID 1543764.0) and is present in the gnomAD database (gnomAD ID 6‑33438473‑C‑T). Prediction tools that classify the variant as benign include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. FoldX and Foldetta report uncertain stability effects. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Taking all available evidence together, the variant is most likely benign, which is consistent with its ClinVar benign annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000Likely Benign 16-33438473-C-T169.91e-6-10.910Likely Pathogenic0.565Likely PathogenicLikely Benign0.256Likely Benign0.06100.3558-0.53Ambiguous0.1-0.46Likely Benign-0.50Ambiguous0.20Likely Benign-3.32Deleterious0.988Probably Damaging0.979Probably Damaging3.40Benign0.59Tolerated3.3733021.926.03256.5-44.40.00.00.20.2XXUncertainThe imidazole ring of the His481 side chain is located in a short helical structure (res. Glu480-Leu482) within an α-α loop connecting the two α-helices (res. Ala461-Phe476 and Leu489-Glu519) at the GAP-Ras interface. In the WT simulations, His481 alternately stacks against Arg485, Arg587, and Glu480 without a definite role. In the variant simulations, Tyr481 also alternately stacks with nearby arginine residues, including Arg485, Arg587, and Arg479. The interaction between Tyr481 and Arg479 affects the α-α loop, causing it to fold into a distorted helical structure, an effect that might be more pronounced during protein folding. Finally, the potential effect of the residue swap on SynGAP-Ras complex formation or GTPase activation cannot be fully addressed using the SynGAP solvent-only simulations.
c.1442A>C
H481P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H481P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, and FATHMM. Those that predict a pathogenic effect comprise SGM Consensus (Likely Pathogenic), PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and PROVEAN. Tools with inconclusive results are Foldetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; Foldetta remains uncertain. Overall, the majority of predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-10.205Likely Pathogenic0.630Likely PathogenicLikely Benign0.385Likely Benign0.19790.3553-0.48Likely Benign0.33.69Destabilizing1.61Ambiguous0.67Ambiguous-5.84Deleterious1.000Probably Damaging1.000Probably Damaging3.43Benign0.26Tolerated0-21.6-40.02
c.1442A>G
H481R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H481R is not listed in ClinVar and has no reported allele in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by AlphaMissense‑Optimized, premPS, and Rosetta. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized is inconclusive; the SGM‑Consensus majority vote (AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; and Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, predicts a benign impact. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-11.753Likely Pathogenic0.823Likely PathogenicAmbiguous0.252Likely Benign0.15150.1690-0.45Likely Benign0.10.68Ambiguous0.12Likely Benign0.59Ambiguous-4.48Deleterious0.983Probably Damaging0.977Probably Damaging3.47Benign0.53Tolerated20-1.319.05
c.1442A>T
H481L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H481L missense variant is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; FoldX is uncertain and therefore not counted. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction or stability result is missing or inconclusive. Overall, the majority of tools (seven benign vs five pathogenic) lean toward a benign interpretation, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign, though a subset of high‑accuracy predictors suggest pathogenicity, indicating some uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-9.097Likely Pathogenic0.587Likely PathogenicLikely Benign0.349Likely Benign0.06610.4678-0.58Ambiguous0.10.15Likely Benign-0.22Likely Benign0.29Likely Benign-5.91Deleterious0.995Probably Damaging0.986Probably Damaging3.41Benign0.48Tolerated-2-37.0-23.98
c.1443C>A
H481Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H481Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give a mixed signal: AlphaMissense‑Optimized classifies the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the balance of evidence leans toward a benign effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-8.524Likely Pathogenic0.663Likely PathogenicLikely Benign0.243Likely Benign0.10520.2797-0.41Likely Benign0.10.31Likely Benign-0.05Likely Benign0.32Likely Benign-4.11Deleterious1.000Probably Damaging0.996Probably Damaging3.55Benign0.51Tolerated30-0.3-9.01
c.1443C>G
H481Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H481Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, and FATHMM; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give a mixed signal: AlphaMissense‑Optimized classifies the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the balance of evidence leans toward a benign effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.257454Structured0.430977Uncertain0.7640.2470.000-8.524Likely Pathogenic0.663Likely PathogenicLikely Benign0.243Likely Benign0.10520.2797-0.41Likely Benign0.10.31Likely Benign-0.05Likely Benign0.32Likely Benign-4.11Deleterious1.000Probably Damaging0.996Probably Damaging3.55Benign0.51Tolerated30-0.3-9.01
c.970C>G
R324G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R324G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default; the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. With the majority of evidence pointing to deleterious impact and two of the three high‑accuracy methods supporting pathogenicity, the variant is most likely pathogenic. This conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.257454Structured0.426893Uncertain0.9540.3970.000-12.266Likely Pathogenic0.708Likely PathogenicLikely Benign0.496Likely Benign0.35460.41352.99Destabilizing0.13.18Destabilizing3.09Destabilizing1.27Destabilizing-2.64Deleterious0.999Probably Damaging0.997Probably Damaging1.84Pathogenic0.39Tolerated-3-24.1-99.14
c.970C>T
R324W
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R324W is listed in ClinVar with an uncertain significance (ClinVar ID 845180.0) and is present in gnomAD (ID 6‑33437875‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and AlphaMissense‑Optimized; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No other stability or functional scores are available. Overall, the preponderance of evidence points to a pathogenic effect, which does not contradict the ClinVar uncertain status but suggests a leaning toward pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.257454Structured0.426893Uncertain0.9540.3970.000Uncertain 16-33437875-C-T21.24e-6-12.906Likely Pathogenic0.694Likely PathogenicLikely Benign0.481Likely Benign0.15170.43611.49Ambiguous0.30.56Ambiguous1.03Ambiguous0.66Ambiguous-3.12Deleterious1.000Probably Damaging0.998Probably Damaging1.82Pathogenic0.16Tolerated3.39222-33.630.03256.639.10.00.10.30.2XPotentially PathogenicThe guanidinium group of Arg324, located at the end of an anti-parallel β sheet strand (res. Ala322-Asp330), faces outward and frequently forms a salt bridge with the carboxylate group of the Asp288 side chain, which is part of a β strand end (res. Met289-Pro298). In the variant simulations, the indole ring of the Trp324 side chain cannot maintain a similar interaction with the negatively charged carboxylate side chain of Asp288, potentially compromising the folding of the anti-parallel β sheet assembly. However, the residue swap does not appear to negatively impact the protein structure or its integrity based on the simulations.
c.971G>A
R324Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R324Q is listed in ClinVar with an uncertain significance (ClinVar ID 2572558.0) and is present in gnomAD (ID 6‑33437876‑G‑A). Prediction tools that classify the variant as benign include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict pathogenicity are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also indicates a likely benign outcome. Protein‑stability predictions from FoldX, Rosetta, and the combined Foldetta method are all uncertain. Overall, the consensus of available computational evidence points to a benign effect for R324Q, which is consistent with its ClinVar status of uncertain significance rather than a pathogenic designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.257454Structured0.426893Uncertain0.9540.3970.000Uncertain 36-33437876-G-A31.86e-6-5.001Likely Benign0.173Likely BenignLikely Benign0.307Likely Benign0.38040.32140.56Ambiguous0.10.63Ambiguous0.60Ambiguous1.02Destabilizing-1.17Neutral0.999Probably Damaging0.994Probably Damaging1.92Pathogenic0.41Tolerated3.3922111.0-28.06
c.971G>C
R324P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R324P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, PROVEAN, and SIFT, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic” because three of the four contributing tools predict pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenic. Based on the preponderance of pathogenic predictions—including the high‑accuracy tools—the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.257454Structured0.426893Uncertain0.9540.3970.000-14.533Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.486Likely Benign0.22910.55564.61Destabilizing0.52.19Destabilizing3.40Destabilizing1.03Destabilizing-2.15Neutral1.000Probably Damaging0.999Probably Damaging1.83Pathogenic0.29Tolerated0-22.9-59.07
c.971G>T
R324L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R324L is catalogued in gnomAD (6-33437876‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, and SIFT; pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts a benign effect, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome, and Foldetta (integrating FoldX‑MD and Rosetta outputs) reports a benign stability change. Overall, the majority of evidence points toward a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.257454Structured0.426893Uncertain0.9540.3970.0006-33437876-G-T16.20e-7-10.328Likely Pathogenic0.575Likely PathogenicLikely Benign0.489Likely Benign0.23100.5607-0.28Likely Benign0.0-0.08Likely Benign-0.18Likely Benign0.29Likely Benign-2.20Neutral0.999Probably Damaging0.997Probably Damaging1.86Pathogenic0.63Tolerated3.3922-2-38.3-43.03
c.1033C>A
L345M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L345M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a benign outcome; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is uncertain. Overall, the majority of evidence points to a benign impact for the L345M variant, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.260850Structured0.354989Uncertain0.9360.4780.125-3.918Likely Benign0.101Likely BenignLikely Benign0.101Likely Benign0.06770.32460.75Ambiguous0.10.80Ambiguous0.78Ambiguous0.54Ambiguous-0.97Neutral0.802Possibly Damaging0.122Benign1.73Pathogenic0.07Tolerated42-1.918.03
c.1033C>G
L345V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L345V missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, Rosetta, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also leans toward benign. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.260850Structured0.354989Uncertain0.9360.4780.125-6.594Likely Benign0.131Likely BenignLikely Benign0.126Likely Benign0.14110.34551.31Ambiguous0.00.18Likely Benign0.75Ambiguous0.92Ambiguous-1.96Neutral0.802Possibly Damaging0.277Benign1.77Pathogenic0.06Tolerated210.4-14.03
c.1034T>A
L345Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L345Q is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into benign (REVEL, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic (premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM). FoldX, Rosetta, and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is unavailable. Overall, the majority of predictions lean toward pathogenicity, while the single high‑accuracy tool that is definitive is benign. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.260850Structured0.354989Uncertain0.9360.4780.125-6.034Likely Benign0.213Likely BenignLikely Benign0.218Likely Benign0.09370.08421.32Ambiguous0.10.86Ambiguous1.09Ambiguous1.26Destabilizing-3.67Deleterious0.993Probably Damaging0.844Possibly Damaging1.82Pathogenic0.03Affected-2-2-7.314.97
c.1034T>C
L345P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L345P is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.354989Uncertain0.9360.4780.125-10.994Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.335Likely Benign0.35810.13423.33Destabilizing0.23.26Destabilizing3.30Destabilizing1.27Destabilizing-4.80Deleterious0.998Probably Damaging0.889Possibly Damaging1.70Pathogenic0.02Affected-3-3-5.4-16.04
c.1034T>G
L345R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L345R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and AlphaMissense‑Optimized, whereas the majority of tools predict pathogenicity: SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic prediction. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is inconclusive. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.354989Uncertain0.9360.4780.125-10.325Likely Pathogenic0.635Likely PathogenicLikely Benign0.247Likely Benign0.11400.06850.96Ambiguous0.11.66Ambiguous1.31Ambiguous1.28Destabilizing-3.98Deleterious0.993Probably Damaging0.796Possibly Damaging1.81Pathogenic0.04Affected-3-2-8.343.03
c.1036G>A
V346M
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant V346M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL and FoldX, whereas the majority of other in silico methods (PolyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, PROVEAN, AlphaMissense‑Optimized, and the SGM‑Consensus score) indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, remains uncertain. Overall, the preponderance of evidence from both general and high‑accuracy predictors points to a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.000-10.218Likely Pathogenic0.963Likely PathogenicLikely Pathogenic0.367Likely Benign0.10500.47490.29Likely Benign0.12.52Destabilizing1.41Ambiguous0.67Ambiguous-2.72Deleterious0.999Probably Damaging0.994Probably Damaging1.48Pathogenic0.05Affected21-2.332.06
c.1036G>C
V346L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346L is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, and SIFT, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Four tools (Foldetta, premPS, AlphaMissense‑Optimized, and Rosetta) give uncertain or inconclusive results and are not used as evidence. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of reliable predictors and the SGM‑Consensus support a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.000-8.178Likely Pathogenic0.834Likely PathogenicAmbiguous0.384Likely Benign0.12370.53480.05Likely Benign0.21.10Ambiguous0.58Ambiguous0.60Ambiguous-2.68Deleterious0.994Probably Damaging0.970Probably Damaging1.58Pathogenic0.09Tolerated21-0.414.03
c.1036G>T
V346L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, and SIFT, while pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Four tools (Foldetta, premPS, AlphaMissense‑Optimized, and Rosetta) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points toward a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.000-8.178Likely Pathogenic0.834Likely PathogenicAmbiguous0.386Likely Benign0.12370.53480.05Likely Benign0.21.10Ambiguous0.58Ambiguous0.60Ambiguous-2.68Deleterious0.994Probably Damaging0.970Probably Damaging1.58Pathogenic0.09Tolerated21-0.414.03
c.1037T>A
V346E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All evaluated in silico predictors classify the change as pathogenic: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic outcome; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts a pathogenic impact. **Conclusion:** The variant is most likely pathogenic based on the unanimous computational evidence, and this assessment is not contradicted by the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.000-14.004Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.720Likely Pathogenic0.10880.15683.30Destabilizing0.44.79Destabilizing4.05Destabilizing2.13Destabilizing-5.52Deleterious0.999Probably Damaging0.991Probably Damaging1.47Pathogenic0.00Affected-2-2-7.729.98
c.1037T>C
V346A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346A is reported in gnomAD (6‑33437942‑T‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to REVEL, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) uniformly predict a pathogenic impact; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.260850Structured0.350921Uncertain0.9490.4610.0006-33437942-T-C16.20e-7-8.556Likely Pathogenic0.856Likely PathogenicAmbiguous0.477Likely Benign0.33410.29672.72Destabilizing0.22.73Destabilizing2.73Destabilizing1.92Destabilizing-3.68Deleterious0.994Probably Damaging0.970Probably Damaging1.70Pathogenic0.01Affected3.372500-2.4-28.05
c.1037T>G
V346G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V346G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All available in‑silico predictors classify it as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports pathogenic. With all evidence converging on a deleterious impact and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.260850Structured0.350921Uncertain0.9490.4610.000-12.779Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.667Likely Pathogenic0.23780.25224.24Destabilizing0.24.62Destabilizing4.43Destabilizing2.15Destabilizing-6.03Deleterious0.991Probably Damaging0.999Probably Damaging1.50Pathogenic0.00Affected-1-3-4.6-42.08
c.1387G>A
D463N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463N missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic impact are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Predictions that are uncertain (Foldetta, AlphaMissense‑Optimized, Rosetta) are treated as unavailable and do not influence the overall assessment. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; Foldetta is uncertain. Overall, the majority of available predictions lean toward a benign effect, and this conclusion does not contradict any ClinVar status (none reported). Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-11.428Likely Pathogenic0.812Likely PathogenicAmbiguous0.217Likely Benign0.11520.55310.10Likely Benign0.11.19Ambiguous0.65Ambiguous0.40Likely Benign-4.37Deleterious0.880Possibly Damaging0.430Benign3.33Benign0.10Tolerated210.0-0.98
c.1387G>C
D463H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D463H is not reported in ClinVar and is absent from gnomAD. Consensus from standard prediction algorithms shows a split: benign predictions come from REVEL, FoldX, SIFT, and FATHMM, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus confirms Likely Pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains Uncertain. No evidence from ClinVar contradicts these findings. Overall, the preponderance of computational evidence indicates that D463H is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-13.151Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.356Likely Benign0.13410.61560.20Likely Benign0.10.85Ambiguous0.53Ambiguous0.57Ambiguous-5.96Deleterious0.996Probably Damaging0.852Possibly Damaging3.35Benign0.11Tolerated1-10.322.05
c.1387G>T
D463Y
2D
3DClick to see structure in 3D Viewer
AIClinVar reports no entry for this SynGAP1 D463Y variant, and it is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Uncertain results come from AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of conventional tools lean toward pathogenicity, while the high‑accuracy Foldetta suggests benign. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-14.387Likely Pathogenic0.904Likely PathogenicAmbiguous0.399Likely Benign0.05400.6213-0.14Likely Benign0.10.77Ambiguous0.32Likely Benign0.07Likely Benign-7.95Deleterious0.998Probably Damaging0.904Possibly Damaging3.35Benign0.14Tolerated-4-32.248.09
c.1388A>C
D463A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463A missense variant has no ClinVar record and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, premPS, SIFT, FATHMM, and the folding‑stability method Foldetta. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely pathogenic, and Foldetta predicts a benign effect on protein stability. Overall, the majority of tools and the consensus high‑accuracy prediction lean toward pathogenicity, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-8.607Likely Pathogenic0.894Likely PathogenicAmbiguous0.425Likely Benign0.35910.5169-0.04Likely Benign0.10.96Ambiguous0.46Likely Benign0.43Likely Benign-6.96Deleterious0.978Probably Damaging0.602Possibly Damaging3.33Benign0.29Tolerated0-25.3-44.01
c.1388A>G
D463G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463G missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, and ESM1b. Five tools favor pathogenicity versus three favor benign, with the remaining five (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yielding uncertain results. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, also remains inconclusive. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-10.713Likely Pathogenic0.921Likely PathogenicAmbiguous0.422Likely Benign0.37510.48980.66Ambiguous0.11.93Ambiguous1.30Ambiguous0.54Ambiguous-6.36Deleterious0.994Probably Damaging0.824Possibly Damaging3.32Benign0.09Tolerated1-13.1-58.04
c.1388A>T
D463V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D463V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, premPS, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain predictions come from Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points toward a pathogenic impact for D463V, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.260850Structured0.305622Uncertain0.9400.1760.000-12.374Likely Pathogenic0.880Likely PathogenicAmbiguous0.521Likely Pathogenic0.07130.55260.23Likely Benign0.10.98Ambiguous0.61Ambiguous0.33Likely Benign-7.95Deleterious0.973Probably Damaging0.658Possibly Damaging3.31Benign0.09Tolerated-2-37.7-15.96
c.1389C>A
D463E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and premPS. Only PROVEAN predicts a pathogenic outcome, while Rosetta and AlphaMissense‑Default are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.260850Structured0.305622Uncertain0.9400.1760.000-5.170Likely Benign0.527AmbiguousLikely Benign0.162Likely Benign0.13300.5177-0.42Likely Benign0.10.50Ambiguous0.04Likely Benign0.47Likely Benign-2.58Deleterious0.012Benign0.003Benign3.47Benign0.29Tolerated320.014.03
c.1389C>G
D463E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D463E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and premPS. Only PROVEAN predicts a pathogenic outcome, while Rosetta and AlphaMissense‑Default are uncertain. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) resolves to benign, and Foldetta also indicates benign stability. No prediction or stability result is missing or inconclusive. Overall, the variant is most likely benign based on the collective evidence, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.260850Structured0.305622Uncertain0.9400.1760.000-5.170Likely Benign0.527AmbiguousLikely Benign0.162Likely Benign0.13300.5177-0.42Likely Benign0.10.50Ambiguous0.04Likely Benign0.47Likely Benign-2.58Deleterious0.012Benign0.003Benign3.47Benign0.29Tolerated320.014.03
c.1030G>A
G344S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G344S is listed in ClinVar (ID 981240.0) as Pathogenic and is not reported in gnomAD. Prediction tools that assess pathogenicity all agree: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic; the only inconclusive result is premPS, which is marked Uncertain. No tool predicts a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.264545Structured0.368110Uncertain0.9130.4850.250Pathogenic 5-11.254Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.790Likely Pathogenic0.27350.53249.02Destabilizing0.76.08Destabilizing7.55Destabilizing0.98Ambiguous-5.28Deleterious1.000Probably Damaging1.000Probably Damaging-0.45Pathogenic0.04Affected3.372510-0.430.03217.3-51.70.00.10.20.1XXPotentially PathogenicBecause Gly344 lacks a proper side chain, it allows the anti-parallel β sheet strand (res. Gly341-Pro349) to have a slight twist. Within a β strand, side chains normally alternate between outward and inward positions, but glycine is an exception as it allows the alternating pattern to skip a residue. Introducing serine or any other residue with a side chain at position 344 prevents this unique skip in the alternating pattern, causing structural strain or likely preventing correct folding altogether. Additionally, Tyr342 shields Gly344 from the solvent, contributing to twist formation in the β sheet and stabilizing the β-strand.In the variant simulations, the side chain of Ser344 assumes the inward position. However, the hydrophobic niche formed by multiple C2 domain residues (e.g., Val365, Val343, Leu327) is not accommodating for its hydroxyl group. The outward position, not seen in the simulations, would be equally disadvantageous due to the presence of hydrophobic residues on that side as well (e.g., Leu345, Tyr342). Serine is also not well-suited for twist formation, as it tends to suppress twisting and bending in β sheets. At this position, the hydroxyl group of Ser344 could also form hydrogen bonds with the backbone atoms of the Gly-rich Ω loop in the C2 domain (e.g., Thr366, Leu367, Gly378; res. Pro364-Pro398), potentially adversely affecting membrane-loop dynamics and ultimately compromising the stability of the SynGAP-membrane association.
c.1030G>C
G344R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G344R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while the only inconclusive result is premPS, which is listed as uncertain. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic status; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports pathogenic. Consequently, the variant is most likely pathogenic, and this assessment is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.264545Structured0.368110Uncertain0.9130.4850.250-12.609Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.801Likely Pathogenic0.08440.461414.84Destabilizing0.813.66Destabilizing14.25Destabilizing0.81Ambiguous-7.17Deleterious1.000Probably Damaging1.000Probably Damaging-0.49Pathogenic0.01Affected-3-2-4.199.14
c.1030G>T
G344C
2D
AIThe SynGAP1 missense variant G344C is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a pathogenic outcome include SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy methods specifically show pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No tool predicts a benign effect. Based on the unanimous pathogenic predictions and the absence of any ClinVar or gnomAD evidence, the variant is most likely pathogenic, with no contradiction to ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.264545Structured0.368110Uncertain0.9130.4850.250-12.880Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.794Likely Pathogenic0.11840.47888.52Destabilizing2.97.52Destabilizing8.02Destabilizing0.59Ambiguous-8.02Deleterious1.000Probably Damaging1.000Probably Damaging-0.47Pathogenic0.01Affected-3-32.946.09
c.1031G>A
G344D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G344D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also predicts pathogenicity. Based on the unanimous pathogenic predictions and the absence of benign calls, the variant is most likely pathogenic, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.264545Structured0.368110Uncertain0.9130.4850.250-12.527Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.897Likely Pathogenic0.15720.157414.53Destabilizing1.511.36Destabilizing12.95Destabilizing1.13Destabilizing-6.30Deleterious1.000Probably Damaging1.000Probably Damaging-0.49Pathogenic0.01Affected1-1-3.158.04
c.1031G>C
G344A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G344A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default, while only SIFT predicts a benign outcome. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. Overall, the consensus of the majority of predictors indicates a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.264545Structured0.368110Uncertain0.9130.4850.250-10.439Likely Pathogenic0.931Likely PathogenicAmbiguous0.873Likely Pathogenic0.39640.56855.11Destabilizing0.44.23Destabilizing4.67Destabilizing0.58Ambiguous-5.38Deleterious1.000Probably Damaging0.999Probably Damaging-0.32Pathogenic0.10Tolerated102.214.03
c.1031G>T
G344V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G344V is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while the only inconclusive result is premPS, which is listed as uncertain. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely pathogenic status; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.264545Structured0.368110Uncertain0.9130.4850.250-14.913Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.889Likely Pathogenic0.12440.474413.33Destabilizing1.514.51Destabilizing13.92Destabilizing0.53Ambiguous-7.97Deleterious1.000Probably Damaging1.000Probably Damaging-0.48Pathogenic0.03Affected-1-34.642.08
c.1384A>C
K462Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K462Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. Overall, the majority of tools and the protein‑stability analysis favor a benign effect, while the consensus pathogenic score introduces uncertainty. Thus, the variant is most likely benign; this assessment does not contradict ClinVar status, which has no entry for K462Q.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-12.144Likely Pathogenic0.809Likely PathogenicAmbiguous0.384Likely Benign0.46390.12860.12Likely Benign0.10.34Likely Benign0.23Likely Benign0.48Likely Benign-3.85Deleterious0.999Probably Damaging0.999Probably Damaging3.40Benign0.15Tolerated110.4-0.04
c.1384A>G
K462E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462E is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Rosetta and Foldetta are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta is uncertain. Overall, the majority of predictions (7 pathogenic vs. 5 benign) and the high‑accuracy tools support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-14.696Likely Pathogenic0.967Likely PathogenicLikely Pathogenic0.433Likely Benign0.41450.10220.34Likely Benign0.01.56Ambiguous0.95Ambiguous0.33Likely Benign-3.88Deleterious0.998Probably Damaging0.991Probably Damaging3.49Benign0.15Tolerated010.40.94
c.1385A>C
K462T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K462T missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-11.586Likely Pathogenic0.948Likely PathogenicAmbiguous0.414Likely Benign0.20950.32570.55Ambiguous0.01.08Ambiguous0.82Ambiguous0.30Likely Benign-5.82Deleterious0.999Probably Damaging1.000Probably Damaging3.47Benign0.08Tolerated0-13.2-27.07
c.1385A>G
K462R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462R is catalogued in gnomAD (ID 6‑33438290‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Three tools (Rosetta, Foldetta, premPS) yield uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta is uncertain, so neither provides decisive evidence. Overall, the majority of reliable predictors lean toward a benign effect. This consensus does not contradict ClinVar status, which is currently absent. Thus, based on available predictions, K462R is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.297737Uncertain0.9210.1590.1256-33438290-A-G16.20e-7-9.980Likely Pathogenic0.184Likely BenignLikely Benign0.246Likely Benign0.49950.12010.13Likely Benign0.10.90Ambiguous0.52Ambiguous0.84Ambiguous-2.75Deleterious0.983Probably Damaging0.962Probably Damaging3.43Benign0.09Tolerated3.373423-0.628.01
c.1385A>T
K462M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K462M missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, FATHMM, premPS, and the protein‑folding stability method Foldetta; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. Rosetta’s output is inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also pathogenic, while Foldetta indicates a benign effect on protein stability. No evidence from ClinVar contradicts these findings. Overall, the majority of predictive tools and the consensus score support a pathogenic classification, suggesting that K462M is most likely pathogenic rather than benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-12.837Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.475Likely Benign0.12820.3932-0.23Likely Benign0.10.86Ambiguous0.32Likely Benign0.17Likely Benign-5.82Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.02Affected0-15.83.02
c.1386G>C
K462N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K462N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts Pathogenic, and the SGM Consensus also indicates Likely Pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result, providing no definitive evidence. Overall, the majority of high‑confidence predictors lean toward pathogenicity, contradicting the absence of a ClinVar classification. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.125-12.823Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.304Likely Benign0.39670.12420.69Ambiguous0.11.67Ambiguous1.18Ambiguous0.90Ambiguous-4.83Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.07Tolerated3.3734010.4-14.07
c.1386G>T
K462N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K462N is reported in gnomAD (ID 6‑33438291‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑based methods (FoldX, Rosetta, premPS) and Foldetta are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM Consensus as likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for K462N. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.297737Uncertain0.9210.1590.1256-33438291-G-T16.20e-7-12.823Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.303Likely Benign0.39670.12420.69Ambiguous0.11.67Ambiguous1.18Ambiguous0.90Ambiguous-4.83Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.07Tolerated3.3734010.4-14.07
c.1414G>A
E472K
2D
AIThe SynGAP1 missense variant E472K is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect; the only inconclusive result is from premPS, which is listed as uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a destabilizing, pathogenic effect. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-15.214Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.670Likely Pathogenic0.30770.56512.01Destabilizing1.23.23Destabilizing2.62Destabilizing0.78Ambiguous-3.95Deleterious0.996Probably Damaging0.987Probably Damaging2.33Pathogenic0.03Affected01-0.4-0.94
c.1414G>C
E472Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E472Q is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only Foldetta, which classifies the variant as benign. Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain or inconclusive predictions come from FoldX, Rosetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a pathogenic impact for E472Q, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-13.760Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.555Likely Pathogenic0.13880.57261.34Ambiguous0.3-0.67Ambiguous0.34Likely Benign0.89Ambiguous-2.95Deleterious0.994Probably Damaging0.986Probably Damaging2.39Pathogenic0.01Affected220.0-0.98
c.1415A>C
E472A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E472A is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; all these methods uniformly classify the change as deleterious. Tools that are inconclusive or uncertain for this variant are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic outcome, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity, while Foldetta’s stability analysis remains uncertain. Taken together, the overwhelming majority of evidence points to a pathogenic effect for E472A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-15.356Likely Pathogenic0.983Likely PathogenicLikely Pathogenic0.732Likely Pathogenic0.46390.63151.81Ambiguous0.30.67Ambiguous1.24Ambiguous0.69Ambiguous-5.90Deleterious0.999Probably Damaging0.998Probably Damaging2.32Pathogenic0.01Affected0-15.3-58.04
c.1415A>G
E472G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E472G is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that assess the variant’s effect largely agree on a deleterious outcome: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic or likely pathogenic. Only premPS predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-15.239Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.744Likely Pathogenic0.33430.49503.06Destabilizing0.22.86Destabilizing2.96Destabilizing0.24Likely Benign-6.83Deleterious1.000Probably Damaging0.998Probably Damaging2.30Pathogenic0.00Affected0-23.1-72.06
c.1415A>T
E472V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E472V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Foldetta and premPS, whereas the remaining tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. No prediction or folding‑stability result is missing or inconclusive; uncertain outputs from FoldX and Rosetta are treated as unavailable. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-14.957Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.733Likely Pathogenic0.08810.63471.05Ambiguous0.3-0.64Ambiguous0.21Likely Benign0.37Likely Benign-6.90Deleterious0.996Probably Damaging0.991Probably Damaging2.29Pathogenic0.00Affected-2-27.7-29.98
c.1416G>C
E472D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E472D is not reported in ClinVar and has no gnomAD entry. Consensus from multiple in‑silico predictors shows a split: benign calls come from REVEL and SIFT, whereas the majority of tools—SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict pathogenicity. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability estimates. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (derived from the four high‑confidence predictors) is pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E472D, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-9.798Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.304Likely Benign0.19750.39181.27Ambiguous0.31.99Ambiguous1.63Ambiguous1.00Destabilizing-2.75Deleterious0.989Probably Damaging0.979Probably Damaging2.43Pathogenic0.06Tolerated320.0-14.03
c.1416G>T
E472D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E472D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and SIFT, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), FATHMM, ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, premPS, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Stability‑based methods (FoldX, Rosetta, Foldetta) yield uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence from multiple independent predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.359300Uncertain0.8780.2310.000-9.798Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.303Likely Benign0.19750.39181.27Ambiguous0.31.99Ambiguous1.63Ambiguous1.00Destabilizing-2.75Deleterious0.989Probably Damaging0.979Probably Damaging2.43Pathogenic0.06Tolerated320.0-14.03
c.1432G>A
E478K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478K is not reported in ClinVar (ClinVar ID: None) and has no entries in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SGM‑Consensus (Likely Pathogenic), PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as benign. Overall, the majority of evidence (eight benign versus five pathogenic predictions) points to a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-12.654Likely Pathogenic0.899Likely PathogenicAmbiguous0.309Likely Benign0.20660.61920.23Likely Benign0.00.12Likely Benign0.18Likely Benign-0.02Likely Benign-3.45Deleterious0.320Benign0.117Benign3.49Benign0.05Affected01-0.4-0.94
c.1432G>C
E478Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478Q is listed in gnomAD (ID 6‑33438464‑G‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and Foldetta as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑vs‑2 split. Overall, the majority of evidence (nine benign vs three pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.0006-33438464-G-C16.20e-7-9.881Likely Pathogenic0.603Likely PathogenicLikely Benign0.222Likely Benign0.10270.5867-0.04Likely Benign0.00.31Likely Benign0.14Likely Benign0.07Likely Benign-2.49Neutral0.623Possibly Damaging0.199Benign3.40Benign0.14Tolerated3.3734220.0-0.98
c.1433A>C
E478A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478A missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No predictions are missing or inconclusive. Overall, the majority of high‑confidence tools lean toward a benign classification, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-8.499Likely Pathogenic0.612Likely PathogenicLikely Benign0.342Likely Benign0.35160.58470.46Likely Benign0.00.45Likely Benign0.46Likely Benign0.02Likely Benign-4.74Deleterious0.585Possibly Damaging0.505Possibly Damaging3.42Benign0.05Affected0-15.3-58.04
c.1433A>G
E478G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and polyPhen‑2 HumDiv. Uncertain predictions come from Rosetta, ESM1b, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to equal benign and pathogenic signals and two uncertain calls; Foldetta likewise yields an uncertain result. Overall, the majority of evaluated tools (seven benign vs. two pathogenic) support a benign classification. This consensus does not contradict any ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.264545Structured0.414660Uncertain0.7870.2490.000-7.897In-Between0.418AmbiguousLikely Benign0.306Likely Benign0.27580.55720.40Likely Benign0.00.73Ambiguous0.57Ambiguous0.02Likely Benign-4.91Deleterious0.923Possibly Damaging0.427Benign3.41Benign0.15Tolerated0-23.1-72.06
c.1433A>T
E478V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E478V missense change is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, Rosetta, polyPhen‑2 (HumDiv and HumVar), FATHMM, and premPS; pathogenic predictions from SGM‑Consensus, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. Two tools give inconclusive results: FoldX (uncertain) and AlphaMissense‑Optimized (uncertain). High‑accuracy assessments further split the signal: the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. With six benign versus five pathogenic calls and no ClinVar evidence, the overall evidence slightly favors a benign interpretation, and there is no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.264545Structured0.414660Uncertain0.7870.2490.000-10.322Likely Pathogenic0.831Likely PathogenicAmbiguous0.385Likely Benign0.05860.66040.55Ambiguous0.00.33Likely Benign0.44Likely Benign0.04Likely Benign-5.84Deleterious0.434Benign0.199Benign3.35Benign0.01Affected-2-27.7-29.98
c.1434A>C
E478D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote) indicates likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.264545Structured0.414660Uncertain0.7870.2490.000-1.004Likely Benign0.085Likely BenignLikely Benign0.175Likely Benign0.17680.3315-0.04Likely Benign0.0-0.65Ambiguous-0.35Likely Benign-0.28Likely Benign0.55Neutral0.000Benign0.001Benign3.53Benign0.70Tolerated320.0-14.03
c.1434A>T
E478D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E478D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, SGM‑Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.264545Structured0.414660Uncertain0.7870.2490.000-1.004Likely Benign0.085Likely BenignLikely Benign0.175Likely Benign0.17680.3315-0.04Likely Benign0.0-0.65Ambiguous-0.35Likely Benign-0.28Likely Benign0.55Neutral0.000Benign0.001Benign3.53Benign0.70Tolerated320.0-14.03
c.613A>C
I205L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the variant as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM Consensus predicts likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No contradictory evidence exists. Based on the collective predictions, the variant is most likely benign, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-5.474Likely Benign0.105Likely BenignLikely Benign0.112Likely Benign0.06820.27020.07Likely Benign0.20.02Likely Benign0.05Likely Benign0.30Likely Benign-0.86Neutral0.004Benign0.012Benign4.17Benign0.34Tolerated22-0.70.00
c.613A>G
I205V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all classify the variant as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, the SGM Consensus predicts likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Based on the consensus of all available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-2.232Likely Benign0.063Likely BenignLikely Benign0.113Likely Benign0.08970.27910.45Likely Benign0.0-0.18Likely Benign0.14Likely Benign0.11Likely Benign-0.11Neutral0.001Benign0.007Benign4.20Benign0.84Tolerated43-0.3-14.03
c.613A>T
I205F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205F missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: SGM‑Consensus, REVEL, FoldX, PROVEAN, SIFT, AlphaMissense‑Default, AlphaMissense‑Optimized, FATHMM, and polyPhen‑2 HumVar all classify it as benign. Only polyPhen‑2 HumDiv predicts a pathogenic outcome. Uncertain results from Foldetta, premPS, ESM1b, and Rosetta are treated as unavailable. High‑accuracy assessments reinforce the benign prediction: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, while Foldetta remains uncertain. Overall, the consensus of the majority of tools indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-7.913In-Between0.271Likely BenignLikely Benign0.113Likely Benign0.04610.22050.30Likely Benign0.30.89Ambiguous0.60Ambiguous0.52Ambiguous-1.80Neutral0.838Possibly Damaging0.368Benign4.08Benign0.10Tolerated10-1.734.02
c.614T>A
I205N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. No evidence from these tools contradicts the lack of ClinVar annotation. Overall, the majority of predictions (five pathogenic vs. four benign) and the pathogenic SGM Consensus suggest the variant is most likely pathogenic, with no ClinVar status to conflict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.264545Structured0.409933Uncertain0.8210.4140.125-10.928Likely Pathogenic0.552AmbiguousLikely Benign0.138Likely Benign0.08020.02120.66Ambiguous0.11.16Ambiguous0.91Ambiguous1.57Destabilizing-3.56Deleterious0.940Possibly Damaging0.641Possibly Damaging4.06Benign0.07Tolerated-2-3-8.00.94
c.614T>C
I205T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the remaining predictions (FoldX, premPS, AlphaMissense‑Default) are uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign effect; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, classifies the variant as benign. Taken together, the consensus of both general and high‑accuracy predictors indicates that I205T is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-6.869Likely Benign0.450AmbiguousLikely Benign0.118Likely Benign0.09330.05410.65Ambiguous0.00.28Likely Benign0.47Likely Benign0.81Ambiguous-2.19Neutral0.421Benign0.156Benign4.16Benign0.15Tolerated0-1-5.2-12.05
c.614T>G
I205S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I205S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Optimized, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and ESM1b. Tools with uncertain or inconclusive results (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of available predictions lean toward a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.264545Structured0.409933Uncertain0.8210.4140.125-8.694Likely Pathogenic0.518AmbiguousLikely Benign0.178Likely Benign0.23460.08001.17Ambiguous0.20.95Ambiguous1.06Ambiguous0.88Ambiguous-2.73Deleterious0.838Possibly Damaging0.368Benign4.12Benign0.24Tolerated-1-2-5.3-26.08
c.615T>G
I205M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I205M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Uncertain results come from Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta as benign. Based on the majority of predictions and the high‑accuracy tools, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.264545Structured0.409933Uncertain0.8210.4140.125-6.693Likely Benign0.142Likely BenignLikely Benign0.119Likely Benign0.05930.20000.20Likely Benign0.20.63Ambiguous0.42Likely Benign0.65Ambiguous-1.16Neutral0.838Possibly Damaging0.467Possibly Damaging4.07Benign0.07Tolerated21-2.618.03
c.1039A>C
T347P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T347P variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, ESM1b, and FATHMM. Three tools (FoldX, premPS, AlphaMissense‑Default) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.268042Structured0.349915Uncertain0.9510.4340.000-9.323Likely Pathogenic0.417AmbiguousLikely Benign0.236Likely Benign0.20000.53500.55Ambiguous0.00.28Likely Benign0.42Likely Benign0.65Ambiguous-2.41Neutral0.627Possibly Damaging0.139Benign1.63Pathogenic0.12Tolerated0-1-0.9-3.99
c.1039A>G
T347A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T347A is catalogued in gnomAD (ID 6‑33437944‑A‑G) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all report benign or tolerated. Only FATHMM predicts a pathogenic outcome, while Foldetta, premPS, and Rosetta are inconclusive. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign, SGM‑Consensus is Likely Benign, and Foldetta remains uncertain. Overall, the consensus of the majority of tools indicates the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.349915Uncertain0.9510.4340.0006-33437944-A-G95.58e-6-5.858Likely Benign0.086Likely BenignLikely Benign0.093Likely Benign0.40320.46150.34Likely Benign0.10.70Ambiguous0.52Ambiguous0.70Ambiguous-1.52Neutral0.031Benign0.016Benign1.68Pathogenic0.42Tolerated3.3725012.5-30.03
c.1039A>T
T347S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T347S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, so they provide no evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of reliable predictors indicate a benign effect, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.349915Uncertain0.9510.4340.000-3.342Likely Benign0.090Likely BenignLikely Benign0.104Likely Benign0.32050.47070.65Ambiguous0.10.82Ambiguous0.74Ambiguous-0.10Likely Benign0.63Neutral0.002Benign0.001Benign1.75Pathogenic0.86Tolerated11-0.1-14.03
c.1040C>A
T347N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T347N is listed in ClinVar with an uncertain significance (ClinVar ID 3672484.0) and is present in the gnomAD database (gnomAD ID 6‑33437945‑C‑A). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to “Likely Benign” (3 benign vs. 1 pathogenic). High‑accuracy assessments are consistent: AlphaMissense‑Optimized is benign, the SGM‑Consensus is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Overall, the collective evidence points to a benign effect, aligning with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.349915Uncertain0.9510.4340.000Uncertain 16-33437945-C-A95.58e-6-5.545Likely Benign0.165Likely BenignLikely Benign0.059Likely Benign0.10700.43590.41Likely Benign0.10.46Likely Benign0.44Likely Benign-0.06Likely Benign1.96Neutral0.001Benign0.001Benign1.67Pathogenic0.60Tolerated3.372500-2.813.00
c.1040C>G
T347S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T347S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, so they provide no evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the majority of reliable predictors indicate a benign effect, and there is no ClinVar annotation to contradict this assessment. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.349915Uncertain0.9510.4340.000-3.342Likely Benign0.090Likely BenignLikely Benign0.054Likely Benign0.32050.47070.65Ambiguous0.10.82Ambiguous0.74Ambiguous-0.10Likely Benign0.63Neutral0.002Benign0.001Benign1.75Pathogenic0.86Tolerated11-0.1-14.03
c.1040C>T
T347I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 T347I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that provide definitive calls cluster into two groups: benign predictions come from REVEL, premPS, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized; pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, ESM1b, and FATHMM. Tools with inconclusive outputs (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) are treated as unavailable. High‑accuracy assessments further split the evidence: AlphaMissense‑Optimized predicts benign, while the SGM consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—predicts pathogenic; Foldetta remains uncertain. Consequently, the variant’s pathogenicity is ambiguous, with an equal number of strong benign and pathogenic calls and no consensus from the most reliable methods. The variant is therefore most likely uncertain, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.349915Uncertain0.9510.4340.000-10.148Likely Pathogenic0.387AmbiguousLikely Benign0.079Likely Benign0.08850.6298-0.79Ambiguous0.1-0.94Ambiguous-0.87Ambiguous0.29Likely Benign-3.12Deleterious0.627Possibly Damaging0.139Benign1.70Pathogenic0.08Tolerated0-15.212.05
c.1390T>A
F464I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are limited to FATHMM, while all other evaluated algorithms—including SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-11.210Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.539Likely Pathogenic0.14390.20024.77Destabilizing0.24.35Destabilizing4.56Destabilizing1.23Destabilizing-5.97Deleterious0.998Probably Damaging0.994Probably Damaging3.44Benign0.03Affected101.7-34.02
c.1390T>C
F464L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability assessments. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD and Rosetta output is uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.482Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.435Likely Benign0.16640.28831.63Ambiguous0.30.95Ambiguous1.29Ambiguous1.12Destabilizing-5.97Deleterious0.998Probably Damaging0.987Probably Damaging3.93Benign0.22Tolerated201.0-34.02
c.1390T>G
F464V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F464V variant is listed in ClinVar with an “Uncertain” status (ClinVar ID 1716596.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the collective predictions, the variant is most likely pathogenic, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000Uncertain 1-12.254Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.592Likely Pathogenic0.15870.22193.61Destabilizing0.12.89Destabilizing3.25Destabilizing1.40Destabilizing-6.96Deleterious0.998Probably Damaging0.996Probably Damaging3.36Benign0.04Affected3.3734-1-11.4-48.04210.140.5-0.10.0-0.90.3XPotentially PathogenicThe phenyl ring of Phe464, located in the middle of an α helix (res. Ala461–Phe476), packs against hydrophobic residues (e.g., Met468, Leu451, Leu455, and Tyr428) in the inter-helix space formed with two other α helices (res. Asn440-Lys460 and res. Pro413-Glu436). The iso-propyl side chain of Val464 is similarly hydrophobic but considerably smaller than the original phenyl ring of Phe464. To compensate for the size difference, neighboring residues need to fill in the gap in the variant simulations.The phenolic side chain of Tyr428, located at the middle bend of an α helix (res. Glu436-Pro413), assumes a new position in the inter-helix space or rotates inward next to the third α helix (res. Asn440-Lys460) when the stable H-bond between Tyr428 and Asp467 seen in the WT simulations breaks. The residue swap also leads to the loss of the methionine-aromatic interaction between the Met468 and Phe464 side chains, which could weaken the integrity of the parent α helix (res. Ala461-Phe476). Although the simulations likely underestimate the full adverse effect of the introduced mutation during folding, the two opposing α helices (res. Ala461–Phe476 and res. Glu436-Pro413) move substantially closer to each other in the variant simulations.
c.1391T>A
F464Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464Y is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome, while AlphaMissense‑Optimized and Foldetta provide uncertain results and are treated as unavailable evidence. Overall, the balance of evidence points to a pathogenic effect for F464Y, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.056Likely Pathogenic0.941Likely PathogenicAmbiguous0.387Likely Benign0.10810.15231.35Ambiguous0.10.24Likely Benign0.80Ambiguous1.31Destabilizing-2.98Deleterious0.979Probably Damaging0.953Probably Damaging3.28Benign0.01Affected73-4.116.00
c.1391T>C
F464S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-13.361Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.748Likely Pathogenic0.37000.03584.84Destabilizing0.04.90Destabilizing4.87Destabilizing2.52Destabilizing-7.96Deleterious1.000Probably Damaging1.000Probably Damaging3.27Benign0.00Affected-3-2-3.6-60.10
c.1391T>G
F464C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only FATHMM, whereas all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-13.011Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.740Likely Pathogenic0.22980.12194.18Destabilizing0.04.31Destabilizing4.25Destabilizing2.20Destabilizing-7.96Deleterious1.000Probably Damaging0.999Probably Damaging3.26Benign0.00Affected-4-2-0.3-44.04
c.1392C>A
F464L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability assessments. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD and Rosetta output is uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because the variant is not yet classified in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.482Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.279Likely Benign0.16640.28831.63Ambiguous0.30.95Ambiguous1.29Ambiguous1.12Destabilizing-5.97Deleterious0.998Probably Damaging0.987Probably Damaging3.93Benign0.22Tolerated201.0-34.02
c.1392C>G
F464L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F464L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are returned by SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive stability assessments. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta’s combined FoldX‑MD and Rosetta output is uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.313424Uncertain0.9610.1780.000-10.482Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.279Likely Benign0.16640.28831.63Ambiguous0.30.95Ambiguous1.29Ambiguous1.12Destabilizing-5.97Deleterious0.998Probably Damaging0.987Probably Damaging3.93Benign0.22Tolerated201.0-34.02
c.1399G>A
D467N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D467N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a predominance of pathogenic calls: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of the four high‑accuracy predictors) all predict a deleterious effect. Benign predictions come from FoldX, premPS, and SIFT. Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive. High‑accuracy methods specifically give an uncertain result for AlphaMissense‑Optimized, a pathogenic verdict for the SGM‑Consensus, and an uncertain outcome for Foldetta. Overall, the balance of evidence favors a pathogenic impact for D467N, and this assessment is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-11.881Likely Pathogenic0.913Likely PathogenicAmbiguous0.673Likely Pathogenic0.09360.48790.43Likely Benign0.11.63Ambiguous1.03Ambiguous0.38Likely Benign-4.82Deleterious0.987Probably Damaging0.990Probably Damaging-1.22Pathogenic0.06Tolerated210.0-0.98
c.1399G>C
D467H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D467H is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include only premPS, whereas the remaining evaluated algorithms uniformly predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta yield uncertain results and are treated as unavailable. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also pathogenic; Foldetta remains uncertain. Overall, the variant is most likely pathogenic based on the consensus of the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-13.348Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.851Likely Pathogenic0.10740.55641.05Ambiguous0.10.59Ambiguous0.82Ambiguous0.32Likely Benign-6.71Deleterious1.000Probably Damaging0.998Probably Damaging-1.31Pathogenic0.02Affected1-10.322.05
c.1399G>T
D467Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D467Y is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Foldetta, premPS, and SIFT, whereas pathogenic calls are made by SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy methods give a clearer picture: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. No evidence from Rosetta is available due to its uncertain status. Overall, the majority of high‑confidence predictions lean toward pathogenicity, and this does not contradict any ClinVar annotation because none exists. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-14.373Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.846Likely Pathogenic0.05170.55210.36Likely Benign0.1-0.60Ambiguous-0.12Likely Benign0.07Likely Benign-8.70Deleterious1.000Probably Damaging0.999Probably Damaging-1.28Pathogenic0.07Tolerated-4-32.248.09
c.1400A>C
D467A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D467A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS and SIFT, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools with uncertain or inconclusive results—FoldX, Rosetta, and Foldetta—do not provide decisive evidence. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-12.499Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.790Likely Pathogenic0.31340.51170.83Ambiguous0.10.79Ambiguous0.81Ambiguous0.23Likely Benign-7.71Deleterious1.000Probably Damaging0.998Probably Damaging-1.19Pathogenic0.07Tolerated0-25.3-44.01
c.1400A>G
D467G
2D
AISynGAP1 missense variant D467G is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: the single benign prediction comes from premPS, while all other evaluated algorithms—including SGM‑Consensus, REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—label the change as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. No prediction is inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-12.973Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.910Likely Pathogenic0.34550.49081.87Ambiguous0.82.55Destabilizing2.21Destabilizing0.23Likely Benign-6.81Deleterious0.999Probably Damaging0.999Probably Damaging-1.32Pathogenic0.03Affected1-13.1-58.04
c.1400A>T
D467V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D467V missense variant is not reported in ClinVar or gnomAD. Prediction tools cluster into two groups: benign predictions come from Rosetta and premPS, while the majority—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—label the change as pathogenic. Two tools, FoldX and Foldetta, give uncertain results. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus indicates likely pathogenic, and Foldetta remains uncertain. Overall, the consensus of high‑confidence predictors points to a pathogenic effect, and this conclusion is consistent with the absence of any ClinVar annotation or gnomAD observation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-15.041Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.893Likely Pathogenic0.06440.52741.24Ambiguous0.10.08Likely Benign0.66Ambiguous0.02Likely Benign-8.70Deleterious0.997Probably Damaging0.997Probably Damaging-1.28Pathogenic0.02Affected-2-37.7-15.96
c.1401C>A
D467E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D467E is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (gnomAD ID: 6‑33438433‑C‑A). Prediction tools that agree on a benign effect include only FoldX. Tools that agree on a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (Likely Pathogenic). Uncertain or inconclusive predictions come from Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of reliable predictors indicate a pathogenic effect, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.0006-33438433-C-A21.24e-6-9.774Likely Pathogenic0.903Likely PathogenicAmbiguous0.576Likely Pathogenic0.10610.45640.36Likely Benign0.10.87Ambiguous0.62Ambiguous0.60Ambiguous-3.63Deleterious0.887Possibly Damaging0.938Probably Damaging-1.08Pathogenic0.04Affected3.3731230.014.03
c.1401C>G
D467E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D467E missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include FoldX. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive predictions come from Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.329932Uncertain0.9400.2460.000-9.774Likely Pathogenic0.903Likely PathogenicAmbiguous0.576Likely Pathogenic0.10610.45640.36Likely Benign0.10.87Ambiguous0.62Ambiguous0.60Ambiguous-3.63Deleterious0.887Possibly Damaging0.938Probably Damaging-1.08Pathogenic0.04Affected3.3731230.014.03
c.1429A>C
M477L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that uniformly indicate a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome; premPS is uncertain and therefore not counted as evidence. High‑accuracy assessments are consistent: AlphaMissense‑Optimized reports Benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Overall, the preponderance of evidence supports a benign classification for M477L, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.000-4.772Likely Benign0.139Likely BenignLikely Benign0.236Likely Benign0.15860.42200.10Likely Benign0.00.19Likely Benign0.15Likely Benign0.58Ambiguous-1.25Neutral0.000Benign0.001Benign-1.18Pathogenic0.17Tolerated421.9-18.03
c.1429A>G
M477V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477V is listed in ClinVar with no submitted interpretation and is present in the gnomAD database (variant ID 6‑33438461‑A‑G). Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen2_HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. Only two tools predict a pathogenic outcome: polyPhen2_HumDiv and FATHMM. Predictions from FoldX and Foldetta are uncertain. High‑accuracy methods reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, while Foldetta remains inconclusive. Taken together, the majority of evidence supports a benign classification for M477V, and this assessment does not contradict the ClinVar status, which currently has no pathogenic claim.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.0006-33438461-A-G16.20e-7-3.995Likely Benign0.127Likely BenignLikely Benign0.209Likely Benign0.30930.34451.64Ambiguous0.30.42Likely Benign1.03Ambiguous0.24Likely Benign-1.04Neutral0.716Possibly Damaging0.204Benign-1.19Pathogenic0.22Tolerated3.3734122.3-32.0610.1016/j.ajhg.2020.11.011
c.1429A>T
M477L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The high‑accuracy methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta)—all uniformly indicate a benign effect. No prediction or folding‑stability result is missing or inconclusive. Based on the consensus of the available evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.268042Structured0.408680Uncertain0.7610.2500.000-4.772Likely Benign0.139Likely BenignLikely Benign0.236Likely Benign0.15860.42200.10Likely Benign0.00.19Likely Benign0.15Likely Benign0.58Ambiguous-1.25Neutral0.000Benign0.001Benign-1.18Pathogenic0.17Tolerated421.9-18.03
c.1430T>A
M477K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477K is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS and FATHMM. Predictions that are uncertain or inconclusive are FoldX, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is unavailable due to mixed or uncertain inputs. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict the current ClinVar status, which contains no report of pathogenicity.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-7.519In-Between0.553AmbiguousLikely Benign0.371Likely Benign0.18170.08470.54Ambiguous0.10.37Likely Benign0.46Likely Benign1.12Destabilizing-1.32Neutral0.254Benign0.122Benign-1.15Pathogenic0.14Tolerated0-1-5.8-3.02
c.1430T>C
M477T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477T has no ClinVar entry and is present in gnomAD (ID 6‑33438462‑T‑C). Prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. The remaining tools (FoldX, Foldetta, premPS, AlphaMissense‑Default) return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign (2 benign vs. 1 pathogenic votes); Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.0006-33438462-T-C21.24e-6-2.509Likely Benign0.373AmbiguousLikely Benign0.273Likely Benign0.21770.19501.62Ambiguous0.20.16Likely Benign0.89Ambiguous0.51Ambiguous-1.33Neutral0.765Possibly Damaging0.363Benign-1.10Pathogenic0.40Tolerated3.3734-1-1-2.6-30.09
c.1430T>G
M477R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, and FATHMM. Tools with uncertain or inconclusive results are Rosetta, Foldetta, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain and is not taken as evidence. Overall, the majority of reliable predictors indicate a benign impact. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-6.786Likely Benign0.552AmbiguousLikely Benign0.442Likely Benign0.19010.08280.48Likely Benign0.20.77Ambiguous0.63Ambiguous1.24Destabilizing-1.12Neutral0.720Possibly Damaging0.242Benign-1.22Pathogenic0.11Tolerated0-1-6.424.99
c.1431G>A
M477I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, indicating no contradiction with existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-2.662Likely Benign0.467AmbiguousLikely Benign0.291Likely Benign0.13680.31760.72Ambiguous0.10.36Likely Benign0.54Ambiguous0.45Likely Benign-1.57Neutral0.000Benign0.001Benign-1.21Pathogenic0.09Tolerated212.6-18.03
c.1431G>C
M477I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts pathogenic, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-2.662Likely Benign0.467AmbiguousLikely Benign0.290Likely Benign0.13680.31760.72Ambiguous0.10.36Likely Benign0.54Ambiguous0.45Likely Benign-1.57Neutral0.000Benign0.001Benign-1.21Pathogenic0.09Tolerated212.6-18.03
c.1431G>T
M477I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M477I is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts pathogenic, while FoldX, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.268042Structured0.408680Uncertain0.7610.2500.000-2.662Likely Benign0.467AmbiguousLikely Benign0.291Likely Benign0.13680.31760.72Ambiguous0.10.36Likely Benign0.54Ambiguous0.45Likely Benign-1.57Neutral0.000Benign0.001Benign-1.21Pathogenic0.09Tolerated212.6-18.03
c.157G>A
G53R
2D
AIThe SynGAP1 missense variant G53R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic + 2 benign), and Foldetta (combining FoldX‑MD and Rosetta outputs) is unavailable. Overall, the majority of available predictions (5 pathogenic vs. 3 benign) lean toward a pathogenic impact. Because there is no ClinVar entry to contradict this assessment, the variant is most likely pathogenic based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.268042Structured0.460894Uncertain0.3860.6660.000-8.400Likely Pathogenic0.901Likely PathogenicAmbiguous0.181Likely Benign0.09530.4347-1.20Neutral0.994Probably Damaging0.990Probably Damaging4.13Benign0.00Affected-3-2-4.199.14
c.157G>C
G53R
2D
AIThe SynGAP1 missense variant G53R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic + 2 benign), and Foldetta (combining FoldX‑MD and Rosetta outputs) is unavailable. Overall, the majority of tools (5 pathogenic vs. 3 benign) predict a pathogenic impact. Thus, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because the variant has not been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.268042Structured0.460894Uncertain0.3860.6660.000-8.400Likely Pathogenic0.901Likely PathogenicAmbiguous0.181Likely Benign0.09530.4347-1.20Neutral0.994Probably Damaging0.990Probably Damaging4.13Benign0.00Affected-3-2-4.199.14
c.157G>T
G53W
2D
AIThe SynGAP1 missense variant G53W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign). Foldetta results are unavailable. Overall, the majority of available predictions (six pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.268042Structured0.460894Uncertain0.3860.6660.000-11.012Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.243Likely Benign0.06780.5071-1.69Neutral0.998Probably Damaging0.993Probably Damaging4.08Benign0.00Affected-7-2-0.5129.16
c.158G>A
G53E
2D
AIThe SynGAP1 missense variant G53E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are not available. Overall, the majority of evidence points toward a benign impact, and this conclusion does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign based on current predictive data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.268042Structured0.460894Uncertain0.3860.6660.000-2.061Likely Benign0.853Likely PathogenicAmbiguous0.198Likely Benign0.14130.4378-0.25Neutral0.994Probably Damaging0.986Probably Damaging4.29Benign0.00Affected0-2-3.172.06
c.158G>C
G53A
2D
AIThe SynGAP1 missense variant G53A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus (majority vote) also as Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.268042Structured0.460894Uncertain0.3860.6660.000-6.329Likely Benign0.616Likely PathogenicLikely Benign0.114Likely Benign0.40930.5550-1.00Neutral0.953Possibly Damaging0.952Probably Damaging4.16Benign0.00Affected102.214.03
c.158G>T
G53V
2D
AIThe SynGAP1 missense variant G53V is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign). Foldetta results are unavailable. Overall, the majority of predictions (six pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.268042Structured0.460894Uncertain0.3860.6660.000-8.308Likely Pathogenic0.959Likely PathogenicLikely Pathogenic0.238Likely Benign0.11930.4833-1.71Neutral0.994Probably Damaging0.990Probably Damaging4.11Benign0.00Affected-1-34.642.08
c.1864A>C
T622P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T622P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as pathogenic. No tool predicts a benign outcome; the only inconclusive result is premPS, which is listed as uncertain. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) also indicates pathogenic. Consequently, the variant is most likely pathogenic, and this conclusion is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.071403Uncertain0.9570.1980.000-16.410Likely Pathogenic0.964Likely PathogenicLikely Pathogenic0.924Likely Pathogenic0.17000.38762.81Destabilizing0.48.90Destabilizing5.86Destabilizing0.78Ambiguous-5.57Deleterious1.000Probably Damaging1.000Probably Damaging-1.57Pathogenic0.01Affected0-1-0.9-3.99
c.1864A>G
T622A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T622A is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FoldX, which scores the variant as benign. In contrast, the majority of tools predict a pathogenic impact: REVEL, SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools with uncertain or inconclusive results—AlphaMissense‑Optimized, Rosetta, Foldetta, and premPS—are treated as unavailable for pathogenicity assessment. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for T622A, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.071403Uncertain0.9570.1980.000-10.953Likely Pathogenic0.827Likely PathogenicAmbiguous0.893Likely Pathogenic0.31910.30910.03Likely Benign0.01.04Ambiguous0.54Ambiguous0.75Ambiguous-4.58Deleterious0.998Probably Damaging0.989Probably Damaging-1.52Pathogenic0.01Affected102.5-30.03
c.1864A>T
T622S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T622S is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from SIFT and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized labeling the variant as benign, whereas the SGM‑Consensus predicts it to be likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. No other folding‑stability tools provide conclusive evidence. Overall, the preponderance of predictions, including the SGM‑Consensus, indicates that T622S is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.071403Uncertain0.9570.1980.000-9.840Likely Pathogenic0.669Likely PathogenicLikely Benign0.705Likely Pathogenic0.25230.31830.78Ambiguous0.11.36Ambiguous1.07Ambiguous0.80Ambiguous-3.52Deleterious0.999Probably Damaging0.998Probably Damaging-1.50Pathogenic0.09Tolerated11-0.1-14.03
c.1865C>A
T622N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T622N has no ClinVar entry and is not reported in gnomAD. Functional prediction tools that agree on a benign effect are SIFT and AlphaMissense‑Optimized, whereas a majority of tools predict a pathogenic impact: REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, and the SGM‑Consensus. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No prediction or stability result is missing; all available data are considered. Overall, the preponderance of evidence points to a pathogenic effect for T622N, and this conclusion is not contradicted by ClinVar status, which currently lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.071403Uncertain0.9570.1980.000-7.962In-Between0.693Likely PathogenicLikely Benign0.564Likely Pathogenic0.09430.28481.00Ambiguous0.12.37Destabilizing1.69Ambiguous0.94Ambiguous-4.14Deleterious1.000Probably Damaging1.000Probably Damaging-1.24Pathogenic0.13Tolerated00-2.813.00
c.1865C>G
T622S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T622S is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from SIFT and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized labeling the variant as benign, whereas the SGM‑Consensus predicts it to be likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. No other folding‑stability tools provide conclusive evidence. Overall, the preponderance of predictions, including the SGM‑Consensus, indicates that T622S is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.071403Uncertain0.9570.1980.000-9.840Likely Pathogenic0.669Likely PathogenicLikely Benign0.595Likely Pathogenic0.25230.31830.78Ambiguous0.11.36Ambiguous1.07Ambiguous0.80Ambiguous-3.52Deleterious0.999Probably Damaging0.998Probably Damaging-1.50Pathogenic0.09Tolerated11-0.1-14.03
c.1865C>T
T622I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T622I is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign are Foldetta and premPS, whereas the remaining tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict it to be pathogenic; FoldX and Rosetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.268042Structured0.071403Uncertain0.9570.1980.000-13.276Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.905Likely Pathogenic0.08550.4926-1.47Ambiguous0.10.67Ambiguous-0.40Likely Benign0.45Likely Benign-5.57Deleterious1.000Probably Damaging0.997Probably Damaging-1.57Pathogenic0.00Affected0-15.212.05
c.610T>A
S204T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S204T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate benign or likely benign. Only polyPhen‑2 HumDiv predicts a pathogenic effect. Stability‑based methods (FoldX, Rosetta, Foldetta, premPS) are inconclusive, providing no definitive evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of reliable predictors classify S204T as benign, and this conclusion does not contradict the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.268042Structured0.420667Uncertain0.8160.4050.125-4.164Likely Benign0.167Likely BenignLikely Benign0.104Likely Benign0.08570.50630.75Ambiguous0.11.19Ambiguous0.97Ambiguous-0.52Ambiguous0.55Neutral0.462Possibly Damaging0.173Benign4.19Benign1.00Tolerated110.114.03
c.610T>C
S204P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 S204P variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and polyPhen‑2 HumVar, whereas a separate group predicts a pathogenic effect: FoldX, Rosetta, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. The remaining tools (premPS) are inconclusive and are not counted in either group. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain (treated as unavailable), the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie and therefore unavailable, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Overall, the majority of consensus predictions lean toward pathogenicity, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.268042Structured0.420667Uncertain0.8160.4050.125-8.855Likely Pathogenic0.820Likely PathogenicAmbiguous0.137Likely Benign0.14300.48153.71Destabilizing0.44.61Destabilizing4.16Destabilizing0.61Ambiguous-1.28Neutral0.808Possibly Damaging0.382Benign4.13Benign0.12Tolerated1-1-0.810.04
c.610T>G
S204A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S204A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from Rosetta, Foldetta, and premPS, which are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.268042Structured0.420667Uncertain0.8160.4050.125-3.330Likely Benign0.084Likely BenignLikely Benign0.091Likely Benign0.37060.3495-0.09Likely Benign0.0-1.17Ambiguous-0.63Ambiguous-0.83Ambiguous0.65Neutral0.004Benign0.004Benign4.28Benign0.27Tolerated112.6-16.00
c.611C>A
S204Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S204Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy consensus (SGM Consensus) is inconclusive because it receives an equal split between pathogenic and benign calls. AlphaMissense‑Optimized, a high‑accuracy model, predicts benign, whereas Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts pathogenic. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.268042Structured0.420667Uncertain0.8160.4050.125-10.518Likely Pathogenic0.782Likely PathogenicLikely Benign0.170Likely Benign0.04520.56258.99Destabilizing3.85.20Destabilizing7.10Destabilizing-0.03Likely Benign-0.96Neutral0.978Probably Damaging0.694Possibly Damaging4.14Benign0.03Affected-3-2-0.576.10
c.611C>G
S204C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 S204C is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include REVEL, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict pathogenicity are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. FoldX and Rosetta individually report uncertain stability changes. Overall, the majority of computational evidence supports a benign effect, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.268042Structured0.420667Uncertain0.8160.4050.125Uncertain 1-6.613Likely Benign0.127Likely BenignLikely Benign0.148Likely Benign0.06650.52370.65Ambiguous0.4-1.13Ambiguous-0.24Likely Benign0.10Likely Benign-0.64Neutral0.978Probably Damaging0.753Possibly Damaging4.13Benign0.05Affected3.44100-13.316.06223.6-13.80.60.30.00.2XUncertainThe hydroxyl-containing Ser204, located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by the thiol-containing cysteine. In the WT simulations, Ser204 simultaneously forms hydrogen bonds with the backbone carbonyl of Asp201 and the hydroxyl group of Thr224, helping to stabilize the two anti-parallel β strands (res. Ile205-Lys207 and Cys219-Thr223) at the end of the β sheet. Since the thiol group of cysteine forms weaker hydrogen bonds than the hydroxyl group of serine, Cys204 does not maintain the hydrogen bond network as stably as Ser204 in the variant simulations. However, because the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.611C>T
S204F
2D
AIThe SynGAP1 missense variant S204F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, and FATHMM, whereas a majority of tools (FoldX, Rosetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact. AlphaMissense‑Optimized is uncertain, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. Foldetta, a protein‑folding‑stability method combining FoldX‑MD and Rosetta outputs, predicts a pathogenic effect. Overall, the balance of evidence—seven pathogenic versus four benign predictions, with high‑accuracy tools supporting pathogenicity—suggests that the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.268042Structured0.420667Uncertain0.8160.4050.125-8.693Likely Pathogenic0.842Likely PathogenicAmbiguous0.161Likely Benign0.04680.57647.35Destabilizing6.14.21Destabilizing5.78Destabilizing-0.09Likely Benign-0.88Neutral0.978Probably Damaging0.694Possibly Damaging4.16Benign0.03Affected-3-23.660.10
c.688T>A
C230S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect are REVEL, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. With an equal split of 7 benign versus 7 pathogenic predictions overall, the higher‑confidence tools lean toward pathogenicity. Therefore, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-9.994Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.859Likely Pathogenic0.49260.18220.42Likely Benign0.10.05Likely Benign0.24Likely Benign1.08Destabilizing-8.24Deleterious0.421Benign0.115Benign5.91Benign0.07Tolerated0-1-3.3-16.06
c.688T>C
C230R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from FoldX and FATHMM, while pathogenic predictions are made by REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts a pathogenic effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates likely pathogenic; Foldetta remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for C230R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-12.478Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.905Likely Pathogenic0.17440.1637-0.48Likely Benign0.0-1.61Ambiguous-1.05Ambiguous1.12Destabilizing-9.88Deleterious0.838Possibly Damaging0.548Possibly Damaging5.91Benign0.01Affected-4-3-7.053.05
c.688T>G
C230G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that reached a consensus fall into two groups: benign predictions come from polyPhen‑2 (HumDiv and HumVar) and FATHMM, while pathogenic predictions are made by REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain or inconclusive results from FoldX, Rosetta, Foldetta, and premPS are treated as unavailable and do not influence the overall assessment. High‑accuracy methods specifically indicate pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also Likely Pathogenic; Foldetta remains uncertain. Based on the aggregate predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-10.888Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.775Likely Pathogenic0.33130.25740.72Ambiguous0.10.86Ambiguous0.79Ambiguous0.81Ambiguous-9.95Deleterious0.001Benign0.004Benign5.85Benign0.03Affected-3-3-2.9-46.09
c.689G>A
C230Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230Y is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that indicate a benign effect include FoldX, Rosetta, premPS, SIFT, and FATHMM, whereas those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score is “Likely Pathogenic,” and the Foldetta stability assessment is “Uncertain.” High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-8.978Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.816Likely Pathogenic0.11590.3655-0.03Likely Benign0.1-2.24Stabilizing-1.14Ambiguous0.00Likely Benign-8.46Deleterious0.940Possibly Damaging0.641Possibly Damaging6.17Benign0.14Tolerated0-2-3.860.04
c.689G>C
C230S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant C230S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools cluster into two groups: benign calls come from FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM; pathogenic calls come from REVEL, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. No prediction or stability result is missing. Overall, the predictions are evenly split between benign and pathogenic, leaving the variant’s functional impact uncertain. This uncertainty does not contradict ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-9.994Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.844Likely Pathogenic0.49260.18220.42Likely Benign0.10.05Likely Benign0.24Likely Benign1.08Destabilizing-8.24Deleterious0.421Benign0.115Benign5.91Benign0.07Tolerated0-1-3.3-16.06
c.689G>T
C230F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, and FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Foldetta and premPS give uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; Foldetta remains uncertain. Overall, the preponderance of evidence indicates that C230F is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-11.134Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.840Likely Pathogenic0.13290.4173-0.09Likely Benign0.1-2.03Stabilizing-1.06Ambiguous0.51Ambiguous-8.73Deleterious0.940Possibly Damaging0.641Possibly Damaging5.96Benign0.03Affected-4-20.344.04
c.690C>G
C230W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C230W is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by FATHMM and FoldX, whereas the majority of other in silico predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic effect. High‑accuracy assessments further support this view: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus confirms a likely pathogenic outcome, and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the preponderance of evidence points to a pathogenic impact for C230W, and this conclusion is not contradicted by any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.268042Structured0.308076Uncertain0.8700.3080.000-11.022Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.739Likely Pathogenic0.15890.3663-0.21Likely Benign0.0-1.87Ambiguous-1.04Ambiguous0.74Ambiguous-8.79Deleterious0.983Probably Damaging0.841Possibly Damaging5.84Benign0.01Affected-8-2-3.483.07
c.787G>A
V263M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263M is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT predict a pathogenic impact. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts Benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Benign. No conflicting evidence is present. **Based on the aggregate predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none reported).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-5.956Likely Benign0.218Likely BenignLikely Benign0.444Likely Benign0.06650.35450.20Likely Benign0.1-0.24Likely Benign-0.02Likely Benign0.43Likely Benign-0.95Neutral0.999Probably Damaging0.994Probably Damaging5.84Benign0.03Affected21-2.332.06
c.787G>C
V263L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are Rosetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.599Likely Benign0.275Likely BenignLikely Benign0.453Likely Benign0.07590.3950-0.16Likely Benign0.1-0.63Ambiguous-0.40Likely Benign0.66Ambiguous-1.26Neutral0.994Probably Damaging0.970Probably Damaging5.85Benign0.18Tolerated21-0.414.03
c.787G>T
V263L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive are Rosetta (Uncertain) and premPS (Uncertain). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.599Likely Benign0.275Likely BenignLikely Benign0.453Likely Benign0.07590.3950-0.16Likely Benign0.1-0.63Ambiguous-0.40Likely Benign0.66Ambiguous-1.26Neutral0.994Probably Damaging0.970Probably Damaging5.85Benign0.18Tolerated21-0.414.03
c.788T>A
V263E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V263E missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools largely agree on a deleterious effect: FATHMM predicts the variant as benign, while the remaining twelve tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify it as pathogenic. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized remains uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic impact for V263E, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.356141Uncertain0.9180.2570.000-13.498Likely Pathogenic0.809Likely PathogenicAmbiguous0.862Likely Pathogenic0.08860.14362.04Destabilizing0.32.18Destabilizing2.11Destabilizing1.99Destabilizing-3.84Deleterious0.999Probably Damaging0.991Probably Damaging5.96Benign0.01Affected-2-2-7.729.98
c.788T>C
V263A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V263A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from Rosetta, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, premPS, polyPhen‑2 (HumDiv and HumVar), and SIFT. Predictions marked “Uncertain” include FoldX, Foldetta, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of evidence points to a benign effect. Thus, the variant is most likely benign based on current predictions, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.356141Uncertain0.9180.2570.000-6.877Likely Benign0.530AmbiguousLikely Benign0.622Likely Pathogenic0.25650.18221.40Ambiguous0.10.00Likely Benign0.70Ambiguous1.26Destabilizing-2.17Neutral0.994Probably Damaging0.970Probably Damaging5.97Benign0.04Affected00-2.4-28.05
c.788T>G
V263G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V263G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are FATHMM and AlphaMissense‑Optimized; those that agree on a pathogenic effect are REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Rosetta and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic. Foldetta’s stability prediction is uncertain. Overall, the preponderance of evidence points to a pathogenic impact for V263G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.268042Structured0.356141Uncertain0.9180.2570.000-10.388Likely Pathogenic0.669Likely PathogenicLikely Benign0.820Likely Pathogenic0.17900.18682.27Destabilizing0.21.63Ambiguous1.95Ambiguous1.88Destabilizing-4.59Deleterious0.991Probably Damaging0.999Probably Damaging6.07Benign0.01Affected-1-3-4.6-42.08
c.967C>A
L323M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L323M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—Foldetta, premPS, AlphaMissense‑Default, ESM1b, and Rosetta—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta is also inconclusive. Taken together, the evidence leans toward a benign impact for the variant, and this assessment does not contradict any ClinVar annotation, as none exists for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.268042Structured0.428564Uncertain0.9560.3690.000-7.065In-Between0.427AmbiguousLikely Benign0.270Likely Benign0.06370.30100.11Likely Benign0.11.82Ambiguous0.97Ambiguous0.93Ambiguous-1.02Neutral0.997Probably Damaging0.939Probably Damaging0.64Pathogenic0.03Affected42-1.918.03
c.967C>G
L323V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L323V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, premPS, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and pathogenic predictions (FoldX, Rosetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM). The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled Likely Benign. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority of the four high‑accuracy tools) also indicates Likely Benign; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Overall, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.268042Structured0.428564Uncertain0.9560.3690.000-3.483Likely Benign0.107Likely BenignLikely Benign0.227Likely Benign0.12770.26562.18Destabilizing0.32.22Destabilizing2.20Destabilizing0.17Likely Benign0.19Neutral0.898Possibly Damaging0.472Possibly Damaging0.80Pathogenic0.80Tolerated210.4-14.03
c.968T>A
L323Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000-14.487Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.728Likely Pathogenic0.09150.07583.19Destabilizing0.23.28Destabilizing3.24Destabilizing1.85Destabilizing-4.54Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.00Affected-2-2-7.314.97
c.968T>C
L323P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323P is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that assess pathogenicity uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000Uncertain 1-12.507Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.762Likely Pathogenic0.36780.12213.39Destabilizing0.68.46Destabilizing5.93Destabilizing2.20Destabilizing-4.80Deleterious0.999Probably Damaging0.977Probably Damaging0.59Pathogenic0.01Affected4.29398-3-3-5.4-16.04201.968.20.00.10.60.3XPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the less bulky cyclic five-membered pyrrolidine ring of Pro323 cannot fill the hydrophobic space as effectively as the branched hydrocarbon side chain of leucine. Notably, the backbone amide group of Leu323 forms a hydrogen bond with the backbone carbonyl group of Cys285. Pro323 cannot form this bond due to the absence of the backbone amide group, resulting in partial unfolding of the anti-parallel β sheet end in the variant simulations.
c.968T>G
L323R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L323R is listed in ClinVar (ID 978601.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool reports a benign effect. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Consequently, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.268042Structured0.428564Uncertain0.9560.3690.000Likely Pathogenic 1-14.568Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.692Likely Pathogenic0.10660.06003.75Destabilizing0.44.47Destabilizing4.11Destabilizing2.15Destabilizing-4.70Deleterious0.999Probably Damaging0.969Probably Damaging0.59Pathogenic0.01Affected3.3922-3-2-8.343.03261.8-61.6-0.40.20.80.2XXXPotentially PathogenicThe iso-butyl side chain of Leu323, located at the beginning of an anti-parallel β sheet strand (res. Ala322-Asp330), packs against multiple hydrophobic leucine residues (e.g., Leu264, Leu266, Leu284, Leu286). In contrast, in the variant simulations, the positively charged guanidinium group of the Arg323 side chain is unsuitable for the hydrophobic niche. Consequently, the side chain either rotates away from the center of the C2 domain or, if it remains within the C2 domain core, it reorients nearby residues to form hydrogen bonds. Regardless, the residue swap extensively disrupts the C2 domain structure.
c.1336G>A
E446K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446K is not reported in ClinVar (ClinVar status: not present) and is found in gnomAD (ID 6‑33438241‑G‑A). Prediction tools that agree on a benign effect include only FATHMM. Tools that agree on a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote). Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy methods give the following: AlphaMissense‑Optimized is uncertain; SGM‑Consensus indicates likely pathogenic; Foldetta is uncertain. Overall, the majority of evidence points to a pathogenic impact. Thus, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.0006-33438241-G-A16.19e-7-14.140Likely Pathogenic0.953Likely PathogenicAmbiguous0.518Likely Pathogenic0.21410.65110.80Ambiguous0.41.57Ambiguous1.19Ambiguous0.81Ambiguous-3.75Deleterious0.994Probably Damaging0.975Probably Damaging3.36Benign0.01Affected3.383110-0.4-0.94
c.1336G>C
E446Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E446Q missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized, whereas the majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No other folding‑stability predictions are available. Overall, the balance of evidence from the consensus of multiple in silico predictors points to a pathogenic classification for E446Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.000-11.107Likely Pathogenic0.752Likely PathogenicLikely Benign0.337Likely Benign0.10490.62180.92Ambiguous0.50.54Ambiguous0.73Ambiguous0.84Ambiguous-2.80Deleterious0.992Probably Damaging0.973Probably Damaging3.24Benign0.04Affected220.0-0.98
c.1337A>C
E446A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446A is not reported in ClinVar and is absent from gnomAD. In silico predictors that classify the variant as benign include REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized. Predictors that classify it as pathogenic comprise SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yielded an inconclusive result and is treated as unavailable. Overall, the majority of predictions lean toward pathogenicity, and this conclusion is not contradicted by the absence of a ClinVar entry. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.000-9.868Likely Pathogenic0.677Likely PathogenicLikely Benign0.443Likely Benign0.31950.58771.66Ambiguous0.70.39Likely Benign1.03Ambiguous0.67Ambiguous-5.60Deleterious0.998Probably Damaging0.996Probably Damaging3.28Benign0.01Affected0-15.3-58.04
c.1337A>G
E446G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E446G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM. The majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta. Predictions that are uncertain or inconclusive are AlphaMissense‑Optimized, Rosetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.000-11.457Likely Pathogenic0.866Likely PathogenicAmbiguous0.510Likely Pathogenic0.26650.52022.62Destabilizing0.71.63Ambiguous2.13Destabilizing0.83Ambiguous-6.42Deleterious1.000Probably Damaging0.997Probably Damaging3.24Benign0.00Affected0-23.1-72.06
c.1337A>T
E446V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E446V missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Rosetta, premPS, and FATHMM, while those that agree on a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evaluated tools (8 pathogenic vs. 3 benign) indicate a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.276479Uncertain0.9400.2160.000-12.231Likely Pathogenic0.884Likely PathogenicAmbiguous0.513Likely Pathogenic0.06180.64331.72Ambiguous0.70.34Likely Benign1.03Ambiguous0.37Likely Benign-6.55Deleterious0.995Probably Damaging0.983Probably Damaging3.19Benign0.00Affected-2-27.7-29.98
c.1338G>C
E446D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E446D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a damaging effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. Predictions that are inconclusive or unavailable are FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Default. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Taken together, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.271506Structured0.276479Uncertain0.9400.2160.000-5.668Likely Benign0.562AmbiguousLikely Benign0.171Likely Benign0.16570.42751.65Ambiguous0.70.80Ambiguous1.23Ambiguous0.68Ambiguous-2.40Neutral0.986Probably Damaging0.960Probably Damaging3.30Benign0.18Tolerated320.0-14.03
c.1338G>T
E446D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change E446D lies in the GAP domain. ClinVar has no entry for this variant and it is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Two tools report a pathogenic signal: polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The remaining predictors (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also benign, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Taken together, the majority of evidence points to a benign effect. Thus, the variant is most likely benign, and this is consistent with the lack of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.271506Structured0.276479Uncertain0.9400.2160.000-5.668Likely Benign0.562AmbiguousLikely Benign0.171Likely Benign0.16570.42751.65Ambiguous0.70.80Ambiguous1.23Ambiguous0.68Ambiguous-2.40Neutral0.986Probably Damaging0.960Probably Damaging3.30Benign0.18Tolerated320.0-14.03
c.1828C>A
L610I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610I is listed in gnomAD (ID 6‑33440880‑C‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions arise from REVEL, polyPhen‑2 (HumDiv and HumVar) and FATHMM. Four tools are uncertain (FoldX, Foldetta, premPS, AlphaMissense‑Default). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores benign, the SGM consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also favors benign, whereas Foldetta’s stability estimate is unavailable. Overall, the balance of evidence points to a benign effect for L610I, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.271506Structured0.209504Uncertain0.8880.2530.0006-33440880-C-A16.19e-7-6.362Likely Benign0.389AmbiguousLikely Benign0.544Likely Pathogenic0.09990.32191.50Ambiguous0.20.18Likely Benign0.84Ambiguous0.76Ambiguous-1.86Neutral0.992Probably Damaging0.997Probably Damaging-1.34Pathogenic0.15Tolerated3.3735220.70.00
c.1828C>G
L610V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L610V is reported in gnomAD (ID 6‑33440880‑C‑G) but has no ClinVar entry. Functional prediction tools largely agree on a deleterious effect: pathogenic calls are made by REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM, while only AlphaMissense‑Optimized predicts a benign outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further support this view: AlphaMissense‑Optimized indicates benign, whereas the SGM Consensus remains pathogenic and Foldetta (combining FoldX‑MD and Rosetta) is inconclusive. With the overwhelming majority of tools predicting pathogenicity and no ClinVar evidence to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.0006-33440880-C-G31.86e-6-11.304Likely Pathogenic0.474AmbiguousLikely Benign0.740Likely Pathogenic0.15150.30392.24Destabilizing0.30.76Ambiguous1.50Ambiguous1.21Destabilizing-2.86Deleterious0.985Probably Damaging0.992Probably Damaging-1.46Pathogenic0.01Affected3.3735120.4-14.03
c.1828C>T
L610F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610F is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—all of which classify the variant as pathogenic. No tools predict a benign outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Based on the consensus of these predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-13.244Likely Pathogenic0.808Likely PathogenicAmbiguous0.782Likely Pathogenic0.08340.28166.24Destabilizing1.13.40Destabilizing4.82Destabilizing0.68Ambiguous-3.92Deleterious0.998Probably Damaging0.997Probably Damaging-1.52Pathogenic0.01Affected20-1.034.02
c.1829T>A
L610H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, indicates a destabilizing, pathogenic effect. All available predictions are concordant and supportive. Based on these computational assessments, the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-14.573Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.927Likely Pathogenic0.10670.07414.83Destabilizing0.54.98Destabilizing4.91Destabilizing2.03Destabilizing-6.91Deleterious1.000Probably Damaging1.000Probably Damaging-1.59Pathogenic0.00Affected-2-3-7.023.98
c.1829T>C
L610P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610P is not reported in ClinVar and is absent from gnomAD. Across the available in‑silico predictors, every tool examined (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classifies the substitution as pathogenic; no tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a pathogenic effect. Because all evidence points to a deleterious impact and there is no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-14.863Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.934Likely Pathogenic0.35990.11136.02Destabilizing0.28.15Destabilizing7.09Destabilizing1.99Destabilizing-6.91Deleterious1.000Probably Damaging1.000Probably Damaging-1.59Pathogenic0.00Affected-3-3-5.4-16.04
c.1829T>G
L610R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L610R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized reports a pathogenic outcome; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic impact. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.209504Uncertain0.8880.2530.000-13.855Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.949Likely Pathogenic0.13340.06155.14Destabilizing0.54.60Destabilizing4.87Destabilizing1.89Destabilizing-5.94Deleterious0.998Probably Damaging0.998Probably Damaging-1.58Pathogenic0.00Affected-3-2-8.343.03
c.2137C>A
P713T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments further clarify the picture: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic, whereas AlphaMissense‑Optimized and Foldetta provide inconclusive results and are treated as unavailable. Taken together, the preponderance of evidence points to a pathogenic effect for P713T, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-9.915Likely Pathogenic0.819Likely PathogenicAmbiguous0.225Likely Benign0.14170.38181.15Ambiguous0.00.46Likely Benign0.81Ambiguous0.65Ambiguous-6.72Deleterious1.000Probably Damaging0.993Probably Damaging3.34Benign0.00Affected0-10.93.99
c.2137C>G
P713A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 P713A is not reported in ClinVar and is absent from gnomAD. Benign predictions are provided by REVEL, Rosetta, FATHMM, and AlphaMissense‑Optimized, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default; the SGM‑Consensus score is labeled Likely Pathogenic. FoldX, Foldetta, and premPS give uncertain results. High‑accuracy tools: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not conflict with the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-8.535Likely Pathogenic0.689Likely PathogenicLikely Benign0.235Likely Benign0.31590.34751.04Ambiguous0.10.15Likely Benign0.60Ambiguous0.75Ambiguous-6.80Deleterious1.000Probably Damaging0.999Probably Damaging3.34Benign0.00Affected1-13.4-26.04
c.2137C>T
P713S
2D
AIThe SynGAP1 missense variant P713S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign predictions come from REVEL, Rosetta, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are provided by FoldX, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this ambiguity: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus indicates a likely pathogenic effect, and Foldetta likewise yields an uncertain stability change. Overall, the majority of tools lean toward a pathogenic interpretation, and this aligns with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-8.496Likely Pathogenic0.846Likely PathogenicAmbiguous0.261Likely Benign0.32340.36740.91Ambiguous0.70.19Likely Benign0.55Ambiguous0.62Ambiguous-6.60Deleterious1.000Probably Damaging0.998Probably Damaging3.29Benign0.00Affected1-10.8-10.04
c.2138C>A
P713Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant P713Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, FoldX, Foldetta, and FATHMM, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain calls are made by Rosetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further highlight this discordance: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the majority of evidence leans toward a benign interpretation, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-10.253Likely Pathogenic0.875Likely PathogenicAmbiguous0.364Likely Benign0.12250.33880.26Likely Benign0.0-0.77Ambiguous-0.26Likely Benign0.95Ambiguous-6.38Deleterious1.000Probably Damaging0.997Probably Damaging3.37Benign0.00Affected0-1-1.931.01
c.2138C>G
P713R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713R has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and FATHMM. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The remaining tools, premPS and AlphaMissense‑Optimized, are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of predictions lean toward pathogenicity, while the most accurate methods give conflicting results. Thus, the variant is most likely pathogenic based on the current evidence, and this assessment does not contradict ClinVar status, which has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-12.101Likely Pathogenic0.930Likely PathogenicAmbiguous0.331Likely Benign0.13660.23350.29Likely Benign0.00.21Likely Benign0.25Likely Benign0.86Ambiguous-7.42Deleterious1.000Probably Damaging0.998Probably Damaging3.29Benign0.00Affected0-2-2.959.07
c.2138C>T
P713L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P713L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized and premPS are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.271506Structured0.393235Uncertain0.9610.3710.000-11.323Likely Pathogenic0.850Likely PathogenicAmbiguous0.324Likely Benign0.19930.52610.18Likely Benign0.1-0.03Likely Benign0.08Likely Benign0.55Ambiguous-8.60Deleterious1.000Probably Damaging0.998Probably Damaging3.34Benign0.00Affected-3-35.416.04
c.622C>A
P208T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta; premPS and Rosetta are uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts benign, but the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta also predicts pathogenic. With the majority of tools, including the high‑accuracy ones, indicating pathogenicity, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as the variant is currently unreported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-9.016Likely Pathogenic0.727Likely PathogenicLikely Benign0.270Likely Benign0.18570.51973.20Destabilizing0.51.27Ambiguous2.24Destabilizing0.94Ambiguous-6.80Deleterious1.000Probably Damaging0.994Probably Damaging3.76Benign0.01Affected0-10.93.99
c.622C>G
P208A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P208A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Predictions that are inconclusive are Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta as uncertain. Overall, the majority of evidence points toward a benign effect, and this is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.271506Structured0.399506Uncertain0.8640.3450.125-5.623Likely Benign0.172Likely BenignLikely Benign0.245Likely Benign0.37270.43902.19Destabilizing0.31.31Ambiguous1.75Ambiguous1.03Destabilizing-6.80Deleterious0.999Probably Damaging0.991Probably Damaging3.80Benign0.04Affected1-13.4-26.04
c.622C>T
P208S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta. Rosetta’s output is uncertain and therefore not counted as evidence. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts benign, but the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to pathogenic, and Foldetta also predicts pathogenic. With no ClinVar annotation to contradict, the overall evidence strongly favors a pathogenic classification for P208S.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-8.363Likely Pathogenic0.587Likely PathogenicLikely Benign0.270Likely Benign0.38080.45372.68Destabilizing0.31.53Ambiguous2.11Destabilizing1.21Destabilizing-6.78Deleterious1.000Probably Damaging0.994Probably Damaging3.79Benign0.02Affected1-10.8-10.04
c.623C>A
P208Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM. The majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and Foldetta. Two tools give uncertain results (AlphaMissense‑Optimized and Rosetta) and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as Pathogenic, reinforcing a deleterious prediction. Overall, the evidence strongly favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-9.746Likely Pathogenic0.906Likely PathogenicAmbiguous0.411Likely Benign0.15700.46633.30Destabilizing0.70.75Ambiguous2.03Destabilizing1.23Destabilizing-6.78Deleterious1.000Probably Damaging0.996Probably Damaging3.78Benign0.00Affected0-1-1.931.01
c.623C>G
P208R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P208R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM. The majority of other in silico predictors (FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score (Likely Pathogenic) all indicate a pathogenic impact, while Rosetta remains uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the preponderance of pathogenic predictions and the absence of any benign consensus, the variant is most likely pathogenic, with no contradiction to ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.125-11.929Likely Pathogenic0.966Likely PathogenicLikely Pathogenic0.472Likely Benign0.16760.31185.25Destabilizing1.61.39Ambiguous3.32Destabilizing1.16Destabilizing-7.50Deleterious1.000Probably Damaging0.996Probably Damaging3.75Benign0.00Affected0-2-2.959.07
c.623C>T
P208L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P208L has no ClinVar entry and is present in gnomAD (ID 6‑33435265‑C‑T). Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, while those that agree on a pathogenic effect include FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions that are inconclusive are Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Based on the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.271506Structured0.399506Uncertain0.8640.3450.1256-33435265-C-T16.20e-7-10.013Likely Pathogenic0.889Likely PathogenicAmbiguous0.466Likely Benign0.22190.61912.35Destabilizing0.50.04Likely Benign1.20Ambiguous0.67Ambiguous-8.49Deleterious1.000Probably Damaging0.996Probably Damaging3.75Benign0.01Affected3.4412-3-35.416.04
c.1207A>C
K403Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K403Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and FATHMM. In contrast, a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. The premPS assessment is uncertain and does not influence the overall consensus. High‑accuracy analyses show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation because no ClinVar claim exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-12.479Likely Pathogenic0.971Likely PathogenicLikely Pathogenic0.376Likely Benign0.44050.19540.36Likely Benign0.00.27Likely Benign0.32Likely Benign0.70Ambiguous-3.59Deleterious0.999Probably Damaging0.997Probably Damaging3.76Benign0.01Affected110.4-0.04
c.1207A>G
K403E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K403E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Predictions from FoldX, Rosetta, Foldetta, and premPS are uncertain and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for K403E, and this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-15.279Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.445Likely Benign0.36500.17151.01Ambiguous0.10.79Ambiguous0.90Ambiguous0.70Ambiguous-3.62Deleterious0.998Probably Damaging0.981Probably Damaging3.79Benign0.04Affected010.40.94
c.1208A>C
K403T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K403T missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to FATHMM, which scores the variant as benign. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenic; SGM‑Consensus predicts likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Other stability predictors (FoldX, Rosetta, premPS) are also uncertain. Overall, the consensus of the majority of tools indicates a pathogenic effect. This conclusion is not contradicted by ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-13.135Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.522Likely Pathogenic0.18610.42301.41Ambiguous0.10.59Ambiguous1.00Ambiguous0.67Ambiguous-5.43Deleterious0.999Probably Damaging1.000Probably Damaging3.73Benign0.01Affected0-13.2-27.07
c.1208A>G
K403R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K403R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. The remaining tools—FoldX, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a tie, and Foldetta also predicts benign. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.275179Structured0.424920Uncertain0.9600.3720.000-7.362In-Between0.355AmbiguousLikely Benign0.335Likely Benign0.48340.1861-0.78Ambiguous0.10.23Likely Benign-0.28Likely Benign0.41Likely Benign-2.56Deleterious0.983Probably Damaging0.926Probably Damaging3.91Benign0.15Tolerated32-0.628.01
c.1208A>T
K403I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K403I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, premPS, and FATHMM, while the remaining tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions (nine pathogenic vs. five benign) and the high‑accuracy tools lean toward a pathogenic effect. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-15.239Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.519Likely Pathogenic0.12230.41410.17Likely Benign0.1-0.46Likely Benign-0.15Likely Benign0.36Likely Benign-7.27Deleterious1.000Probably Damaging0.999Probably Damaging3.70Benign0.00Affected-2-38.4-15.01
c.1209A>C
K403N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K403N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) predict a pathogenic impact. Predictions from FoldX, Foldetta, and premPS are uncertain or inconclusive and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-10.913Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.201Likely Benign0.33740.24921.87Ambiguous0.10.41Likely Benign1.14Ambiguous0.74Ambiguous-4.51Deleterious1.000Probably Damaging0.996Probably Damaging3.73Benign0.05Affected100.4-14.07
c.1209A>T
K403N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K403N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) predict a pathogenic impact. Predictions from FoldX, Foldetta, and premPS are uncertain or inconclusive and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.424920Uncertain0.9600.3720.000-10.913Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.201Likely Benign0.33740.24921.87Ambiguous0.10.41Likely Benign1.14Ambiguous0.74Ambiguous-4.51Deleterious1.000Probably Damaging0.996Probably Damaging3.73Benign0.05Affected100.4-14.07
c.1594A>C
T532P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T532P is listed in ClinVar as Benign (ClinVar ID 1598909.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote). Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM Consensus, and Foldetta (combining FoldX‑MD and Rosetta outputs)—all indicate a benign impact. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion is consistent with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.275179Structured0.021478Uncertain0.8890.3850.000Benign 1-2.143Likely Benign0.061Likely BenignLikely Benign0.201Likely Benign0.18500.3811-0.30Likely Benign0.20.06Likely Benign-0.12Likely Benign0.08Likely Benign-0.90Neutral0.005Benign0.008Benign-1.28Pathogenic0.18Tolerated3.37350-1-0.9-3.99174.235.10.40.00.10.0XPotentially BenignThr532 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560) facing the membrane. In the WT simulations, the hydroxyl group of Thr532 occasionally forms hydrogen bonds with the backbone atoms of other loop residues without any specific interaction. In the variant simulations, the Pro532 residue swap does not cause structural changes. Although hydrophilic residues seem more favorable in the loop, the pyrrolidine side chain of proline is well suited for unstructured protein regions such as loops. However, due to its location at the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.1594A>G
T532A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T532A is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only FATHMM predicts a pathogenic outcome. Grouping by consensus, the benign‑predicting tools outnumber the single pathogenic prediction. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.275179Structured0.021478Uncertain0.8890.3850.000-2.907Likely Benign0.088Likely BenignLikely Benign0.165Likely Benign0.35730.31140.16Likely Benign0.00.13Likely Benign0.15Likely Benign0.11Likely Benign-0.80Neutral0.032Benign0.023Benign-1.15Pathogenic0.14Tolerated102.5-30.03
c.1594A>T
T532S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T532S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as benign. Only FATHMM predicts a pathogenic outcome. When high‑accuracy methods are considered separately, AlphaMissense‑Optimized remains benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a benign effect. No prediction or stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.275179Structured0.021478Uncertain0.8890.3850.0000.616Likely Benign0.062Likely BenignLikely Benign0.160Likely Benign0.29880.28660.15Likely Benign0.1-0.23Likely Benign-0.04Likely Benign-0.10Likely Benign0.53Neutral0.005Benign0.013Benign-1.22Pathogenic1.00Tolerated11-0.1-14.03
c.1595C>A
T532K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T532K missense variant is not reported in ClinVar and has no entries in gnomAD. Prediction tools that classify the change as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. With ten benign versus four pathogenic predictions and two of the three high‑accuracy tools supporting a benign outcome, the variant is most likely benign. This assessment does not contradict the ClinVar status, which currently has no classification for T532K.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.021478Uncertain0.8890.3850.000-8.460Likely Pathogenic0.644Likely PathogenicLikely Benign0.376Likely Benign0.09430.1992-0.44Likely Benign0.20.24Likely Benign-0.10Likely Benign0.34Likely Benign-1.97Neutral0.259Benign0.033Benign-1.21Pathogenic0.29Tolerated0-1-3.227.07
c.1595C>G
T532R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T532R missense variant is not listed in ClinVar and has no reported allele in gnomAD. Prediction tools that agree on a benign effect include REVEL, Foldetta, premPS, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, FATHMM, and AlphaMissense‑Default. FoldX and Rosetta provide uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling it likely pathogenic, and Foldetta predicting a benign effect. Overall, the balance of evidence (seven benign versus five pathogenic predictions) indicates that the variant is most likely benign, and this conclusion does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.021478Uncertain0.8890.3850.000-6.564Likely Benign0.608Likely PathogenicLikely Benign0.495Likely Benign0.08410.1755-0.57Ambiguous0.20.68Ambiguous0.06Likely Benign0.48Likely Benign-2.62Deleterious0.694Possibly Damaging0.230Benign-1.20Pathogenic0.06Tolerated-1-1-3.855.08
c.1595C>T
T532I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T532I is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, polyPhen‑2 HumVar, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The high‑accuracy methods give a mixed picture: AlphaMissense‑Optimized classifies the variant as benign, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) reports a benign effect. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.021478Uncertain0.8890.3850.000-9.031Likely Pathogenic0.591Likely PathogenicLikely Benign0.428Likely Benign0.07130.4983-0.11Likely Benign0.20.87Ambiguous0.38Likely Benign0.22Likely Benign-3.31Deleterious0.633Possibly Damaging0.202Benign-1.31Pathogenic0.03Affected0-15.212.05
c.1834C>A
Q612K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q612K is not reported in ClinVar (ClinVar status: not listed) and has no entry in gnomAD (gnomAD ID: none). Prediction tools that indicate a benign effect include FoldX, Rosetta, Foldetta, and SIFT, whereas pathogenic predictions come from SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default; premPS and AlphaMissense‑Optimized are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools predict pathogenicity, and the high‑accuracy consensus also leans pathogenic, while the folding‑stability method suggests benign. Thus, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-12.393Likely Pathogenic0.849Likely PathogenicAmbiguous0.619Likely Pathogenic0.18100.36410.15Likely Benign0.10.48Likely Benign0.32Likely Benign0.81Ambiguous-3.88Deleterious0.931Possibly Damaging0.931Probably Damaging-1.22Pathogenic0.19Tolerated11-0.40.04
c.1834C>G
Q612E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q612E is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). In silico predictors that agree on a benign effect include REVEL, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Predictors that agree on a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. FoldX, Rosetta, and Foldetta are inconclusive, with Foldetta specifically yielding an uncertain stability change. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus predicts pathogenic, and Foldetta remains uncertain. Overall, the majority of consensus‑based and high‑accuracy predictions lean toward pathogenicity. Thus, the variant is most likely pathogenic, and this assessment does not contradict the current ClinVar status, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-12.179Likely Pathogenic0.338Likely BenignLikely Benign0.423Likely Benign0.13930.20990.52Ambiguous0.41.01Ambiguous0.77Ambiguous1.03Destabilizing-2.89Deleterious0.995Probably Damaging0.981Probably Damaging-1.17Pathogenic0.26Tolerated220.00.98
c.1835A>C
Q612P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q612P is listed in ClinVar (ID 3660462.0) with an uncertain significance annotation and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, SIFT, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, PolyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, PROVEAN, and the SGM Consensus score (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). The high‑accuracy AlphaMissense‑Optimized predicts benign, whereas the SGM Consensus predicts likely pathogenic; Foldetta, a folding‑stability method combining FoldX‑MD and Rosetta outputs, returns an uncertain result and is therefore not factored into the consensus. Overall, the majority of evidence supports a pathogenic effect, which contrasts with the ClinVar uncertain classification. Thus, based on current predictions, the variant is most likely pathogenic, contradicting the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000Uncertain 1-9.684Likely Pathogenic0.673Likely PathogenicLikely Benign0.671Likely Pathogenic0.22520.4050-0.19Likely Benign0.33.06Destabilizing1.44Ambiguous0.56Ambiguous-5.84Deleterious1.000Probably Damaging1.000Probably Damaging-1.31Pathogenic0.19Tolerated0-11.9-31.01
c.1835A>G
Q612R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q612R is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are SIFT and FoldX. Tools that agree on a pathogenic effect are SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while AlphaMissense‑Optimized and Foldetta are uncertain. No high‑accuracy tool provides a benign prediction. Overall, the majority of available evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-10.571Likely Pathogenic0.837Likely PathogenicAmbiguous0.683Likely Pathogenic0.14800.2196-0.35Likely Benign0.21.56Ambiguous0.61Ambiguous0.78Ambiguous-3.85Deleterious0.956Probably Damaging0.969Probably Damaging-1.29Pathogenic0.10Tolerated11-1.028.06
c.1835A>T
Q612L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q612L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, premPS, and SIFT, whereas those that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain (unavailable), SGM Consensus as likely pathogenic, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) as benign. Overall, the majority of conventional tools lean toward pathogenicity, and the SGM Consensus supports this, while the high‑accuracy Foldetta result is contradictory. Thus, the variant is most likely pathogenic based on the prevailing predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-12.076Likely Pathogenic0.799Likely PathogenicAmbiguous0.730Likely Pathogenic0.07630.4756-0.12Likely Benign0.10.12Likely Benign0.00Likely Benign0.44Likely Benign-6.84Deleterious0.971Probably Damaging0.954Probably Damaging-1.33Pathogenic0.08Tolerated-2-27.3-14.97
c.1836G>C
Q612H
2D
AIThe SynGAP1 missense variant Q612H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to Rosetta, which scores the variant as benign. All other evaluated predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM Consensus confirms a likely pathogenic status, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. FoldX and premPS are inconclusive, and Foldetta is unavailable for definitive interpretation. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-9.733Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.550Likely Pathogenic0.13790.30840.70Ambiguous0.90.39Likely Benign0.55Ambiguous0.79Ambiguous-4.55Deleterious0.991Probably Damaging0.986Probably Damaging-1.26Pathogenic0.02Affected300.39.01
c.1836G>T
Q612H
2D
AIThe SynGAP1 missense variant Q612H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are limited to Rosetta, which scores the variant as benign. All other evaluated predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM Consensus confirms a likely pathogenic status, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. FoldX and premPS are inconclusive, and Foldetta is unavailable for definitive interpretation. Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.203988Uncertain0.8220.2630.000-9.733Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.550Likely Pathogenic0.13790.30840.70Ambiguous0.90.39Likely Benign0.55Ambiguous0.79Ambiguous-4.55Deleterious0.991Probably Damaging0.986Probably Damaging-1.26Pathogenic0.02Affected300.39.01
c.1837G>A
E613K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E613K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from FoldX, Foldetta, and premPS, whereas pathogenic calls are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic. High‑accuracy assessments give AlphaMissense‑Optimized as pathogenic, SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. No prediction is inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-11.892Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.567Likely Pathogenic0.29790.59420.34Likely Benign0.6-0.54Ambiguous-0.10Likely Benign-0.08Likely Benign-3.72Deleterious0.996Probably Damaging0.987Probably Damaging-1.15Pathogenic0.04Affected01-0.4-0.94
c.1837G>C
E613Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E613Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, and SIFT, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts a likely pathogenic outcome, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a benign effect. Overall, the balance of evidence leans toward pathogenicity, and this assessment does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-9.245Likely Pathogenic0.887Likely PathogenicAmbiguous0.495Likely Benign0.16500.61810.41Likely Benign0.4-0.84Ambiguous-0.22Likely Benign0.11Likely Benign-2.79Deleterious0.994Probably Damaging0.986Probably Damaging-1.28Pathogenic0.09Tolerated220.0-0.98
c.1838A>C
E613A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E613A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include Rosetta, premPS, and Foldetta, whereas the majority of tools predict a pathogenic impact: REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) as benign. Overall, the preponderance of evidence (10 pathogenic vs. 3 benign predictions) indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-10.841Likely Pathogenic0.906Likely PathogenicAmbiguous0.688Likely Pathogenic0.46960.59290.90Ambiguous0.5-0.17Likely Benign0.37Likely Benign0.32Likely Benign-5.57Deleterious0.999Probably Damaging0.998Probably Damaging-1.26Pathogenic0.02Affected0-15.3-58.04
c.1838A>G
E613G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E613G is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include only premPS, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) uniformly predict a pathogenic impact. The high‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain. No prediction or stability assessment is missing or inconclusive beyond the uncertain labels. Overall, the preponderance of evidence points to a pathogenic effect for E613G, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-12.417Likely Pathogenic0.911Likely PathogenicAmbiguous0.641Likely Pathogenic0.34220.52661.49Ambiguous0.31.34Ambiguous1.42Ambiguous0.08Likely Benign-6.56Deleterious1.000Probably Damaging0.998Probably Damaging-1.26Pathogenic0.01Affected0-23.1-72.06
c.1838A>T
E613V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E613V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are Foldetta and premPS, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—consistently predict a pathogenic impact. FoldX and Rosetta give uncertain results and are not included in the agreement groups. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as likely pathogenic, and Foldetta as benign. Because the majority of evidence points to a deleterious effect, the variant is most likely pathogenic, which is consistent with the lack of ClinVar annotation and gnomAD observation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-12.799Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.767Likely Pathogenic0.09350.65650.72Ambiguous0.5-0.76Ambiguous-0.02Likely Benign0.31Likely Benign-6.57Deleterious0.996Probably Damaging0.991Probably Damaging-1.25Pathogenic0.03Affected-2-27.7-29.98
c.1839G>C
E613D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E613D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, and SIFT, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Three tools—FoldX, Foldetta, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the majority of evidence points to a pathogenic impact for E613D. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-8.795Likely Pathogenic0.842Likely PathogenicAmbiguous0.474Likely Benign0.19980.40000.67Ambiguous0.30.48Likely Benign0.58Ambiguous0.13Likely Benign-2.79Deleterious0.989Probably Damaging0.979Probably Damaging-1.27Pathogenic0.15Tolerated320.0-14.03
c.1839G>T
E613D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E613D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, premPS, and SIFT, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Three tools—FoldX, Foldetta, and AlphaMissense‑Optimized—return uncertain or inconclusive results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the majority of evidence points to a pathogenic impact for E613D. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.275179Structured0.193489Uncertain0.8160.2540.000-8.795Likely Pathogenic0.842Likely PathogenicAmbiguous0.474Likely Benign0.19980.40000.67Ambiguous0.30.48Likely Benign0.58Ambiguous0.13Likely Benign-2.79Deleterious0.989Probably Damaging0.979Probably Damaging-1.27Pathogenic0.15Tolerated320.0-14.03
c.925G>A
G309S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that classify the variant as benign include REVEL and SIFT, whereas a majority of other in silico predictors (AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SGM‑Consensus, and FoldX) predict it to be pathogenic. Tools with uncertain outcomes (Foldetta, Rosetta, premPS) provide no definitive evidence. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that G309S is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-11.335Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.487Likely Benign0.28280.55912.82Destabilizing0.50.73Ambiguous1.78Ambiguous0.72Ambiguous-5.52Deleterious1.000Probably Damaging1.000Probably Damaging1.73Pathogenic0.07Tolerated10-0.430.03
c.925G>C
G309R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates a likely pathogenic outcome. No tool in the dataset predicts a benign effect. Uncertainty remains for FoldX, Rosetta, Foldetta, and premPS, which are listed as uncertain and do not influence the overall assessment. High‑accuracy evaluations show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-14.375Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.572Likely Pathogenic0.09640.50971.99Ambiguous0.50.52Ambiguous1.26Ambiguous0.55Ambiguous-7.35Deleterious1.000Probably Damaging1.000Probably Damaging1.70Pathogenic0.04Affected-3-2-4.199.14
c.925G>T
G309C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a deleterious effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score, all of which classify the change as pathogenic or likely pathogenic. Tools with inconclusive results—Rosetta, Foldetta, and premPS—return uncertain outcomes and do not alter the overall assessment. High‑accuracy methods further support a damaging effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, whereas Foldetta’s stability analysis is inconclusive. Taken together, the evidence strongly favors a pathogenic interpretation, and this conclusion is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-14.331Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.656Likely Pathogenic0.13780.45742.60Destabilizing0.41.09Ambiguous1.85Ambiguous0.67Ambiguous-8.27Deleterious1.000Probably Damaging1.000Probably Damaging1.66Pathogenic0.00Affected-3-32.946.09
c.926G>A
G309D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are provided by SIFT and Rosetta, whereas the remaining 12 tools (REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM‑Consensus) are pathogenic. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta is inconclusive. Taken together, the majority of evidence supports a pathogenic effect. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-15.264Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.523Likely Pathogenic0.18890.26782.89Destabilizing0.5-0.03Likely Benign1.43Ambiguous0.75Ambiguous-6.43Deleterious1.000Probably Damaging1.000Probably Damaging1.88Pathogenic0.06Tolerated1-1-3.158.04
c.926G>C
G309A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G309A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, SIFT, and Rosetta, whereas pathogenic calls are made by FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Foldetta, premPS, and ESM1b. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates pathogenic, while Foldetta remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for G309A. This conclusion is not contradicted by ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-7.980In-Between0.986Likely PathogenicLikely Pathogenic0.373Likely Benign0.39490.49742.44Destabilizing0.40.30Likely Benign1.37Ambiguous0.71Ambiguous-5.52Deleterious1.000Probably Damaging0.999Probably Damaging1.69Pathogenic0.09Tolerated102.214.03
c.926G>T
G309V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G309V is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while premPS remains uncertain. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is consistent with the absence of a ClinVar entry (no contradiction).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.275179Structured0.338439Uncertain0.8820.3420.125-13.595Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.531Likely Pathogenic0.12560.39104.55Destabilizing0.53.61Destabilizing4.08Destabilizing0.76Ambiguous-8.27Deleterious1.000Probably Damaging1.000Probably Damaging1.67Pathogenic0.00Affected-1-34.642.08
c.1405G>A
A469T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A469T is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from premPS, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and the Foldetta stability assessment (combining FoldX‑MD and Rosetta). The high‑accuracy subset shows AlphaMissense‑Optimized as benign, whereas SGM Consensus and Foldetta both predict pathogenic. Overall, the majority of evidence supports a pathogenic effect, and this conclusion does not conflict with the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.343926Uncertain0.9100.2760.000Uncertain 1-9.540Likely Pathogenic0.723Likely PathogenicLikely Benign0.527Likely Pathogenic0.10050.58842.26Destabilizing0.11.90Ambiguous2.08Destabilizing0.34Likely Benign-1.46Neutral0.994Probably Damaging0.986Probably Damaging-1.21Pathogenic0.42Tolerated10-2.530.03
c.1405G>C
A469P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A469P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Based on the overwhelming consensus of these predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.343926Uncertain0.9100.2760.000-16.072Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.774Likely Pathogenic0.16060.40925.06Destabilizing0.38.83Destabilizing6.95Destabilizing1.02Destabilizing-2.69Deleterious0.999Probably Damaging0.996Probably Damaging-1.33Pathogenic0.21Tolerated1-1-3.426.04
c.1405G>T
A469S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A469S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include PROVEAN, SIFT, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are SGM‑Consensus, REVEL, Rosetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. FoldX, Foldetta, and premPS give uncertain or inconclusive results. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts a benign change; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is uncertain. Overall, the majority of evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.343926Uncertain0.9100.2760.000-9.051Likely Pathogenic0.627Likely PathogenicLikely Benign0.558Likely Pathogenic0.21130.45050.86Ambiguous0.02.10Destabilizing1.48Ambiguous0.81Ambiguous-1.53Neutral0.953Possibly Damaging0.985Probably Damaging-1.30Pathogenic0.41Tolerated11-2.616.00
c.1406C>A
A469D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A469D is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that assess the variant’s effect fall into two groups: the single benign prediction from SIFT, and a consensus of pathogenic predictions from the remaining 15 tools (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus). High‑accuracy methods further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenic. Taken together, the overwhelming majority of evidence points to a pathogenic effect, which is consistent with the ClinVar uncertain status rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.343926Uncertain0.9100.2760.000Uncertain 1-14.643Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.738Likely Pathogenic0.13720.15835.09Destabilizing0.24.16Destabilizing4.63Destabilizing1.68Destabilizing-3.48Deleterious0.999Probably Damaging0.996Probably Damaging-1.34Pathogenic0.21Tolerated3.37340-2-5.344.01237.0-58.2-0.20.10.80.1XXPotentially PathogenicThe methyl group of Ala469, located in an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Trp572, Leu588, Met470) in an inter-helix space formed by two other α helices (res. Glu582–Ser604, res. Arg563–Gly580). In the variant simulations, Asp469 introduces a negatively charged and bulky side chain into the hydrophobic niche. Consequently, the side chain of Asp469 rotates outward, allowing the carboxylate group to form a salt bridge with the guanidinium group of Arg575 on the protein surface. This interaction affects the continuity of the parent α helix (Ala461–Phe476). Due to the importance of hydrophobic packing, the structural effects could be more pronounced during actual protein folding.
c.1406C>G
A469G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A469G is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD. Prediction tools that agree on a benign effect include PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise REVEL, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, and AlphaMissense‑Default; FoldX is uncertain. High‑accuracy methods give mixed results: AlphaMissense‑Optimized indicates benign, Foldetta indicates pathogenic, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of tools (12 vs. 4) predict pathogenicity, and there is no ClinVar entry to contradict this assessment. Thus, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.343926Uncertain0.9100.2760.000-4.438Likely Benign0.733Likely PathogenicLikely Benign0.569Likely Pathogenic0.17970.30781.99Ambiguous0.12.22Destabilizing2.11Destabilizing1.01Destabilizing-2.42Neutral0.997Probably Damaging0.990Probably Damaging-1.32Pathogenic0.37Tolerated10-2.2-14.03
c.1406C>T
A469V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A469V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect comprise FoldX, Rosetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and Foldetta; premPS and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts pathogenic. With seven tools supporting pathogenicity versus four supporting benignity, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.343926Uncertain0.9100.2760.000-8.858Likely Pathogenic0.459AmbiguousLikely Benign0.426Likely Benign0.08270.54212.30Destabilizing0.42.66Destabilizing2.48Destabilizing-0.77Ambiguous0.26Neutral0.997Probably Damaging0.976Probably Damaging-1.20Pathogenic0.60Tolerated002.428.05
c.2134G>A
G712S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact comprise FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Uncertain results come from premPS, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive and therefore unavailable. Overall, the majority of evidence points to a pathogenic effect for G712S. This conclusion does not contradict ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.384858Uncertain0.9470.3650.000-7.942In-Between0.422AmbiguousLikely Benign0.282Likely Benign0.28620.45012.30Destabilizing0.14.79Destabilizing3.55Destabilizing0.62Ambiguous-4.84Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.02Affected10-0.430.03
c.2134G>C
G712R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G712R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the majority of other in silico predictors—PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, SIFT, ESM1b, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, Rosetta, and the SGM Consensus—classify it as pathogenic. Two tools, FoldX and premPS, return uncertain results. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta each predict a deleterious effect. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.000-11.776Likely Pathogenic0.963Likely PathogenicLikely Pathogenic0.458Likely Benign0.12290.44821.75Ambiguous0.04.68Destabilizing3.22Destabilizing0.82Ambiguous-6.58Deleterious1.000Probably Damaging0.999Probably Damaging3.35Benign0.01Affected-3-2-4.199.14
c.2134G>T
G712C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712C is catalogued in gnomAD (6‑33441599‑G‑T) but has no ClinVar entry. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441599-G-T16.20e-7-11.376Likely Pathogenic0.829Likely PathogenicAmbiguous0.516Likely Pathogenic0.15130.39472.54Destabilizing0.05.72Destabilizing4.13Destabilizing0.56Ambiguous-7.75Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected3.509-3-32.946.09
c.2135G>A
G712D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G712D is catalogued in gnomAD (ID 6‑33441600‑G‑A) but has no ClinVar entry. In silico predictors show mixed results: benign calls come from REVEL, SIFT, and FATHMM, while pathogenic calls are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. Uncertain predictions are reported by premPS and AlphaMissense‑Optimized. The high‑accuracy consensus tools give a pathogenic verdict: AlphaMissense‑Optimized is inconclusive, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Overall, the majority of reliable predictors and the consensus methods lean toward a pathogenic effect, and this assessment does not conflict with ClinVar, which has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.0006-33441600-G-A16.20e-7-8.211Likely Pathogenic0.946Likely PathogenicAmbiguous0.320Likely Benign0.21460.25332.87Destabilizing0.15.37Destabilizing4.12Destabilizing0.90Ambiguous-5.69Deleterious1.000Probably Damaging0.999Probably Damaging3.67Benign0.12Tolerated3.509-11-3.158.04
c.2135G>C
G712A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 G712A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and SIFT. Two tools report uncertainty: premPS and AlphaMissense‑Default. High‑accuracy assessments further refine the picture. AlphaMissense‑Optimized classifies the variant as benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign verdict (2 benign vs. 1 pathogenic vote). Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Because the majority of conventional predictors (7/11) indicate pathogenicity, the overall consensus leans toward a pathogenic impact, despite the mixed high‑accuracy results. This conclusion does not contradict ClinVar status, as the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.278302Structured0.384858Uncertain0.9470.3650.000-6.444Likely Benign0.553AmbiguousLikely Benign0.281Likely Benign0.39930.41052.89Destabilizing0.14.98Destabilizing3.94Destabilizing0.70Ambiguous-4.99Deleterious0.999Probably Damaging0.991Probably Damaging3.44Benign0.02Affected102.214.03
c.2135G>T
G712V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G712V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, while the majority of tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Two tools report uncertainty: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.278302Structured0.384858Uncertain0.9470.3650.000-10.466Likely Pathogenic0.877Likely PathogenicAmbiguous0.410Likely Benign0.13950.37123.79Destabilizing0.06.18Destabilizing4.99Destabilizing0.79Ambiguous-7.55Deleterious1.000Probably Damaging0.999Probably Damaging3.32Benign0.00Affected-1-34.642.08
c.649G>A
E217K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 E217K is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Computational predictions cluster into two groups: benign calls from premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, and FATHMM; pathogenic calls from REVEL, Rosetta, polyPhen‑2 HumDiv, AlphaMissense‑Default, and AlphaMissense‑Optimized. Three tools give uncertain results: FoldX, Foldetta, and ESM1b. High‑accuracy methods give conflicting outcomes: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; Foldetta remains uncertain. Because the majority of standard tools are split evenly and the high‑accuracy predictions are discordant, the evidence does not decisively support either outcome. The variant is therefore most likely pathogenic based on the preponderance of pathogenic predictions, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.278302Structured0.404912Uncertain0.8230.2840.000-7.169In-Between0.990Likely PathogenicLikely Pathogenic0.563Likely Pathogenic0.27420.82160.52Ambiguous0.52.14Destabilizing1.33Ambiguous0.45Likely Benign-2.38Neutral0.900Possibly Damaging0.307Benign5.95Benign0.13Tolerated01-0.4-0.94
c.649G>C
E217Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant E217Q is reported in gnomAD (ID 6‑33435291‑G‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, PROVEAN, SIFT, ESM1b, and FATHMM, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With six benign versus three pathogenic calls and a benign consensus from the high‑accuracy panel, the variant is most likely benign. This conclusion does not contradict ClinVar, which contains no classification for this change.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.278302Structured0.404912Uncertain0.8230.2840.0006-33435291-G-C16.20e-7-6.810Likely Benign0.949Likely PathogenicAmbiguous0.459Likely Benign0.14740.84730.25Likely Benign0.21.61Ambiguous0.93Ambiguous0.67Ambiguous-1.89Neutral0.900Possibly Damaging0.461Possibly Damaging5.83Benign0.14Tolerated3.4113220.0-0.98
c.650A>C
E217A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E217A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, polyPhen‑2 HumVar, SIFT, and FATHMM, whereas those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, AlphaMissense‑Default, and AlphaMissense‑Optimized. Four tools (FoldX, Rosetta, Foldetta, and ESM1b) returned uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; Foldetta’s stability prediction is uncertain. Overall, the majority of available predictions support a pathogenic impact for E217A. This conclusion is not contradicted by ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.278302Structured0.404912Uncertain0.8230.2840.000-7.294In-Between0.960Likely PathogenicLikely Pathogenic0.619Likely Pathogenic0.44420.80900.67Ambiguous0.50.61Ambiguous0.64Ambiguous0.50Likely Benign-3.88Deleterious0.900Possibly Damaging0.307Benign5.81Benign0.12Tolerated0-15.3-58.04
c.650A>G
E217G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E217G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumVar, SIFT, and FATHMM, while those that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized predicts a pathogenic impact, the SGM‑Consensus also indicates a likely pathogenic outcome, and Foldetta’s stability analysis is inconclusive. Overall, the majority of evidence points to a pathogenic effect for E217G, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.278302Structured0.404912Uncertain0.8230.2840.000-8.076Likely Pathogenic0.968Likely PathogenicLikely Pathogenic0.684Likely Pathogenic0.32780.69411.13Ambiguous0.41.87Ambiguous1.50Ambiguous0.59Ambiguous-3.93Deleterious0.816Possibly Damaging0.307Benign5.82Benign0.06Tolerated0-23.1-72.06
c.650A>T
E217V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E217V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include Rosetta, FATHMM, and premPS, whereas the majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). FoldX and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for E217V. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.278302Structured0.404912Uncertain0.8230.2840.000-10.194Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.723Likely Pathogenic0.09190.83400.76Ambiguous0.60.39Likely Benign0.58Ambiguous0.23Likely Benign-4.84Deleterious0.900Possibly Damaging0.461Possibly Damaging5.79Benign0.03Affected-2-27.7-29.98
c.651G>C
E217D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E217D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all classify the change as benign. The only inconclusive result comes from AlphaMissense‑Default, which is listed as uncertain. High‑accuracy assessments corroborate this benign profile: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports a benign outcome. No pathogenic predictions are present. Therefore, based on the available computational evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.278302Structured0.404912Uncertain0.8230.2840.000-2.268Likely Benign0.453AmbiguousLikely Benign0.276Likely Benign0.20660.59760.24Likely Benign0.3-0.07Likely Benign0.09Likely Benign-0.34Likely Benign0.66Neutral0.014Benign0.007Benign5.85Benign0.85Tolerated3.4113230.0-14.03
c.651G>T
E217D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant E217D is present in gnomAD (6‑33435293‑G‑T) but has no ClinVar entry. Functional prediction tools uniformly classify it as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and Foldetta all report benign or benign‑like outcomes. No tool predicts pathogenicity. The high‑accuracy consensus methods corroborate this: AlphaMissense‑Optimized indicates benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Benign”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports benign. AlphaMissense‑Default remains uncertain and is treated as unavailable. Overall, the evidence strongly supports a benign effect for E217D, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.278302Structured0.404912Uncertain0.8230.2840.0006-33435293-G-T16.20e-7-2.268Likely Benign0.453AmbiguousLikely Benign0.276Likely Benign0.20660.59760.24Likely Benign0.3-0.07Likely Benign0.09Likely Benign-0.34Likely Benign0.66Neutral0.014Benign0.007Benign5.85Benign0.85Tolerated3.4113230.0-14.03
c.1075A>C
T359P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359P is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.250-6.884Likely Benign0.319Likely BenignLikely Benign0.248Likely Benign0.23520.56110.97Ambiguous0.11.27Ambiguous1.12Ambiguous0.68Ambiguous-2.36Neutral0.627Possibly Damaging0.091Benign1.78Pathogenic0.14Tolerated0-1-0.9-3.99
c.1075A>G
T359A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only FATHMM predicts a pathogenic outcome, while Rosetta remains uncertain. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Based on the preponderance of evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.250-2.948Likely Benign0.062Likely BenignLikely Benign0.103Likely Benign0.42150.47130.09Likely Benign0.00.73Ambiguous0.41Likely Benign0.45Likely Benign-0.73Neutral0.000Benign0.001Benign1.79Pathogenic0.34Tolerated102.5-30.03
c.1075A>T
T359S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T359S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score. Only FATHMM predicts a pathogenic outcome, while FoldX, Rosetta, Foldetta, and premPS are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also favors benign. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is uncertain. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.250-4.624Likely Benign0.091Likely BenignLikely Benign0.100Likely Benign0.36370.49960.50Ambiguous0.00.73Ambiguous0.62Ambiguous0.66Ambiguous-1.87Neutral0.146Benign0.024Benign1.76Pathogenic0.27Tolerated11-0.1-14.03
c.1076C>A
T359K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T359K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are ESM1b and FATHMM. The remaining tools—FoldX, Rosetta, premPS, and AlphaMissense‑Default—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of predictions (seven benign vs. two pathogenic) support a benign classification, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign based on current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.281712Structured0.414952Uncertain0.9390.4800.250-10.822Likely Pathogenic0.517AmbiguousLikely Benign0.163Likely Benign0.16180.3483-0.65Ambiguous0.10.66Ambiguous0.01Likely Benign0.75Ambiguous-2.23Neutral0.255Benign0.045Benign1.79Pathogenic0.24Tolerated0-1-3.227.07
c.1076C>G
T359R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T359R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign effects include REVEL, Rosetta, Foldetta, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and FATHMM. Uncertain results come from FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, more tools favor a benign outcome, but a significant minority predict pathogenicity, leaving the variant’s clinical significance unresolved. The variant is most likely benign based on the prevailing predictions, and this does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.281712Structured0.414952Uncertain0.9390.4800.250-8.675Likely Pathogenic0.402AmbiguousLikely Benign0.157Likely Benign0.13230.3748-0.74Ambiguous0.1-0.20Likely Benign-0.47Likely Benign0.54Ambiguous-2.86Deleterious0.627Possibly Damaging0.091Benign1.75Pathogenic0.23Tolerated-1-1-3.855.08
c.1076C>T
T359I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T359I is reported in gnomAD (variant ID 6‑33437981‑C‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. Uncertain results are reported for FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign effect. There is no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.281712Structured0.414952Uncertain0.9390.4800.2506-33437981-C-T16.22e-7-2.594Likely Benign0.181Likely BenignLikely Benign0.085Likely Benign0.11230.5921-0.66Ambiguous0.1-0.64Ambiguous-0.65Ambiguous-0.63Ambiguous0.77Neutral0.070Benign0.006Benign1.80Pathogenic0.23Tolerated3.3824-105.212.05
c.1351C>A
L451I
2D
AIThe SynGAP1 L451I missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results come from FoldX, Rosetta, premPS, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta is also inconclusive. Overall, the majority of available predictions (five pathogenic versus four benign) indicate that the variant is most likely pathogenic, and this assessment does not contradict the absence of a ClinVar record.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.281712Structured0.314017Uncertain0.9780.2320.000-11.046Likely Pathogenic0.658Likely PathogenicLikely Benign0.284Likely Benign0.06810.29581.43Ambiguous0.80.70Ambiguous1.07Ambiguous0.94Ambiguous-1.94Neutral0.997Probably Damaging0.989Probably Damaging2.75Benign0.02Affected220.70.00
c.1351C>G
L451V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451V is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Rosetta is uncertain and does not contribute to the consensus. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic; and Foldetta predicts pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for L451V. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000-10.732Likely Pathogenic0.635Likely PathogenicLikely Benign0.325Likely Benign0.10650.28562.83Destabilizing0.11.81Ambiguous2.32Destabilizing1.39Destabilizing-2.90Deleterious0.995Probably Damaging0.970Probably Damaging2.54Benign0.01Affected210.4-14.03
c.1352T>A
L451Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451Q is not reported in ClinVar and is absent from gnomAD. Prediction tools uniformly indicate a deleterious effect: pathogenic predictions are returned by REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the change as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a pathogenic effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000-15.426Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.708Likely Pathogenic0.08690.05582.91Destabilizing0.02.48Destabilizing2.70Destabilizing2.30Destabilizing-5.79Deleterious1.000Probably Damaging1.000Probably Damaging2.43Pathogenic0.00Affected-2-2-7.314.97
c.1352T>C
L451P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451P is reported in ClinVar as Pathogenic (ClinVar ID 3064222.0) and is not found in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on these predictions, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000Likely Pathogenic 1-14.549Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.750Likely Pathogenic0.28230.12216.92Destabilizing0.28.57Destabilizing7.75Destabilizing2.58Destabilizing-6.81Deleterious1.000Probably Damaging1.000Probably Damaging2.43Pathogenic0.00Affected3.3734-3-3-5.4-16.04
c.1352T>G
L451R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L451R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All available in‑silico predictors classify the substitution as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports a pathogenic effect. Based on the unanimous pathogenic predictions and the absence of benign calls, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.314017Uncertain0.9780.2320.000-16.162Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.726Likely Pathogenic0.11300.05583.32Destabilizing0.13.76Destabilizing3.54Destabilizing2.25Destabilizing-5.82Deleterious0.999Probably Damaging0.992Probably Damaging2.43Pathogenic0.00Affected-3-2-8.343.03
c.1591T>A
C531S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C531S is not reported in ClinVar and has no entries in gnomAD. Prediction tools that assess pathogenicity largely agree on a deleterious effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict pathogenic. In contrast, only three tools predict a benign outcome: FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy methods provide a mixed picture: AlphaMissense‑Optimized reports a benign effect, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta also predicts benign stability. Overall, the preponderance of evidence points to a pathogenic impact for C531S. This conclusion is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-8.213Likely Pathogenic0.575Likely PathogenicLikely Benign0.519Likely Pathogenic0.37160.1782-0.02Likely Benign0.00.77Ambiguous0.38Likely Benign1.23Destabilizing-8.00Deleterious0.958Probably Damaging0.533Possibly Damaging-1.18Pathogenic0.01Affected0-1-3.3-16.06
c.1591T>C
C531R
2D
AIThe SynGAP1 missense variant C531R is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include FoldX, Rosetta, Foldetta, and polyPhen‑2 HumVar, whereas the remaining tools—REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar classification because the variant is currently unreported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-12.600Likely Pathogenic0.966Likely PathogenicLikely Pathogenic0.619Likely Pathogenic0.13220.15660.31Likely Benign2.0-0.27Likely Benign0.02Likely Benign1.40Destabilizing-9.85Deleterious0.929Possibly Damaging0.385Benign-1.24Pathogenic0.00Affected-4-3-7.053.05
c.1591T>G
C531G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C531G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX and AlphaMissense‑Optimized, while the majority of other in silico predictors (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) indicate a pathogenic impact. Uncertain results come from Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as inconclusive. Overall, the balance of evidence leans toward pathogenicity, with no ClinVar entry to contradict this assessment. Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-10.037Likely Pathogenic0.577Likely PathogenicLikely Benign0.545Likely Pathogenic0.26530.22970.47Likely Benign0.31.49Ambiguous0.98Ambiguous1.42Destabilizing-9.76Deleterious0.985Probably Damaging0.832Possibly Damaging-1.24Pathogenic0.00Affected-3-3-2.9-46.09
c.1592G>A
C531Y
2D
AIThe SynGAP1 missense variant C531Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only Rosetta, whereas the remaining tools—REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus—consistently predict a pathogenic impact. Uncertain or inconclusive results come from AlphaMissense‑Optimized, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for C531Y. This prediction does not contradict ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-11.667Likely Pathogenic0.914Likely PathogenicAmbiguous0.551Likely Pathogenic0.08430.32663.09Destabilizing4.60.15Likely Benign1.62Ambiguous0.65Ambiguous-8.95Deleterious0.976Probably Damaging0.480Possibly Damaging-1.24Pathogenic0.00Affected0-2-3.860.04
c.1592G>C
C531S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C531S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from FoldX, Foldetta, and AlphaMissense‑Optimized, whereas pathogenic predictions are made by SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; Rosetta remains uncertain. High‑accuracy assessments further support a pathogenic bias: AlphaMissense‑Optimized indicates benign, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—classifies the variant as pathogenic, and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. Overall, the preponderance of evidence points to a pathogenic effect for C531S, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-8.213Likely Pathogenic0.575Likely PathogenicLikely Benign0.508Likely Pathogenic0.37160.1782-0.02Likely Benign0.00.77Ambiguous0.38Likely Benign1.23Destabilizing-8.00Deleterious0.958Probably Damaging0.533Possibly Damaging-1.18Pathogenic0.01Affected0-1-3.3-16.06
c.1592G>T
C531F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C531F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include Rosetta and polyPhen‑2 HumVar, while the majority of tools (SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) predict a pathogenic impact. Tools with inconclusive or uncertain results are AlphaMissense‑Optimized, Foldetta, and premPS. High‑accuracy assessments show SGM‑Consensus as “Likely Pathogenic”; AlphaMissense‑Optimized is uncertain; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is also uncertain. Taken together, the preponderance of evidence from multiple pathogenic‑predicting algorithms and the SGM‑Consensus score indicates that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-10.428Likely Pathogenic0.842Likely PathogenicAmbiguous0.519Likely Pathogenic0.11030.37842.47Destabilizing1.60.26Likely Benign1.37Ambiguous0.59Ambiguous-8.89Deleterious0.866Possibly Damaging0.244Benign-1.23Pathogenic0.01Affected-4-20.344.04
c.1593C>G
C531W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant C531W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a deleterious effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized, all of which classify the change as pathogenic. Tools with uncertain or mixed outputs are Rosetta (uncertain) and premPS (uncertain). High‑accuracy assessments further support a damaging impact: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also reports pathogenic. Based on the overwhelming agreement among pathogenic predictions and the corroborating high‑accuracy tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.281712Structured0.017941Uncertain0.8780.4010.000-14.107Likely Pathogenic0.970Likely PathogenicLikely Pathogenic0.510Likely Pathogenic0.12340.30745.27Destabilizing3.40.63Ambiguous2.95Destabilizing0.70Ambiguous-9.12Deleterious0.998Probably Damaging0.871Possibly Damaging-1.25Pathogenic0.00Affected-8-2-3.483.07
c.652T>A
F218I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218I is reported in gnomAD (variant ID 6‑33435294‑T‑A) but has no ClinVar entry. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized, while benign predictions are limited to polyPhen‑2 (HumVar), SIFT, and FATHMM. High‑accuracy assessments reinforce the pathogenic view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.0006-33435294-T-A16.20e-7-12.211Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.612Likely Pathogenic0.21060.24594.69Destabilizing0.25.93Destabilizing5.31Destabilizing1.18Destabilizing-3.81Deleterious0.510Possibly Damaging0.066Benign5.85Benign0.08Tolerated3.4113011.7-34.02
c.652T>C
F218L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict a pathogenic effect comprise REVEL, Rosetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). FoldX and Foldetta provide uncertain results and are therefore considered unavailable for interpretation. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic impact for F218L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.861Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.546Likely Pathogenic0.23310.32410.96Ambiguous0.42.36Destabilizing1.66Ambiguous1.08Destabilizing-3.80Deleterious0.158Benign0.025Benign5.90Benign0.15Tolerated201.0-34.02
c.652T>G
F218V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; pathogenic predictions arise from REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled “Likely Pathogenic.” High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus agrees on a likely pathogenic outcome, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenicity. No predictions or stability results are missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion aligns with the absence of a ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-10.081Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.691Likely Pathogenic0.21730.22584.18Destabilizing0.26.35Destabilizing5.27Destabilizing1.15Destabilizing-4.14Deleterious0.300Benign0.066Benign5.81Benign0.08Tolerated-1-11.4-48.04
c.653T>A
F218Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). All available in silico predictors classify the substitution as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign effect. The high‑accuracy folding‑stability tool Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a benign impact. No tool predicts pathogenicity, and no contradictory evidence exists in ClinVar. **Based on the consensus of all predictions, the variant is most likely benign, and this assessment does not conflict with ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.281712Structured0.408725Uncertain0.8480.2720.000-3.596Likely Benign0.104Likely BenignLikely Benign0.229Likely Benign0.15320.27250.26Likely Benign0.1-0.40Likely Benign-0.07Likely Benign-0.44Likely Benign0.63Neutral0.001Benign0.002Benign5.95Benign0.52Tolerated73-4.116.00
c.653T>C
F218S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218S has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumVar, SIFT, and FATHMM, whereas the remaining tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.882Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.731Likely Pathogenic0.38020.04542.35Destabilizing0.13.00Destabilizing2.68Destabilizing1.22Destabilizing-4.62Deleterious0.808Possibly Damaging0.225Benign5.80Benign0.07Tolerated-3-2-3.6-60.10
c.653T>G
F218C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33435295‑T‑G). Prediction tools that agree on a benign effect include only FATHMM, whereas the majority of tools (REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default) predict a pathogenic impact. Results that are uncertain or unavailable are FoldX, ESM1b, AlphaMissense‑Optimized, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic prediction (2 pathogenic vs. 1 benign votes); and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic effect for F218C, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.281712Structured0.408725Uncertain0.8480.2720.0006-33435295-T-G16.20e-7-7.234In-Between0.948Likely PathogenicAmbiguous0.744Likely Pathogenic0.23300.13211.49Ambiguous0.12.20Destabilizing1.85Ambiguous1.02Destabilizing-4.92Deleterious0.994Probably Damaging0.667Possibly Damaging5.78Benign0.03Affected3.4113-2-4-0.3-44.04
c.654C>A
F218L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that agree on a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), Rosetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Foldetta are inconclusive and are treated as unavailable. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts Likely Pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact. There is no ClinVar annotation to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.861Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.477Likely Benign0.23310.32410.96Ambiguous0.42.36Destabilizing1.66Ambiguous1.08Destabilizing-3.80Deleterious0.158Benign0.025Benign5.90Benign0.15Tolerated201.0-34.02
c.654C>G
F218L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F218L is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Tools that agree on a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), Rosetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX and Foldetta are inconclusive and are treated as unavailable. High‑accuracy methods further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also predicts Likely Pathogenic; Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic impact. There is no ClinVar annotation to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.281712Structured0.408725Uncertain0.8480.2720.000-8.861Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.477Likely Benign0.23310.32410.96Ambiguous0.42.36Destabilizing1.66Ambiguous1.08Destabilizing-3.80Deleterious0.158Benign0.025Benign5.90Benign0.15Tolerated201.0-34.02
c.1402A>C
M468L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumVar and FATHMM. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments—all available—show benign predictions: AlphaMissense‑Optimized (Benign), SGM‑Consensus (Likely Benign), and Foldetta (Benign). Based on the overall consensus of the majority of tools and the high‑accuracy predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.284882Structured0.339253Uncertain0.9320.2570.000-6.886Likely Benign0.290Likely BenignLikely Benign0.412Likely Benign0.15640.44080.43Likely Benign0.1-0.38Likely Benign0.03Likely Benign-0.35Likely Benign0.19Neutral0.359Benign0.654Possibly Damaging-0.73Pathogenic1.00Tolerated421.9-18.03
c.1402A>G
M468V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from PROVEAN, SIFT, and AlphaMissense‑Optimized, while pathogenic predictions are made by REVEL, FoldX, Rosetta, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. The remaining tools, premPS and AlphaMissense‑Default, return uncertain results. High‑accuracy assessments further clarify the variant’s impact: AlphaMissense‑Optimized predicts a benign effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also classifies the variant as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which does not contradict the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.284882Structured0.339253Uncertain0.9320.2570.000Uncertain 1-9.461Likely Pathogenic0.361AmbiguousLikely Benign0.570Likely Pathogenic0.33090.38452.69Destabilizing0.12.20Destabilizing2.45Destabilizing0.89Ambiguous-1.66Neutral0.998Probably Damaging0.993Probably Damaging-1.21Pathogenic0.08Tolerated3.3731122.3-32.06
c.1402A>T
M468L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumVar and FATHMM. The SGM‑Consensus, which is a majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta (combining FoldX‑MD and Rosetta outputs)—all indicate a benign outcome. No prediction or folding‑stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.284882Structured0.339253Uncertain0.9320.2570.000-6.886Likely Benign0.290Likely BenignLikely Benign0.412Likely Benign0.15640.44080.43Likely Benign0.1-0.38Likely Benign0.03Likely Benign-0.35Likely Benign0.19Neutral0.359Benign0.654Possibly Damaging-0.73Pathogenic1.00Tolerated421.9-18.03
c.1403T>A
M468K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468K is listed in ClinVar (ID 642691.0) as Pathogenic and is not reported in gnomAD. All available in silico predictors classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000Likely Pathogenic 1-16.982Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.828Likely Pathogenic0.15760.04563.21Destabilizing0.13.30Destabilizing3.26Destabilizing2.57Destabilizing-4.61Deleterious0.878Possibly Damaging0.922Probably Damaging-1.34Pathogenic0.04Affected3.37310-1-5.8-3.02188.769.30.00.0-0.10.2XXPotentially PathogenicThe thioether group of Met468, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Phe464, Leu465, Leu489) in an inter-helix space formed by two other α helices (res. Ala461–Phe476, res. Thr488–Gly502). In the variant simulations, the positively charged side chain of Lys468 rotates outward to escape the hydrophobic niche, forming an H-bond with the hydroxyl group of the Ser471 side chain and a salt bridge with the carboxylate group of the Glu472 side chain. This residue swap also disrupts the methionine-aromatic stacking with the phenyl ring of the Phe464 side chain. Although no large-scale structural changes are observed during the variant simulations, the importance of hydrophobic packing suggests that the effects could be more pronounced during protein folding.
c.1403T>C
M468T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468T is listed in ClinVar with an “Uncertain” status and is present in the gnomAD database. Prediction tools that are available all converge on a pathogenic interpretation: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool reports a benign outcome. High‑accuracy assessments are consistent: AlphaMissense‑Optimized is “Uncertain,” SGM Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. **Based on the aggregate predictions, the variant is most likely pathogenic, which does not contradict the ClinVar “Uncertain” classification.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000Uncertain 26-33438435-T-C16.20e-7-12.399Likely Pathogenic0.862Likely PathogenicAmbiguous0.801Likely Pathogenic0.20940.19503.47Destabilizing0.13.10Destabilizing3.29Destabilizing1.84Destabilizing-3.85Deleterious0.994Probably Damaging0.985Probably Damaging-1.31Pathogenic0.01Affected3.3731-1-1-2.6-30.09214.647.10.00.00.10.0XPotentially PathogenicThe thioether group of Met468, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues (e.g., Phe464, Leu465, Leu489) in an inter-helix space formed by two other α helices (res. Ala461–Phe476, res. Thr488–Gly502). In the variant simulations, the hydrophilic side chain of Thr468 does not pack favorably in the hydrophobic niche, and the methionine-aromatic stacking is lost. Although the hydroxyl group of Thr468 forms an H-bond with the backbone carbonyl group of Phe464, the integrity of the α helix is not affected in the simulations. No large-scale structural changes are observed during the variant simulations; however, due to the importance of hydrophobic packing, the effects could be more pronounced during protein folding.
c.1403T>G
M468R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468R is not reported in ClinVar and is absent from gnomAD. All evaluated in‑silico predictors classify the substitution as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic based on the consensus of predictive tools, and this assessment does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000-16.180Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.837Likely Pathogenic0.17170.06372.66Destabilizing0.22.23Destabilizing2.45Destabilizing2.43Destabilizing-4.64Deleterious0.939Possibly Damaging0.943Probably Damaging-1.34Pathogenic0.00Affected0-1-6.424.99
c.1404G>A
M468I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M468I is listed in ClinVar with an uncertain significance (ClinVar ID 3657719.0) and is present in gnomAD (6‑33438436‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from premPS, PROVEAN, and SIFT, while pathogenic predictions arise from REVEL, FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools report uncertainty: AlphaMissense‑Optimized and Rosetta. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, SGM Consensus is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Overall, the preponderance of evidence indicates a pathogenic impact for M468I, which does not contradict the ClinVar uncertain status but suggests a likely pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000Uncertain 16-33438436-G-A16.20e-7-8.583Likely Pathogenic0.907Likely PathogenicAmbiguous0.508Likely Pathogenic0.13690.33542.53Destabilizing0.21.89Ambiguous2.21Destabilizing0.37Likely Benign-1.06Neutral0.748Possibly Damaging0.886Possibly Damaging-1.10Pathogenic0.07Tolerated3.3731122.6-18.03
c.1404G>C
M468I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468I is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include premPS, PROVEAN, and SIFT, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default—classify the change as pathogenic. Two methods report uncertainty: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious outcome: the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also indicates a pathogenic effect. AlphaMissense‑Optimized remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for M468I, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000-8.583Likely Pathogenic0.907Likely PathogenicAmbiguous0.508Likely Pathogenic0.13690.33542.53Destabilizing0.21.89Ambiguous2.21Destabilizing0.37Likely Benign-1.06Neutral0.748Possibly Damaging0.886Possibly Damaging-1.10Pathogenic0.07Tolerated3.3731122.6-18.03
c.1404G>T
M468I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M468I is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include premPS, PROVEAN, and SIFT, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, Foldetta, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default—classify the change as pathogenic. Two methods report uncertainty: Rosetta and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious outcome: the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also indicates a pathogenic effect; AlphaMissense‑Optimized remains inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for M468I, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.284882Structured0.339253Uncertain0.9320.2570.000-8.583Likely Pathogenic0.907Likely PathogenicAmbiguous0.510Likely Pathogenic0.13690.33542.53Destabilizing0.21.89Ambiguous2.21Destabilizing0.37Likely Benign-1.06Neutral0.748Possibly Damaging0.886Possibly Damaging-1.10Pathogenic0.07Tolerated3.3731122.6-18.03
c.178G>A
D60N
2D
AIThe SynGAP1 D60N missense variant has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.284882Structured0.480942Uncertain0.5210.6760.000-3.610Likely Benign0.577Likely PathogenicLikely Benign0.128Likely Benign0.12190.8168-0.22Neutral0.805Possibly Damaging0.857Possibly Damaging4.13Benign0.00Affected210.0-0.98
c.178G>C
D60H
2D
AIThe SynGAP1 missense variant D60H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are not available. Overall, the balance of evidence leans toward a benign interpretation, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.284882Structured0.480942Uncertain0.5210.6760.000-5.257Likely Benign0.934Likely PathogenicAmbiguous0.165Likely Benign0.14330.8401-1.59Neutral0.972Probably Damaging0.969Probably Damaging3.91Benign0.00Affected1-10.322.05
c.178G>T
D60Y
2D
AIThe SynGAP1 D60Y missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. ESM1b is uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict (2 pathogenic vs. 1 benign). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the D60Y variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.284882Structured0.480942Uncertain0.5210.6760.000-7.748In-Between0.971Likely PathogenicLikely Pathogenic0.221Likely Benign0.05170.7790-2.60Deleterious0.972Probably Damaging0.969Probably Damaging3.90Benign0.00Affected-4-32.248.09
c.179A>C
D60A
2D
AIThe SynGAP1 D60A missense variant has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain” and the SGM‑Consensus as “Likely Benign”; Foldetta results are unavailable. Overall, the majority of evaluated tools lean toward a benign interpretation, with no evidence of pathogenicity from the high‑confidence methods. Consequently, the variant is most likely benign, and this assessment does not contradict any ClinVar status, as none exists for this allele.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.284882Structured0.480942Uncertain0.5210.6760.000-4.500Likely Benign0.918Likely PathogenicAmbiguous0.167Likely Benign0.38510.7405-2.17Neutral0.909Possibly Damaging0.857Possibly Damaging3.96Benign0.00Affected0-25.3-44.01
c.179A>G
D60G
2D
AIThe SynGAP1 D60G missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.284882Structured0.480942Uncertain0.5210.6760.000-4.423Likely Benign0.775Likely PathogenicLikely Benign0.128Likely Benign0.41430.7069-1.67Neutral0.805Possibly Damaging0.857Possibly Damaging3.94Benign0.00Affected1-13.1-58.04
c.179A>T
D60V
2D
AIThe SynGAP1 D60V missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of evaluated predictors (7 of 10) indicate pathogenicity, while only three suggest benignity. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.284882Structured0.480942Uncertain0.5210.6760.000-6.576Likely Benign0.980Likely PathogenicLikely Pathogenic0.254Likely Benign0.07650.7962-2.72Deleterious0.972Probably Damaging0.954Probably Damaging3.91Benign0.00Affected-2-37.7-15.96
c.180T>A
D60E
2D
AIThe SynGAP1 D60E missense variant has no ClinVar record and is not listed in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.284882Structured0.480942Uncertain0.5210.6760.000-3.818Likely Benign0.780Likely PathogenicLikely Benign0.089Likely Benign0.13420.7869-0.90Neutral0.643Possibly Damaging0.785Possibly Damaging4.05Benign0.00Affected320.014.03
c.180T>G
D60E
2D
AIThe SynGAP1 D60E missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also resolves to benign. Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.284882Structured0.480942Uncertain0.5210.6760.000-3.818Likely Benign0.780Likely PathogenicLikely Benign0.089Likely Benign0.13420.7869-0.90Neutral0.643Possibly Damaging0.785Possibly Damaging4.05Benign0.00Affected320.014.03
c.586T>A
L196M
2D
AIThe SynGAP1 missense variant L196M is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool rates the variant as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) has no available result. Overall, more tools predict pathogenicity (5) than benignity (3), and the high‑accuracy predictions do not overturn this trend. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.284882Structured0.429452Uncertain0.4890.5210.125-8.957Likely Pathogenic0.902Likely PathogenicAmbiguous0.094Likely Benign0.06890.2786-1.48Neutral0.971Probably Damaging0.691Possibly Damaging3.64Benign0.01Affected42-1.918.03
c.586T>G
L196V
2D
AIThe SynGAP1 missense variant L196V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta results are unavailable. Overall, the majority of evidence (five benign vs three pathogenic) points to a benign impact. This conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.284882Structured0.429452Uncertain0.4890.5210.125-8.702Likely Pathogenic0.898Likely PathogenicAmbiguous0.106Likely Benign0.14360.2850-2.31Neutral0.243Benign0.097Benign3.71Benign0.01Affected210.4-14.03
c.587T>C
L196S
2D
AIThe SynGAP1 missense variant L196S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect comprise PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is Likely Pathogenic, while Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.284882Structured0.429452Uncertain0.4890.5210.125-9.987Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.353Likely Benign0.34730.0736-4.75Deleterious0.437Benign0.186Benign3.65Benign0.00Affected-3-2-4.6-26.08
c.587T>G
L196W
2D
AIThe SynGAP1 missense variant L196W has no ClinVar entry (ClinVar status: not reported) and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, and the SGM‑Consensus is labeled Likely Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for this variant, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.284882Structured0.429452Uncertain0.4890.5210.125-12.148Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.293Likely Benign0.05510.2718-4.91Deleterious0.992Probably Damaging0.869Possibly Damaging3.58Benign0.00Affected-2-2-4.773.05
c.588G>C
L196F
2D
AIThe SynGAP1 missense variant L196F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.284882Structured0.429452Uncertain0.4890.5210.125-10.245Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.177Likely Benign0.05570.2756-3.17Deleterious0.917Possibly Damaging0.502Possibly Damaging3.64Benign0.01Affected20-1.034.02
c.588G>T
L196F
2D
AIThe SynGAP1 missense variant L196F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the collective predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.284882Structured0.429452Uncertain0.4890.5210.125-10.245Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.177Likely Benign0.05570.2756-3.17Deleterious0.917Possibly Damaging0.502Possibly Damaging3.64Benign0.01Affected20-1.034.02
c.781G>A
D261N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that indicate a benign effect include premPS, FATHMM, and AlphaMissense‑Optimized, while the majority of tools predict a pathogenic outcome: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-11.804Likely Pathogenic0.746Likely PathogenicLikely Benign0.579Likely Pathogenic0.07670.47451.58Ambiguous0.71.28Ambiguous1.43Ambiguous0.23Likely Benign-2.94Deleterious0.997Probably Damaging0.989Probably Damaging5.82Benign0.02Affected210.0-0.98
c.781G>C
D261H
2D
AIThe SynGAP1 missense variant D261H is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are premPS and FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; Rosetta is uncertain and is treated as unavailable. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic (3 pathogenic vs. 1 benign); and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Thus, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-13.688Likely Pathogenic0.961Likely PathogenicLikely Pathogenic0.780Likely Pathogenic0.09370.54654.33Destabilizing3.20.93Ambiguous2.63Destabilizing0.33Likely Benign-3.67Deleterious1.000Probably Damaging0.997Probably Damaging6.04Benign0.01Affected1-10.322.05
c.781G>T
D261Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D261Y missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are premPS and FATHMM, while the remaining tools—SGM‑Consensus, REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic effect; and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No prediction or folding stability result is missing or inconclusive beyond the stated uncertainties. Overall, the preponderance of evidence points to a pathogenic effect for D261Y, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-14.961Likely Pathogenic0.955Likely PathogenicAmbiguous0.886Likely Pathogenic0.04740.54762.93Destabilizing2.10.81Ambiguous1.87Ambiguous-0.12Likely Benign-5.50Deleterious1.000Probably Damaging0.997Probably Damaging5.73Benign0.01Affected-4-32.248.09
c.782A>C
D261A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D261A missense variant is not reported in ClinVar (status: None) and has no entries in gnomAD. Prediction tools that agree on a benign effect include premPS and FATHMM, while the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Given the preponderance of pathogenic predictions and the lack of conflicting evidence, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-11.426Likely Pathogenic0.913Likely PathogenicAmbiguous0.839Likely Pathogenic0.27850.45771.70Ambiguous0.31.46Ambiguous1.58Ambiguous0.04Likely Benign-4.59Deleterious0.999Probably Damaging0.994Probably Damaging5.80Benign0.04Affected0-25.3-44.01
c.782A>G
D261G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261G is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, while the remaining tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default) all predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Based on the aggregate predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-10.847Likely Pathogenic0.945Likely PathogenicAmbiguous0.850Likely Pathogenic0.29240.45622.81Destabilizing0.52.96Destabilizing2.89Destabilizing0.21Likely Benign-4.77Deleterious0.997Probably Damaging0.989Probably Damaging5.81Benign0.02Affected1-13.1-58.04
c.782A>T
D261V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, and FATHMM, while those that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of available predictions lean toward pathogenicity, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.422514Uncertain0.8830.2640.125-12.138Likely Pathogenic0.923Likely PathogenicAmbiguous0.869Likely Pathogenic0.05530.47341.72Ambiguous0.6-0.68Ambiguous0.52Ambiguous-0.01Likely Benign-5.50Deleterious0.999Probably Damaging0.996Probably Damaging5.73Benign0.08Tolerated-2-37.7-15.96
c.783C>A
D261E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The high‑accuracy consensus from AlphaMissense‑Optimized and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) both indicate a benign outcome, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is inconclusive. Overall, the majority of evidence points to a benign impact. This assessment is consistent with the absence of ClinVar annotation and does not contradict any existing database status. Based on the predictions, the variant is most likely benign, and this does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.422514Uncertain0.8830.2640.125-2.646Likely Benign0.268Likely BenignLikely Benign0.377Likely Benign0.09630.43591.44Ambiguous0.80.79Ambiguous1.12Ambiguous-0.03Likely Benign0.20Neutral0.994Probably Damaging0.978Probably Damaging5.88Benign1.00Tolerated320.014.03
c.783C>G
D261E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D261E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. Protein‑stability calculations from FoldX and Rosetta are uncertain. Overall, the majority of evidence points to a benign impact, which is consistent with the absence of a ClinVar claim and gnomAD observation. Thus, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.422514Uncertain0.8830.2640.125-2.646Likely Benign0.268Likely BenignLikely Benign0.377Likely Benign0.09630.43591.44Ambiguous0.80.79Ambiguous1.12Ambiguous-0.03Likely Benign0.20Neutral0.994Probably Damaging0.978Probably Damaging5.88Benign1.00Tolerated320.014.03
c.784A>C
N262H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Rosetta, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. FoldX and Foldetta results are uncertain, providing no clear direction. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign impact for this variant, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.284882Structured0.399879Uncertain0.9120.2400.000-6.932Likely Benign0.154Likely BenignLikely Benign0.694Likely Pathogenic0.11220.48601.82Ambiguous0.50.41Likely Benign1.12Ambiguous0.33Likely Benign-3.44Deleterious0.999Probably Damaging0.994Probably Damaging5.81Benign0.41Tolerated210.323.04
c.784A>G
N262D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262D is reported in gnomAD (ID 6‑33437689‑A‑G) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions from FoldX, Rosetta, Foldetta, and FATHMM; pathogenic predictions from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is Uncertain, SGM‑Consensus remains Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not contradict any ClinVar classification because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.0006-33437689-A-G16.20e-7-13.363Likely Pathogenic0.848Likely PathogenicAmbiguous0.820Likely Pathogenic0.16960.25860.27Likely Benign0.10.36Likely Benign0.32Likely Benign1.16Destabilizing-4.31Deleterious0.997Probably Damaging0.980Probably Damaging5.85Benign0.05Affected3.4014120.00.98
c.784A>T
N262Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262Y is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, FATHMM, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Default) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of predictions (seven pathogenic vs. three benign) lean toward a pathogenic impact, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-12.177Likely Pathogenic0.490AmbiguousLikely Benign0.858Likely Pathogenic0.04450.38771.86Ambiguous0.50.52Ambiguous1.19Ambiguous0.36Likely Benign-6.48Deleterious0.999Probably Damaging0.996Probably Damaging5.85Benign0.01Affected-2-22.249.07
c.785A>C
N262T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262T has no ClinVar record and is not reported in gnomAD. Functional prediction tools cluster into three groups: benign predictions come from SIFT, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions arise from REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and ESM1b; the remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments further refine the picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta’s stability analysis is uncertain. Overall, the balance of evidence leans toward pathogenicity, with no conflict with ClinVar status (which is absent). Thus, the variant is most likely pathogenic based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-11.478Likely Pathogenic0.544AmbiguousLikely Benign0.723Likely Pathogenic0.10550.51641.40Ambiguous0.31.44Ambiguous1.42Ambiguous0.74Ambiguous-5.23Deleterious0.997Probably Damaging0.980Probably Damaging5.88Benign0.19Tolerated002.8-13.00
c.785A>G
N262S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant N262S is not listed in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools cluster into two groups: benign predictions come from SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions come from REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Uncertain results are reported by FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods give the following: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is uncertain. Consequently, the overall evidence is mixed, with a slight tilt toward pathogenicity because five tools predict pathogenic while four predict benign. The variant is most likely pathogenic based on the current predictions, and this assessment does not contradict ClinVar status, as the variant is not yet reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.284882Structured0.399879Uncertain0.9120.2400.000-8.841Likely Pathogenic0.182Likely BenignLikely Benign0.638Likely Pathogenic0.31010.51580.91Ambiguous0.20.90Ambiguous0.91Ambiguous0.69Ambiguous-4.31Deleterious0.997Probably Damaging0.970Probably Damaging5.84Benign0.16Tolerated112.7-27.03
c.785A>T
N262I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262I is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include premPS and FATHMM, whereas the majority of tools predict a pathogenic outcome: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are uncertain and therefore treated as unavailable. High‑accuracy methods give an uncertain result for AlphaMissense‑Optimized, a pathogenic consensus from SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an uncertain result for Foldetta. Overall, the evidence points to a pathogenic effect for the variant, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-15.203Likely Pathogenic0.868Likely PathogenicAmbiguous0.777Likely Pathogenic0.04490.46381.21Ambiguous0.40.54Ambiguous0.88Ambiguous0.09Likely Benign-7.79Deleterious0.999Probably Damaging0.994Probably Damaging5.88Benign0.01Affected-2-38.0-0.94
c.786T>A
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not present in gnomAD. Prediction tools that indicate a benign effect include FoldX, premPS, and FATHMM. Those that predict a pathogenic effect comprise REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as inconclusive. Overall, the majority of evidence points to a pathogenic impact for N262K. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.531Likely Pathogenic0.17990.34130.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected10-0.414.07
c.786T>G
N262K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant N262K has no ClinVar entry and is not reported in gnomAD. Functional prediction tools largely disagree: benign predictions come from FoldX, premPS, and FATHMM, while pathogenic predictions are made by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain results are reported by Rosetta and Foldetta. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as inconclusive. Taken together, the majority of evidence points to a pathogenic effect for N262K. This conclusion is consistent with the absence of a ClinVar classification, as there is no existing report to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.284882Structured0.399879Uncertain0.9120.2400.000-12.512Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.532Likely Pathogenic0.17990.34130.47Likely Benign0.21.00Ambiguous0.74Ambiguous0.33Likely Benign-5.13Deleterious0.997Probably Damaging0.986Probably Damaging5.84Benign0.02Affected10-0.414.07
c.1027G>A
V343I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343I is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33437932‑G‑A). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to “Likely Benign” (3 benign vs. 1 pathogenic). High‑accuracy assessments are consistent: AlphaMissense‑Optimized is benign; the SGM‑Consensus is likely benign; and Foldetta, combining FoldX‑MD and Rosetta outputs, is benign. Overall, the collective evidence strongly supports a benign classification, and this does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.291804Structured0.383911Uncertain0.8820.4970.250Uncertain 26-33437932-G-A16.20e-7-6.020Likely Benign0.117Likely BenignLikely Benign0.020Likely Benign0.10950.4536-0.27Likely Benign0.0-0.04Likely Benign-0.16Likely Benign-0.39Likely Benign-0.14Neutral0.159Benign0.084Benign1.98Pathogenic0.27Tolerated3.3725430.314.03240.2-26.9-0.20.2-0.20.2XPotentially BenignThe iso-propyl side chain of Val343, located in an anti-parallel β sheet strand (res. Gly341-Pro349), is packing against multiple hydrophobic residues of the C2 domain (e.g., Leu327, Leu274, Val365). In the variant simulations, the sec-butyl side chain of Ile343 is basically able to form the same interactions as valine due to its similar hydrophobic profile. The residue swap also does not seem to cause negative effects on the protein structure based on the simulations.
c.1027G>C
V343L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all predict benign or likely benign. Only FATHMM predicts a pathogenic outcome, while FoldX and Rosetta provide uncertain results and are therefore not considered decisive. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign. Overall, the majority of evidence supports a benign classification, and this is consistent with the absence of ClinVar reporting.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.291804Structured0.383911Uncertain0.8820.4970.250-6.268Likely Benign0.310Likely BenignLikely Benign0.033Likely Benign0.13610.5008-0.93Ambiguous0.20.66Ambiguous-0.14Likely Benign0.16Likely Benign-1.09Neutral0.005Benign0.013Benign2.12Pathogenic0.64Tolerated21-0.414.03
c.1027G>T
V343F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by REVEL and premPS, whereas pathogenic predictions are made by SIFT, polyPhen‑2 (HumDiv and HumVar), PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. No evidence from FoldX or Rosetta alone is available. Overall, the majority of predictions support a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-10.709Likely Pathogenic0.799Likely PathogenicAmbiguous0.324Likely Benign0.09150.45521.51Ambiguous0.41.28Ambiguous1.40Ambiguous0.23Likely Benign-3.37Deleterious0.976Probably Damaging0.759Possibly Damaging1.61Pathogenic0.01Affected-1-1-1.448.04
c.1028T>A
V343D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343D is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity uniformly indicate a deleterious effect: REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, PROVEAN, ESM1b, FATHMM, premPS, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. Rosetta and Foldetta, which evaluate protein‑folding stability, also predict a pathogenic outcome, while FoldX remains uncertain. No tool in the dataset predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta is pathogenic. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-15.523Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.530Likely Pathogenic0.17810.22611.57Ambiguous0.23.40Destabilizing2.49Destabilizing1.73Destabilizing-5.62Deleterious0.996Probably Damaging0.930Probably Damaging1.59Pathogenic0.00Affected-2-3-7.715.96
c.1028T>C
V343A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and AlphaMissense‑Optimized, whereas the remaining tools—SGM‑Consensus, FoldX (uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support this: AlphaMissense‑Optimized classifies the variant as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenicity. Overall, the preponderance of evidence points to a pathogenic effect for V343A, and this conclusion does not contradict the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.291804Structured0.383911Uncertain0.8820.4970.250-8.088Likely Pathogenic0.588Likely PathogenicLikely Benign0.218Likely Benign0.31370.33011.66Ambiguous0.12.33Destabilizing2.00Destabilizing1.69Destabilizing-3.15Deleterious0.826Possibly Damaging0.551Possibly Damaging1.63Pathogenic0.01Affected00-2.4-28.05
c.1028T>G
V343G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V343G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—classify the variant as pathogenic. AlphaMissense‑Optimized is uncertain, providing no definitive direction. High‑accuracy assessments further support pathogenicity: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Thus, the preponderance of evidence indicates that V343G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.291804Structured0.383911Uncertain0.8820.4970.250-11.332Likely Pathogenic0.926Likely PathogenicAmbiguous0.421Likely Benign0.19820.33412.49Destabilizing0.14.40Destabilizing3.45Destabilizing1.68Destabilizing-5.84Deleterious0.898Possibly Damaging0.996Probably Damaging1.60Pathogenic0.00Affected-1-3-4.6-42.08
c.151A>C
I51L
2D
AIThe SynGAP1 missense variant I51L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic prediction comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also indicates a benign outcome. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, has no available result for this variant. Overall, the consensus of the majority of tools and the high‑accuracy predictions point to a benign effect, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.454181Uncertain0.6060.7100.0000.408Likely Benign0.147Likely BenignLikely Benign0.080Likely Benign0.09240.39930.14Neutral0.000Benign0.001Benign4.35Benign0.00Affected22-0.70.00
c.151A>G
I51V
2D
AIThe SynGAP1 missense variant I51V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect. The variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.454181Uncertain0.6060.7100.000-3.397Likely Benign0.195Likely BenignLikely Benign0.065Likely Benign0.13300.3602-0.24Neutral0.004Benign0.007Benign4.26Benign0.00Affected43-0.3-14.03
c.151A>T
I51F
2D
AIThe SynGAP1 missense variant I51F is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, SGM‑Consensus indicates Likely Benign, and Foldetta results are unavailable. Overall, the preponderance of evidence points to a benign effect for I51F, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.454181Uncertain0.6060.7100.000-5.687Likely Benign0.526AmbiguousLikely Benign0.114Likely Benign0.05650.3070-0.87Neutral0.099Benign0.039Benign4.13Benign0.00Affected10-1.734.02
c.152T>A
I51N
2D
AIThe SynGAP1 missense variant I51N is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD: not present). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Foldetta, a protein‑folding stability method, has no available output for this variant. Consequently, the evidence is split evenly between benign and pathogenic predictions, with no decisive support from the most accurate methods. The variant is therefore inconclusive; it is not contradicted by any ClinVar record.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.454181Uncertain0.6060.7100.000-9.287Likely Pathogenic0.909Likely PathogenicAmbiguous0.155Likely Benign0.10050.0769-1.77Neutral0.704Possibly Damaging0.272Benign4.13Benign0.00Affected-2-3-8.00.94
c.152T>C
I51T
2D
AIThe SynGAP1 missense variant I51T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default, while AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Benign, AlphaMissense‑Optimized remains Uncertain, and no Foldetta stability result is available. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.454181Uncertain0.6060.7100.000-5.861Likely Benign0.881Likely PathogenicAmbiguous0.135Likely Benign0.11800.1265-1.07Neutral0.084Benign0.050Benign4.16Benign0.00Affected0-1-5.2-12.05
c.152T>G
I51S
2D
AIThe SynGAP1 missense variant I51S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The remaining tools, ESM1b and AlphaMissense‑Optimized, are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (2 benign vs. 1 pathogenic vote). Foldetta, a protein‑folding stability method, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.454181Uncertain0.6060.7100.000-7.603In-Between0.879Likely PathogenicAmbiguous0.220Likely Benign0.31420.0957-1.39Neutral0.182Benign0.099Benign4.15Benign0.00Affected-1-2-5.3-26.08
c.153C>G
I51M
2D
AIThe SynGAP1 missense variant I51M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized all classify the change as benign, while the only pathogenic call comes from SIFT. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, SGM‑Consensus indicates likely benign, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Based on the collective predictions, the I51M substitution is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.454181Uncertain0.6060.7100.000-4.732Likely Benign0.381AmbiguousLikely Benign0.093Likely Benign0.07640.3281-0.27Neutral0.099Benign0.075Benign4.13Benign0.00Affected21-2.618.03
c.154T>A
S52T
2D
AIThe SynGAP1 missense variant S52T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumVar and SIFT. The high‑accuracy consensus (SGM‑Consensus, derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. No Foldetta stability result is available. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.457753Uncertain0.4990.6770.000-5.731Likely Benign0.224Likely BenignLikely Benign0.070Likely Benign0.15050.67510.06Neutral0.140Benign0.481Possibly Damaging4.33Benign0.00Affected110.114.03
c.154T>C
S52P
2D
AIThe SynGAP1 missense variant S52P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all predict a pathogenic outcome. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic versus two benign votes); and Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic impact for S52P. This conclusion does not contradict ClinVar, as the variant has no existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.457753Uncertain0.4990.6770.000-10.007Likely Pathogenic0.797Likely PathogenicAmbiguous0.144Likely Benign0.22760.5909-1.28Neutral0.676Possibly Damaging0.693Possibly Damaging4.07Benign0.00Affected1-1-0.810.04
c.154T>G
S52A
2D
AIThe SynGAP1 missense variant S52A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool predicting a pathogenic outcome is SIFT. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely benign classification. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of available predictions strongly supports a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.291804Structured0.457753Uncertain0.4990.6770.000-5.326Likely Benign0.196Likely BenignLikely Benign0.040Likely Benign0.53890.5073Strenghten-0.69Neutral0.140Benign0.355Benign4.17Benign0.00Affected112.6-16.00
c.155C>G
S52W
2D
AIThe SynGAP1 missense variant S52W is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign). AlphaMissense‑Optimized is uncertain, and Foldetta results are unavailable. Overall, more tools (five) predict pathogenicity than benign (three), and no high‑accuracy consensus or folding‑stability evidence contradicts this trend. Thus, the variant is most likely pathogenic based on the available predictions, and this assessment does not conflict with the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.457753Uncertain0.4990.6770.000-8.649Likely Pathogenic0.909Likely PathogenicAmbiguous0.155Likely Benign0.05800.6254-1.85Neutral0.986Probably Damaging0.968Probably Damaging4.05Benign0.00Affected-2-3-0.199.14
c.155C>T
S52L
2D
AISynGAP1 missense variant S52L is listed in ClinVar with an uncertain significance and is present in the gnomAD database (ID 6‑33423564‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default; ESM1b remains uncertain. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also favors benign. The Foldetta protein‑folding stability analysis is unavailable for this variant. Overall, the collective evidence points to a likely benign effect, which does not contradict the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.291804Structured0.457753Uncertain0.4990.6770.000Uncertain 16-33423564-C-T16.20e-7-7.199In-Between0.688Likely PathogenicLikely Benign0.087Likely Benign0.09910.6100-1.41Neutral0.829Possibly Damaging0.706Possibly Damaging4.10Benign0.00Affected4.321-3-24.626.08
c.148A>C
I50L
2D
AIThe SynGAP1 missense variant I50L is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign, while the single pathogenic prediction comes from SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) is benign; Foldetta results are not available. Overall, the consensus of the available predictions indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-3.509Likely Benign0.300Likely BenignLikely Benign0.076Likely Benign0.07490.3247-0.73Neutral0.010Benign0.004Benign3.91Benign0.00Affected22-0.70.00
c.148A>G
I50V
2D
AIThe SynGAP1 missense variant I50V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus methods also support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Benign.” No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence indicates that I50V is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-1.051Likely Benign0.141Likely BenignLikely Benign0.082Likely Benign0.10910.3159-0.24Neutral0.000Benign0.001Benign4.18Benign0.00Affected43-0.3-14.03
c.148A>T
I50F
2D
AIThe SynGAP1 missense variant I50F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as Likely Benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact for I50F, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-5.631Likely Benign0.681Likely PathogenicLikely Benign0.100Likely Benign0.04830.2560-1.27Neutral0.334Benign0.074Benign3.75Benign0.00Affected10-1.734.02
c.149T>A
I50N
2D
AIThe SynGAP1 missense variant I50N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; ESM1b remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, whereas the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves as benign. Foldetta results are unavailable. Overall, the predictions are mixed, with an equal split between benign and pathogenic calls, but the most reliable single‑tool prediction (AlphaMissense‑Optimized) and the majority of individual tools lean toward pathogenicity. Thus, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.295083Structured0.449965Uncertain0.5450.7080.000-7.091In-Between0.962Likely PathogenicLikely Pathogenic0.135Likely Benign0.08240.0412-2.37Neutral0.842Possibly Damaging0.272Benign3.73Benign0.00Affected-2-3-8.00.94
c.149T>C
I50T
2D
AIThe SynGAP1 missense variant I50T is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools largely agree that the change is benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM all classify it as benign. In contrast, SIFT and AlphaMissense‑Default predict a pathogenic effect. AlphaMissense‑Optimized returns an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this variant. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, yields a “Likely Benign” verdict. High‑accuracy assessments therefore point to a benign outcome: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is benign, and Foldetta data are missing. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-5.121Likely Benign0.949Likely PathogenicAmbiguous0.128Likely Benign0.09500.0708-1.61Neutral0.092Benign0.037Benign3.76Benign0.00Affected0-1-5.2-12.05
c.149T>G
I50S
2D
AIThe SynGAP1 I50S missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM all classify it as benign. In contrast, SIFT and AlphaMissense‑Default predict a pathogenic impact. AlphaMissense‑Optimized yields an uncertain result, and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available prediction for this residue. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments therefore point to a benign outcome: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus is likely benign, and Foldetta data are missing. Based on the collective evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-4.257Likely Benign0.946Likely PathogenicAmbiguous0.209Likely Benign0.26260.0800-2.03Neutral0.334Benign0.099Benign3.74Benign0.00Affected-1-2-5.3-26.08
c.150C>G
I50M
2D
AIThe SynGAP1 missense variant I50M is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and SIFT, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from multiple prediction algorithms and high‑accuracy tools indicates that the I50M variant is most likely benign, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.295083Structured0.449965Uncertain0.5450.7080.000-5.707Likely Benign0.383AmbiguousLikely Benign0.030Likely Benign0.06030.2524-0.95Neutral0.637Possibly Damaging0.202Benign3.76Benign0.00Affected21-2.618.03
c.772C>A
R258S
2D
AIThe SynGAP1 missense variant R258S is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect are limited to FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the preponderance of evidence points to a pathogenic effect for R258S, and this conclusion is consistent with the absence of ClinVar annotation or gnomAD frequency data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.336Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.796Likely Pathogenic0.30570.38812.11Destabilizing0.81.29Ambiguous1.70Ambiguous1.14Destabilizing-4.92Deleterious0.997Probably Damaging0.987Probably Damaging5.89Benign0.01Affected0-13.7-69.11
c.772C>G
R258G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R258G is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining twelve tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify the variant as pathogenic; premPS remains uncertain. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a pathogenic verdict; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. No prediction is missing or inconclusive. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.239Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.788Likely Pathogenic0.31660.34472.42Destabilizing0.52.33Destabilizing2.38Destabilizing0.94Ambiguous-5.83Deleterious0.997Probably Damaging0.987Probably Damaging5.78Benign0.04Affected-3-24.1-99.14
c.772C>T
R258C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 R258C missense variant is listed in ClinVar with an “Uncertain” status and is present in gnomAD (variant ID 6‑33437677‑C‑T). Prediction tools that agree on a benign effect include only FATHMM. All other evaluated predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—indicate a pathogenic or likely pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which does not contradict its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250Uncertain 16-33437677-C-T16.20e-7-10.285Likely Pathogenic0.790Likely PathogenicAmbiguous0.771Likely Pathogenic0.33070.34111.17Ambiguous0.41.76Ambiguous1.47Ambiguous0.87Ambiguous-6.79Deleterious1.000Probably Damaging0.993Probably Damaging5.77Benign0.00Affected3.3915-3-47.0-53.05
c.773G>A
R258H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R258H is listed as Benign in ClinVar (ID 949697.0) and is present in gnomAD (6‑33437678‑G‑A). Prediction tools that agree on a benign effect include FATHMM and AlphaMissense‑Optimized. Those that predict a pathogenic effect are REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. Uncertain calls come from FoldX, Rosetta, Foldetta, and AlphaMissense‑Default. The high‑accuracy consensus (SGM) derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN yields a pathogenic verdict. AlphaMissense‑Optimized remains benign, while Foldetta is inconclusive. Overall, the majority of evidence points to a pathogenic impact, which contradicts the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.295083Structured0.293667Uncertain0.8940.2600.250Benign/Likely benign 36-33437678-G-A106.20e-6-10.533Likely Pathogenic0.525AmbiguousLikely Benign0.830Likely Pathogenic0.29250.19801.60Ambiguous0.61.00Ambiguous1.30Ambiguous1.47Destabilizing-4.06Deleterious1.000Probably Damaging0.991Probably Damaging5.77Benign0.01Affected3.3915201.3-19.05212.581.80.10.0-0.50.2XPotentially PathogenicThe guanidinium group of Arg258, located at the end of an α-β loop connecting the PH domain to the C2 domain (res. Lys251-Arg258), forms hydrogen bonds with the carboxamide groups of Asn727 and Asn729 side chains, as well as with the backbone carbonyl groups of Ala724, Leu725, and Asn727 in the WT simulations. Although the imidazole group of His258 can act as a hydrogen bond donor/acceptor, the swapped residue is unable to maintain an equally well-coordinated hydrogen bond network for linking the C2 and GAP domains in the variant simulations.
c.773G>C
R258P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R258P is not reported in ClinVar and has no entries in gnomAD. Consensus from multiple in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while only FATHMM predicts a benign outcome. Predictions of uncertain status come from FoldX, Rosetta, and Foldetta. High‑accuracy tools reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta remains inconclusive. Overall, the preponderance of evidence supports a pathogenic classification for R258P, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.250-14.293Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.924Likely Pathogenic0.21480.45571.26Ambiguous0.40.92Ambiguous1.09Ambiguous1.00Destabilizing-5.83Deleterious0.999Probably Damaging0.995Probably Damaging5.79Benign0.01Affected0-22.9-59.07
c.773G>T
R258L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R258L is not reported in ClinVar and is present in gnomAD (ID 6‑33437678‑G‑T). Prediction tools that agree on a benign effect include FoldX, Rosetta, FATHMM, and the combined Foldetta stability method. Tools that predict a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Two tools give inconclusive results: premPS and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a pathogenic impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.295083Structured0.293667Uncertain0.8940.2600.2506-33437678-G-T16.20e-7-13.302Likely Pathogenic0.905Likely PathogenicAmbiguous0.908Likely Pathogenic0.16060.46020.14Likely Benign0.20.10Likely Benign0.12Likely Benign0.52Ambiguous-5.90Deleterious0.997Probably Damaging0.987Probably Damaging5.84Benign0.01Affected3.3915-2-38.3-43.03
c.1408A>C
M470L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M470L is listed in ClinVar as benign (ClinVar ID 536996.0) and is present in gnomAD (variant ID 6‑33438440‑A‑C). Functional prediction tools cluster into two groups: benign predictions come from SIFT and AlphaMissense‑Optimized, while pathogenic predictions are made by REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No definitive folding‑stability change is reported by FoldX or Rosetta individually. Overall, the majority of predictive algorithms favor a pathogenic effect, directly contradicting the benign classification in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000Likely Benign 16-33438440-A-C16.20e-7-8.993Likely Pathogenic0.406AmbiguousLikely Benign0.678Likely Pathogenic0.11920.40710.73Ambiguous0.10.84Ambiguous0.79Ambiguous1.04Destabilizing-2.72Deleterious0.484Possibly Damaging0.654Possibly Damaging-1.22Pathogenic0.16Tolerated3.3734421.9-18.03225.317.90.00.0-0.80.5XPotentially BenignThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, Met470 also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the iso-butyl side chain of Leu470 packs similarly with the hydrophobic residues as methionine, resulting in no negative effects on the protein structure during the simulation.
c.1408A>G
M470V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M470V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Consensus from most in silico predictors indicates a pathogenic effect: SGM‑Consensus, REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM all score it as deleterious. Only two tools—SIFT and AlphaMissense‑Optimized—classify it as benign, while Rosetta and AlphaMissense‑Default remain inconclusive. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized reports a benign outcome, but the SGM‑Consensus (derived from a majority of pathogenic calls among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining pathogenic FoldX with uncertain Rosetta) both predict pathogenicity. Overall, the preponderance of evidence supports a likely pathogenic classification, which does not conflict with the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000Uncertain 1-8.856Likely Pathogenic0.478AmbiguousLikely Benign0.770Likely Pathogenic0.27100.32562.73Destabilizing0.11.88Ambiguous2.31Destabilizing1.31Destabilizing-3.58Deleterious0.999Probably Damaging0.993Probably Damaging-1.20Pathogenic0.15Tolerated3.3734122.3-32.06
c.1408A>T
M470L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M470L is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on benign effect include SIFT and AlphaMissense‑Optimized. Tools that agree on pathogenic effect include SGM Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. AlphaMissense‑Default, FoldX, Rosetta, and Foldetta are inconclusive and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, whereas the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is uncertain. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-8.993Likely Pathogenic0.406AmbiguousLikely Benign0.678Likely Pathogenic0.11920.40710.73Ambiguous0.10.84Ambiguous0.79Ambiguous1.04Destabilizing-2.72Deleterious0.484Possibly Damaging0.654Possibly Damaging-1.22Pathogenic0.16Tolerated3.3734421.9-18.03225.317.90.00.0-0.80.5XPotentially BenignThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, Met470 also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the iso-butyl side chain of Leu470 packs similarly with the hydrophobic residues as methionine, resulting in no negative effects on the protein structure during the simulation.
c.1409T>A
M470K
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant M470K is not reported in ClinVar (status: None) and is absent from gnomAD. Prediction tools cluster into two groups: the single benign call comes from SIFT, while all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—label the change as pathogenic or likely pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also reports pathogenic. Thus, the variant is most likely pathogenic based on the consensus of available predictions, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-14.327Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.823Likely Pathogenic0.11570.06562.77Destabilizing0.12.67Destabilizing2.72Destabilizing1.55Destabilizing-5.42Deleterious0.923Possibly Damaging0.922Probably Damaging-1.06Pathogenic0.20Tolerated0-1-5.8-3.02
c.1409T>C
M470T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M470T is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN)—all predict a pathogenic impact. High‑accuracy methods further support this: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus is “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding‑stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, which is consistent with the ClinVar “Uncertain” classification rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000Uncertain 1-8.104Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.763Likely Pathogenic0.17820.19503.19Destabilizing0.12.68Destabilizing2.94Destabilizing1.49Destabilizing-5.30Deleterious0.996Probably Damaging0.985Probably Damaging-1.08Pathogenic0.24Tolerated3.3734-1-1-2.6-30.09213.846.50.00.0-0.20.2XXPotentially PathogenicThe thioether group of Met470, located in the middle of an α helix (res. Ala461–Phe476), interacts with hydrophobic residues in the inter-helix space (e.g., Val473, Leu558, Cys576, Trp572) formed by two other α helices (res. Ser604–Arg581, res. Pro562–Arg579). In the WT simulations, the Met470 side chain also packs against the positively charged guanidinium groups of Arg575, Arg429, and Arg579, which form salt bridges with the negatively charged carboxylate groups of the Asp474 and Asp467 side chains at the protein surface. In the variant simulations, the hydroxyl group of the Thr470 side chain forms an H-bond with the backbone carbonyl group of Ser466 in the α helix, potentially lowering its structural integrity. Importantly, the hydroxyl group of Thr470 also forms an H-bond with the guanidinium group of Arg575, which helps it form a more permanent salt bridge with Asp467.
c.1409T>G
M470R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant M470R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include only SIFT, whereas all other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming consensus of pathogenic predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-13.161Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.823Likely Pathogenic0.13990.07572.75Destabilizing0.12.75Destabilizing2.75Destabilizing1.57Destabilizing-5.47Deleterious0.963Probably Damaging0.943Probably Damaging-1.19Pathogenic0.17Tolerated0-1-6.424.99
c.1410G>A
M470I
2D
AIThe SynGAP1 missense variant M470I is not reported in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the remaining tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic impact. Predictions marked as uncertain (AlphaMissense‑Optimized, FoldX, Rosetta, Foldetta, premPS) are treated as unavailable. High‑accuracy assessments show the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, while AlphaMissense‑Optimized and Foldetta are uncertain. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-9.474Likely Pathogenic0.936Likely PathogenicAmbiguous0.747Likely Pathogenic0.10610.28271.53Ambiguous0.71.34Ambiguous1.44Ambiguous0.84Ambiguous-3.55Deleterious0.833Possibly Damaging0.886Possibly Damaging-1.26Pathogenic0.07Tolerated212.6-18.03
c.1410G>C
M470I
2D
AIThe SynGAP1 missense variant M470I is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include only SIFT, whereas the remaining evidence—REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—predict pathogenicity. Results from high‑accuracy methods are mixed: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta is uncertain. Overall, the preponderance of predictions supports a pathogenic effect for M470I, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-9.474Likely Pathogenic0.936Likely PathogenicAmbiguous0.747Likely Pathogenic0.10610.28271.53Ambiguous0.71.34Ambiguous1.44Ambiguous0.84Ambiguous-3.55Deleterious0.833Possibly Damaging0.886Possibly Damaging-1.26Pathogenic0.07Tolerated212.6-18.03
c.1410G>T
M470I
2D
AIThe SynGAP1 missense variant M470I is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include only SIFT, whereas the remaining evidence—REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—predict pathogenicity. Results from high‑accuracy methods are mixed: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, and Foldetta is uncertain. Overall, the preponderance of predictions supports a pathogenic effect for M470I, and this assessment does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.351497Uncertain0.9080.2720.000-9.474Likely Pathogenic0.936Likely PathogenicAmbiguous0.747Likely Pathogenic0.10610.28271.53Ambiguous0.71.34Ambiguous1.44Ambiguous0.84Ambiguous-3.55Deleterious0.833Possibly Damaging0.886Possibly Damaging-1.26Pathogenic0.07Tolerated212.6-18.03
c.142T>A
F48I
2D
AIThe SynGAP1 missense variant F48I is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM, while SIFT and AlphaMissense‑Default predict a pathogenic impact. Two tools—ESM1b and AlphaMissense‑Optimized—return uncertain results. High‑accuracy assessments further clarify the variant’s likely benign nature: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, favors benign; AlphaMissense‑Optimized remains uncertain, and Foldetta (which would evaluate protein‑folding stability) is unavailable. Overall, the balance of evidence points to a benign classification, and this conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.298791Structured0.440452Uncertain0.5580.7070.125-7.994In-Between0.808Likely PathogenicAmbiguous0.108Likely Benign0.25610.2301-1.67Neutral0.092Benign0.050Benign3.99Benign0.00Affected101.7-34.02
c.142T>C
F48L
2D
AIThe SynGAP1 missense variant F48L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions lean toward a benign impact, but the high‑accuracy tools provide conflicting evidence and no Foldetta data is available. Thus, the variant is most likely benign based on the consensus of available predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.298791Structured0.440452Uncertain0.5580.7070.125-4.955Likely Benign0.956Likely PathogenicLikely Pathogenic0.108Likely Benign0.26410.3082-1.56Neutral0.022Benign0.016Benign4.16Benign0.00Affected201.0-34.02
c.142T>G
F48V
2D
AIThe SynGAP1 missense variant F48V is not reported in ClinVar and is absent from gnomAD. Consensus from routine in silico predictors shows six tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, AlphaMissense‑Optimized) classifying the change as benign, while two (SIFT, AlphaMissense‑Default) predict pathogenicity; ESM1b remains uncertain. High‑accuracy assessment further supports a benign outcome: AlphaMissense‑Optimized is benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a benign majority vote, and Foldetta data are unavailable. Consequently, the overall evidence points to a benign effect for F48V, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.298791Structured0.440452Uncertain0.5580.7070.125-7.591In-Between0.756Likely PathogenicLikely Benign0.144Likely Benign0.25330.2300-1.87Neutral0.092Benign0.037Benign4.00Benign0.00Affected-1-11.4-48.04
c.143T>A
F48Y
2D
AIThe SynGAP1 missense variant F48Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is Likely Benign. Foldetta results are unavailable. Overall, the majority of evidence indicates that F48Y is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.298791Structured0.440452Uncertain0.5580.7070.125-1.983Likely Benign0.124Likely BenignLikely Benign0.113Likely Benign0.16570.2778-0.20Neutral0.000Benign0.001Benign4.26Benign0.00Affected73-4.116.00
c.143T>C
F48S
2D
AIThe SynGAP1 missense variant F48S has no ClinVar assertion and is not reported in gnomAD. High‑accuracy predictors: AlphaMissense‑Optimized returned an uncertain classification; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely benign effect; Foldetta predictions are unavailable. Among the remaining tools, six predict benign (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM) while two predict pathogenic (SIFT, AlphaMissense‑Default). Based on the aggregate predictions, the variant is most likely benign; this is consistent with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.298791Structured0.440452Uncertain0.5580.7070.125-6.382Likely Benign0.916Likely PathogenicAmbiguous0.214Likely Benign0.45770.0901-2.25Neutral0.334Benign0.099Benign3.95Benign0.00Affected-3-2-3.6-60.10
c.143T>G
F48C
2D
AIThe SynGAP1 missense variant F48C is not reported in ClinVar (ClinVar ID = None) and has no entries in gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign (3 benign vs. 1 pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.298791Structured0.440452Uncertain0.5580.7070.125-5.950Likely Benign0.676Likely PathogenicLikely Benign0.153Likely Benign0.26570.1962-2.31Neutral0.953Possibly Damaging0.431Benign3.93Benign0.00Affected-4-2-0.3-44.04
c.144C>A
F48L
2D
AIThe SynGAP1 missense variant F48L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions lean toward a benign impact, but the high‑accuracy tools provide conflicting evidence and no Foldetta data is available. Thus, the variant is most likely benign based on the consensus of available predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.298791Structured0.440452Uncertain0.5580.7070.125-4.955Likely Benign0.956Likely PathogenicLikely Pathogenic0.052Likely Benign0.26410.3082-1.56Neutral0.022Benign0.016Benign4.16Benign0.00Affected201.0-34.02
c.144C>G
F48L
2D
AIThe SynGAP1 missense variant F48L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, while the SGM‑Consensus remains benign; Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of predictions lean toward a benign impact, but the high‑accuracy tools provide conflicting evidence and no Foldetta data is available. Thus, the variant is most likely benign based on the consensus of available predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.298791Structured0.440452Uncertain0.5580.7070.125-4.955Likely Benign0.956Likely PathogenicLikely Pathogenic0.053Likely Benign0.26410.3082-1.56Neutral0.022Benign0.016Benign4.16Benign0.00Affected201.0-34.02
c.2152C>A
L718I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718I is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus (Likely Pathogenic), FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Three tools (Foldetta, premPS, Rosetta) give uncertain results and are not considered evidence. High‑accuracy methods specifically show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Because the majority of reliable predictors (eight out of eleven) indicate pathogenicity, the variant is most likely pathogenic. This assessment does not contradict ClinVar, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-10.560Likely Pathogenic0.615Likely PathogenicLikely Benign0.296Likely Benign0.08760.32062.21Destabilizing0.21.37Ambiguous1.79Ambiguous0.89Ambiguous-1.90Neutral0.999Probably Damaging0.997Probably Damaging1.37Pathogenic0.00Affected220.70.00
c.2152C>G
L718V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718V is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL and AlphaMissense‑Optimized, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized reports benign, the SGM Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the preponderance of pathogenic predictions and the high‑accuracy consensus, the variant is most likely pathogenic; this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-11.585Likely Pathogenic0.693Likely PathogenicLikely Benign0.237Likely Benign0.14850.26563.15Destabilizing0.12.11Destabilizing2.63Destabilizing1.14Destabilizing-2.83Deleterious0.998Probably Damaging0.992Probably Damaging1.36Pathogenic0.00Affected210.4-14.03
c.2152C>T
L718F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718F lies in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools cluster into two groups: benign predictions are made only by REVEL, whereas the remaining tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict pathogenicity; premPS is uncertain and is not counted as evidence. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Based on the overwhelming consensus of these predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-11.302Likely Pathogenic0.982Likely PathogenicLikely Pathogenic0.347Likely Benign0.05900.29793.87Destabilizing0.22.64Destabilizing3.26Destabilizing0.78Ambiguous-3.73Deleterious1.000Probably Damaging0.997Probably Damaging1.32Pathogenic0.00Affected20-1.034.02
c.2153T>A
L718H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718H is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools cluster into two groups: the single benign predictor REVEL, and a consensus of pathogenic predictions from FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are inconclusive or missing. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-14.923Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.460Likely Benign0.10200.05263.84Destabilizing0.12.68Destabilizing3.26Destabilizing2.69Destabilizing-6.64Deleterious1.000Probably Damaging1.000Probably Damaging1.28Pathogenic0.00Affected-2-3-7.023.98
c.2153T>C
L718P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718P is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity are unanimous: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool in the dataset predicts a benign effect, so the benign‑prediction group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Consequently, the variant is most likely pathogenic based on the available predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-15.643Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.660Likely Pathogenic0.38540.12216.56Destabilizing0.19.69Destabilizing8.13Destabilizing2.35Destabilizing-6.64Deleterious1.000Probably Damaging1.000Probably Damaging1.28Pathogenic0.00Affected-3-3-5.4-16.04
c.2153T>G
L718R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L718R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.298791Structured0.438417Uncertain0.9660.3850.000-16.119Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.484Likely Benign0.12540.06005.90Destabilizing0.25.05Destabilizing5.48Destabilizing2.57Destabilizing-5.69Deleterious1.000Probably Damaging0.998Probably Damaging1.28Pathogenic0.00Affected-3-2-8.343.03
c.616A>C
I206L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206L is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and Foldetta. Those that predict a pathogenic effect are ESM1b and AlphaMissense‑Default. Uncertain or inconclusive results come from premPS, AlphaMissense‑Optimized, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta predicts a benign outcome. Overall, the majority of tools (seven benign vs two pathogenic) support a benign classification. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.298791Structured0.405123Uncertain0.8630.3910.125-9.488Likely Pathogenic0.790Likely PathogenicAmbiguous0.080Likely Benign0.06320.36080.05Likely Benign0.10.75Ambiguous0.40Likely Benign0.78Ambiguous-1.72Neutral0.004Benign0.012Benign3.78Benign0.08Tolerated22-0.70.00
c.616A>G
I206V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta. No tool predicts a pathogenic outcome; the only inconclusive results are from FoldX (uncertain) and Foldetta (uncertain). High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, while Foldetta remains uncertain. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.298791Structured0.405123Uncertain0.8630.3910.125-5.709Likely Benign0.165Likely BenignLikely Benign0.051Likely Benign0.08330.29201.22Ambiguous0.10.24Likely Benign0.73Ambiguous0.40Likely Benign-0.51Neutral0.001Benign0.007Benign4.27Benign0.53Tolerated43-0.3-14.03
c.616A>T
I206F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I206F missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FATHMM, and polyPhen‑2 HumVar. Those that predict a pathogenic effect comprise SGM‑Consensus, Foldetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta. Predictions that are uncertain or inconclusive are FoldX and premPS. High‑accuracy methods all support a deleterious outcome: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-12.669Likely Pathogenic0.961Likely PathogenicLikely Pathogenic0.133Likely Benign0.04280.27211.82Ambiguous0.43.39Destabilizing2.61Destabilizing0.70Ambiguous-3.40Deleterious0.838Possibly Damaging0.368Benign3.64Benign0.01Affected10-1.734.02
c.617T>A
I206N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I206N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL and FATHMM, while the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. No prediction or folding result is missing or inconclusive. Based on the overwhelming majority of pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-15.211Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.334Likely Benign0.06890.03402.98Destabilizing0.22.57Destabilizing2.78Destabilizing2.04Destabilizing-5.55Deleterious0.940Possibly Damaging0.641Possibly Damaging3.62Benign0.00Affected-2-3-8.00.94
c.617T>C
I206T
2D
AIThe SynGAP1 I206T missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. In contrast, the majority of tools predict a pathogenic impact: SGM‑Consensus (Likely Pathogenic), FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy methods give consistent results: AlphaMissense‑Optimized is pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overall evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because the variant is not currently listed.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-10.812Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.252Likely Benign0.08300.06692.43Destabilizing0.52.68Destabilizing2.56Destabilizing1.94Destabilizing-3.78Deleterious0.421Benign0.156Benign3.65Benign0.00Affected0-1-5.2-12.05
c.617T>G
I206S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I206S missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and polyPhen‑2 HumVar. All other evaluated algorithms (SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic or likely pathogenic impact. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, is pathogenic. Based on the preponderance of evidence from these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.298791Structured0.405123Uncertain0.8630.3910.125-13.711Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.251Likely Benign0.21890.07283.73Destabilizing0.33.89Destabilizing3.81Destabilizing1.74Destabilizing-4.86Deleterious0.838Possibly Damaging0.368Benign3.63Benign0.00Affected-1-2-5.3-26.08
c.618C>G
I206M
2D
AIThe SynGAP1 I206M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, and FATHMM, whereas tools that predict a pathogenic effect are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. With six pathogenic predictions versus four benign and three uncertain, the overall evidence leans toward pathogenicity. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.298791Structured0.405123Uncertain0.8630.3910.125-10.008Likely Pathogenic0.878Likely PathogenicAmbiguous0.085Likely Benign0.05760.27160.42Likely Benign0.61.21Ambiguous0.82Ambiguous1.08Destabilizing-2.42Neutral0.838Possibly Damaging0.467Possibly Damaging3.64Benign0.01Affected21-2.618.03
c.919T>A
F307I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307I is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign are FoldX, Rosetta, and Foldetta. Tools that predict it as pathogenic include SGM‑Consensus (Likely Pathogenic), REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments give AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Benign. Overall, the majority of predictions (10/13) indicate pathogenicity, while only three tools suggest benign. Therefore, the variant is most likely pathogenic based on current computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-13.114Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.632Likely Pathogenic0.25310.30360.49Likely Benign0.20.19Likely Benign0.34Likely Benign0.61Ambiguous-5.52Deleterious0.997Probably Damaging0.994Probably Damaging2.06Pathogenic0.01Affected101.7-34.02
c.919T>C
F307L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Rosetta and Foldetta, whereas the majority of tools predict it to be pathogenic: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (FoldX and premPS) give uncertain results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized and the SGM Consensus both indicate a likely pathogenic effect, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Overall, the bulk of evidence points to a pathogenic impact, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-10.173Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.597Likely Pathogenic0.28000.42070.54Ambiguous0.10.14Likely Benign0.34Likely Benign0.57Ambiguous-5.52Deleterious0.992Probably Damaging0.987Probably Damaging2.04Pathogenic0.01Affected201.0-34.02
c.919T>G
F307V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307V is not reported in ClinVar and has no entries in gnomAD. Prediction tools that indicate a benign effect include Rosetta and premPS, whereas the majority of other in silico predictors (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) and the consensus score SGM‑Consensus all classify the change as pathogenic or likely pathogenic. High‑accuracy methods give a pathogenic call from AlphaMissense‑Optimized, a likely pathogenic result from the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an inconclusive result from Foldetta (combining FoldX‑MD and Rosetta). No prediction is missing or inconclusive enough to alter the overall assessment. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-12.262Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.605Likely Pathogenic0.25230.33930.91Ambiguous0.10.10Likely Benign0.51Ambiguous0.36Likely Benign-6.43Deleterious0.997Probably Damaging0.992Probably Damaging2.29Pathogenic0.05Affected-1-11.4-48.04
c.920T>A
F307Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307Y is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas the majority of tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default) predict a pathogenic impact. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion does not contradict the ClinVar status, which currently contains no assertion for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-9.870Likely Pathogenic0.889Likely PathogenicAmbiguous0.596Likely Pathogenic0.15700.23250.36Likely Benign0.1-0.21Likely Benign0.08Likely Benign0.11Likely Benign-2.76Deleterious0.997Probably Damaging0.987Probably Damaging1.96Pathogenic0.05Affected73-4.116.00
c.920T>C
F307S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. In silico predictors that provide a definitive call all classify the variant as pathogenic: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a likely pathogenic verdict. Predictions that are inconclusive or uncertain include FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, while Foldetta (combining FoldX‑MD and Rosetta outputs) remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-12.282Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.766Likely Pathogenic0.45760.07581.58Ambiguous0.21.22Ambiguous1.40Ambiguous0.99Ambiguous-7.32Deleterious0.999Probably Damaging0.996Probably Damaging1.97Pathogenic0.01Affected-3-2-3.6-60.10
c.920T>G
F307C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 F307C missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). In silico predictors overwhelmingly indicate a deleterious effect: all tools that provide a definitive call—REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The only predictions that are inconclusive are FoldX, Rosetta, and Foldetta, which are treated as unavailable. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic status; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. **Based on the consensus of the available predictions, the variant is most likely pathogenic, and this assessment is not contradicted by any ClinVar status.**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-11.484Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.754Likely Pathogenic0.27290.16281.36Ambiguous0.11.44Ambiguous1.40Ambiguous1.05Destabilizing-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.92Pathogenic0.00Affected-4-2-0.3-44.04
c.921C>A
F307L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include Rosetta and Foldetta, whereas the majority of tools predict it to be pathogenic: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Two tools (FoldX and premPS) give uncertain results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized and the SGM Consensus both indicate a likely pathogenic effect, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign outcome. Overall, the bulk of evidence points to a pathogenic impact, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-10.173Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.529Likely Pathogenic0.28000.42070.54Ambiguous0.10.14Likely Benign0.34Likely Benign0.57Ambiguous-5.52Deleterious0.992Probably Damaging0.987Probably Damaging2.04Pathogenic0.01Affected201.0-34.02
c.921C>G
F307L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F307L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include Rosetta and Foldetta, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv/HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) classify the change as pathogenic. Uncertain results are reported by FoldX and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as likely pathogenic, and Foldetta as benign. Overall, the consensus of the majority of tools points to a pathogenic effect, and this is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.298791Structured0.327302Uncertain0.9000.3150.125-10.173Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.529Likely Pathogenic0.28000.42070.54Ambiguous0.10.14Likely Benign0.34Likely Benign0.57Ambiguous-5.52Deleterious0.992Probably Damaging0.987Probably Damaging2.04Pathogenic0.01Affected201.0-34.02
c.130T>A
W44R
2D
AIThe SynGAP1 W44R missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split, and Foldetta results are unavailable. Overall, the majority of tools (seven pathogenic vs. three benign) indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-4.850Likely Benign0.989Likely PathogenicLikely Pathogenic0.291Likely Benign0.42680.0749-5.06Deleterious0.943Possibly Damaging0.888Possibly Damaging3.16Benign0.00Affected2-3-3.6-30.03
c.130T>C
W44R
2D
AISynGAP1 W44R is not reported in ClinVar and is absent from gnomAD. Consensus from standard predictors shows a split: benign calls come from REVEL, ESM1b, and FATHMM, while pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessment focuses on AlphaMissense‑Optimized, which predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive, and Foldetta results are unavailable. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-4.850Likely Benign0.989Likely PathogenicLikely Pathogenic0.291Likely Benign0.42680.0749-5.06Deleterious0.943Possibly Damaging0.888Possibly Damaging3.16Benign0.00Affected2-3-3.6-30.03
c.130T>G
W44G
2D
AIThe SynGAP1 missense variant W44G is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta results are unavailable. Overall, more tools predict pathogenicity (5) than benign (3), and no ClinVar evidence contradicts this assessment. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-4.658Likely Benign0.850Likely PathogenicAmbiguous0.323Likely Benign0.41980.2164-4.80Deleterious0.659Possibly Damaging0.693Possibly Damaging3.16Benign0.00Affected-7-20.5-129.16
c.131G>C
W44S
2D
AIThe SynGAP1 missense variant W44S is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas a majority of tools (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default) predict a pathogenic impact; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is a 2‑vs‑2 tie, and Foldetta results are unavailable. Overall, the balance of evidence favors a pathogenic classification, and this assessment does not contradict any ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-5.113Likely Benign0.921Likely PathogenicAmbiguous0.275Likely Benign0.41390.2371-4.68Deleterious0.824Possibly Damaging0.775Possibly Damaging3.16Benign0.00Affected-2-30.1-99.14
c.131G>T
W44L
2D
AIThe SynGAP1 missense variant W44L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Consensus from standard predictors shows a split: benign calls come from REVEL, ESM1b, and FATHMM, while pathogenic calls come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized returns an uncertain result. High‑accuracy assessment is inconclusive: the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is a 2‑vs‑2 tie, and Foldetta stability analysis is unavailable. Overall, the balance of evidence favors a pathogenic interpretation, with no conflict with ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-5.743Likely Benign0.869Likely PathogenicAmbiguous0.211Likely Benign0.25840.3413-4.37Deleterious0.659Possibly Damaging0.693Possibly Damaging3.20Benign0.00Affected-2-24.7-73.05
c.132G>C
W44C
2D
AIThe SynGAP1 missense variant W44C is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of evaluated tools (seven pathogenic vs. three benign) indicate a pathogenic impact. Thus, the variant is most likely pathogenic, and this prediction does not contradict any ClinVar status because the variant has not yet been classified in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-6.216Likely Benign0.975Likely PathogenicLikely Pathogenic0.321Likely Benign0.35420.2370-4.70Deleterious0.943Possibly Damaging0.941Probably Damaging3.14Benign0.00Affected-8-23.4-83.07
c.132G>T
W44C
2D
AIThe SynGAP1 missense variant W44C is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized predicts pathogenic. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic vs. two benign). Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evaluated tools (seven pathogenic vs. three benign) indicate a pathogenic effect. This prediction is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.301917Structured0.431379Uncertain0.3770.7480.375-6.216Likely Benign0.975Likely PathogenicLikely Pathogenic0.321Likely Benign0.35420.2370-4.70Deleterious0.943Possibly Damaging0.941Probably Damaging3.14Benign0.00Affected-8-23.4-83.07
c.2032A>C
S678R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta predicts a benign effect. Overall, the majority of tools (8 benign vs. 4 pathogenic) support a benign classification. Thus, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.708Likely Pathogenic0.878Likely PathogenicAmbiguous0.106Likely Benign0.09500.3519-0.37Likely Benign0.20.48Likely Benign0.06Likely Benign0.32Likely Benign-2.07Neutral0.454Possibly Damaging0.057Benign3.44Benign0.02Affected0-1-3.769.11
c.2032A>G
S678G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, FATHMM, PROVEAN, PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, SIFT, REVEL, FoldX, premPS, and Foldetta. No tool predicts a pathogenic outcome; the only inconclusive result is from Rosetta, which is listed as “Uncertain.” High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.000-4.379Likely Benign0.069Likely BenignLikely Benign0.082Likely Benign0.28070.49610.24Likely Benign0.20.55Ambiguous0.40Likely Benign-0.24Likely Benign1.90Neutral0.000Benign0.001Benign3.43Benign1.00Tolerated100.4-30.03
c.2032A>T
S678C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678C is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, Foldetta, premPS, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Tools with uncertain results are Rosetta and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (2 benign vs. 1 pathogenic, 1 uncertain), and Foldetta also predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the preponderance of evidence indicates the variant is most likely benign, and this conclusion does not contradict any ClinVar status because the variant is not yet classified in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-7.879In-Between0.095Likely BenignLikely Benign0.094Likely Benign0.10800.58750.21Likely Benign0.20.55Ambiguous0.38Likely Benign0.35Likely Benign-3.31Deleterious0.947Possibly Damaging0.527Possibly Damaging3.37Benign0.01Affected0-13.316.06
c.2033G>A
S678N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678N is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33441292‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome. High‑accuracy assessments are consistent: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Benign; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. Overall, the variant is most likely benign, and this conclusion does not contradict ClinVar status, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.0006-33441292-G-A16.20e-7-3.355Likely Benign0.139Likely BenignLikely Benign0.067Likely Benign0.14350.4863-0.10Likely Benign0.1-0.47Likely Benign-0.29Likely Benign0.38Likely Benign-0.63Neutral0.001Benign0.002Benign3.43Benign0.14Tolerated3.431911-2.727.03
c.2033G>C
S678T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678T is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify the change as benign: REVEL, FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). No tool predicts pathogenicity. High‑accuracy assessments likewise support a benign effect: AlphaMissense‑Optimized is benign, the SGM Consensus is “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Based on the unanimous computational evidence, the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.301917Structured0.123585Uncertain0.6600.3210.000-5.389Likely Benign0.083Likely BenignLikely Benign0.053Likely Benign0.14940.63510.32Likely Benign0.10.41Likely Benign0.37Likely Benign0.14Likely Benign-1.82Neutral0.255Benign0.053Benign3.41Benign0.11Tolerated110.114.03
c.2033G>T
S678I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of evidence (10 benign vs. 3 pathogenic) supports a benign classification. This consensus does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.735Likely Pathogenic0.253Likely BenignLikely Benign0.119Likely Benign0.09410.59540.36Likely Benign0.3-0.01Likely Benign0.18Likely Benign-0.11Likely Benign-3.99Deleterious0.294Benign0.057Benign3.45Benign0.01Affected-1-25.326.08
c.2034C>A
S678R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678R is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Tools that predict a pathogenic effect are SIFT, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is classified as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta predicts a benign effect. Overall, the majority of evidence (8 benign vs. 4 pathogenic) supports a benign classification. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.708Likely Pathogenic0.878Likely PathogenicAmbiguous0.158Likely Benign0.09500.3519-0.37Likely Benign0.20.48Likely Benign0.06Likely Benign0.32Likely Benign-2.07Neutral0.454Possibly Damaging0.057Benign3.44Benign0.02Affected0-1-3.769.11
c.2034C>G
S678R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S678R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is classified as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta predicts a benign stability change. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.301917Structured0.123585Uncertain0.6600.3210.000-9.708Likely Pathogenic0.878Likely PathogenicAmbiguous0.157Likely Benign0.09500.3519-0.37Likely Benign0.20.48Likely Benign0.06Likely Benign0.32Likely Benign-2.07Neutral0.454Possibly Damaging0.057Benign3.44Benign0.02Affected0-1-3.769.11
c.2041G>A
G681S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, and FATHMM, while those that predict a pathogenic outcome are SGM‑Consensus, FoldX, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) yielding an uncertain result. Overall, the majority of tools lean toward pathogenicity, but the presence of a benign prediction from AlphaMissense‑Optimized and an uncertain Foldetta score leaves the assessment inconclusive. No ClinVar entry exists, so there is no contradiction with clinical database status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-9.913Likely Pathogenic0.716Likely PathogenicLikely Benign0.483Likely Benign0.25910.45842.11Destabilizing1.3-0.23Likely Benign0.94Ambiguous0.41Likely Benign-5.99Deleterious0.997Probably Damaging0.780Possibly Damaging3.45Benign0.08Tolerated10-0.430.03
c.2041G>C
G681R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681R is listed in gnomAD (6-33441300-G-C) but has no ClinVar entry. In silico predictors largely converge on a deleterious effect: benign calls are limited to FATHMM, whereas the remaining tools—SGM‑Consensus, REVEL, FoldX, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—report pathogenicity. premPS is inconclusive. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) indicates pathogenic folding instability. No prediction tool suggests a benign outcome, and the variant’s presence in gnomAD does not alter the consensus. Thus, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.0006-33441300-G-C16.20e-7-12.170Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.556Likely Pathogenic0.10220.38792.25Destabilizing1.75.46Destabilizing3.86Destabilizing0.99Ambiguous-7.98Deleterious0.999Probably Damaging0.928Probably Damaging3.42Benign0.00Affected3.4314-2-3-4.199.14
c.2041G>T
G681C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681C is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all classify it as pathogenic, while only FATHMM predicts a benign outcome. Uncertain calls come from FoldX, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments reinforce the pathogenic signal: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, Foldetta (combining FoldX‑MD and Rosetta) is pathogenic, and AlphaMissense‑Optimized remains inconclusive. Overall, the evidence strongly favors a pathogenic interpretation, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-12.374Likely Pathogenic0.941Likely PathogenicAmbiguous0.554Likely Pathogenic0.11940.38861.89Ambiguous1.32.63Destabilizing2.26Destabilizing0.66Ambiguous-8.98Deleterious1.000Probably Damaging0.959Probably Damaging3.33Benign0.00Affected-3-32.946.09
c.2042G>A
G681D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a deleterious effect: benign predictions come from REVEL and FATHMM, whereas the remaining 11 tools (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM‑Consensus score all predict pathogenicity. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized returns a pathogenic classification; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts a pathogenic effect. premPS is inconclusive and is treated as unavailable. Taken together, the overwhelming majority of evidence points to a pathogenic impact for G681D. This conclusion is consistent with the absence of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-12.451Likely Pathogenic0.966Likely PathogenicLikely Pathogenic0.471Likely Benign0.16970.16952.62Destabilizing1.54.54Destabilizing3.58Destabilizing0.96Ambiguous-6.98Deleterious0.999Probably Damaging0.840Possibly Damaging3.45Benign0.00Affected1-1-3.158.04
c.2042G>C
G681A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G681A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign calls come from REVEL, polyPhen‑2 HumVar, SIFT, and FATHMM, while pathogenic calls are made by PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. Predictions labeled uncertain include FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the preponderance of evidence points to a pathogenic effect for G681A. This conclusion is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-11.958Likely Pathogenic0.836Likely PathogenicAmbiguous0.354Likely Benign0.38790.44011.77Ambiguous1.00.89Ambiguous1.33Ambiguous0.68Ambiguous-5.99Deleterious0.968Probably Damaging0.427Benign3.41Benign0.07Tolerated102.214.03
c.2042G>T
G681V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G681V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; SGM‑Consensus predicts a likely pathogenic effect; Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic outcome. No other high‑confidence predictions are available. Taken together, the consensus of pathogenic predictions outweighs the single benign call, indicating that G681V is most likely pathogenic. This assessment is not contradicted by ClinVar, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.301917Structured0.140647Uncertain0.6940.3200.000-14.043Likely Pathogenic0.953Likely PathogenicAmbiguous0.572Likely Pathogenic0.13500.38403.21Destabilizing2.06.12Destabilizing4.67Destabilizing0.64Ambiguous-8.98Deleterious0.999Probably Damaging0.928Probably Damaging3.33Benign0.01Affected-1-34.642.08
c.1003C>A
R335S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R335S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, premPS, and SIFT; pathogenic predictions from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is labeled Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX or Rosetta alone is available. Based on the preponderance of pathogenic predictions and the high‑accuracy tools, the variant is most likely pathogenic, which is consistent with the absence of ClinVar reporting and gnomAD data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500-9.286Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.184Likely Benign0.25980.40050.68Ambiguous0.10.72Ambiguous0.70Ambiguous0.14Likely Benign-3.30Deleterious0.999Probably Damaging0.997Probably Damaging1.89Pathogenic0.11Tolerated0-13.7-69.11
c.1003C>G
R335G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R335G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, and SIFT, whereas those that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, more tools predict pathogenicity than benignity, and the high‑accuracy consensus also leans pathogenic. Therefore, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500-11.860Likely Pathogenic0.880Likely PathogenicAmbiguous0.194Likely Benign0.30000.35541.01Ambiguous0.10.44Likely Benign0.73Ambiguous0.20Likely Benign-4.77Deleterious0.999Probably Damaging0.997Probably Damaging2.01Pathogenic0.10Tolerated-3-24.1-99.14
c.1003C>T
R335C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R335C is listed in ClinVar with an uncertain significance (ClinVar ID 2835865.0) and is present in gnomAD (ID 6‑33437908‑C‑T). Functional prediction tools cluster into two groups: benign predictions come from REVEL and premPS, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive are AlphaMissense‑Optimized, FoldX, Rosetta, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion aligns with the ClinVar designation of uncertain significance, which does not contradict the prediction that the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500Uncertain 16-33437908-C-T16.20e-7-14.354Likely Pathogenic0.938Likely PathogenicAmbiguous0.277Likely Benign0.28820.32900.53Ambiguous0.10.85Ambiguous0.69Ambiguous0.46Likely Benign-5.69Deleterious1.000Probably Damaging0.998Probably Damaging1.67Pathogenic0.01Affected3.3822-3-47.0-53.05
c.1004G>A
R335H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R335H is listed in ClinVar with an uncertain significance and is present in gnomAD (variant ID 6-33437909‑G‑A). Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and Foldetta, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results are reported by FoldX, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels the variant as pathogenic, whereas Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts a benign effect. Overall, the preponderance of evidence points to a pathogenic impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500Uncertain 16-33437909-G-A21.24e-6-12.521Likely Pathogenic0.831Likely PathogenicAmbiguous0.132Likely Benign0.23160.23300.58Ambiguous0.10.22Likely Benign0.40Likely Benign0.72Ambiguous-3.02Deleterious1.000Probably Damaging0.998Probably Damaging1.70Pathogenic0.03Affected3.3822201.3-19.05242.482.1-2.40.6-0.10.1UncertainThe guanidinium group of Arg335, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Ala322-Asp330, res. Gly341-Pro349), faces the post-synaptic inner membrane surface. In the WT simulations, the Arg335 side chain dynamically forms salt bridges with the carboxylate groups of Asp322, Asp338, and Asp616. In contrast, the imidazole ring of His335, which is not double protonated and thus not positively charged in the variant simulations, continues to move dynamically without forming any lasting or strong interactions. Importantly, the positively charged arginine residues of the C2 domain are ideal membrane anchors for ensuring SynGAP-membrane association. However, this phenomenon cannot be addressed using solvent-only simulations.
c.1004G>C
R335P
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R335P has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and SIFT, whereas pathogenic predictions are reported by FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments give a more focused view: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts a pathogenic effect. Taken together, the majority of evidence points to a pathogenic impact for R335P, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500-13.952Likely Pathogenic0.948Likely PathogenicAmbiguous0.250Likely Benign0.18660.44973.23Destabilizing0.85.73Destabilizing4.48Destabilizing0.43Likely Benign-4.22Deleterious1.000Probably Damaging0.999Probably Damaging1.69Pathogenic0.09Tolerated0-22.9-59.07
c.1004G>T
R335L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R335L is not listed in ClinVar (ClinVar ID None) and has no reported allele in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, Foldetta, and premPS. Tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. AlphaMissense‑Optimized and FoldX are uncertain and are treated as unavailable for pathogenicity inference. High‑accuracy assessments: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign. Overall, the majority of predictions (8 pathogenic vs. 4 benign) indicate that the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar assertion is present.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.331028Uncertain0.4830.4280.500-13.226Likely Pathogenic0.938Likely PathogenicAmbiguous0.196Likely Benign0.13820.47530.51Ambiguous0.0-0.19Likely Benign0.16Likely Benign0.40Likely Benign-4.77Deleterious0.999Probably Damaging0.997Probably Damaging1.73Pathogenic0.04Affected-3-28.3-43.03
c.1081C>A
Q361K
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361K is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors indicates a benign effect: REVEL, FoldX, Rosetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all score the substitution as tolerated, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also classifies it as likely benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic outcome. High‑accuracy tools that integrate structural and evolutionary information—AlphaMissense‑Optimized, the SGM‑Consensus, and Foldetta (combining FoldX‑MD and Rosetta outputs)—all return benign predictions. No prediction or folding‑stability result is missing or inconclusive. Based on the aggregate evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.305330Structured0.427593Uncertain0.9450.5340.250-5.147Likely Benign0.286Likely BenignLikely Benign0.217Likely Benign0.17390.47010.17Likely Benign0.00.36Likely Benign0.27Likely Benign-0.44Likely Benign1.29Neutral0.969Probably Damaging0.930Probably Damaging1.73Pathogenic1.00Tolerated11-0.40.04
c.1081C>G
Q361E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Uncertain predictions come from Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, while Foldetta remains uncertain. Taken together, the majority of evidence supports a benign impact for Q361E, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.305330Structured0.427593Uncertain0.9450.5340.250-7.544In-Between0.289Likely BenignLikely Benign0.153Likely Benign0.12170.30180.29Likely Benign0.01.02Ambiguous0.66Ambiguous0.21Likely Benign-0.89Neutral0.969Probably Damaging0.930Probably Damaging1.70Pathogenic0.26Tolerated220.00.98
c.1082A>C
Q361P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361P is listed in ClinVar as Pathogenic (ClinVar ID 3235087.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and premPS. All other evaluated algorithms—FoldX, Rosetta, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy methods specifically give a pathogenic verdict: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is Pathogenic. Based on the overwhelming agreement of these predictions, the variant is most likely pathogenic, which is consistent with its ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.427593Uncertain0.9450.5340.250Likely Pathogenic 1-13.280Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.482Likely Benign0.19860.51513.12Destabilizing0.03.45Destabilizing3.29Destabilizing0.38Likely Benign-3.03Deleterious0.996Probably Damaging0.979Probably Damaging1.63Pathogenic0.05Affected3.3725-101.9-31.01
c.1082A>G
Q361R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q361R has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two groups: benign predictions include REVEL, SIFT, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Rosetta; pathogenic predictions come from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign; the SGM‑Consensus itself is benign; and Foldetta, which integrates FoldX‑MD (Uncertain) and Rosetta (Benign), yields a benign prediction. Overall, the consensus of available computational evidence indicates that the variant is most likely benign, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.305330Structured0.427593Uncertain0.9450.5340.250-6.898Likely Benign0.289Likely BenignLikely Benign0.296Likely Benign0.13210.2955-0.88Ambiguous0.0-0.07Likely Benign-0.48Likely Benign-0.20Likely Benign-0.56Neutral0.987Probably Damaging0.953Probably Damaging1.71Pathogenic0.41Tolerated11-1.028.06
c.1082A>T
Q361L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Q361L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools (8 benign vs 5 pathogenic) favor a benign effect, and this consensus does not contradict the absence of a ClinVar classification. Thus, the variant is most likely benign based on current predictions, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.305330Structured0.427593Uncertain0.9450.5340.250-10.678Likely Pathogenic0.238Likely BenignLikely Benign0.406Likely Benign0.07200.52130.12Likely Benign0.10.46Likely Benign0.29Likely Benign0.21Likely Benign-3.95Deleterious0.987Probably Damaging0.953Probably Damaging1.71Pathogenic0.06Tolerated-2-27.3-14.97
c.1083G>C
Q361H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—FoldX, Rosetta, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also unavailable. Overall, the majority of conventional predictors lean toward pathogenicity, while the single high‑accuracy tool suggests benign. No ClinVar annotation exists to contradict these findings. Thus, based on the collective evidence, the variant is most likely pathogenic, with no conflict with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.305330Structured0.427593Uncertain0.9450.5340.250-7.269In-Between0.410AmbiguousLikely Benign0.281Likely Benign0.13520.41510.68Ambiguous0.10.52Ambiguous0.60Ambiguous0.32Likely Benign-2.73Deleterious0.996Probably Damaging0.986Probably Damaging1.79Pathogenic0.04Affected300.39.01
c.1083G>T
Q361H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Q361H is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. The remaining tools—FoldX, Rosetta, ESM1b, and AlphaMissense‑Default—return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also unavailable. Overall, the majority of conventional predictors (five pathogenic vs. three benign) lean toward a pathogenic interpretation, while the single high‑accuracy tool suggests benign. No ClinVar entry exists, so there is no contradiction with clinical database status. Based on the collective evidence, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.305330Structured0.427593Uncertain0.9450.5340.250-7.269In-Between0.410AmbiguousLikely Benign0.281Likely Benign0.13520.41510.68Ambiguous0.10.52Ambiguous0.60Ambiguous0.32Likely Benign-2.73Deleterious0.996Probably Damaging0.986Probably Damaging1.79Pathogenic0.04Affected300.39.01
c.1411T>A
S471T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only FATHMM predicts pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments reinforce this: AlphaMissense‑Optimized is benign; the SGM‑Consensus (3 benign vs. 1 pathogenic) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is benign. No prediction or stability result is inconclusive. Overall, the evidence overwhelmingly supports a benign classification, and this is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.305330Structured0.355411Uncertain0.8880.2610.000-5.780Likely Benign0.072Likely BenignLikely Benign0.257Likely Benign0.13070.50460.59Ambiguous0.2-0.47Likely Benign0.06Likely Benign0.20Likely Benign-1.96Neutral0.000Benign0.000Benign-1.18Pathogenic0.09Tolerated110.114.03
c.1411T>C
S471P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471P is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include only polyPhen‑2 HumVar, whereas the remaining evaluated algorithms (REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict a pathogenic or likely pathogenic outcome. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among the majority of tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.305330Structured0.355411Uncertain0.8880.2610.000-12.379Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.530Likely Pathogenic0.20070.47693.65Destabilizing0.29.24Destabilizing6.45Destabilizing0.84Ambiguous-4.03Deleterious0.552Possibly Damaging0.141Benign-1.31Pathogenic0.05Affected1-1-0.810.04
c.1411T>G
S471A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471A is not reported in ClinVar and is absent from gnomAD. Across the spectrum of in‑silico predictors, the majority (REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) classify the change as benign, whereas only FATHMM predicts it as pathogenic; Rosetta is inconclusive. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. No evidence suggests pathogenicity, and the predictions do not contradict the absence of ClinVar annotation. Therefore, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.305330Structured0.355411Uncertain0.8880.2610.000-5.516Likely Benign0.077Likely BenignLikely Benign0.252Likely Benign0.44390.36910.11Likely Benign0.1-0.61Ambiguous-0.25Likely Benign0.23Likely Benign-1.93Neutral0.010Benign0.037Benign-1.22Pathogenic0.29Tolerated112.6-16.00
c.1412C>A
S471Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, premPS, and AlphaMissense‑Optimized; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The high‑accuracy AlphaMissense‑Optimized scores the variant as benign, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—labels it as likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, returns an uncertain stability change. No evidence from ClinVar contradicts these computational assessments. Overall, the preponderance of pathogenic predictions and the SGM Consensus suggest the variant is most likely pathogenic, consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.305330Structured0.355411Uncertain0.8880.2610.000-11.257Likely Pathogenic0.493AmbiguousLikely Benign0.446Likely Benign0.06070.4417-0.33Likely Benign0.1-1.31Ambiguous-0.82Ambiguous0.19Likely Benign-4.79Deleterious0.980Probably Damaging0.584Possibly Damaging-1.27Pathogenic0.03Affected-3-2-0.576.10
c.1412C>G
S471C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471C is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33438444‑C‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of predictions (10 benign vs. 3 pathogenic) indicate that the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no reported pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.305330Structured0.355411Uncertain0.8880.2610.0006-33438444-C-G16.20e-7-3.454Likely Benign0.093Likely BenignLikely Benign0.273Likely Benign0.10480.49130.36Likely Benign0.0-0.05Likely Benign0.16Likely Benign0.07Likely Benign-2.90Deleterious0.000Benign0.001Benign-1.32Pathogenic0.01Affected3.3734-103.316.06
c.1412C>T
S471F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S471F is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, and AlphaMissense‑Optimized, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. The remaining tools—AlphaMissense‑Default, FoldX, Rosetta, and Foldetta—return uncertain or inconclusive results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized predicts a benign effect; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Taken together, the majority of evidence points toward a pathogenic impact for S471F, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.305330Structured0.355411Uncertain0.8880.2610.000-10.777Likely Pathogenic0.492AmbiguousLikely Benign0.423Likely Benign0.05530.4691-0.54Ambiguous0.1-1.51Ambiguous-1.03Ambiguous0.12Likely Benign-4.75Deleterious0.942Possibly Damaging0.487Possibly Damaging-1.26Pathogenic0.02Affected-3-23.660.10
c.124C>A
P42T
2D
AIThe SynGAP1 missense variant P42T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for P42T, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.375-3.626Likely Benign0.101Likely BenignLikely Benign0.109Likely Benign0.18340.4896-0.97Neutral0.909Possibly Damaging0.901Possibly Damaging4.29Benign0.00Affected0-10.93.99
c.124C>G
P42A
2D
AIThe SynGAP1 missense variant P42A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available. Overall, the majority of evidence—including the high‑accuracy tools—points to a benign effect for P42A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.375-3.945Likely Benign0.082Likely BenignLikely Benign0.051Likely Benign0.34410.4323-1.27Neutral0.805Possibly Damaging0.857Possibly Damaging4.32Benign0.00Affected1-13.4-26.04
c.124C>T
P42S
2D
AIThe SynGAP1 missense variant P42S is listed in gnomAD (ID 6‑33423533‑C‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are reported by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for P42S, and this conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.3756-33423533-C-T16.20e-7-3.472Likely Benign0.109Likely BenignLikely Benign0.048Likely Benign0.34620.4470-1.12Neutral0.909Possibly Damaging0.901Possibly Damaging4.24Benign0.00Affected4.321-110.8-10.04
c.125C>A
P42H
2D
AIThe SynGAP1 missense variant P42H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.375-3.088Likely Benign0.167Likely BenignLikely Benign0.140Likely Benign0.19950.3705-1.95Neutral0.992Probably Damaging0.977Probably Damaging4.16Benign0.00Affected0-2-1.640.02
c.125C>G
P42R
2D
AIThe SynGAP1 missense variant P42R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for P42R, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.375-2.498Likely Benign0.200Likely BenignLikely Benign0.087Likely Benign0.16190.3082-1.79Neutral0.972Probably Damaging0.954Probably Damaging4.20Benign0.00Affected0-2-2.959.07
c.125C>T
P42L
2D
AIThe SynGAP1 missense variant P42L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431487Uncertain0.4200.7710.375-3.781Likely Benign0.136Likely BenignLikely Benign0.077Likely Benign0.23120.5560-1.87Neutral0.909Possibly Damaging0.927Probably Damaging4.19Benign0.00Affected-3-35.416.04
c.127G>A
G43S
2D
AIThe SynGAP1 missense variant G43S is listed in ClinVar with an “Uncertain” status and is present in gnomAD (6‑33423536‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only SIFT predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (derived from the same four high‑accuracy tools) also as benign; Foldetta results are unavailable. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.375Uncertain 26-33423536-G-A16.20e-7-3.301Likely Benign0.078Likely BenignLikely Benign0.057Likely Benign0.25590.4064-0.30Neutral0.162Benign0.096Benign4.29Benign0.00Affected4.32110-0.430.03
c.127G>C
G43R
2D
AIThe SynGAP1 missense variant G43R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available. Overall, the majority of evidence points to a benign effect for G43R, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.375-2.104Likely Benign0.266Likely BenignLikely Benign0.085Likely Benign0.10250.3645-1.26Neutral0.870Possibly Damaging0.500Possibly Damaging4.22Benign0.00Affected-3-2-4.199.14
c.127G>T
G43C
2D
AIThe SynGAP1 missense variant G43C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.375-4.599Likely Benign0.109Likely BenignLikely Benign0.077Likely Benign0.14450.3438-0.90Neutral0.987Probably Damaging0.750Possibly Damaging4.18Benign0.00Affected-3-32.946.09
c.128G>A
G43D
2D
AIThe SynGAP1 missense variant G43D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, and this is consistent with the lack of any ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.375-5.867Likely Benign0.204Likely BenignLikely Benign0.082Likely Benign0.20180.2339-0.84Neutral0.870Possibly Damaging0.500Possibly Damaging4.21Benign0.00Affected1-1-3.158.04
c.128G>C
G43A
2D
AIThe SynGAP1 missense variant G43A is reported in gnomAD (variant ID 6-33423537‑G‑C) but has no ClinVar entry. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. Only SIFT predicts it to be pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus itself is likely benign; Foldetta results are not available. Overall, the preponderance of evidence points to a benign effect for G43A, and this conclusion does not contradict any ClinVar status, as none is currently assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.3756-33423537-G-C21.24e-6-3.925Likely Benign0.073Likely BenignLikely Benign0.026Likely Benign0.36770.3450-0.52Neutral0.001Benign0.005Benign4.29Benign0.00Affected4.321012.214.03
c.128G>T
G43V
2D
AIThe SynGAP1 missense variant G43V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only SIFT predicts a pathogenic outcome. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.308712Structured0.431462Uncertain0.3960.7620.375-3.745Likely Benign0.081Likely BenignLikely Benign0.115Likely Benign0.11560.3120-0.79Neutral0.320Benign0.140Benign4.28Benign0.00Affected-1-34.642.08
c.1588A>C
K530Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K530Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include FoldX, premPS, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Rosetta and Foldetta are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of tools (13/16) predict pathogenicity, whereas only three predict benign. Therefore, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.018455Uncertain0.8910.4090.000-10.593Likely Pathogenic0.574Likely PathogenicLikely Benign0.524Likely Pathogenic0.30010.09410.31Likely Benign0.00.87Ambiguous0.59Ambiguous0.13Likely Benign-3.18Deleterious0.698Possibly Damaging0.694Possibly Damaging-1.61Pathogenic0.01Affected110.4-0.04
c.1588A>G
K530E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K530E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include premPS and polyPhen‑2 HumVar, whereas a majority of tools predict a pathogenic impact: REVEL, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain, the SGM‑Consensus remains Likely Pathogenic, and Foldetta is uncertain. Overall, the preponderance of evidence points to a pathogenic effect for K530E. This conclusion is consistent with the lack of a ClinVar entry, so there is no contradiction with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.018455Uncertain0.8910.4090.000-14.450Likely Pathogenic0.951Likely PathogenicAmbiguous0.581Likely Pathogenic0.25050.08100.79Ambiguous0.21.27Ambiguous1.03Ambiguous0.43Likely Benign-3.45Deleterious0.703Possibly Damaging0.276Benign-1.57Pathogenic0.00Affected010.40.94
c.1589A>C
K530T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K530T missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include only premPS, whereas the remaining nine tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of the pathogenic‑predominant tools) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a deleterious impact. Consequently, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which currently contains no classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.018455Uncertain0.8910.4090.000-11.506Likely Pathogenic0.852Likely PathogenicAmbiguous0.610Likely Pathogenic0.13510.27801.06Ambiguous0.31.06Ambiguous1.06Ambiguous0.27Likely Benign-5.17Deleterious0.921Possibly Damaging0.950Probably Damaging-1.63Pathogenic0.00Affected0-13.2-27.07
c.1589A>G
K530R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K530R is catalogued in gnomAD (6‑33438832‑A‑G) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.308712Structured0.018455Uncertain0.8910.4090.0006-33438832-A-G16.19e-7-3.836Likely Benign0.081Likely BenignLikely Benign0.234Likely Benign0.32970.0716-0.02Likely Benign0.10.18Likely Benign0.08Likely Benign0.33Likely Benign-1.39Neutral0.000Benign0.002Benign-1.54Pathogenic0.08Tolerated3.373523-0.628.01
c.1589A>T
K530M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K530M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only premPS. Tools that agree on a pathogenic effect are REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Based on the predominance of pathogenic predictions and the SGM Consensus result, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.018455Uncertain0.8910.4090.000-12.235Likely Pathogenic0.953Likely PathogenicAmbiguous0.671Likely Pathogenic0.07450.31230.51Ambiguous0.01.26Ambiguous0.89Ambiguous0.24Likely Benign-5.17Deleterious0.999Probably Damaging0.988Probably Damaging-1.69Pathogenic0.00Affected0-15.83.02
c.1590G>C
K530N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K530N missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, Rosetta, and Foldetta, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus—predict a pathogenic or likely pathogenic outcome; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions (10/13) support pathogenicity, with only three tools indicating benign. Therefore, the variant is most likely pathogenic based on the available computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.018455Uncertain0.8910.4090.000-12.459Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.553Likely Pathogenic0.23500.10860.42Likely Benign0.10.23Likely Benign0.33Likely Benign0.56Ambiguous-4.18Deleterious0.950Possibly Damaging0.703Possibly Damaging-1.65Pathogenic0.00Affected100.4-14.07
c.1590G>T
K530N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K530N missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include FoldX, Rosetta, and Foldetta, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus—predict a pathogenic or likely pathogenic outcome; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta as benign. Overall, the majority of predictions (10/13) support pathogenicity, with only three tools indicating benign. Therefore, the variant is most likely pathogenic based on the available computational evidence, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.018455Uncertain0.8910.4090.000-12.459Likely Pathogenic0.960Likely PathogenicLikely Pathogenic0.553Likely Pathogenic0.23500.10860.42Likely Benign0.10.23Likely Benign0.33Likely Benign0.56Ambiguous-4.18Deleterious0.950Possibly Damaging0.703Possibly Damaging-1.65Pathogenic0.00Affected100.4-14.07
c.2131C>A
L711M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑vs‑2 split, and Foldetta reports an uncertain stability change, which is treated as unavailable evidence. Overall, the majority of individual predictors (six pathogenic vs. five benign) and the available high‑accuracy results lean toward a pathogenic interpretation. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.308712Structured0.377436Uncertain0.9500.3640.000-9.368Likely Pathogenic0.679Likely PathogenicLikely Benign0.216Likely Benign0.07550.27580.39Likely Benign0.01.11Ambiguous0.75Ambiguous1.40Destabilizing-1.86Neutral1.000Probably Damaging1.000Probably Damaging3.34Benign0.00Affected42-1.918.03
c.2131C>G
L711V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L711V is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33441596‑C‑G). Prediction tools that indicate a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—classify the change as pathogenic, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as likely pathogenic. High‑accuracy assessments further show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which does not conflict with the ClinVar designation of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000Uncertain16-33441596-C-G16.20e-7-10.045Likely Pathogenic0.709Likely PathogenicLikely Benign0.170Likely Benign0.13180.30103.48Destabilizing0.12.22Destabilizing2.85Destabilizing1.40Destabilizing-2.59Deleterious0.992Probably Damaging0.970Probably Damaging3.34Benign0.00Affected3.509120.4-14.03
c.2132T>A
L711Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711Q is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM. Tools that predict a pathogenic effect include FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, SGM Consensus, and Foldetta; Rosetta is uncertain. High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts Pathogenic, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. No predictions are missing or inconclusive. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-11.792Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.388Likely Benign0.10410.04882.93Destabilizing0.01.68Ambiguous2.31Destabilizing1.63Destabilizing-5.67Deleterious1.000Probably Damaging1.000Probably Damaging3.31Benign0.00Affected-2-2-7.314.97
c.2132T>C
L711P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change L711P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-12.128Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.375Likely Benign0.33000.09865.70Destabilizing0.18.15Destabilizing6.93Destabilizing2.09Destabilizing-6.59Deleterious1.000Probably Damaging1.000Probably Damaging3.28Benign0.00Affected-3-3-5.4-16.04
c.2132T>G
L711R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L711R lies in the GAP domain. ClinVar has no entry for this variant, and it is not present in gnomAD. Prediction tools that agree on a benign effect are REVEL and FATHMM; all other evaluated algorithms (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact, and the SGM‑Consensus score is “Likely Pathogenic.” High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the overwhelming majority of computational evidence, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.308712Structured0.377436Uncertain0.9500.3640.000-14.009Likely Pathogenic0.994Likely PathogenicLikely Pathogenic0.432Likely Benign0.13450.04883.71Destabilizing0.03.98Destabilizing3.85Destabilizing2.13Destabilizing-5.71Deleterious0.999Probably Damaging0.992Probably Damaging3.35Benign0.00Affected-3-2-8.343.03
c.121C>A
R41S
2D
AIThe SynGAP1 missense variant R41S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for R41S, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.311707Structured0.431757Uncertain0.3440.7650.375-3.367Likely Benign0.393AmbiguousLikely Benign0.130Likely Benign0.31900.5013-0.22Neutral0.686Possibly Damaging0.735Possibly Damaging4.24Benign0.00Affected0-13.7-69.11
c.121C>G
R41G
2D
AIThe SynGAP1 missense variant R41G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for R41G, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.311707Structured0.431757Uncertain0.3440.7650.375-3.737Likely Benign0.227Likely BenignLikely Benign0.086Likely Benign0.36200.4306-1.12Neutral0.686Possibly Damaging0.630Possibly Damaging4.16Benign0.00Affected-3-24.1-99.14
c.121C>T
R41C
2D
AIThe SynGAP1 missense variant R41C is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33423530‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and SIFT. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as benign, and no result is available from Foldetta (protein‑folding stability). Taken together, the majority of evidence points to a benign impact for R41C, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.311707Structured0.431757Uncertain0.3440.7650.375Conflicting 36-33423530-C-T74.34e-6-4.745Likely Benign0.207Likely BenignLikely Benign0.093Likely Benign0.34850.4520-1.10Neutral0.976Probably Damaging0.919Probably Damaging4.13Benign0.00Affected4.321-4-37.0-53.05
c.122G>A
R41H
2D
AIThe SynGAP1 missense variant R41H is reported in gnomAD (variant ID 6-33423531‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: the majority (REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a benign effect, while a minority (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT) predict pathogenicity. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized classifies the variant as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Benign. No Foldetta stability data are available, so it does not influence the overall assessment. Based on the preponderance of evidence from both general and high‑accuracy predictors, the variant is most likely benign, and this conclusion is not contradicted by any ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.311707Structured0.431757Uncertain0.3440.7650.3756-33423531-G-A63.72e-6-4.425Likely Benign0.106Likely BenignLikely Benign0.059Likely Benign0.33880.3065-0.74Neutral0.976Probably Damaging0.848Possibly Damaging4.17Benign0.00Affected4.321021.3-19.0510.1016/j.ajhg.2020.11.011
c.122G>C
R41P
2D
AIThe SynGAP1 missense variant R41P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for R41P, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.311707Structured0.431757Uncertain0.3440.7650.375-3.863Likely Benign0.307Likely BenignLikely Benign0.128Likely Benign0.22440.5735-0.70Neutral0.841Possibly Damaging0.809Possibly Damaging4.14Benign0.00Affected0-22.9-59.07
c.122G>T
R41L
2D
AIThe SynGAP1 missense variant R41L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (which is “Likely Benign”). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates likely benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for R41L, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.311707Structured0.431757Uncertain0.3440.7650.375-3.173Likely Benign0.261Likely BenignLikely Benign0.111Likely Benign0.21340.5868-0.58Neutral0.686Possibly Damaging0.630Possibly Damaging4.18Benign0.00Affected-3-28.3-43.03
c.1396T>A
S466T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S466T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Uncertain results come from Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Benign. Taken together, the majority of evidence points to a benign impact. Therefore, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.311707Structured0.322353Uncertain0.9330.2270.000-5.488Likely Benign0.314Likely BenignLikely Benign0.414Likely Benign0.09280.51520.30Likely Benign0.2-1.02Ambiguous-0.36Likely Benign-0.65Ambiguous1.05Neutral0.740Possibly Damaging0.872Possibly Damaging-1.51Pathogenic1.00Tolerated110.114.03
c.1396T>C
S466P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S466P is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect; the only inconclusive result is from premPS (Uncertain). High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts Pathogenic. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.311707Structured0.322353Uncertain0.9330.2270.000-13.107Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.811Likely Pathogenic0.16170.49152.67Destabilizing0.22.83Destabilizing2.75Destabilizing0.95Ambiguous-3.02Deleterious0.995Probably Damaging0.986Probably Damaging-1.55Pathogenic0.04Affected1-1-0.810.04
c.1396T>G
S466A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S466A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: pathogenic scores are given by REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM, whereas benign predictions come from SIFT, PROVEAN, premPS, ESM1b, Rosetta, Foldetta, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, the SGM‑Consensus itself is Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports Benign. FoldX alone is Uncertain, but this does not alter the overall consensus. Taken together, the majority of evidence indicates the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.311707Structured0.322353Uncertain0.9330.2270.000-6.928Likely Benign0.228Likely BenignLikely Benign0.537Likely Pathogenic0.42450.3996-0.50Ambiguous0.10.06Likely Benign-0.22Likely Benign0.37Likely Benign-1.46Neutral0.909Possibly Damaging0.987Probably Damaging-1.51Pathogenic0.10Tolerated112.6-16.00
c.1397C>T
S466L
2D
AIThe SynGAP1 missense variant S466L is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include FoldX, while the majority of tools predict a pathogenic impact: REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score. Tools with uncertain or inconclusive results are AlphaMissense‑Optimized, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for S466L. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.311707Structured0.322353Uncertain0.9330.2270.000-9.417Likely Pathogenic0.806Likely PathogenicAmbiguous0.768Likely Pathogenic0.06660.4884-0.36Likely Benign1.6-1.60Ambiguous-0.98Ambiguous-0.52Ambiguous-3.05Deleterious0.995Probably Damaging0.991Probably Damaging-1.56Pathogenic0.03Affected-3-24.626.08
c.997A>C
K333Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K333Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, while those that agree on a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Tools with inconclusive results are AlphaMissense‑Optimized, Foldetta, premPS, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign (combining FoldX‑MD and Rosetta outputs). Overall, the majority of evidence points toward a pathogenic classification, which does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.647Likely Pathogenic0.866Likely PathogenicAmbiguous0.444Likely Benign0.40150.12190.00Likely Benign0.10.51Ambiguous0.26Likely Benign0.76Ambiguous-3.11Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.08Tolerated110.4-0.04
c.997A>G
K333E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K333E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and SIFT. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points to a pathogenic impact for K333E. This conclusion is not contradicted by ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-14.059Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.488Likely Benign0.34290.1039-0.06Likely Benign0.20.30Likely Benign0.12Likely Benign0.89Ambiguous-3.21Deleterious0.999Probably Damaging0.995Probably Damaging1.91Pathogenic0.09Tolerated010.40.94
c.998A>C
K333T
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K333T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include Rosetta, Foldetta, premPS, and SIFT, whereas a larger set—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score—predict a pathogenic impact. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) reports a benign effect. Overall, the majority of evidence points to a pathogenic effect for K333T, and this conclusion does not conflict with any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.358Likely Pathogenic0.949Likely PathogenicAmbiguous0.506Likely Pathogenic0.18390.33540.51Ambiguous0.0-0.15Likely Benign0.18Likely Benign0.46Likely Benign-4.82Deleterious1.000Probably Damaging0.998Probably Damaging1.96Pathogenic0.08Tolerated0-13.2-27.07
c.998A>G
K333R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K333R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster into two groups: benign (REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus “Likely Benign”) and pathogenic (polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM). High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Benign”, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates benign stability. No prediction or folding result is missing or inconclusive. Overall, the majority of evidence points to a benign effect for K333R, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.311707Structured0.330781Uncertain0.5370.4470.500-4.897Likely Benign0.120Likely BenignLikely Benign0.232Likely Benign0.42940.1134-0.23Likely Benign0.00.15Likely Benign-0.04Likely Benign0.33Likely Benign-2.02Neutral0.999Probably Damaging0.995Probably Damaging2.01Pathogenic0.14Tolerated32-0.628.01
c.998A>T
K333I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K333I missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX and premPS, whereas the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict a pathogenic impact; Rosetta and Foldetta give uncertain results. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports it as Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-14.517Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.544Likely Pathogenic0.09310.35210.30Likely Benign0.00.95Ambiguous0.63Ambiguous0.43Likely Benign-6.49Deleterious1.000Probably Damaging0.999Probably Damaging1.89Pathogenic0.03Affected-2-38.4-15.01
c.999A>C
K333N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K333N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split opinion: benign predictions come from REVEL, FoldX, Rosetta, and SIFT, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy subset yields contrasting results: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus also indicates Likely Pathogenic, while Foldetta (combining FoldX‑MD and Rosetta stability outputs) predicts benign. premPS is inconclusive. Overall, the majority of tools lean toward pathogenicity, and the high‑accuracy predictions are not uniformly supportive of benign status. Therefore, K333N is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.821Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.359Likely Benign0.32670.13150.30Likely Benign0.10.42Likely Benign0.36Likely Benign0.55Ambiguous-4.03Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.13Tolerated100.4-14.07
c.999A>T
K333N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K333N has no ClinVar record and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and SIFT, whereas a larger group predicts pathogenicity: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The high‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates likely pathogenic, whereas Foldetta (combining FoldX‑MD and Rosetta outputs) reports a benign stability change. premPS is inconclusive and is treated as unavailable. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.311707Structured0.330781Uncertain0.5370.4470.500-11.821Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.366Likely Benign0.32670.13150.30Likely Benign0.10.42Likely Benign0.36Likely Benign0.55Ambiguous-4.03Deleterious1.000Probably Damaging0.998Probably Damaging1.91Pathogenic0.13Tolerated100.4-14.07
c.1201C>G
R401G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM; all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenic. Based on the overwhelming agreement among these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.000-13.353Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.741Likely Pathogenic0.35490.28663.06Destabilizing0.24.31Destabilizing3.69Destabilizing1.01Destabilizing-6.45Deleterious0.997Probably Damaging0.987Probably Damaging5.45Benign0.00Affected-3-24.1-99.14
c.1201C>T
R401W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401W is listed in gnomAD (ID 6‑33438106‑C‑T) but has no ClinVar entry. Functional prediction tools largely agree on a deleterious effect: pathogenic predictions are returned by REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). Only FATHMM predicts a benign outcome; all other tools are either pathogenic or inconclusive. High‑accuracy assessments reinforce this trend: AlphaMissense‑Optimized classifies the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Taken together, the overwhelming majority of predictions support a pathogenic effect, and this conclusion is not contradicted by ClinVar data, which currently contains no classification for the variant. Based on the aggregate predictions, the variant is most likely pathogenic, and this is consistent with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.0006-33438106-C-T21.24e-6-10.712Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.711Likely Pathogenic0.12520.37911.59Ambiguous0.21.04Ambiguous1.32Ambiguous0.73Ambiguous-7.34Deleterious1.000Probably Damaging0.993Probably Damaging5.40Benign0.00Affected3.3827-323.630.03
c.1202G>A
R401Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401Q is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33438107‑G‑A). Prediction tools that agree on a benign effect are limited to FATHMM, whereas the majority of algorithms (REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) predict a pathogenic impact. Uncertain results are reported by FoldX, Rosetta, and Foldetta. High‑accuracy methods reinforce the pathogenic prediction: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic,” and Foldetta’s stability assessment is inconclusive. Overall, the preponderance of evidence points to a pathogenic effect, which does not contradict the current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.000Uncertain 16-33438107-G-A-11.213Likely Pathogenic0.969Likely PathogenicLikely Pathogenic0.780Likely Pathogenic0.32340.22690.96Ambiguous0.11.50Ambiguous1.23Ambiguous1.20Destabilizing-3.69Deleterious0.999Probably Damaging0.978Probably Damaging5.47Benign0.04Affected3.3827111.0-28.06
c.1202G>C
R401P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while the remaining twelve tools—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. The high‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No predictions are missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.000-14.090Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.892Likely Pathogenic0.22650.40649.69Destabilizing0.38.07Destabilizing8.88Destabilizing0.77Ambiguous-6.45Deleterious0.999Probably Damaging0.995Probably Damaging5.42Benign0.00Affected0-22.9-59.07
c.1202G>T
R401L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R401L is not reported in ClinVar and is present in gnomAD (ID 6‑33438107‑G‑T). Prediction tools that classify the variant as benign include Rosetta, FATHMM, and premPS, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) indicate a pathogenic effect. High‑accuracy assessments further support a deleterious outcome: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. No evidence from FoldX alone is available. Based on the preponderance of pathogenic predictions and the corroborating high‑accuracy tools, R401L is most likely pathogenic; this assessment does not contradict any ClinVar status, as none is assigned.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.314870Structured0.424277Uncertain0.9610.4190.0006-33438107-G-T16.20e-7-12.280Likely Pathogenic0.972Likely PathogenicLikely Pathogenic0.858Likely Pathogenic0.19720.4263-1.52Ambiguous0.1-0.23Likely Benign-0.88Ambiguous0.22Likely Benign-6.42Deleterious0.997Probably Damaging0.987Probably Damaging5.44Benign0.02Affected3.3827-2-38.3-43.03
c.1840T>A
Y614N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y614N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas the majority of other in silico predictors (Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) indicate a pathogenic impact; FoldX is inconclusive and is treated as unavailable. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Taken together, the preponderance of evidence points to a pathogenic effect for Y614N, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-13.004Likely Pathogenic0.982Likely PathogenicLikely Pathogenic0.471Likely Benign0.19440.05731.32Ambiguous0.53.16Destabilizing2.24Destabilizing1.58Destabilizing-8.86Deleterious1.000Probably Damaging1.000Probably Damaging3.42Benign0.06Tolerated-2-2-2.2-49.07
c.1840T>C
Y614H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y614H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and Rosetta. Tools with uncertain or inconclusive results (FoldX, Foldetta, premPS) are not considered evidence for either side. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-9.678Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.397Likely Benign0.19480.03731.17Ambiguous0.52.38Destabilizing1.78Ambiguous0.91Ambiguous-4.95Deleterious1.000Probably Damaging1.000Probably Damaging3.58Benign0.27Tolerated02-1.9-26.03
c.1840T>G
Y614D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y614D is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM predicts it to be benign, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) all classify it as pathogenic. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-15.073Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.597Likely Pathogenic0.40130.05732.14Destabilizing0.64.16Destabilizing3.15Destabilizing1.69Destabilizing-9.83Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.02Affected-4-3-2.2-48.09
c.1841A>C
Y614S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y614S is not reported in ClinVar and is present in gnomAD (ID 6‑33440893‑A‑C). Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas the majority of algorithms—AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, PROVEAN, polyPhen‑2 (HumDiv and HumVar), premPS, Rosetta, Foldetta, and the SGM Consensus—indicate pathogenicity; FoldX remains uncertain. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized scores the variant as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labels it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a destabilizing, pathogenic effect. Overall, the preponderance of evidence points to a pathogenic classification, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.0006-33440893-A-C16.20e-7-12.709Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.482Likely Benign0.41550.12201.74Ambiguous0.43.25Destabilizing2.50Destabilizing2.05Destabilizing-8.83Deleterious1.000Probably Damaging1.000Probably Damaging3.48Benign0.09Tolerated3.3735-2-30.5-76.10
c.1841A>G
Y614C
2D
AIThe SynGAP1 missense variant Y614C is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are limited to FATHMM, whereas the remaining 13 tools (SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels it likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. Consequently, the variant is most likely pathogenic based on the collective predictions, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.182134Uncertain0.8520.2540.000-11.716Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.539Likely Pathogenic0.30810.16791.56Ambiguous0.73.21Destabilizing2.39Destabilizing1.76Destabilizing-8.83Deleterious1.000Probably Damaging1.000Probably Damaging3.41Benign0.02Affected0-23.8-60.04
c.1841A>T
Y614F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y614F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or unavailable results come from Foldetta, premPS, and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is unavailable. Overall, the majority of reliable predictors indicate a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.314870Structured0.182134Uncertain0.8520.2540.000-5.584Likely Benign0.630Likely PathogenicLikely Benign0.364Likely Benign0.19090.27620.09Likely Benign0.20.98Ambiguous0.54Ambiguous0.78Ambiguous-3.75Deleterious1.000Probably Damaging0.996Probably Damaging3.42Benign0.07Tolerated734.1-16.00
c.2140C>A
L714M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714M is not reported in ClinVar (no entry) and is absent from gnomAD. Benign predictions are provided by REVEL, FoldX, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (likely benign). Pathogenic predictions come from Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy tools give mixed results: AlphaMissense‑Optimized is uncertain; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely benign; Foldetta (combining FoldX‑MD and Rosetta) predicts pathogenic. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.314870Structured0.402311Uncertain0.9610.3690.000-0.989Likely Benign0.827Likely PathogenicAmbiguous0.249Likely Benign0.06870.26260.45Likely Benign0.04.49Destabilizing2.47Destabilizing1.00Destabilizing-1.86Neutral1.000Probably Damaging1.000Probably Damaging3.09Benign0.00Affected42-1.918.03
c.2140C>G
L714V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714V has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign). Overall, the majority of predictions (10 pathogenic vs. 4 benign) indicate a likely pathogenic impact. This conclusion is not contradicted by ClinVar status, which has no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.314870Structured0.402311Uncertain0.9610.3690.000-4.966Likely Benign0.781Likely PathogenicLikely Benign0.259Likely Benign0.14210.26893.91Destabilizing0.16.19Destabilizing5.05Destabilizing1.21Destabilizing-2.76Deleterious0.995Probably Damaging0.970Probably Damaging3.16Benign0.00Affected210.4-14.03
c.2141T>A
L714Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714Q is not reported in ClinVar (ClinVar: not reported) and is absent from gnomAD (gnomAD: not found). Prediction tools that agree on a benign effect are REVEL and FATHMM. All other evaluated tools—including FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion is not contradicted by the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.145Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.378Likely Benign0.10960.05582.91Destabilizing0.05.23Destabilizing4.07Destabilizing2.13Destabilizing-5.56Deleterious1.000Probably Damaging1.000Probably Damaging3.11Benign0.00Affected-2-2-7.314.97
c.2141T>C
L714P
2D
AIThe SynGAP1 missense variant L714P is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect are REVEL and FATHMM, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely pathogenic outcome; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, also classifies the variant as pathogenic. Based on the preponderance of evidence from these tools, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.562Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.441Likely Benign0.35720.12537.48Destabilizing1.913.54Destabilizing10.51Destabilizing2.26Destabilizing-6.44Deleterious1.000Probably Damaging1.000Probably Damaging3.08Benign0.00Affected-3-3-5.4-16.04
c.2141T>G
L714R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L714R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the remaining tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) uniformly predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No prediction or folding stability result is missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.314870Structured0.402311Uncertain0.9610.3690.000-12.763Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.402Likely Benign0.11860.05584.38Destabilizing0.27.54Destabilizing5.96Destabilizing2.09Destabilizing-5.62Deleterious0.999Probably Damaging0.992Probably Damaging3.09Benign0.00Affected-3-2-8.343.03
c.607G>A
D203N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D203N is reported in gnomAD (variant ID 6-33435249‑G‑A) and has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar; ESM1b is uncertain. The high‑accuracy consensus methods give a consistent benign signal: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports “Likely Benign,” and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts benign. No prediction or folding stability result is missing or inconclusive. Based on the aggregate evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.314870Structured0.427620Uncertain0.7400.4070.1256-33435249-G-A16.20e-7-7.465In-Between0.159Likely BenignLikely Benign0.121Likely Benign0.08000.4296-0.19Likely Benign0.1-0.12Likely Benign-0.16Likely Benign-0.03Likely Benign-2.26Neutral0.970Probably Damaging0.749Possibly Damaging4.06Benign0.06Tolerated3.4410120.0-0.98
c.607G>C
D203H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. No prediction or folding result is missing or inconclusive. Overall, the predictions are mixed, but the two high‑accuracy tools favor a benign outcome, giving a slight bias toward benign. Thus, the variant is most likely benign, and this assessment does not contradict the ClinVar status (which is currently unreported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.314870Structured0.427620Uncertain0.7400.4070.125-9.130Likely Pathogenic0.593Likely PathogenicLikely Benign0.218Likely Benign0.09620.48150.00Likely Benign0.10.18Likely Benign0.09Likely Benign-0.04Likely Benign-3.28Deleterious0.999Probably Damaging0.936Probably Damaging3.98Benign0.02Affected1-10.322.05
c.607G>T
D203Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203Y missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as benign. No prediction or folding result is missing or inconclusive. Overall, the majority of individual tools lean toward benign, and two of the three high‑accuracy methods also predict benign, so the variant is most likely benign. This assessment does not contradict ClinVar status, as no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.314870Structured0.427620Uncertain0.7400.4070.125-11.651Likely Pathogenic0.597Likely PathogenicLikely Benign0.260Likely Benign0.03820.4436-0.36Likely Benign0.00.09Likely Benign-0.14Likely Benign0.05Likely Benign-4.38Deleterious0.999Probably Damaging0.936Probably Damaging3.96Benign0.01Affected-4-32.248.09
c.608A>C
D203A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. All available predictions and stability analyses point to a benign impact. Therefore, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.314870Structured0.427620Uncertain0.7400.4070.125-6.807Likely Benign0.373AmbiguousLikely Benign0.174Likely Benign0.25270.41280.07Likely Benign0.10.49Likely Benign0.28Likely Benign0.12Likely Benign-3.34Deleterious0.941Possibly Damaging0.607Possibly Damaging4.05Benign0.17Tolerated0-25.3-44.01
c.608A>G
D203G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that classify the variant as benign include REVEL, FoldX, premPS, ESM1b, FATHMM, AlphaMissense‑Optimized, and Foldetta. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools give uncertain results: Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) resolves to benign (two benign vs. one pathogenic, one uncertain); and Foldetta also predicts benign. No prediction or folding stability result is missing or inconclusive. Overall, the majority of evidence supports a benign effect, and this is consistent with the lack of any ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.314870Structured0.427620Uncertain0.7400.4070.125-6.332Likely Benign0.350AmbiguousLikely Benign0.231Likely Benign0.27080.43120.07Likely Benign0.10.72Ambiguous0.40Likely Benign0.03Likely Benign-3.42Deleterious0.990Probably Damaging0.681Possibly Damaging4.01Benign0.04Affected1-13.1-58.04
c.608A>T
D203V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of tools and the SGM Consensus lean toward a pathogenic interpretation, whereas two high‑accuracy methods (AlphaMissense‑Optimized and Foldetta) suggest benign. Because ClinVar contains no entry for this variant, there is no contradiction between the predictions and existing clinical annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.314870Structured0.427620Uncertain0.7400.4070.125-10.660Likely Pathogenic0.523AmbiguousLikely Benign0.289Likely Benign0.05340.40840.32Likely Benign0.00.44Likely Benign0.38Likely Benign0.05Likely Benign-4.07Deleterious0.991Probably Damaging0.781Possibly Damaging3.98Benign0.02Affected-2-37.7-15.96
c.609T>A
D203E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203E missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two PolyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta)—all uniformly classify the variant as benign. No prediction or folding‑stability result is missing or inconclusive. Based on the consensus of the majority of tools and the unanimous high‑accuracy predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.314870Structured0.427620Uncertain0.7400.4070.125-4.067Likely Benign0.201Likely BenignLikely Benign0.152Likely Benign0.09750.41890.10Likely Benign0.00.08Likely Benign0.09Likely Benign-0.07Likely Benign-0.93Neutral0.990Probably Damaging0.675Possibly Damaging4.15Benign0.81Tolerated320.014.03
c.609T>G
D203E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D203E missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two PolyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy methods—AlphaMissense‑Optimized, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta)—all uniformly classify the variant as benign. No prediction or folding‑stability result is missing or inconclusive. Based on the consensus of the majority of tools and the unanimous high‑accuracy predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.314870Structured0.427620Uncertain0.7400.4070.125-4.067Likely Benign0.201Likely BenignLikely Benign0.152Likely Benign0.09750.41890.10Likely Benign0.00.08Likely Benign0.09Likely Benign-0.07Likely Benign-0.93Neutral0.990Probably Damaging0.675Possibly Damaging4.15Benign0.81Tolerated320.014.03
c.1006A>C
K336Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K336Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and polyPhen‑2 HumVar. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) as benign. Because the predictions are evenly split and the high‑accuracy methods give conflicting results, the variant is best classified as of uncertain significance. This assessment does not contradict any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.318242Structured0.338219Uncertain0.3960.4280.500-12.876Likely Pathogenic0.829Likely PathogenicAmbiguous0.211Likely Benign0.46980.15140.02Likely Benign0.0-0.17Likely Benign-0.08Likely Benign0.18Likely Benign-3.30Deleterious0.801Possibly Damaging0.252Benign1.58Pathogenic0.02Affected110.4-0.04
c.1006A>G
K336E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K336E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and polyPhen‑2 HumVar. Tools that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points toward a pathogenic impact for K336E, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.318242Structured0.338219Uncertain0.3960.4280.500-16.091Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.236Likely Benign0.40030.1082-0.28Likely Benign0.00.19Likely Benign-0.05Likely Benign0.35Likely Benign-3.43Deleterious0.625Possibly Damaging0.192Benign1.60Pathogenic0.01Affected010.40.94
c.1007A>C
K336T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K336T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and polyPhen‑2 HumVar. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy assessment shows AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points toward a pathogenic impact for K336T, and this conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.318242Structured0.338219Uncertain0.3960.4280.500-13.468Likely Pathogenic0.971Likely PathogenicLikely Pathogenic0.212Likely Benign0.20140.40480.33Likely Benign0.1-0.08Likely Benign0.13Likely Benign0.15Likely Benign-4.94Deleterious0.891Possibly Damaging0.315Benign1.58Pathogenic0.01Affected0-13.2-27.07
c.1007A>G
K336R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K336R is not reported in ClinVar (ClinVar status: not listed) but is present in the gnomAD database (gnomAD ID: 6‑33437912‑A‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool predicting a pathogenic outcome is FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, the SGM‑Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. No predictions or folding‑stability results are missing or inconclusive. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.318242Structured0.338219Uncertain0.3960.4280.5006-33437912-A-G16.20e-7-5.897Likely Benign0.089Likely BenignLikely Benign0.038Likely Benign0.48990.12400.00Likely Benign0.0-0.15Likely Benign-0.08Likely Benign0.52Ambiguous-2.01Neutral0.002Benign0.005Benign1.69Pathogenic0.12Tolerated3.382223-0.628.01
c.1007A>T
K336M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K336M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (REVEL, FoldX, premPS) and pathogenic predictions (SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized). The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is labeled “Likely Pathogenic.” Stability‑based assessments are inconclusive: Foldetta is uncertain, and Rosetta is also uncertain. High‑accuracy tools specifically indicate pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus confirms pathogenic, while Foldetta remains uncertain. Based on the overall pattern of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.318242Structured0.338219Uncertain0.3960.4280.500-15.395Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.301Likely Benign0.11850.47600.34Likely Benign0.10.82Ambiguous0.58Ambiguous-0.23Likely Benign-5.07Deleterious0.989Probably Damaging0.832Possibly Damaging1.53Pathogenic0.00Affected0-15.83.02
c.1008G>C
K336N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K336N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show discordant results: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, and polyPhen‑2 HumVar, whereas pathogenic predictions are reported by PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, indicates a likely pathogenic outcome. High‑accuracy assessments further highlight this split: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus also predicts likely pathogenic, while Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, predicts benign. No prediction or stability result is missing. Overall, the majority of tools and the high‑accuracy methods lean toward pathogenicity, which is consistent with the lack of ClinVar annotation and gnomAD absence. Thus, the variant is most likely pathogenic, and this prediction does not contradict ClinVar status because ClinVar has no entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.318242Structured0.338219Uncertain0.3960.4280.500-13.307Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.186Likely Benign0.37100.15990.20Likely Benign0.1-0.02Likely Benign0.09Likely Benign0.20Likely Benign-4.09Deleterious0.801Possibly Damaging0.315Benign1.59Pathogenic0.01Affected100.4-14.07
c.1008G>T
K336N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K336N is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and polyPhen‑2 HumVar. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (derived from the unanimous pathogenic vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of evidence points toward a pathogenic impact for K336N, and this conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.318242Structured0.338219Uncertain0.3960.4280.500-13.307Likely Pathogenic0.990Likely PathogenicLikely Pathogenic0.186Likely Benign0.37100.15990.20Likely Benign0.1-0.02Likely Benign0.09Likely Benign0.20Likely Benign-4.09Deleterious0.801Possibly Damaging0.315Benign1.59Pathogenic0.01Affected100.4-14.07
c.139C>G
R47G
2D
AIThe SynGAP1 missense variant R47G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the balance of evidence points to a benign impact for R47G, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.318242Structured0.436559Uncertain0.5200.7190.125-6.670Likely Benign0.616Likely PathogenicLikely Benign0.169Likely Benign0.34710.3758-1.79Neutral0.686Possibly Damaging0.630Possibly Damaging4.04Benign0.00Affected-3-24.1-99.14
c.139C>T
R47W
2D
AIThe SynGAP1 missense variant R47W is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33423548‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split; Foldetta results are unavailable. Overall, the majority of predictions (five pathogenic vs four benign) indicate a pathogenic impact. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.318242Structured0.436559Uncertain0.5200.7190.1256-33423548-C-T16.20e-7-9.201Likely Pathogenic0.752Likely PathogenicLikely Benign0.201Likely Benign0.11010.4158-2.17Neutral0.994Probably Damaging0.919Probably Damaging4.00Benign0.00Affected4.321-323.630.03
c.140G>A
R47Q
2D
AIThe SynGAP1 missense variant R47Q is listed in ClinVar (ID 436920.0) as Benign and is present in gnomAD (6‑33423549‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default is uncertain, and Foldetta results are unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Benign, and no Foldetta data to influence the conclusion. Overall, the majority of evidence points to a benign impact, consistent with the ClinVar classification; there is no contradiction with the reported ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.318242Structured0.436559Uncertain0.5200.7190.125Likely Benign 16-33423549-G-A42.48e-6-4.989Likely Benign0.347AmbiguousLikely Benign0.096Likely Benign0.33260.2591-0.57Neutral0.829Possibly Damaging0.614Possibly Damaging4.12Benign0.00Affected4.321111.0-28.0610.1016/j.ajhg.2020.11.011
c.140G>C
R47P
2D
AIThe SynGAP1 missense variant R47P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (two pathogenic, two benign) and therefore unavailable as evidence. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no reported result for this variant and is likewise unavailable. High‑accuracy tools specifically indicate a benign prediction from AlphaMissense‑Optimized, while the other high‑accuracy methods (SGM Consensus, Foldetta) provide no definitive assessment. Overall, the balance of evidence (five pathogenic vs. four benign predictions) suggests the variant is most likely pathogenic, and this conclusion does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.318242Structured0.436559Uncertain0.5200.7190.125-10.316Likely Pathogenic0.746Likely PathogenicLikely Benign0.195Likely Benign0.20500.4956-1.63Neutral0.841Possibly Damaging0.809Possibly Damaging4.02Benign0.00Affected0-22.9-59.07
c.140G>T
R47L
2D
AIThe SynGAP1 missense variant R47L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for R47L. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.318242Structured0.436559Uncertain0.5200.7190.125-5.758Likely Benign0.664Likely PathogenicLikely Benign0.130Likely Benign0.19040.5206-1.76Neutral0.686Possibly Damaging0.630Possibly Damaging4.04Benign0.00Affected-3-28.3-43.03
c.1585A>C
I529L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529L is listed in gnomAD (variant ID 6‑33438828‑A‑C) but has no ClinVar entry. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments further support benignity: AlphaMissense‑Optimized is benign; the SGM‑Consensus (majority vote) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is benign. No prediction or folding result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.0006-33438828-A-C16.20e-70.920Likely Benign0.066Likely BenignLikely Benign0.309Likely Benign0.08190.3789-0.13Likely Benign0.0-0.11Likely Benign-0.12Likely Benign-0.21Likely Benign0.00Neutral0.001Benign0.022Benign-1.24Pathogenic0.48Tolerated3.373522-0.70.00
c.1585A>G
I529V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529V is not reported in ClinVar (ClinVar status: not listed) but is present in gnomAD (gnomAD ID 6‑33438828‑A‑G). Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, the SGM Consensus is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Benign. Based on the collective predictions, the variant is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.0006-33438828-A-G16.20e-7-2.342Likely Benign0.068Likely BenignLikely Benign0.230Likely Benign0.10430.35260.18Likely Benign0.00.03Likely Benign0.11Likely Benign0.36Likely Benign-0.21Neutral0.019Benign0.014Benign-1.24Pathogenic1.00Tolerated3.373534-0.3-14.03
c.1585A>T
I529F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529F is not reported in ClinVar and is present in gnomAD (variant ID 6‑33438828‑A‑T). Consensus from most in‑silico predictors classifies the change as benign: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic effect. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign; the SGM Consensus is Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Overall, the preponderance of evidence indicates that I529F is most likely benign, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.0006-33438828-A-T42.48e-6-5.669Likely Benign0.235Likely BenignLikely Benign0.320Likely Benign0.05220.2713-0.21Likely Benign0.00.06Likely Benign-0.08Likely Benign0.06Likely Benign-0.97Neutral0.266Benign0.054Benign-1.30Pathogenic0.23Tolerated3.373501-1.734.02
c.1586T>A
I529N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign) all predict a neutral impact. In contrast, polyPhen‑2 (HumDiv and HumVar) and FATHMM predict a pathogenic outcome. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores the variant as benign; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates Likely Benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign effect. Taken together, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000-4.478Likely Benign0.283Likely BenignLikely Benign0.378Likely Benign0.07220.07000.12Likely Benign0.2-0.05Likely Benign0.04Likely Benign0.46Likely Benign-0.31Neutral0.997Probably Damaging0.952Probably Damaging-1.24Pathogenic0.20Tolerated-2-3-8.00.94
c.1586T>C
I529T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529T is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus “Likely Benign” call. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts benign. Overall, the majority of evidence points to a benign effect, and this is consistent with the ClinVar “Uncertain” classification—there is no contradiction between the predictions and the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000Uncertain 1-0.539Likely Benign0.336Likely BenignLikely Benign0.343Likely Benign0.08970.09890.22Likely Benign0.20.16Likely Benign0.19Likely Benign0.17Likely Benign0.24Neutral0.872Possibly Damaging0.820Possibly Damaging-1.23Pathogenic0.55Tolerated3.37350-1-5.2-12.05207.229.80.20.00.20.1XPotentially BenignIle529 is located on an α-α loop between the two α-helices (res. Gly502-Tyr518 and Ala533-Val560). In the WT simulations, the sec-butyl side chain of Ile529 faces the membrane interface and shows no specific interactions. In the variant simulations, the hydroxyl group of Thr529 forms a hydrogen bond with the carboxylate side chain of Asp527, but no negative structural changes are observed. However, due to its location near the SynGAP-membrane interface, the effect of the residue swap cannot be fully addressed using the SynGAP solvent-only simulations.
c.1586T>G
I529S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Foldetta, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) all indicate benign or likely benign. In contrast, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM predict pathogenicity, while Rosetta remains uncertain. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized scores benign, the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign stability. Overall, the majority of evidence supports a benign classification and is consistent with the absence of a ClinVar assertion. Therefore, the variant is most likely benign and does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.000-0.171Likely Benign0.197Likely BenignLikely Benign0.383Likely Benign0.24020.08870.13Likely Benign0.3-0.53Ambiguous-0.20Likely Benign0.00Likely Benign1.62Neutral0.979Probably Damaging0.820Possibly Damaging-1.14Pathogenic0.40Tolerated-1-2-5.3-26.08
c.1587C>G
I529M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I529M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome; Rosetta is uncertain and therefore treated as unavailable. High‑accuracy assessments—AlphaMissense‑Optimized, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta (combining FoldX‑MD and Rosetta outputs)—all uniformly indicate a benign effect. Consequently, the variant is most likely benign based on the collective predictions, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.318242Structured0.019545Uncertain0.9010.4030.0001.489Likely Benign0.063Likely BenignLikely Benign0.215Likely Benign0.06730.28760.10Likely Benign0.10.68Ambiguous0.39Likely Benign-0.17Likely Benign0.71Neutral0.035Benign0.063Benign-1.27Pathogenic0.15Tolerated21-2.618.03
c.1009A>C
K337Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K337Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, and Foldetta. Those that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as benign. Overall, the majority of predictions (8 pathogenic vs. 4 benign) indicate that the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-9.944Likely Pathogenic0.934Likely PathogenicAmbiguous0.305Likely Benign0.36720.12190.00Likely Benign0.00.88Ambiguous0.44Likely Benign0.43Likely Benign-3.48Deleterious0.999Probably Damaging0.997Probably Damaging1.70Pathogenic0.01Affected110.4-0.04
c.1009A>G
K337E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K337E missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and Foldetta. Those that predict a pathogenic impact comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). The premPS score is uncertain and does not influence the overall assessment. High‑accuracy analyses show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as benign. Based on the majority of predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-13.673Likely Pathogenic0.992Likely PathogenicLikely Pathogenic0.316Likely Benign0.31020.1039-0.05Likely Benign0.10.49Likely Benign0.22Likely Benign0.52Ambiguous-3.48Deleterious0.997Probably Damaging0.992Probably Damaging1.76Pathogenic0.02Affected010.40.94
c.1010A>C
K337T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K337T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two consensus groups: benign predictions come from REVEL, FoldX, and premPS, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Three tools report uncertainty: Rosetta, Foldetta, and AlphaMissense‑Optimized. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Pathogenic. In the high‑accuracy subset, AlphaMissense‑Optimized remains uncertain, SGM‑Consensus is Likely Pathogenic, and Foldetta is uncertain. Taken together, the majority of evidence points toward a deleterious effect. Therefore, K337T is most likely pathogenic, and this assessment does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-10.896Likely Pathogenic0.953Likely PathogenicAmbiguous0.338Likely Benign0.17410.33540.45Likely Benign0.21.33Ambiguous0.89Ambiguous0.25Likely Benign-5.32Deleterious0.999Probably Damaging0.997Probably Damaging1.70Pathogenic0.01Affected0-13.2-27.07
c.1010A>G
K337R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K337R has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into benign and pathogenic groups: benign predictions come from REVEL, FoldX, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta; pathogenic predictions come from polyPhen2_HumDiv, polyPhen2_HumVar, and FATHMM, while Rosetta remains uncertain. High‑accuracy methods reinforce the benign assessment: AlphaMissense‑Optimized predicts benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts benign. Consequently, the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.321458Structured0.348540Uncertain0.4490.4380.500-6.302Likely Benign0.249Likely BenignLikely Benign0.142Likely Benign0.39130.1134-0.30Likely Benign0.21.07Ambiguous0.39Likely Benign0.12Likely Benign-2.36Neutral0.997Probably Damaging0.992Probably Damaging1.70Pathogenic0.07Tolerated32-0.628.01
c.1010A>T
K337M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K337M missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that classify it as benign include REVEL, FoldX, premPS, and the protein‑folding stability method Foldetta. In contrast, the majority of in‑silico predictors flag it as pathogenic: SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Pathogenic” verdict. For high‑accuracy assessment, AlphaMissense‑Optimized remains pathogenic, the SGM‑Consensus also indicates likely pathogenic, whereas Foldetta predicts benign stability. No prediction is inconclusive; Rosetta is uncertain but not counted as evidence. Overall, the preponderance of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar classification because none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-13.406Likely Pathogenic0.984Likely PathogenicLikely Pathogenic0.345Likely Benign0.08620.38710.28Likely Benign0.10.61Ambiguous0.45Likely Benign-0.24Likely Benign-5.32Deleterious1.000Probably Damaging0.998Probably Damaging1.66Pathogenic0.00Affected0-15.83.02
c.1011G>C
K337N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K337N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, premPS, and SIFT. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions (seven pathogenic vs. five benign) and the high‑accuracy consensus lean toward a pathogenic impact. Thus, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-13.095Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.280Likely Benign0.29450.13150.12Likely Benign0.10.36Likely Benign0.24Likely Benign-0.02Likely Benign-4.38Deleterious0.999Probably Damaging0.997Probably Damaging1.87Pathogenic0.11Tolerated100.4-14.07
c.1011G>T
K337N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K337N is not reported in ClinVar and has no entries in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Rosetta, premPS, and SIFT, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. With seven tools supporting pathogenicity versus five supporting benign, the overall prediction leans toward pathogenic. No ClinVar entry contradicts this assessment, and the variant is absent from gnomAD, so the pathogenic prediction is not challenged by population data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.348540Uncertain0.4490.4380.500-13.095Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.280Likely Benign0.29450.13150.12Likely Benign0.10.36Likely Benign0.24Likely Benign-0.02Likely Benign-4.38Deleterious0.999Probably Damaging0.997Probably Damaging1.87Pathogenic0.11Tolerated100.4-14.07
c.1087T>A
Y363N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363N is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include only REVEL, which scores the variant as benign. All other evaluated algorithms—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify Y363N as pathogenic. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic, SGM‑Consensus (majority vote) predicts likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.435392Uncertain0.9540.5860.125-12.121Likely Pathogenic0.958Likely PathogenicLikely Pathogenic0.477Likely Benign0.31170.20212.06Destabilizing0.12.85Destabilizing2.46Destabilizing1.45Destabilizing-8.04Deleterious0.999Probably Damaging0.994Probably Damaging1.55Pathogenic0.01Affected-2-2-2.2-49.07
c.1087T>C
Y363H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, while the majority of other in silico predictors (Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, Foldetta) indicate a pathogenic impact; FoldX and ESM1b are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect for Y363H, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.435392Uncertain0.9540.5860.125-7.003In-Between0.747Likely PathogenicLikely Benign0.419Likely Benign0.32670.20211.75Ambiguous0.12.40Destabilizing2.08Destabilizing1.04Destabilizing-4.38Deleterious0.999Probably Damaging0.994Probably Damaging1.56Pathogenic0.01Affected02-1.9-26.03
c.1087T>G
Y363D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are none; all evaluated algorithms predict a deleterious impact. Pathogenic predictions come from SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.435392Uncertain0.9540.5860.125-13.840Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.635Likely Pathogenic0.47200.18532.86Destabilizing0.23.03Destabilizing2.95Destabilizing1.73Destabilizing-8.94Deleterious0.999Probably Damaging0.994Probably Damaging1.54Pathogenic0.00Affected-4-3-2.2-48.09
c.1088A>C
Y363S
2D
AIThe SynGAP1 missense variant Y363S is not reported in ClinVar (ClinVar status: none) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious outcome: the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Pathogenic”; AlphaMissense‑Optimized is classified as “Uncertain”; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a pathogenic effect. Taken together, the overwhelming majority of evidence points to a pathogenic effect for Y363S, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.435392Uncertain0.9540.5860.125-11.578Likely Pathogenic0.952Likely PathogenicAmbiguous0.420Likely Benign0.57500.4208Weaken3.09Destabilizing0.63.92Destabilizing3.51Destabilizing1.45Destabilizing-8.04Deleterious0.999Probably Damaging0.991Probably Damaging1.56Pathogenic0.01Affected-3-20.5-76.10
c.1088A>G
Y363C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363C is not reported in ClinVar (ClinVar ID: None) but is present in gnomAD (ID 6‑33437993‑A‑G). Prediction tools cluster into two groups: benign predictions come from REVEL and AlphaMissense‑Optimized, whereas the remaining tools—FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus—indicate pathogenicity. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. With the majority of evidence pointing to deleterious effects and no ClinVar annotation to contradict, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.435392Uncertain0.9540.5860.1256-33437993-A-G17.13e-7-9.059Likely Pathogenic0.721Likely PathogenicLikely Benign0.414Likely Benign0.37590.34632.21Destabilizing0.13.96Destabilizing3.09Destabilizing2.05Destabilizing-8.07Deleterious1.000Probably Damaging0.996Probably Damaging1.54Pathogenic0.00Affected3.3924-203.8-60.04
c.1088A>T
Y363F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y363F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, seven tools predict benign while four predict pathogenic, with no evidence of pathogenicity from the most accurate methods. Therefore, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.321458Structured0.435392Uncertain0.9540.5860.125-6.621Likely Benign0.114Likely BenignLikely Benign0.293Likely Benign0.27810.3583-0.23Likely Benign0.00.42Likely Benign0.10Likely Benign0.58Ambiguous-3.42Deleterious0.997Probably Damaging0.970Probably Damaging1.74Pathogenic0.18Tolerated734.1-16.00
c.1348G>A
A450T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450T missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Default) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Because the majority of conventional tools lean toward benign and no ClinVar evidence contradicts this, the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.306281Uncertain0.9630.2340.000-9.149Likely Pathogenic0.380AmbiguousLikely Benign0.233Likely Benign0.09430.59020.50Ambiguous0.20.98Ambiguous0.74Ambiguous0.81Ambiguous-3.35Deleterious0.996Probably Damaging0.973Probably Damaging3.40Benign0.06Tolerated10-2.530.03
c.1348G>C
A450P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450P missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL, SIFT, and FATHMM, whereas the majority of other in silico predictors (FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized) and the SGM Consensus score all classify the change as pathogenic. The high‑accuracy predictors give consistent pathogenic results: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. premPS remains uncertain. Based on the preponderance of pathogenic predictions, the variant is most likely pathogenic, which is consistent with the absence of a benign ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000-15.378Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.459Likely Benign0.14940.43092.75Destabilizing0.38.32Destabilizing5.54Destabilizing0.72Ambiguous-4.67Deleterious0.999Probably Damaging0.992Probably Damaging3.40Benign0.08Tolerated1-1-3.426.04
c.1348G>T
A450S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 A450S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The remaining methods—FoldX, Rosetta, Foldetta, and premPS—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie and thus unavailable; Foldetta is uncertain. Overall, the balance of evidence (five benign versus four pathogenic predictions, with three uncertain) suggests the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.306281Uncertain0.9630.2340.000-9.257Likely Pathogenic0.274Likely BenignLikely Benign0.268Likely Benign0.20030.43220.81Ambiguous0.01.35Ambiguous1.08Ambiguous0.69Ambiguous-2.70Deleterious0.965Probably Damaging0.972Probably Damaging3.47Benign0.10Tolerated11-2.616.00
c.1349C>A
A450E
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A450E is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that classify the variant as benign include SIFT and FATHMM, whereas the majority of tools predict it to be pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenicity. No predictions are inconclusive. Overall, the evidence strongly favors a pathogenic impact for A450E, which does not contradict the current ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000Uncertain 1-16.578Likely Pathogenic0.989Likely PathogenicLikely Pathogenic0.653Likely Pathogenic0.08230.16953.86Destabilizing0.25.23Destabilizing4.55Destabilizing1.59Destabilizing-4.67Deleterious0.999Probably Damaging0.992Probably Damaging3.38Benign0.07Tolerated3.37320-1-5.358.04240.1-82.60.00.00.70.0XXPotentially PathogenicThe methyl group of Ala450, located in an α helix (res. Asn440-Thr458), packs against hydrophobic residues in the inter-helix space (e.g., Leu692). In the variant simulations, the carboxylate group of the Glu450 side chain rotates outward, away from the hydrophobic niche, where it does not form any lasting salt bridges or H-bonds. Although the residue swap does not negatively affect the protein structure based on the simulations, it is possible that the introduction of the negatively charged residue adversely affects the folding process or tertiary assembly.
c.1349C>G
A450G
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant A450G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FATHMM, and AlphaMissense‑Optimized. The majority of other in silico predictors (SGM‑Consensus, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default) classify the variant as pathogenic; FoldX is inconclusive. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized predicts benign, but the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta) both predict pathogenic. Overall, the preponderance of evidence indicates that A450G is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.000-11.090Likely Pathogenic0.695Likely PathogenicLikely Benign0.355Likely Benign0.16700.30781.79Ambiguous0.02.29Destabilizing2.04Destabilizing1.23Destabilizing-3.82Deleterious0.998Probably Damaging0.980Probably Damaging3.40Benign0.04Affected10-2.2-14.03
c.1349C>T
A450V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant A450V is not reported in ClinVar and is present in gnomAD (ID 6‑33438254‑C‑T). Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give mixed results: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of tools lean toward a benign effect, and there is no ClinVar entry to contradict this assessment. Thus, the variant is most likely benign based on current predictions, with a single high‑accuracy tool suggesting pathogenicity but not overturning the overall benign consensus.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.306281Uncertain0.9630.2340.0006-33438254-C-T16.20e-7-11.489Likely Pathogenic0.578Likely PathogenicLikely Benign0.306Likely Benign0.07920.56380.04Likely Benign0.20.27Likely Benign0.16Likely Benign0.46Likely Benign-3.69Deleterious0.998Probably Damaging0.955Probably Damaging3.55Benign0.04Affected3.3732002.428.05
c.2128A>C
K710Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K710Q missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic predictions from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and ESM1b. The high‑accuracy AlphaMissense‑Optimized score classifies the variant as benign, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (uncertain), ESM1b (pathogenic), FATHMM (benign), and PROVEAN (pathogenic)—indicates pathogenicity. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts a benign effect. Overall, the majority of evidence points to a benign impact, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.321458Structured0.370438Uncertain0.9490.3680.000-8.920Likely Pathogenic0.372AmbiguousLikely Benign0.183Likely Benign0.30430.12140.12Likely Benign0.00.02Likely Benign0.07Likely Benign0.49Likely Benign-3.58Deleterious0.999Probably Damaging0.999Probably Damaging3.39Benign0.01Affected110.4-0.04
c.2128A>G
K710E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K710E missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, SIFT, and FATHMM, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and Foldetta as uncertain. Overall, the majority of evidence points toward a pathogenic effect. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-11.405Likely Pathogenic0.885Likely PathogenicAmbiguous0.178Likely Benign0.26550.07890.56Ambiguous0.00.94Ambiguous0.75Ambiguous0.39Likely Benign-3.53Deleterious0.998Probably Damaging0.991Probably Damaging3.45Benign0.08Tolerated010.40.94
c.2129A>C
K710T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K710T is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Pathogenic (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as uncertain (no definitive stability change). Other stability predictions (FoldX, Rosetta) are also uncertain and thus unavailable for interpretation. Overall, the majority of evidence points to a pathogenic impact. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-10.454Likely Pathogenic0.759Likely PathogenicLikely Benign0.305Likely Benign0.14870.30001.02Ambiguous0.01.57Ambiguous1.30Ambiguous0.21Likely Benign-5.45Deleterious0.999Probably Damaging1.000Probably Damaging3.41Benign0.06Tolerated0-13.2-27.07
c.2129A>G
K710R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K710R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments—all of which are available—show benign predictions: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) is benign. Based on the collective evidence, the variant is most likely benign, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignGAP0.321458Structured0.370438Uncertain0.9490.3680.000-6.295Likely Benign0.141Likely BenignLikely Benign0.209Likely Benign0.33510.07890.04Likely Benign0.0-0.14Likely Benign-0.05Likely Benign0.29Likely Benign-2.78Deleterious0.983Probably Damaging0.962Probably Damaging3.44Benign0.02Affected32-0.628.01
c.2129A>T
K710M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K710M missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, and FATHMM. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM Consensus as Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of individual predictors (seven pathogenic vs. six benign) and the SGM Consensus lean toward a pathogenic interpretation, while the high‑accuracy Foldetta result is contradictory. Based on the collective evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-13.081Likely Pathogenic0.822Likely PathogenicAmbiguous0.298Likely Benign0.08350.3444-0.13Likely Benign0.00.28Likely Benign0.08Likely Benign0.20Likely Benign-5.61Deleterious1.000Probably Damaging1.000Probably Damaging3.38Benign0.00Affected0-15.83.02
c.2130G>C
K710N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K710N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, premPS, and FATHMM, while pathogenic calls are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain or unavailable results are reported for FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence points to a pathogenic impact for K710N, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-9.330Likely Pathogenic0.943Likely PathogenicAmbiguous0.201Likely Benign0.24850.11240.85Ambiguous0.00.50Ambiguous0.68Ambiguous0.33Likely Benign-4.39Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.04Affected100.4-14.07
c.2130G>T
K710N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K710N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that indicate a benign effect include REVEL, premPS, and FATHMM. In contrast, a majority of algorithms predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy assessment shows AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not conflict with the ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.321458Structured0.370438Uncertain0.9490.3680.000-9.330Likely Pathogenic0.943Likely PathogenicAmbiguous0.201Likely Benign0.24850.11240.85Ambiguous0.00.50Ambiguous0.68Ambiguous0.33Likely Benign-4.39Deleterious1.000Probably Damaging0.998Probably Damaging3.42Benign0.04Affected100.4-14.07
c.2299A>C
I767L
2D
AIThe SynGAP1 missense variant I767L is not reported in ClinVar and is absent from gnomAD, indicating no documented allele frequency data. Functional prediction tools uniformly classify the variant as benign: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a benign effect. No tool in the dataset indicates pathogenicity. High‑accuracy assessments corroborate this benign prediction: AlphaMissense‑Optimized reports a benign outcome, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a “Likely Benign” classification. Foldetta results are not available, so they do not influence the assessment. Based on the collective predictions, the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-1.881Likely Benign0.112Likely BenignLikely Benign0.159Likely Benign0.10200.4317-0.73Neutral0.001Benign0.002Benign4.13Benign0.34Tolerated22-0.70.00
c.2299A>G
I767V
2D
AIThe SynGAP1 missense variant I767V is listed in ClinVar (ID 1402700.0) with an “Uncertain” clinical significance and is not reported in gnomAD. All evaluated in‑silico predictors classify the substitution as benign: REVEL, PROVEAN, PolyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all return benign scores. The SGM‑Consensus, which aggregates the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports a “Likely Benign” outcome. No tool predicts pathogenicity. High‑accuracy assessments confirm this: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, while Foldetta (combining FoldX‑MD and Rosetta stability predictions) has no available result for this variant. Overall, the computational evidence strongly supports a benign effect, and this conclusion does not contradict the current ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125Uncertain 1-2.791Likely Benign0.064Likely BenignLikely Benign0.096Likely Benign0.14180.42270.10Neutral0.072Benign0.029Benign4.21Benign1.00Tolerated3.64643-0.3-14.03
c.2299A>T
I767F
2D
AIThe SynGAP1 missense variant I767F is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta results are unavailable. Overall, the variant is most likely benign, and this conclusion does not contradict any ClinVar status, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-3.618Likely Benign0.162Likely BenignLikely Benign0.213Likely Benign0.06430.3567-1.37Neutral0.003Benign0.002Benign4.04Benign0.06Tolerated10-1.734.02
c.2300T>A
I767N
2D
AIThe SynGAP1 missense variant I767N is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while polyPhen‑2 (HumDiv and HumVar) predict a pathogenic outcome. AlphaMissense‑Default is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates a likely benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-5.117Likely Benign0.541AmbiguousLikely Benign0.122Likely Benign0.10390.1012-0.16Neutral0.977Probably Damaging0.632Possibly Damaging4.04Benign0.06Tolerated-2-3-8.00.94
c.2300T>C
I767T
2D
AIThe SynGAP1 missense variant I767T is listed in ClinVar (ID 1044161.0) with an “Uncertain” status and is not reported in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv flags the variant as pathogenic, creating a single discordant prediction. The high‑accuracy consensus from SGM (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a “Likely Benign” classification, and AlphaMissense‑Optimized also reports benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125Uncertain 1-3.749Likely Benign0.252Likely BenignLikely Benign0.138Likely Benign0.12740.1889-0.78Neutral0.625Possibly Damaging0.249Benign4.12Benign0.46Tolerated3.6460-1-5.2-12.05
c.2300T>G
I767S
2D
AIThe SynGAP1 missense variant I767S is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in‑silico tools cluster around a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all indicate benign. Only polyPhen‑2 HumDiv flags it as pathogenic, while AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign outcome. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus likewise indicates likely benign; Foldetta results are not available. Taken together, the preponderance of evidence points to a benign classification for I767S, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-3.030Likely Benign0.388AmbiguousLikely Benign0.126Likely Benign0.32420.1782-0.64Neutral0.925Possibly Damaging0.329Benign4.13Benign0.25Tolerated-1-2-5.3-26.08
c.2301C>G
I767M
2D
AIThe SynGAP1 missense variant I767M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign and the SGM‑Consensus is likely benign; Foldetta results are not available. Overall, the preponderance of evidence supports a benign classification for I767M, and this conclusion does not contradict any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.321458Structured0.927771Binding0.3690.8720.125-2.384Likely Benign0.084Likely BenignLikely Benign0.089Likely Benign0.07880.3377-0.60Neutral0.835Possibly Damaging0.486Possibly Damaging4.05Benign0.11Tolerated21-2.618.03
c.895C>A
R299S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 R299S is not reported in ClinVar and is absent from gnomAD. Among in‑silico predictors, benign calls come from REVEL and SIFT, while pathogenic calls are made by FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. Uncertain results are reported by Rosetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy methods give a pathogenic verdict: AlphaMissense‑Optimized is inconclusive, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) also predicts pathogenic. Overall, the evidence points to a pathogenic effect, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-7.276In-Between0.882Likely PathogenicAmbiguous0.241Likely Benign0.27800.50572.86Destabilizing0.31.46Ambiguous2.16Destabilizing1.07Destabilizing-3.20Deleterious0.999Probably Damaging0.997Probably Damaging1.75Pathogenic0.07Tolerated0-13.7-69.11
c.895C>G
R299G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R299G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and AlphaMissense‑Optimized, whereas the remaining 13 tools (FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized indicates a benign change, but the SGM‑Consensus (derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) and Foldetta (combining FoldX‑MD and Rosetta outputs) both predict pathogenicity. With the majority of evidence pointing to a damaging effect, the variant is most likely pathogenic. This conclusion is consistent with the lack of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-8.354Likely Pathogenic0.629Likely PathogenicLikely Benign0.248Likely Benign0.33610.41503.58Destabilizing0.23.16Destabilizing3.37Destabilizing1.37Destabilizing-3.84Deleterious0.999Probably Damaging0.997Probably Damaging1.79Pathogenic0.02Affected-3-24.1-99.14
c.895C>T
R299C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R299C is listed in ClinVar with an uncertain significance (ClinVar ID 1335623.0) and is present in gnomAD (ID 6‑33437800‑C‑T). Prediction tools that classify the variant as benign include REVEL, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as likely pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Other stability predictors (FoldX, Rosetta, premPS) are also uncertain. Overall, the balance of evidence favors a pathogenic interpretation, which does not contradict the ClinVar uncertain status but suggests a higher likelihood of disease relevance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500Conflicting 26-33437800-C-T31.86e-6-6.326Likely Benign0.572Likely PathogenicLikely Benign0.344Likely Benign0.30350.45641.85Ambiguous0.40.61Ambiguous1.23Ambiguous0.76Ambiguous-3.54Deleterious1.000Probably Damaging0.998Probably Damaging1.65Pathogenic0.06Tolerated3.3919-4-37.0-53.05210.791.30.10.00.00.2XXPotentially PathogenicThe guanidinium group of Arg299, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), forms hydrogen bonds that stabilize the tight turn. In the WT simulations, the Arg299 side chain hydrogen bonds with the loop backbone carbonyl groups (e.g., Ser302, Thr305, Leu274, Gly303), the hydroxyl group of Ser300, and even forms a salt bridge with the carboxylate group of Asp304.In the variant simulations, the thiol group of the Cys299 side chain is unable to form any of these well-coordinated or strong interactions, which could affect the initial formation of the secondary hairpin loop during folding. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Moreover, the positively charged Arg299 side chain faces the polar head group region of the inner leaflet membrane and could directly anchor the C2 domain to the membrane. In short, the residue swap could negatively affect both protein folding and the stability of the SynGAP-membrane association.
c.896G>A
R299H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R299H is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33437801‑G‑A). Functional prediction tools cluster into two groups: benign predictions from REVEL and AlphaMissense‑Optimized, and pathogenic predictions from FoldX, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; Rosetta, ESM1b, and AlphaMissense‑Default are inconclusive. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a tie between pathogenic and uncertain calls. Overall, the majority of evidence points to a pathogenic effect, which is consistent with the ClinVar uncertain designation rather than contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.321458Structured0.262979Uncertain0.8190.2950.500Conflicting 26-33437801-G-A106.20e-6-7.731In-Between0.388AmbiguousLikely Benign0.238Likely Benign0.32930.29823.97Destabilizing1.00.94Ambiguous2.46Destabilizing1.41Destabilizing-3.35Deleterious1.000Probably Damaging0.998Probably Damaging1.69Pathogenic0.02Affected3.3919201.3-19.05211.272.5-0.10.2-0.20.3XPotentially PathogenicThe guanidinium group of Arg299, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), forms hydrogen bonds that stabilize the tight turn. In the WT simulations, the Arg299 side chain hydrogen bonds with the loop backbone carbonyl groups (e.g., Ser302, Thr305, Leu274, Gly303), the hydroxyl group of Ser300, and even forms a salt bridge with the carboxylate group of Asp304.In the variant simulations, the imidazole ring of His299 (epsilon protonated state) hydrogen bonds with the carbonyl group of Asp304 and the hydroxyl group of Ser300. However, it does not form as many or as strong interactions as arginine, which could affect the initial formation of the secondary hairpin loop during folding. β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant.Additionally, His299 prefers to hydrophobically interact with other hydrophobic residues inside the C2 domain core (e.g., Val306, Leu274), which destabilizes the C2 domain. Indeed, the β strand partially unfolds during the second simulation. Moreover, the positively charged Arg299 side chain faces the polar head group region of the inner leaflet membrane and could directly anchor the C2 domain to the membrane. In short, the residue swap could negatively affect both protein folding and the stability of the SynGAP-membrane association.
c.896G>C
R299P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R299P is not reported in ClinVar or gnomAD, indicating no publicly available frequency data. Prediction tools cluster into benign and pathogenic groups: benign predictions include REVEL and AlphaMissense‑Optimized, while pathogenic predictions are made by FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen2_HumDiv, polyPhen2_HumVar, SIFT, FATHMM, and AlphaMissense‑Default; ESM1b is uncertain. The SGM‑Consensus label is Likely Pathogenic. High‑accuracy tools give a clear signal: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenic, and Foldetta also predicts pathogenic. Overall, the predictions strongly favor a pathogenic interpretation, with no ClinVar status to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-7.662In-Between0.722Likely PathogenicLikely Benign0.295Likely Benign0.20720.53794.10Destabilizing0.23.01Destabilizing3.56Destabilizing1.19Destabilizing-4.09Deleterious1.000Probably Damaging0.999Probably Damaging1.68Pathogenic0.02Affected0-22.9-59.07
c.896G>T
R299L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R299L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, ESM1b, and AlphaMissense‑Optimized. Those that predict pathogenicity are SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Stability‑based methods FoldX, Rosetta, Foldetta, and premPS returned uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the majority of consensus predictions favor a pathogenic effect, and the high‑accuracy tools do not overturn this trend. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists for R299L.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.321458Structured0.262979Uncertain0.8190.2950.500-5.171Likely Benign0.645Likely PathogenicLikely Benign0.356Likely Benign0.20270.52021.37Ambiguous0.60.77Ambiguous1.07Ambiguous0.59Ambiguous-4.03Deleterious0.999Probably Damaging0.997Probably Damaging1.65Pathogenic0.02Affected-3-28.3-43.03
c.1084T>A
W362R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-14.004Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.706Likely Pathogenic0.48110.05712.64Destabilizing0.33.90Destabilizing3.27Destabilizing1.10Destabilizing-12.87Deleterious0.999Probably Damaging0.996Probably Damaging1.28Pathogenic0.00Affected3.39242-3-3.6-30.03287.5-34.1-0.20.1-0.60.2XXXPotentially PathogenicThe indole ring of Trp362, located on the surface of an anti-parallel β sheet (res. Thr359-Pro364) in the C2 domain, stacks with nearby residues (e.g., Arg401, Arg272). In the variant simulations, the guanidinium group of the introduced residue Arg362 forms a salt bridge with the carboxylate group of Glu273 and, like Trp362, stacks with other arginine residues (e.g., Arg401, Arg272). This residue is at both the C2-membrane interface and the C2-RasGTPase interface, so the residue swap could potentially affect both interactions. However, these phenomena cannot be addressed using solvent-only simulations. Notably, Arg272, which stacks with both the non-mutated Trp362 and the mutated Arg362, forms a salt bridge directly with Asp105 of Ras in the WT simulations. Therefore, the residue swap could affect the C2 domain stability, the SynGAP-membrane association, and the SynGAP-Ras association.10.1016/j.ajhg.2020.11.011
c.1084T>C
W362R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362R (ClinVar ID 41461.0) is listed as Pathogenic and is not reported in gnomAD. All available in silico predictors classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments concur: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125Pathogenic 2-14.004Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.706Likely Pathogenic0.48110.05712.64Destabilizing0.33.90Destabilizing3.27Destabilizing1.10Destabilizing-12.87Deleterious0.999Probably Damaging0.996Probably Damaging1.28Pathogenic0.00Affected3.39242-3-3.6-30.03287.5-34.1-0.20.1-0.60.2XXXPotentially PathogenicThe indole ring of Trp362, located on the surface of an anti-parallel β sheet (res. Thr359-Pro364) in the C2 domain, stacks with nearby residues (e.g., Arg401, Arg272). In the variant simulations, the guanidinium group of the introduced residue Arg362 forms a salt bridge with the carboxylate group of Glu273 and, like Trp362, stacks with other arginine residues (e.g., Arg401, Arg272). This residue is at both the C2-membrane interface and the C2-RasGTPase interface, so the residue swap could potentially affect both interactions. However, these phenomena cannot be addressed using solvent-only simulations. Notably, Arg272, which stacks with both the non-mutated Trp362 and the mutated Arg362, forms a salt bridge directly with Asp105 of Ras in the WT simulations. Therefore, the residue swap could affect the C2 domain stability, the SynGAP-membrane association, and the SynGAP-Ras association.10.1016/j.ajhg.2020.11.011
c.1084T>G
W362G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD, so no population frequency data are available. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the single uncertain call (premPS) does not alter the overall consensus. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Thus, based on the collective predictions, the variant is most likely pathogenic, and this conclusion is consistent with the absence of any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-14.242Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.707Likely Pathogenic0.47510.12814.22Destabilizing0.15.28Destabilizing4.75Destabilizing0.95Ambiguous-11.95Deleterious0.997Probably Damaging0.986Probably Damaging1.25Pathogenic0.00Affected-7-20.5-129.16
c.1085G>C
W362S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362S is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as pathogenic, while premPS remains uncertain. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports likely pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta outputs) also indicates pathogenic. No tool predicts a benign outcome. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-13.228Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.625Likely Pathogenic0.51060.1215Weaken4.08Destabilizing0.04.55Destabilizing4.32Destabilizing0.95Ambiguous-12.87Deleterious0.999Probably Damaging0.994Probably Damaging1.31Pathogenic0.00Affected-2-30.1-99.14
c.1085G>T
W362L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362L is not reported in ClinVar and is absent from gnomAD. All tools except premPS predict pathogenic, leaving no benign predictions. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while premPS remains uncertain. High‑accuracy methods corroborate this assessment: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is consistent with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-12.748Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.523Likely Pathogenic0.27010.24522.16Destabilizing0.12.60Destabilizing2.38Destabilizing0.71Ambiguous-11.95Deleterious0.997Probably Damaging0.986Probably Damaging1.32Pathogenic0.01Affected-2-24.7-73.05
c.1086G>C
W362C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362C is not reported in ClinVar and is absent from gnomAD. All available in‑silico predictors classify it as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods reinforce this assessment: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. Consequently, the variant is most likely pathogenic based on the consensus of all predictions, and this conclusion does not contradict the ClinVar status, which simply lacks an entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-11.200Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.618Likely Pathogenic0.41580.16223.68Destabilizing0.14.06Destabilizing3.87Destabilizing1.00Destabilizing-11.95Deleterious1.000Probably Damaging0.996Probably Damaging1.24Pathogenic0.00Affected-8-23.4-83.07
c.1086G>T
W362C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W362C is not reported in ClinVar (ClinVar status: not listed) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity uniformly classify the variant as deleterious: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized indicates pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also reports Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic impact on protein stability. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.430310Uncertain0.9570.5520.125-11.200Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.618Likely Pathogenic0.41580.16223.68Destabilizing0.14.06Destabilizing3.87Destabilizing1.00Destabilizing-11.95Deleterious1.000Probably Damaging0.996Probably Damaging1.24Pathogenic0.00Affected-8-23.4-83.07
c.724T>A
W242R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant W242R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that assess evolutionary conservation and protein function uniformly indicate a deleterious effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic. No tool predicts a benign outcome; the only inconclusive results come from FoldX, Rosetta, and Foldetta, which are treated as unavailable evidence. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Consequently, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-11.948Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.859Likely Pathogenic0.42060.07710.85Ambiguous0.51.15Ambiguous1.00Ambiguous1.34Destabilizing-12.71Deleterious0.995Probably Damaging0.854Possibly Damaging1.52Pathogenic0.00Affected3.4014-32-3.6-30.03
c.724T>C
W242R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W242R is reported in gnomAD (ID 6‑33435575‑T‑C) but has no ClinVar entry. Across the evaluated predictors, every tool that provides a definitive call classifies the substitution as pathogenic: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No predictor reports a benign effect. FoldX, Rosetta, and Foldetta return uncertain results and are treated as unavailable evidence. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, while Foldetta remains inconclusive. Consequently, the variant is most likely pathogenic based on the consensus of pathogenic predictions, and this assessment does not contradict any ClinVar status because no ClinVar claim exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.0006-33435575-T-C21.24e-6-11.948Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.858Likely Pathogenic0.42060.07710.85Ambiguous0.51.15Ambiguous1.00Ambiguous1.34Destabilizing-12.71Deleterious0.995Probably Damaging0.854Possibly Damaging1.52Pathogenic0.00Affected3.4014-32-3.6-30.03
c.724T>G
W242G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W242G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD, so no population frequency data are available. Prediction tools that assess pathogenicity all converge on a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, while the single uncertain call from premPS is treated as unavailable. No tool predicts a benign outcome. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the unanimous pathogenic predictions and the lack of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-14.319Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.883Likely Pathogenic0.43780.18512.70Destabilizing0.32.48Destabilizing2.59Destabilizing0.83Ambiguous-11.80Deleterious0.900Possibly Damaging0.452Possibly Damaging1.52Pathogenic0.00Affected-7-20.5-129.16
c.725G>C
W242S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W242S, located in the PH domain, is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. No tool predicts a benign outcome. High‑accuracy assessments further support a harmful impact: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic,” while Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the consensus of available predictions indicates that W242S is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-14.674Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.797Likely Pathogenic0.44240.14181.96Ambiguous0.21.97Ambiguous1.97Ambiguous0.83Ambiguous-12.71Deleterious0.900Possibly Damaging0.535Possibly Damaging1.52Pathogenic0.00Affected-2-30.1-99.14
c.725G>T
W242L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W242L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions (FoldX, Rosetta, Foldetta, premPS) and pathogenic predictions (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score of Likely Pathogenic). High‑accuracy assessments further support this dichotomy: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic, whereas Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, reports a benign effect. Overall, the majority of evidence points toward a pathogenic impact for W242L. This conclusion is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-12.297Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.799Likely Pathogenic0.23700.2986-0.29Likely Benign0.30.12Likely Benign-0.09Likely Benign0.44Likely Benign-11.80Deleterious0.948Possibly Damaging0.533Possibly Damaging1.52Pathogenic0.01Affected-2-24.7-73.05
c.726G>C
W242C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 W242C missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and premPS, and no tools predict a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Based on the collective predictions, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as ClinVar has not yet classified the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-13.117Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.889Likely Pathogenic0.36260.16171.77Ambiguous0.41.62Ambiguous1.70Ambiguous0.63Ambiguous-11.80Deleterious0.999Probably Damaging0.887Possibly Damaging1.52Pathogenic0.00Affected-8-23.4-83.07
c.726G>T
W242C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W242C is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a pathogenic effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and premPS, and no tools predict a benign outcome. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Based on the collective predictions, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as ClinVar has not yet classified the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.328603Structured0.352582Uncertain0.8470.3410.000-13.117Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.889Likely Pathogenic0.36260.16171.77Ambiguous0.41.62Ambiguous1.70Ambiguous0.63Ambiguous-11.80Deleterious0.999Probably Damaging0.887Possibly Damaging1.52Pathogenic0.00Affected-8-23.4-83.07
c.880A>C
T294P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T294P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX (Uncertain), Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. No tool reports a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-17.477Likely Pathogenic0.996Likely PathogenicLikely Pathogenic0.741Likely Pathogenic0.19060.44791.97Ambiguous0.35.18Destabilizing3.58Destabilizing1.15Destabilizing-5.52Deleterious1.000Probably Damaging0.998Probably Damaging-0.19Pathogenic0.01Affected0-1-0.9-3.99
c.880A>G
T294A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294A missense variant is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a pathogenic effect include SGM‑Consensus (Likely Pathogenic), REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized; the only tool with an uncertain call is FoldX. High‑accuracy methods give consistent results: AlphaMissense‑Optimized predicts Pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts Likely Pathogenic, and Foldetta predicts Pathogenic. Based on the overwhelming agreement among these predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-12.371Likely Pathogenic0.971Likely PathogenicLikely Pathogenic0.719Likely Pathogenic0.36870.34941.87Ambiguous0.12.27Destabilizing2.07Destabilizing1.05Destabilizing-4.60Deleterious0.997Probably Damaging0.992Probably Damaging-0.18Pathogenic0.03Affected102.5-30.03
c.880A>T
T294S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294S missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). In silico predictors that classify the variant as benign are absent; all available tools that provide a definitive call predict a deleterious effect. Pathogenic predictions come from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of pathogenic calls and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no opposing evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-7.785In-Between0.954Likely PathogenicAmbiguous0.613Likely Pathogenic0.29830.33961.12Ambiguous0.21.70Ambiguous1.41Ambiguous1.19Destabilizing-3.68Deleterious0.999Probably Damaging0.992Probably Damaging0.08Pathogenic0.03Affected11-0.1-14.03
c.881C>A
T294N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T294N is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy methods reinforce this assessment: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts pathogenic. Based on the unanimous pathogenic predictions and the absence of any benign calls, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status (no report).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-14.925Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.630Likely Pathogenic0.10400.32392.74Destabilizing0.22.66Destabilizing2.70Destabilizing1.56Destabilizing-4.60Deleterious1.000Probably Damaging0.998Probably Damaging-0.18Pathogenic0.01Affected00-2.813.00
c.881C>G
T294S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T294S missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). In silico predictors that classify the variant as benign are absent; all available tools that provide a definitive call predict a deleterious effect. Pathogenic predictions come from REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results are reported for FoldX, Rosetta, Foldetta, ESM1b, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta as Uncertain. Overall, the preponderance of pathogenic calls and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no opposing evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-7.785In-Between0.954Likely PathogenicAmbiguous0.583Likely Pathogenic0.29830.33961.12Ambiguous0.21.70Ambiguous1.41Ambiguous1.19Destabilizing-3.68Deleterious0.999Probably Damaging0.992Probably Damaging0.08Pathogenic0.03Affected11-0.1-14.03
c.881C>T
T294I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T294I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on pathogenicity include REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools with uncertain or inconclusive results are Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Based on the overwhelming agreement among pathogenic predictions and the high‑accuracy tool results, the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.316932Uncertain0.9190.2670.125-15.302Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.768Likely Pathogenic0.08080.54854.09Destabilizing0.21.33Ambiguous2.71Destabilizing0.54Ambiguous-5.52Deleterious1.000Probably Damaging0.998Probably Damaging-0.19Pathogenic0.01Affected0-15.212.05
c.892C>A
P298T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298T is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar) and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, and ESM1b—return uncertain results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also yields a benign prediction, while Foldetta remains uncertain. Overall, the preponderance of evidence points to a benign effect for P298T, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.328603Structured0.268765Uncertain0.8600.2830.500-7.366In-Between0.104Likely BenignLikely Benign0.209Likely Benign0.15950.63491.44Ambiguous0.21.03Ambiguous1.24Ambiguous0.04Likely Benign-0.13Neutral0.939Possibly Damaging0.739Possibly Damaging1.96Pathogenic1.00Tolerated0-10.93.99
c.892C>G
P298A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. No evidence from FoldX or Rosetta alone is conclusive. Based on the preponderance of benign predictions and the lack of pathogenic consensus, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.328603Structured0.268765Uncertain0.8600.2830.500-6.082Likely Benign0.074Likely BenignLikely Benign0.191Likely Benign0.37610.57871.22Ambiguous0.11.17Ambiguous1.20Ambiguous0.50Likely Benign-0.98Neutral0.885Possibly Damaging0.589Possibly Damaging1.94Pathogenic0.66Tolerated1-13.4-26.04
c.892C>T
P298S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298S is listed in ClinVar as Benign (ClinVar ID 2965590.0) and is present in gnomAD (ID 6‑33437797‑C‑T). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. No evidence from FoldX, Rosetta, or premPS is available to support either outcome. Overall, the majority of predictions support a benign impact, aligning with the ClinVar designation. Thus, the variant is most likely benign and does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.328603Structured0.268765Uncertain0.8600.2830.500Benign 16-33437797-C-T53.10e-6-6.342Likely Benign0.144Likely BenignLikely Benign0.189Likely Benign0.36780.58551.38Ambiguous0.21.41Ambiguous1.40Ambiguous0.58Ambiguous-1.20Neutral0.991Probably Damaging0.898Possibly Damaging2.03Pathogenic0.85Tolerated3.3920-110.8-10.04
c.893C>A
P298H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P298H missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Remaining tools (AlphaMissense‑Default, FoldX, Rosetta, Foldetta, premPS) are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta is uncertain. Overall, the majority of predictions (five pathogenic vs. three benign) and the SGM Consensus support a pathogenic interpretation. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.328603Structured0.268765Uncertain0.8600.2830.500-9.777Likely Pathogenic0.443AmbiguousLikely Benign0.313Likely Benign0.17690.49431.57Ambiguous0.21.49Ambiguous1.53Ambiguous0.83Ambiguous-2.37Neutral0.999Probably Damaging0.964Probably Damaging1.92Pathogenic0.04Affected0-2-1.640.02
c.893C>G
P298R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P298R has no ClinVar entry and is not reported in gnomAD. Computational predictors fall into two consensus groups: benign predictions come from REVEL, FoldX, PROVEAN, SIFT, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain results are reported only by Foldetta and premPS. High‑accuracy tools give a mixed picture: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts likely pathogenic, and Foldetta reports an uncertain stability change. Overall, the majority of evidence points toward a pathogenic effect, and this assessment is not contradicted by ClinVar, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.268765Uncertain0.8600.2830.500-11.427Likely Pathogenic0.733Likely PathogenicLikely Benign0.280Likely Benign0.12990.38720.45Likely Benign0.02.08Destabilizing1.27Ambiguous0.61Ambiguous-1.83Neutral0.997Probably Damaging0.952Probably Damaging2.03Pathogenic0.09Tolerated0-2-2.959.07
c.893C>T
P298L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P298L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The remaining tools—FoldX, Rosetta, Foldetta, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign outcome; and Foldetta’s stability prediction is unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.328603Structured0.268765Uncertain0.8600.2830.500-7.334In-Between0.107Likely BenignLikely Benign0.267Likely Benign0.21370.67950.60Ambiguous0.21.53Ambiguous1.07Ambiguous-0.16Likely Benign-0.82Neutral0.885Possibly Damaging0.589Possibly Damaging1.91Pathogenic0.21Tolerated-3-35.416.04
c.922T>A
W308R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-12.264Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.868Likely Pathogenic0.47510.03615.40Destabilizing0.54.27Destabilizing4.84Destabilizing1.88Destabilizing-12.87Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.38192-3-3.6-30.03290.4-26.7-0.10.10.00.2XXXPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The guanidinium group of Arg308 is comparably sized to the tryptophan it replaced; however, it is also positively charged.In the variant simulations, the charged side chain remains buried deep in the hydrophobic part of the C2 domain, where it forms new hydrogen bonds with the backbone carbonyl atoms of surrounding residues (e.g., Val306, Ile268). However, the residue swap is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.922T>C
W308R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308R is listed in ClinVar (ID 391294.0) as Pathogenic and is not reported in gnomAD. All available in‑silico predictors classify the change as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments confirm this: AlphaMissense‑Optimized predicts Pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts Pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125Pathogenic 1-12.264Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.868Likely Pathogenic0.47510.03615.40Destabilizing0.54.27Destabilizing4.84Destabilizing1.88Destabilizing-12.87Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.38192-3-3.6-30.03290.4-26.7-0.10.10.00.2XXXPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The guanidinium group of Arg308 is comparably sized to the tryptophan it replaced; however, it is also positively charged.In the variant simulations, the charged side chain remains buried deep in the hydrophobic part of the C2 domain, where it forms new hydrogen bonds with the backbone carbonyl atoms of surrounding residues (e.g., Val306, Ile268). However, the residue swap is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.922T>G
W308G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308G is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool predicts a benign effect, so the benign group is empty. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. Based on the unanimous predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which simply lacks an entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-16.271Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.860Likely Pathogenic0.48840.16446.88Destabilizing0.25.07Destabilizing5.98Destabilizing1.97Destabilizing-11.95Deleterious0.999Probably Damaging0.996Probably Damaging0.48Pathogenic0.00Affected-7-20.5-129.16
c.923G>C
W308S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308S is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-15.425Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.861Likely Pathogenic0.50890.1406Weaken6.42Destabilizing0.25.31Destabilizing5.87Destabilizing1.93Destabilizing-12.87Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected-2-30.1-99.14
c.923G>T
W308L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308L is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that assess pathogenicity unanimously classify the variant as deleterious: REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates “Likely Pathogenic.” Only Rosetta and premPS yield uncertain results, which are treated as unavailable evidence. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No tools predict benign effects. **Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-13.349Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.811Likely Pathogenic0.27310.27543.53Destabilizing0.51.52Ambiguous2.53Destabilizing0.53Ambiguous-11.95Deleterious0.999Probably Damaging0.996Probably Damaging0.49Pathogenic0.00Affected-2-24.7-73.05
c.924G>C
W308C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308C is listed in ClinVar as Pathogenic (ClinVar ID 981381.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields “Likely Pathogenic”; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. Thus, the variant is most likely pathogenic, and this prediction aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125Pathogenic/Likely path. 2-12.791Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.738Likely Pathogenic0.43900.16215.56Destabilizing0.34.38Destabilizing4.97Destabilizing1.26Destabilizing-11.95Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.3819-8-23.4-83.07230.860.5-0.30.1-0.40.4XPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The introduced Cys308 is smaller than the tryptophan it replaced. The thiol group of the Cys308 side chain is well-suited for the inner hydrophobic part of the C2 domain. Although the negative effects are essentially missing from the simulations, the side chain size difference between the residues is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.924G>T
W308C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant W308C is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts pathogenic. All available evidence points to a deleterious effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.328603Structured0.333942Uncertain0.9070.3140.125-12.791Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.738Likely Pathogenic0.43900.16215.56Destabilizing0.34.38Destabilizing4.97Destabilizing1.26Destabilizing-11.95Deleterious1.000Probably Damaging0.999Probably Damaging0.48Pathogenic0.00Affected3.3819-8-23.4-83.07230.860.5-0.30.1-0.40.4XPotentially PathogenicThe indole ring of Trp308, located in an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Ile268, Val306, Cys282). The indole group of Trp308 also hydrogen bonds with the backbone atoms of the C2 domain residues forming the anti-parallel β sheet (e.g., Tyr280, Thr294). The introduced Cys308 is smaller than the tryptophan it replaced. The thiol group of the Cys308 side chain is well-suited for the inner hydrophobic part of the C2 domain. Although the negative effects are essentially missing from the simulations, the side chain size difference between the residues is likely to disrupt the hydrophobic packing during folding. At a minimum, the residue swap could affect the C2 domain stability and membrane association.
c.163C>A
Q55K
2D
AIThe SynGAP1 missense variant Q55K is listed in ClinVar (ID 520688.0) with an “Uncertain” status and is present in gnomAD (variant ID 6‑33423572‑C‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this is not in conflict with the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.470108Uncertain0.4610.6570.000Uncertain 26-33423572-C-A241.49e-5-5.840Likely Benign0.612Likely PathogenicLikely Benign0.085Likely Benign0.20470.4129-1.21Neutral0.140Benign0.184Benign3.91Benign0.00Affected4.32111-0.40.04
c.163C>G
Q55E
2D
AIThe SynGAP1 missense variant Q55E is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, while SIFT uniquely predicts pathogenic. ESM1b is uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely benign. High‑accuracy assessments reinforce this: AlphaMissense‑Optimized predicts benign and the SGM‑Consensus also indicates likely benign; Foldetta results are unavailable. Overall, the consensus of the available predictions points to a benign impact, and this is consistent with the lack of ClinVar evidence; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.470108Uncertain0.4610.6570.000-7.361In-Between0.265Likely BenignLikely Benign0.052Likely Benign0.13800.2632-0.98Neutral0.064Benign0.184Benign3.89Benign0.00Affected220.00.98
c.164A>C
Q55P
2D
AIThe SynGAP1 missense variant Q55P is not reported in ClinVar (ClinVar status: none) but is present in gnomAD (ID 6‑33423573‑A‑C). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM, whereas those that agree on a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (two pathogenic vs two benign), and Foldetta results are unavailable. Overall, more tools predict pathogenicity than benignity, and no ClinVar entry contradicts this assessment. Therefore, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.332115Structured0.470108Uncertain0.4610.6570.0006-33423573-A-C16.20e-7-13.163Likely Pathogenic0.897Likely PathogenicAmbiguous0.260Likely Benign0.25570.5508-2.06Neutral0.462Possibly Damaging0.480Possibly Damaging3.83Benign0.00Affected4.321-101.9-31.01
c.164A>G
Q55R
2D
AIThe SynGAP1 missense variant Q55R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence from both general and high‑accuracy predictors indicates that the variant is most likely benign, and this conclusion does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.470108Uncertain0.4610.6570.000-6.626Likely Benign0.578Likely PathogenicLikely Benign0.166Likely Benign0.16070.1558-1.15Neutral0.140Benign0.275Benign3.87Benign0.00Affected11-1.028.06
c.164A>T
Q55L
2D
AIThe SynGAP1 missense variant Q55L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and FATHMM. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as likely benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation (none exists). Thus, the variant is most likely benign based on current predictive data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.470108Uncertain0.4610.6570.000-5.823Likely Benign0.844Likely PathogenicAmbiguous0.173Likely Benign0.07760.5982-1.99Neutral0.273Benign0.275Benign3.83Benign0.00Affected-2-27.3-14.97
c.165G>C
Q55H
2D
AIThe SynGAP1 missense variant Q55H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.470108Uncertain0.4610.6570.000-5.624Likely Benign0.678Likely PathogenicLikely Benign0.184Likely Benign0.13520.4143-1.76Neutral0.676Possibly Damaging0.585Possibly Damaging3.81Benign0.00Affected300.39.01
c.165G>T
Q55H
2D
AIThe SynGAP1 missense variant Q55H is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicating a likely benign outcome; the Foldetta protein‑folding stability analysis is unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.470108Uncertain0.4610.6570.000-5.624Likely Benign0.678Likely PathogenicLikely Benign0.184Likely Benign0.13520.4143-1.76Neutral0.676Possibly Damaging0.585Possibly Damaging3.81Benign0.00Affected300.39.01
c.2302G>A
D768N
2D
AIThe SynGAP1 missense variant D768N is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33442460‑G‑A). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). No tool predicts a pathogenic outcome; AlphaMissense‑Default is uncertain. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus is “Likely Benign,” and Foldetta data are unavailable. Overall, the consensus of available predictions indicates that the variant is most likely benign, which does not contradict the ClinVar “Uncertain” designation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.928237Binding0.3140.8770.250Uncertain 16-33442460-G-A22.57e-6-6.892Likely Benign0.453AmbiguousLikely Benign0.048Likely Benign0.11780.7843-0.77Neutral0.106Benign0.009Benign4.07Benign0.96Tolerated3.646120.0-0.98
c.2302G>C
D768H
2D
AIThe SynGAP1 D768H missense variant is not reported in ClinVar (ClinVar status: not reported) and is absent from gnomAD (gnomAD: not present). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs. 2 benign), and Foldetta results are unavailable. Overall, the majority of predictions (5 benign vs. 4 pathogenic) and the high‑accuracy benign call suggest the variant is most likely benign, with no ClinVar status to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.332115Structured0.928237Binding0.3140.8770.250-8.673Likely Pathogenic0.783Likely PathogenicLikely Benign0.160Likely Benign0.14500.8136-1.85Neutral0.966Probably Damaging0.737Possibly Damaging4.03Benign0.12Tolerated1-10.322.05
c.2302G>T
D768Y
2D
AIThe SynGAP1 missense variant D768Y is listed in ClinVar with status “Uncertain” (ClinVar ID 1061652.0) and is present in gnomAD (variant ID 6‑33442460‑G‑T). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as “Uncertain,” SGM‑Consensus as “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) is unavailable for this variant. Overall, the majority of computational evidence points to a pathogenic impact, which does not contradict the ClinVar designation of uncertainty. Thus, based on current predictions, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.332115Structured0.928237Binding0.3140.8770.250Uncertain 16-33442460-G-T-9.866Likely Pathogenic0.824Likely PathogenicAmbiguous0.234Likely Benign0.05810.7525-2.86Deleterious0.989Probably Damaging0.806Possibly Damaging4.01Benign0.07Tolerated3.646-4-32.248.09
c.2303A>C
D768A
2D
AIThe SynGAP1 D768A variant is listed in gnomAD (ID 6‑33442461‑A‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM) and pathogenic predictions (ESM1b, AlphaMissense‑Default). AlphaMissense‑Optimized returns an uncertain result. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is a 2‑vs‑2 tie and thus unavailable; Foldetta stability analysis is not reported. Overall, the preponderance of evidence (six benign vs two pathogenic) points to a benign effect. This conclusion does not contradict ClinVar, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.332115Structured0.928237Binding0.3140.8770.2506-33442461-A-C-8.153Likely Pathogenic0.786Likely PathogenicAmbiguous0.174Likely Benign0.39240.7662-1.84Neutral0.245Benign0.096Benign4.09Benign0.14Tolerated3.646-205.3-44.01
c.2303A>G
D768G
2D
AIThe SynGAP1 D768G missense variant is not reported in ClinVar and is absent from gnomAD. Consensus from multiple in‑silico predictors shows a predominance of benign calls: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized all predict benign, whereas AlphaMissense‑Default predicts pathogenic. The high‑accuracy AlphaMissense‑Optimized result is benign, and the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—also yields a benign classification (2 benign vs. 1 pathogenic, with one uncertain). Foldetta, which would provide a protein‑folding stability assessment, has no available output for this variant. Overall, the preponderance of evidence points to a benign effect, and this assessment does not conflict with the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.332115Structured0.928237Binding0.3140.8770.250-7.150In-Between0.697Likely PathogenicLikely Benign0.184Likely Benign0.41300.74760.03Neutral0.393Benign0.131Benign4.09Benign0.72Tolerated1-13.1-58.04
c.2303A>T
D768V
2D
AIThe SynGAP1 D768V variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumVar, and FATHMM, whereas pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is unavailable for this variant. Based on the preponderance of pathogenic predictions and the SGM‑Consensus result, the variant is most likely pathogenic; this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.332115Structured0.928237Binding0.3140.8770.250-9.528Likely Pathogenic0.880Likely PathogenicAmbiguous0.164Likely Benign0.08020.8019-2.62Deleterious0.611Possibly Damaging0.140Benign4.04Benign0.02Affected-2-37.7-15.96
c.2304C>A
D768E
2D
AIThe SynGAP1 missense variant D768E is not reported in ClinVar and is absent from gnomAD. Consensus predictions from multiple in silico tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM all classify the change as benign, and AlphaMissense‑Optimized also predicts a benign outcome. No tool predicts pathogenicity; AlphaMissense‑Default remains uncertain. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a likely benign classification. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the computational evidence strongly supports a benign effect for D768E, and this conclusion is consistent with the absence of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.928237Binding0.3140.8770.250-4.611Likely Benign0.380AmbiguousLikely Benign0.065Likely Benign0.13680.7729-1.23Neutral0.393Benign0.171Benign4.16Benign0.17Tolerated320.014.03
c.2304C>G
D768E
2D
AIThe SynGAP1 missense variant D768E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; AlphaMissense‑Default is uncertain. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (majority vote) also indicates Likely Benign. Foldetta results are unavailable, so they do not influence the assessment. Overall, the computational evidence strongly suggests that D768E is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.332115Structured0.928237Binding0.3140.8770.250-4.611Likely Benign0.380AmbiguousLikely Benign0.065Likely Benign0.13680.7729-1.23Neutral0.393Benign0.171Benign4.16Benign0.17Tolerated320.014.03
c.1012G>A
D338N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D338N missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, premPS, and polyPhen‑2 HumVar, whereas a majority of tools predict pathogenicity: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. No evidence from FoldX, Rosetta, or Foldetta supports a benign outcome. Overall, the balance of evidence favors a pathogenic interpretation; this is consistent with the absence of ClinVar annotation, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.363354Uncertain0.4600.4380.375-9.520Likely Pathogenic0.809Likely PathogenicAmbiguous0.442Likely Benign0.13990.59700.95Ambiguous0.41.34Ambiguous1.15Ambiguous0.06Likely Benign-3.62Deleterious0.801Possibly Damaging0.315Benign1.71Pathogenic0.02Affected210.0-0.98
c.1012G>C
D338H
2D
AIThe SynGAP1 missense variant D338H is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: benign predictions are limited to premPS, whereas the remaining 11 tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all classify the variant as pathogenic or likely pathogenic. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates likely pathogenic, while Foldetta’s stability analysis is inconclusive. Overall, the preponderance of evidence points to a pathogenic impact for D338H, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.363354Uncertain0.4600.4380.375-12.325Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.515Likely Pathogenic0.16710.66541.32Ambiguous1.20.76Ambiguous1.04Ambiguous0.18Likely Benign-4.42Deleterious0.966Probably Damaging0.770Possibly Damaging1.71Pathogenic0.01Affected1-10.322.05
c.1012G>T
D338Y
2D
AIThe SynGAP1 D338Y missense variant is not reported in ClinVar and has no entries in gnomAD. Functional prediction tools largely agree on a deleterious effect: premPS is the sole predictor labeling it benign, whereas the remaining seven tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM—classify it as pathogenic. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive. High‑accuracy assessments further support a pathogenic interpretation: the SGM Consensus (derived from a unanimous majority of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, AlphaMissense‑Optimized remains uncertain, and Foldetta is also uncertain. Overall, the preponderance of evidence indicates that D338Y is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.363354Uncertain0.4600.4380.375-14.190Likely Pathogenic0.945Likely PathogenicAmbiguous0.552Likely Pathogenic0.06870.56091.10Ambiguous1.30.91Ambiguous1.01Ambiguous0.22Likely Benign-6.49Deleterious0.989Probably Damaging0.832Possibly Damaging1.66Pathogenic0.00Affected-4-32.248.09
c.1013A>C
D338A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D338A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, premPS, polyPhen‑2 HumVar, and SIFT, while pathogenic predictions arise from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points toward a pathogenic effect. This conclusion is not contradicted by ClinVar, which contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.363354Uncertain0.4600.4380.375-10.639Likely Pathogenic0.902Likely PathogenicAmbiguous0.479Likely Benign0.38300.59881.22Ambiguous0.31.11Ambiguous1.17Ambiguous0.16Likely Benign-5.74Deleterious0.625Possibly Damaging0.192Benign1.73Pathogenic0.11Tolerated0-25.3-44.01
c.1013A>G
D338G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D338G missense variant is not reported in ClinVar and has no gnomAD entry. Prediction tools that agree on a benign effect include REVEL, premPS, and polyPhen‑2 HumVar. Those that predict a pathogenic effect comprise SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Because the majority of available predictors (seven versus three) indicate a deleterious impact, the variant is most likely pathogenic, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.363354Uncertain0.4600.4380.375-8.875Likely Pathogenic0.871Likely PathogenicAmbiguous0.487Likely Benign0.40140.59341.33Ambiguous0.51.75Ambiguous1.54Ambiguous0.15Likely Benign-5.51Deleterious0.771Possibly Damaging0.315Benign1.69Pathogenic0.01Affected1-13.1-58.04
c.1013A>T
D338V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D338V missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only premPS, whereas the remaining tools—SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict pathogenicity. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No prediction or folding‑stability result is missing or inconclusive. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.363354Uncertain0.4600.4380.375-11.494Likely Pathogenic0.927Likely PathogenicAmbiguous0.553Likely Pathogenic0.08790.57451.64Ambiguous0.21.08Ambiguous1.36Ambiguous0.23Likely Benign-6.79Deleterious0.891Possibly Damaging0.492Possibly Damaging1.73Pathogenic0.01Affected-2-37.7-15.96
c.1014C>A
D338E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D338E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also indicates a likely benign classification, while Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No other tools provide conflicting evidence. Based on the preponderance of benign predictions and the lack of pathogenic support from high‑accuracy methods, the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.335645Structured0.363354Uncertain0.4600.4380.375-5.264Likely Benign0.254Likely BenignLikely Benign0.080Likely Benign0.15840.53970.85Ambiguous0.30.31Likely Benign0.58Ambiguous-0.01Likely Benign-1.95Neutral0.002Benign0.005Benign1.85Pathogenic0.55Tolerated320.014.03
c.1014C>G
D338E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D338E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Only FATHMM predicts a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also indicates a likely benign classification, while Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. No other tools provide conflicting evidence. Based on the preponderance of benign predictions and the lack of pathogenic support from high‑accuracy methods, the variant is most likely benign. This conclusion does not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.335645Structured0.363354Uncertain0.4600.4380.375-5.264Likely Benign0.254Likely BenignLikely Benign0.080Likely Benign0.15840.53970.85Ambiguous0.30.31Likely Benign0.58Ambiguous-0.01Likely Benign-1.95Neutral0.002Benign0.005Benign1.85Pathogenic0.55Tolerated320.014.03
c.1354G>A
V452I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V452I is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 (HumDiv and HumVar) and SIFT, while ESM1b also predicts pathogenicity. Uncertain predictions come from Rosetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Taken together, the majority of evidence points to a benign impact. This conclusion does not contradict the ClinVar “Uncertain” classification, which remains inconclusive.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.335645Structured0.315167Uncertain0.9700.2290.000Uncertain 1-8.985Likely Pathogenic0.361AmbiguousLikely Benign0.218Likely Benign0.06300.3476-0.08Likely Benign0.10.51Ambiguous0.22Likely Benign0.25Likely Benign-0.99Neutral0.947Possibly Damaging0.851Possibly Damaging3.26Benign0.05Affected430.314.03
c.1354G>C
V452L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 V452L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, premPS, SIFT, and FATHMM, while those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Because the majority of tools (six) predict benign and the high‑accuracy Foldetta also supports benign, the variant is most likely benign, and this assessment does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.335645Structured0.315167Uncertain0.9700.2290.000-11.285Likely Pathogenic0.929Likely PathogenicAmbiguous0.316Likely Benign0.07770.40610.29Likely Benign0.1-0.25Likely Benign0.02Likely Benign0.34Likely Benign-2.96Deleterious0.947Possibly Damaging0.851Possibly Damaging3.54Benign0.11Tolerated21-0.414.03
c.1354G>T
V452F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V452F variant is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. Prediction tools that agree on a benign effect are Rosetta and FATHMM, whereas the remaining tools (REVEL, FoldX, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict a pathogenic impact. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts pathogenicity. Based on the preponderance of evidence, the variant is most likely pathogenic, a conclusion that contradicts its current ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.335645Structured0.315167Uncertain0.9700.2290.000Uncertain 1-14.769Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.511Likely Pathogenic0.05640.34519.21Destabilizing0.10.37Likely Benign4.79Destabilizing0.61Ambiguous-4.94Deleterious0.999Probably Damaging0.993Probably Damaging3.29Benign0.00Affected3.3734-1-1-1.448.04249.4-35.70.00.00.40.1XPotentially PathogenicThe iso-propyl side chain of Val452, located in the middle of an α helix (res. Val441-Ser457), packs against hydrophobic residues in the inter-helix space at the intersection of three α helices (e.g., Leu500, His453, Leu465). In the variant simulations, the larger side chain of Phe452 cannot pack against the opposing α helix (res. Leu489-Glu519) as efficiently as valine. Due to space restrictions, the phenol ring adjusts to make room by rotating slightly sideways in the inter-helix space. Besides this small and local shift, no large-scale effects on the protein structure are seen based on the simulations. However, the size difference between the swapped residues could affect the protein folding process.
c.1355T>A
V452D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V452D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools largely agree on a deleterious effect: benign predictions are limited to FATHMM, while all other evaluated algorithms—SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the variant as pathogenic. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenic. No prediction or folding stability result is missing or inconclusive. Based on the overwhelming agreement among both general and high‑accuracy predictors, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.335645Structured0.315167Uncertain0.9700.2290.000-15.793Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.630Likely Pathogenic0.13200.06103.92Destabilizing0.13.37Destabilizing3.65Destabilizing2.52Destabilizing-6.92Deleterious1.000Probably Damaging1.000Probably Damaging3.16Benign0.00Affected-2-3-7.715.96
c.1355T>C
V452A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V452A is not reported in ClinVar and has no entry in gnomAD. Prediction tools largely agree on a deleterious effect: FATHMM is the sole benign predictor, while SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, yields an uncertain result and is treated as unavailable evidence. High‑accuracy assessments reinforce the pathogenic prediction: AlphaMissense‑Optimized reports pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic, and Foldetta remains inconclusive. Overall, the consensus of the available tools points to a pathogenic effect for V452A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.335645Structured0.315167Uncertain0.9700.2290.000-10.423Likely Pathogenic0.963Likely PathogenicLikely Pathogenic0.505Likely Pathogenic0.26420.25212.21Destabilizing0.01.51Ambiguous1.86Ambiguous2.18Destabilizing-3.95Deleterious1.000Probably Damaging0.999Probably Damaging3.21Benign0.00Affected00-2.4-28.05
c.1355T>G
V452G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V452G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only FATHMM, whereas the remaining tools—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default—consistently predict a pathogenic impact. AlphaMissense‑Optimized is uncertain, providing no definitive direction. High‑accuracy assessments further support pathogenicity: the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) yields a pathogenic verdict, and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. AlphaMissense‑Optimized remains uncertain. Overall, the preponderance of evidence indicates that V452G is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.335645Structured0.315167Uncertain0.9700.2290.000-13.410Likely Pathogenic0.946Likely PathogenicAmbiguous0.570Likely Pathogenic0.19480.25673.70Destabilizing0.13.37Destabilizing3.54Destabilizing2.46Destabilizing-6.92Deleterious1.000Probably Damaging1.000Probably Damaging3.17Benign0.00Affected-1-3-4.6-42.08
c.877C>A
R293S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293S is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a deleterious effect include REVEL, FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Tools that are inconclusive or uncertain are Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus indicating a likely pathogenic outcome, while Foldetta’s stability analysis remains uncertain. Taken together, the overwhelming majority of evidence points to a pathogenic impact for R293S. This conclusion is consistent with the lack of ClinVar annotation, as there is no conflicting status to contradict the prediction.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125-14.103Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.561Likely Pathogenic0.27940.50452.66Destabilizing0.21.30Ambiguous1.98Ambiguous0.71Ambiguous-5.52Deleterious0.999Probably Damaging0.997Probably Damaging1.51Pathogenic0.01Affected0-13.7-69.11
c.877C>G
R293G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as pathogenic, while premPS remains uncertain. High‑accuracy assessments corroborate this trend: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports a likely pathogenic outcome, and Foldetta (integrating FoldX‑MD and Rosetta stability outputs) also indicates pathogenicity. No tool suggests a benign effect. Consequently, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125-15.861Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.604Likely Pathogenic0.32350.37383.70Destabilizing0.22.35Destabilizing3.03Destabilizing0.57Ambiguous-6.43Deleterious0.999Probably Damaging0.997Probably Damaging1.45Pathogenic0.02Affected-3-24.1-99.14
c.877C>T
R293C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant R293C is listed in ClinVar with an uncertain significance (ClinVar ID 2500611.0) and is present in gnomAD (6‑33437782‑C‑T). Prediction tools that classify the variant as benign include premPS, whereas the remaining tools—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict it to be pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, and the SGM Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an uncertain result. Consequently, the overwhelming majority of computational evidence indicates a pathogenic impact for R293C. This prediction aligns with the ClinVar designation of uncertain significance, not contradicting it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125Uncertain 16-33437782-C-T31.86e-6-12.844Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.579Likely Pathogenic0.30310.43631.38Ambiguous0.10.62Ambiguous1.00Ambiguous0.02Likely Benign-7.35Deleterious1.000Probably Damaging0.998Probably Damaging1.46Pathogenic0.00Affected3.3823-4-37.0-53.05226.096.50.00.00.10.1XXXPotentially PathogenicThe guanidinium group of the Arg293 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against the phenol ring of the Tyr281 side chain or forms a salt bridge with the carboxylate group of Glu283 on the outer side of the C2 domain. The positively charged guanidinium side chain of arginine is on the outside surface of the hydrophobic C2 domain, resulting in a twist in the β strand. Although this twist is maintained in the variant simulations, replacing the positively charged residue with a more hydrophobic one, such as cysteine, could remove the twist during protein folding.Because Arg293 is positioned at the C2 and PH domain interface, the residue swap could significantly impact the tertiary structure assembly. Notably, Arg293 is located at the SynGAP-Ras interface, and its role in complex formation cannot be fully understood through solvent-only simulations.
c.878G>A
R293H
2D
AISynGAP1 missense variant R293H is listed in ClinVar with an uncertain significance (ClinVar ID 3901513.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL and premPS, whereas the remaining 13 tools—FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, classifies the variant as pathogenic. Overall, the preponderance of evidence indicates that R293H is most likely pathogenic, a conclusion that does not contradict the current ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125Uncertain 1-13.009Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.438Likely Benign0.31200.25734.45Destabilizing2.32.12Destabilizing3.29Destabilizing0.32Likely Benign-4.60Deleterious1.000Probably Damaging0.998Probably Damaging1.45Pathogenic0.04Affected201.3-19.05
c.878G>C
R293P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293P is listed in ClinVar as Pathogenic (ClinVar ID 571092.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect include REVEL and premPS, whereas the remaining tools—FoldX, Rosetta, Foldetta, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic outcome. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized scores the variant as Pathogenic; the SGM Consensus, derived from the majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability predictions, classifies it as Pathogenic. Consequently, the variant is most likely pathogenic, and this prediction is concordant with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125Likely Pathogenic 1-16.275Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.497Likely Benign0.21620.47783.62Destabilizing0.49.06Destabilizing6.34Destabilizing0.47Likely Benign-6.43Deleterious1.000Probably Damaging0.999Probably Damaging1.45Pathogenic0.01Affected3.38230-22.9-59.07202.3132.00.10.00.10.1XXXPotentially PathogenicThe guanidinium group of the Arg293 side chain, located in an anti-parallel β sheet strand (res. Met289-Pro298), packs against the phenol ring of the Tyr281 side chain or forms a salt bridge with the carboxylate group of Glu283 on the outer side of the C2 domain. In the WT simulations, the positively charged side chain of arginine remains outside the hydrophobic C2 domain, resulting in a twist in the β strand. The backbone amide bond of Arg293 potentially maintains this twist by forming a hydrogen bond with the carbonyl group of His210 or the hydroxyl group of Ser211 in the anti-parallel β sheet.Although this twist is also maintained in the variant simulations, replacing the positively charged residue with proline, which lacks the backbone amide group altogether, causes the β strand to unfold. Because Arg293 is positioned at the C2 and PH domain interface, the residue swap could significantly impact the tertiary structure assembly. Notably, Arg293 is located at the SynGAP-Ras interface, and its role in complex formation cannot be fully understood through solvent-only simulations.
c.878G>T
R293L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant R293L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions are made by REVEL and premPS, while the remaining evaluated tools (SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus) all predict pathogenicity. Uncertain results from FoldX, Rosetta, and Foldetta are treated as unavailable. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is pathogenic, and Foldetta provides no definitive stability change. Consequently, the variant is most likely pathogenic based on the consensus of predictive tools, and this assessment does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.338192Uncertain0.9240.2690.125-15.502Likely Pathogenic0.993Likely PathogenicLikely Pathogenic0.493Likely Benign0.18150.49871.56Ambiguous0.20.93Ambiguous1.25Ambiguous0.08Likely Benign-6.43Deleterious0.999Probably Damaging0.997Probably Damaging1.46Pathogenic0.01Affected-3-28.3-43.03
c.979C>A
L327M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L327M missense variant is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, AlphaMissense‑Optimized, and Foldetta, whereas those that predict a pathogenic outcome are SGM‑Consensus, premPS, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta predicting a benign effect. Overall, the majority of tools indicate a pathogenic effect, and this assessment does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-10.320Likely Pathogenic0.727Likely PathogenicLikely Benign0.320Likely Benign0.08060.38070.20Likely Benign0.00.72Ambiguous0.46Likely Benign1.07Destabilizing-1.61Neutral1.000Probably Damaging0.999Probably Damaging1.53Pathogenic0.01Affected42-1.918.03
c.979C>G
L327V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327V is reported in gnomAD (ID 6‑33437884‑C‑G) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” classification. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.335645Structured0.409189Uncertain0.9390.4900.0006-33437884-C-G31.86e-6-8.978Likely Pathogenic0.148Likely BenignLikely Benign0.208Likely Benign0.16480.42061.38Ambiguous0.10.67Ambiguous1.03Ambiguous1.31Destabilizing-1.87Neutral0.999Probably Damaging0.994Probably Damaging2.66Benign0.13Tolerated3.3823120.4-14.03
c.980T>A
L327Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all indicate a pathogenic or likely pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. With all available evidence pointing to a harmful impact and no ClinVar entry to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-14.243Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.605Likely Pathogenic0.11310.10423.03Destabilizing0.12.17Destabilizing2.60Destabilizing2.11Destabilizing-5.26Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected-2-2-7.314.97
c.980T>C
L327P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327P (ClinVar ID 660421) is classified as Pathogenic in ClinVar and is not reported in gnomAD. Prediction tools that assess functional impact uniformly indicate a deleterious effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict pathogenicity, leaving no tools in the benign category. High‑accuracy assessments further support this: AlphaMissense‑Optimized is Pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is Pathogenic. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000Pathogenic/Likely path. 4-16.602Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.658Likely Pathogenic0.39210.17035.38Destabilizing0.14.00Destabilizing4.69Destabilizing2.62Destabilizing-5.97Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.01Affected3.3823-3-3-5.4-16.04221.769.40.10.00.60.1XPotentially PathogenicThe backbone amide group of Leu327, located in the middle of an anti-parallel β sheet strand (res. Ala322-Asp330), forms a hydrogen bond with the carbonyl group of Gly344 on a neighboring β strand (res. Lys336-Pro349) in the WT simulations. In contrast, in the variant simulations, the introduction of Pro327 destabilizes the hydrogen bonding between the two anti-parallel β strands because proline lacks the backbone amide group altogether. Additionally, in the WT simulations, the iso-butyl side chain of Leu327 packs against multiple hydrophobic residues (e.g., Leu274, V400, Val343), whereas the less bulky cyclic five-membered pyrrolidine ring of Pro327 cannot fill the same space as effectively. Thus, although no large-scale unfolding is observed during the variant simulations, the residue swap is likely to cause severe problems for the correct C2 domain folding, which could also affect the SynGAP-membrane association.10.1016/j.ajhg.2020.11.011
c.980T>G
L327R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L327R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity all agree that the variant is deleterious: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify it as pathogenic. No tool predicts a benign effect. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, predicts a destabilizing, pathogenic effect. All available predictions are concordant and indicate a likely pathogenic impact. Thus, based on the current computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.335645Structured0.409189Uncertain0.9390.4900.000-13.403Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.619Likely Pathogenic0.12810.10854.46Destabilizing0.34.75Destabilizing4.61Destabilizing1.95Destabilizing-5.28Deleterious1.000Probably Damaging0.999Probably Damaging1.52Pathogenic0.00Affected-3-2-8.343.03
c.994G>A
D332N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D332N is not reported in ClinVar and is absent from gnomAD. Benign predictions come from REVEL, Rosetta, premPS, and SIFT, while pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default; SGM‑Consensus indicates a likely pathogenic outcome. FoldX and Foldetta give uncertain results. High‑accuracy tools show AlphaMissense‑Optimized as benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) as uncertain. Overall, the majority of conventional predictors lean toward pathogenicity, but the high‑accuracy AlphaMissense‑Optimized result is benign and Foldetta is inconclusive. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment does not contradict ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-10.931Likely Pathogenic0.771Likely PathogenicLikely Benign0.396Likely Benign0.07850.39631.20Ambiguous0.1-0.16Likely Benign0.52Ambiguous0.49Likely Benign-4.14Deleterious0.999Probably Damaging0.997Probably Damaging1.32Pathogenic0.11Tolerated210.0-0.98
c.994G>C
D332H
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D332H has no ClinVar entry and is absent from gnomAD. Functional prediction tools that agree on a benign effect are Rosetta and premPS, whereas the majority of predictors—REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—classify the change as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Taken together, the preponderance of evidence indicates that D332H is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-13.255Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.505Likely Pathogenic0.10050.45421.50Ambiguous0.4-0.28Likely Benign0.61Ambiguous0.22Likely Benign-5.63Deleterious1.000Probably Damaging0.999Probably Damaging1.23Pathogenic0.01Affected1-10.322.05
c.994G>T
D332Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D332Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, and premPS, while pathogenic predictions are made by PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, labels the variant as Likely Pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, SGM‑Consensus confirms a likely pathogenic status, and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, yields an uncertain result. Overall, the majority of evidence points to a pathogenic impact for D332Y, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-14.210Likely Pathogenic0.966Likely PathogenicLikely Pathogenic0.485Likely Benign0.03720.40181.15Ambiguous0.6-0.07Likely Benign0.54Ambiguous0.41Likely Benign-7.33Deleterious1.000Probably Damaging0.999Probably Damaging1.20Pathogenic0.00Affected-4-32.248.09
c.995A>C
D332A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL and Rosetta, while the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain or inconclusive results come from FoldX, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-12.290Likely Pathogenic0.876Likely PathogenicAmbiguous0.458Likely Benign0.29980.41761.19Ambiguous0.20.32Likely Benign0.76Ambiguous0.54Ambiguous-6.45Deleterious1.000Probably Damaging0.998Probably Damaging1.24Pathogenic0.02Affected0-25.3-44.01
c.995A>G
D332G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332G missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include only SIFT, whereas the majority of tools (REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. Predictions that are inconclusive or uncertain are given by FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for D332G, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-10.844Likely Pathogenic0.860Likely PathogenicAmbiguous0.539Likely Pathogenic0.30520.47651.78Ambiguous0.30.69Ambiguous1.24Ambiguous0.63Ambiguous-5.98Deleterious0.999Probably Damaging0.997Probably Damaging1.31Pathogenic0.07Tolerated1-13.1-58.04
c.995A>T
D332V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332V missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Foldetta, and premPS, whereas a majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Uncertain results come from FoldX, Rosetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the balance of evidence favors a pathogenic classification; this conclusion does not contradict any ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.339168Structured0.336528Uncertain0.5370.4450.375-13.710Likely Pathogenic0.933Likely PathogenicAmbiguous0.484Likely Benign0.05730.41321.39Ambiguous0.1-0.52Ambiguous0.44Likely Benign0.50Likely Benign-7.27Deleterious1.000Probably Damaging0.999Probably Damaging1.21Pathogenic0.03Affected-2-37.7-15.96
c.996C>A
D332E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332E missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it yields a 2‑to‑2 split. Overall, the majority of evidence points to a benign effect. This conclusion does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.339168Structured0.336528Uncertain0.5370.4450.375-4.915Likely Benign0.320Likely BenignLikely Benign0.191Likely Benign0.09700.39150.50Ambiguous0.20.04Likely Benign0.27Likely Benign0.35Likely Benign-2.66Deleterious0.997Probably Damaging0.994Probably Damaging1.29Pathogenic0.24Tolerated320.014.03
c.996C>G
D332E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D332E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign classification. This conclusion is consistent with the lack of ClinVar annotation and does not contradict any existing clinical database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.339168Structured0.336528Uncertain0.5370.4450.375-4.915Likely Benign0.320Likely BenignLikely Benign0.188Likely Benign0.09700.39150.50Ambiguous0.20.04Likely Benign0.27Likely Benign0.35Likely Benign-2.66Deleterious0.997Probably Damaging0.994Probably Damaging1.29Pathogenic0.24Tolerated320.014.03
c.166C>A
L56M
2D
AIThe SynGAP1 missense variant L56M is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools, ESM1b and AlphaMissense‑Default, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive because it contains two benign and two uncertain calls, and Foldetta data are unavailable. Overall, the balance of evidence (four benign versus three pathogenic predictions, with two uncertain) suggests the variant is most likely benign. This conclusion does not contradict ClinVar status, as the variant has not been reported there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.342579Structured0.476218Uncertain0.4950.6570.000-7.470In-Between0.345AmbiguousLikely Benign0.109Likely Benign0.07970.3574-0.51Neutral0.824Possibly Damaging0.910Probably Damaging3.86Benign0.00Affected42-1.918.03
c.166C>G
L56V
2D
AIThe SynGAP1 missense variant L56V is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and ESM1b; AlphaMissense‑Default is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also leans benign (2 benign vs 1 pathogenic, 1 uncertain). Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for the L56V variant, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.342579Structured0.476218Uncertain0.4950.6570.000-8.104Likely Pathogenic0.471AmbiguousLikely Benign0.123Likely Benign0.16350.3655-0.99Neutral0.458Possibly Damaging0.745Possibly Damaging3.90Benign0.00Affected210.4-14.03
c.167T>A
L56Q
2D
AIThe SynGAP1 missense variant L56Q is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 pathogenic vs 2 benign), and Foldetta results are unavailable. Overall, the majority of available predictions (5 pathogenic vs 3 benign) indicate a pathogenic impact. There is no ClinVar entry to contradict this assessment, so the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.342579Structured0.476218Uncertain0.4950.6570.000-11.064Likely Pathogenic0.926Likely PathogenicAmbiguous0.293Likely Benign0.10830.0842-2.03Neutral0.943Possibly Damaging0.944Probably Damaging3.79Benign0.00Affected-2-2-7.314.97
c.167T>C
L56P
2D
AIThe SynGAP1 missense variant L56P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized classifies the variant as pathogenic, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Pathogenic. No Foldetta stability prediction is available for this variant. Overall, the preponderance of computational evidence points to a pathogenic effect, and this conclusion is not contradicted by any ClinVar annotation, which is currently absent.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.342579Structured0.476218Uncertain0.4950.6570.000-9.991Likely Pathogenic0.971Likely PathogenicLikely Pathogenic0.307Likely Benign0.38060.1342-2.62Deleterious0.943Possibly Damaging0.944Probably Damaging3.77Benign0.00Affected-3-3-5.4-16.04
c.167T>G
L56R
2D
AIThe SynGAP1 missense variant L56R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments are mixed: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 vs 2), and Foldetta results are unavailable. Overall, the majority of available predictions (5 pathogenic vs 3 benign) indicate a likely pathogenic impact. This conclusion is not contradicted by ClinVar status, as the variant has no existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.342579Structured0.476218Uncertain0.4950.6570.000-10.194Likely Pathogenic0.918Likely PathogenicAmbiguous0.264Likely Benign0.11910.0685-1.92Neutral0.943Possibly Damaging0.944Probably Damaging3.79Benign0.00Affected-3-2-8.343.03
c.976C>A
H326N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326N has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect are REVEL and SIFT, whereas a majority (seven) predict a pathogenic outcome: SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default. The remaining tools (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as likely pathogenic, and Foldetta as uncertain. Overall, the balance of evidence points to a pathogenic impact for H326N, and this conclusion does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.914Likely Pathogenic0.925Likely PathogenicAmbiguous0.409Likely Benign0.19290.25520.81Ambiguous0.21.48Ambiguous1.15Ambiguous0.97Ambiguous-5.63Deleterious0.997Probably Damaging0.992Probably Damaging1.95Pathogenic0.11Tolerated21-0.3-23.04
c.976C>G
H326D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326D missense variant is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only SIFT, which scores the variant as benign. All other evaluated algorithms—REVEL, Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic outcome. Tools with inconclusive results are FoldX, Foldetta, and premPS, which are listed as uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also yields a pathogenic verdict. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, reports an uncertain result. Overall, the preponderance of evidence indicates the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-13.000Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.561Likely Pathogenic0.26120.16110.87Ambiguous0.62.00Destabilizing1.44Ambiguous0.96Ambiguous-7.67Deleterious0.997Probably Damaging0.994Probably Damaging2.04Pathogenic0.10Tolerated1-1-0.3-22.05
c.976C>T
H326Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include FoldX, Rosetta, Foldetta, and premPS, whereas a majority of tools (REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus) predict a pathogenic impact. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the preponderance of evidence points to a pathogenic effect for H326Y, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.896Likely Pathogenic0.855Likely PathogenicAmbiguous0.562Likely Pathogenic0.07960.43230.03Likely Benign0.40.25Likely Benign0.14Likely Benign0.07Likely Benign-5.32Deleterious0.997Probably Damaging0.992Probably Damaging1.92Pathogenic0.02Affected021.926.03
c.977A>C
H326P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326P is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions are absent; pathogenic predictions are reported by REVEL, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). The only inconclusive result is premPS, which is listed as Uncertain. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) reports Pathogenic. Based on the consensus of these predictions, the variant is most likely pathogenic, and this conclusion is consistent with the absence of ClinVar evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-18.452Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.711Likely Pathogenic0.23830.44922.67Destabilizing0.32.59Destabilizing2.63Destabilizing0.88Ambiguous-8.73Deleterious0.999Probably Damaging0.998Probably Damaging1.92Pathogenic0.03Affected0-21.6-40.02
c.977A>G
H326R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326R missense variant is not listed in ClinVar and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT and Foldetta, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) all predict a pathogenic impact. High‑accuracy methods give the following results: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports it as likely pathogenic; Foldetta, a protein‑folding stability approach that integrates FoldX‑MD and Rosetta outputs, predicts a benign effect. Because the majority of evidence points to a deleterious change, the variant is most likely pathogenic, and this assessment is not contradicted by the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-12.369Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.601Likely Pathogenic0.18320.2413-0.65Ambiguous0.11.40Ambiguous0.38Likely Benign0.83Ambiguous-6.89Deleterious0.997Probably Damaging0.994Probably Damaging1.97Pathogenic0.10Tolerated20-1.319.05
c.977A>T
H326L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 H326L missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that agree on a benign effect include SIFT, premPS, Rosetta, and Foldetta. Tools that agree on a pathogenic effect include REVEL, SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. High‑accuracy methods give mixed results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; and Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta) predicts benign. No evidence is available from FoldX or AlphaMissense‑Optimized to support either outcome. Overall, the majority of predictions (nine pathogenic vs. four benign) indicate that H326L is most likely pathogenic, and this assessment does not contradict the ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-10.421Likely Pathogenic0.888Likely PathogenicAmbiguous0.627Likely Pathogenic0.09920.5799-0.85Ambiguous0.20.36Likely Benign-0.25Likely Benign0.44Likely Benign-9.64Deleterious0.999Probably Damaging0.996Probably Damaging1.95Pathogenic0.08Tolerated-2-37.0-23.98
c.978T>A
H326Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, whereas a majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Foldetta (combining FoldX‑MD and Rosetta) and Rosetta alone, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus as Likely Pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for H326Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.688Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.444Likely Benign0.14850.35000.46Likely Benign0.11.67Ambiguous1.07Ambiguous1.00Destabilizing-6.89Deleterious0.999Probably Damaging0.996Probably Damaging2.07Pathogenic0.10Tolerated30-0.3-9.01
c.978T>G
H326Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H326Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, and SIFT, whereas a majority of tools predict a pathogenic outcome: premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). Two tools, Foldetta (combining FoldX‑MD and Rosetta) and Rosetta alone, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus also indicates likely pathogenic, while Foldetta remains uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for H326Q. This conclusion is not contradicted by ClinVar status, which currently contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.342579Structured0.418150Uncertain0.9440.4550.000-8.688Likely Pathogenic0.976Likely PathogenicLikely Pathogenic0.444Likely Benign0.14850.35000.46Likely Benign0.11.67Ambiguous1.07Ambiguous1.00Destabilizing-6.89Deleterious0.999Probably Damaging0.996Probably Damaging2.07Pathogenic0.10Tolerated30-0.3-9.01
c.1393C>A
L465I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L465I missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized score classifies the variant as benign, whereas the Foldetta stability assessment is uncertain. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive due to a 2‑to‑2 split. Overall, the evidence is mixed; the balance of predictions leans toward a benign interpretation, and this does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.346032Structured0.319240Uncertain0.9560.2020.000-9.672Likely Pathogenic0.770Likely PathogenicLikely Benign0.258Likely Benign0.09670.35391.21Ambiguous0.11.27Ambiguous1.24Ambiguous0.78Ambiguous-1.99Neutral0.998Probably Damaging0.997Probably Damaging2.54Benign0.08Tolerated220.70.00
c.1393C>G
L465V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465V is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL and SIFT, while the remaining tools—FoldX, Rosetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default—indicate pathogenicity. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports likely pathogenic; and Foldetta, which combines FoldX‑MD and Rosetta stability outputs, predicts pathogenic. Overall, the majority of evidence points to a pathogenic impact, which is consistent with the ClinVar uncertain status and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000Uncertain 1-9.893Likely Pathogenic0.838Likely PathogenicAmbiguous0.276Likely Benign0.14930.33782.46Destabilizing0.12.66Destabilizing2.56Destabilizing1.21Destabilizing-2.98Deleterious0.996Probably Damaging0.992Probably Damaging2.44Pathogenic0.10Tolerated3.3734210.4-14.03204.330.90.00.0-0.40.6XPotentially BenignThe iso-butyl side chain of Leu465, located in the middle of an α helix (res. Ala461–Phe476), packs with hydrophobic residues (e.g., Phe464, Met468, Tyr497, Ile494) in an inter-helix space formed with two other α helices (res. Ala461–Phe476 and res. Thr488-Gly502). In the variant simulations, the iso-propyl side chain of Val465 is equally sized and similarly hydrophobic as the original side chain of Leu465. Hence, the mutation does not exert any negative effects on the protein structure based on the variant simulations.
c.1393C>T
L465F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465F is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL and Rosetta, whereas the majority of tools predict a pathogenic impact: FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Two tools (Foldetta and premPS) give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM Consensus also pathogenic, and Foldetta remains uncertain. Overall, the consensus of high‑confidence predictors points to a pathogenic effect for L465F. This conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000-12.626Likely Pathogenic0.979Likely PathogenicLikely Pathogenic0.432Likely Benign0.07710.27593.11Destabilizing0.70.05Likely Benign1.58Ambiguous0.52Ambiguous-3.98Deleterious0.999Probably Damaging0.997Probably Damaging2.44Pathogenic0.01Affected20-1.034.02
c.1394T>A
L465H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465H is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: SGM‑Consensus (Likely Pathogenic), REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts pathogenic. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this conclusion is not contradicted by ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000-16.751Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.764Likely Pathogenic0.12890.10893.15Destabilizing0.42.29Destabilizing2.72Destabilizing2.54Destabilizing-6.96Deleterious1.000Probably Damaging1.000Probably Damaging2.29Pathogenic0.00Affected-2-3-7.023.98
c.1394T>C
L465P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465P is listed in ClinVar as Pathogenic (ClinVar ID 1067821.0) and is not reported in gnomAD. Prediction tools that assess functional impact uniformly classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool predicts a benign effect. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates Likely Pathogenic; and Foldetta (combining FoldX‑MD and Rosetta outputs) also predicts pathogenicity. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this conclusion aligns with its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000Likely Pathogenic 1-14.824Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.778Likely Pathogenic0.33870.15827.18Destabilizing0.310.85Destabilizing9.02Destabilizing2.73Destabilizing-6.96Deleterious1.000Probably Damaging1.000Probably Damaging2.29Pathogenic0.00Affected3.3734-3-3-5.4-16.04211.165.90.10.0-0.20.0XPotentially PathogenicThe iso-butyl side chain of Leu465, located in the middle of an α helix (res. Ala461–Phe476), packs with hydrophobic residues (e.g., Phe464, Met468, Tyr497, Ile494) in an inter-helix space formed with two other α helices (res. Ala461–Phe476 and res. Thr488-Gly502). In the variant simulations, the cyclic five-membered pyrrolidine ring of Pro465 is not as optimal as the side chain of Leu465 for filling the three α helix hydrophobic niche. Although the residue swap does not cause a large-scale conformational shift during the simulations, the H-bond between the backbone amide group of Leu465 and the backbone carbonyl group of Ala461 is lost. This, in turn, breaks the continuity of the α helix secondary structure element.
c.1394T>G
L465R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L465R is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly indicate a deleterious effect. Benign predictions: none. Pathogenic predictions: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) reports Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, also predicts pathogenic. No inconclusive or missing results are present. Based on the consensus of all available predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation (none available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.346032Structured0.319240Uncertain0.9560.2020.000-17.976Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.761Likely Pathogenic0.15970.09634.52Destabilizing0.74.44Destabilizing4.48Destabilizing2.41Destabilizing-5.97Deleterious0.999Probably Damaging0.998Probably Damaging2.29Pathogenic0.00Affected-3-2-8.343.03
c.583G>A
A195T
2D
AIThe SynGAP1 missense variant A195T is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The remaining tools, ESM1b and AlphaMissense‑Optimized, return uncertain results. High‑accuracy assessment shows that the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—leans benign (2 benign vs. 1 pathogenic, 1 uncertain). Foldetta, which would provide a protein‑folding stability estimate, has no available output for this variant. Overall, the preponderance of evidence indicates that A195T is most likely benign, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.346032Structured0.430388Uncertain0.3630.5330.125-7.060In-Between0.883Likely PathogenicAmbiguous0.085Likely Benign0.09370.6006-2.09Neutral0.970Probably Damaging0.681Possibly Damaging4.08Benign0.14Tolerated10-2.530.03
c.583G>C
A195P
2D
AIThe SynGAP1 missense variant A195P is listed in ClinVar as Pathogenic (ClinVar ID 375527.0) and is not reported in gnomAD. Prediction tools that indicate a benign effect are REVEL and FATHMM, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus—predict a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic and the SGM‑Consensus as likely pathogenic; Foldetta results are unavailable. Overall, the preponderance of evidence supports a pathogenic classification, which aligns with the ClinVar status and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.346032Structured0.430388Uncertain0.3630.5330.125Likely Pathogenic 1-9.715Likely Pathogenic0.978Likely PathogenicLikely Pathogenic0.152Likely Benign0.14030.4402-3.03Deleterious0.997Probably Damaging0.916Probably Damaging4.00Benign0.04Affected3.5461-1-3.426.04
c.583G>T
A195S
2D
AIThe SynGAP1 missense variant A195S is listed in gnomAD (6‑33435225‑G‑T) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as likely benign. High‑accuracy assessments further support this: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority of the four high‑accuracy predictors) also indicates benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the consensus of the available predictions points to a benign effect, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.346032Structured0.430388Uncertain0.3630.5330.1256-33435225-G-T16.20e-7-4.936Likely Benign0.618Likely PathogenicLikely Benign0.078Likely Benign0.18460.4427-1.13Neutral0.990Probably Damaging0.760Possibly Damaging4.10Benign0.08Tolerated3.54611-2.616.00
c.584C>A
A195E
2D
AIThe SynGAP1 missense variant A195E is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools predict a pathogenic impact: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Pathogenic). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized classifies the variant as pathogenic; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates a likely pathogenic outcome. Foldetta results are unavailable, so they do not influence the overall assessment. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.346032Structured0.430388Uncertain0.3630.5330.125-10.909Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.237Likely Benign0.08550.1877-3.20Deleterious0.997Probably Damaging0.879Possibly Damaging4.12Benign0.02Affected0-1-5.358.04
c.584C>G
A195G
2D
AIThe SynGAP1 missense variant A195G is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and FATHMM, while those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. Two tools give uncertain results: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessment shows that AlphaMissense‑Optimized remains uncertain, whereas the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (pathogenic)—favors a pathogenic outcome. Foldetta, which would provide a protein‑folding stability estimate, has no available result for this variant. Overall, the preponderance of evidence points to a pathogenic impact for A195G, and this conclusion does not contradict any ClinVar annotation, as none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.346032Structured0.430388Uncertain0.3630.5330.125-7.186In-Between0.907Likely PathogenicAmbiguous0.146Likely Benign0.16940.3388-2.64Deleterious0.990Probably Damaging0.760Possibly Damaging4.01Benign0.05Affected10-2.2-14.03
c.584C>T
A195V
2D
AIThe SynGAP1 missense variant A195V is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Tools that predict a pathogenic effect are PROVEAN and AlphaMissense‑Default. High‑accuracy methods give no definitive verdict: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive (2 pathogenic vs. 2 benign votes), and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.346032Structured0.430388Uncertain0.3630.5330.125-5.830Likely Benign0.924Likely PathogenicAmbiguous0.210Likely Benign0.07820.5560-2.63Deleterious0.384Benign0.070Benign4.05Benign0.12Tolerated002.428.05
c.589G>A
E197K
2D
AIThe SynGAP1 missense variant E197K is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show a split: benign calls come from REVEL, polyPhen‑2 (HumDiv and HumVar) and FATHMM, whereas pathogenic calls arise from PROVEAN, SIFT, ESM1b, AlphaMissense‑Default and AlphaMissense‑Optimized. Grouping by consensus, the majority of high‑confidence predictors (AlphaMissense‑Optimized, SGM‑Consensus, PROVEAN, SIFT, ESM1b) indicate pathogenicity, while a minority (REVEL, polyPhen‑2, FATHMM) suggest benign impact. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM and PROVEAN, is classified as Likely Pathogenic. AlphaMissense‑Optimized also predicts Pathogenic. Foldetta results are unavailable. Overall, the preponderance of evidence points to a pathogenic effect for E197K, and this assessment does not conflict with ClinVar, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.349426Structured0.431896Uncertain0.4520.4920.125-11.045Likely Pathogenic0.962Likely PathogenicLikely Pathogenic0.198Likely Benign0.18240.5890-2.50Deleterious0.118Benign0.037Benign4.09Benign0.02Affected01-0.4-0.94
c.589G>C
E197Q
2D
AIThe SynGAP1 E197Q variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are SIFT and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, is derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and therefore reports a likely benign outcome. AlphaMissense‑Optimized also predicts benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.349426Structured0.431896Uncertain0.4520.4920.125-6.347Likely Benign0.723Likely PathogenicLikely Benign0.145Likely Benign0.08670.5228-1.75Neutral0.396Benign0.067Benign4.05Benign0.02Affected220.0-0.98
c.590A>C
E197A
2D
AIThe SynGAP1 E197A missense variant is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Those that predict a pathogenic effect are PROVEAN, SIFT, and AlphaMissense‑Default. Two tools give uncertain results: ESM1b and AlphaMissense‑Optimized. High‑accuracy assessment shows that the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts pathogenicity, while AlphaMissense‑Optimized remains uncertain and Foldetta (which would combine FoldX‑MD and Rosetta outputs) has no available result. Overall, the balance of evidence—including the pathogenic majority in the high‑accuracy consensus—suggests that the variant is most likely pathogenic. This conclusion does not contradict ClinVar status, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.349426Structured0.431896Uncertain0.4520.4920.125-7.956In-Between0.787Likely PathogenicAmbiguous0.155Likely Benign0.31340.5290-3.56Deleterious0.055Benign0.016Benign4.06Benign0.02Affected0-15.3-58.04
c.590A>G
E197G
2D
AIThe SynGAP1 missense variant E197G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign impact include REVEL, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Tools that predict pathogenicity are PROVEAN, SIFT, ESM1b, and AlphaMissense‑Default. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Pathogenic, while AlphaMissense‑Optimized remains benign; Foldetta results are unavailable. Overall, the majority of individual predictors lean toward pathogenicity, and the SGM‑Consensus supports this view. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.349426Structured0.431896Uncertain0.4520.4920.125-8.480Likely Pathogenic0.749Likely PathogenicLikely Benign0.165Likely Benign0.26380.4615-3.13Deleterious0.118Benign0.037Benign4.03Benign0.01Affected0-23.1-72.06
c.590A>T
E197V
2D
AIThe SynGAP1 missense variant E197V is not reported in ClinVar and has no entries in gnomAD, indicating it is not catalogued in these databases. Functional prediction tools show a split opinion: benign calls come from REVEL, polyPhen‑2 (HumDiv and HumVar) and FATHMM, while pathogenic calls arise from PROVEAN, SIFT, ESM1b and AlphaMissense‑Default. When predictions are grouped by consensus, four tools predict benign and four predict pathogenic. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, but the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM and PROVEAN—labels the variant as Likely Pathogenic. Foldetta, a protein‑folding stability predictor, has no available result for this residue. Taken together, the preponderance of evidence from both general and high‑accuracy predictors indicates that E197V is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Pathogenic0.349426Structured0.431896Uncertain0.4520.4920.125-9.023Likely Pathogenic0.932Likely PathogenicAmbiguous0.247Likely Benign0.04900.6024-4.51Deleterious0.396Benign0.099Benign4.01Benign0.00Affected-2-27.7-29.98
c.591G>C
E197D
2D
AIThe SynGAP1 missense variant E197D is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign.” Foldetta results are unavailable. Overall, the consensus of all available predictions strongly supports a benign classification, and this is consistent with the lack of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.349426Structured0.431896Uncertain0.4520.4920.1250.784Likely Benign0.130Likely BenignLikely Benign0.066Likely Benign0.15790.33451.81Neutral0.000Benign0.000Benign4.66Benign1.00Tolerated320.0-14.03
c.591G>T
E197D
2D
AIThe SynGAP1 missense variant E197D is not reported in ClinVar and is absent from gnomAD. In silico prediction tools uniformly indicate a benign effect: REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the change as benign. No tool predicts pathogenicity. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely benign outcome. Foldetta results are unavailable. Overall, the consensus of all available predictions strongly supports a benign classification, and this is consistent with the lack of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.349426Structured0.431896Uncertain0.4520.4920.1250.784Likely Benign0.130Likely BenignLikely Benign0.066Likely Benign0.15790.33451.81Neutral0.000Benign0.000Benign4.66Benign1.00Tolerated320.0-14.03
c.1357C>A
H453N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H453N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, while pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. A third set of methods (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yield uncertain or inconclusive results. High‑accuracy assessments further clarify the picture: AlphaMissense‑Optimized remains uncertain; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, predicts pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is also uncertain. Overall, the majority of evidence points toward a pathogenic effect for H453N. This conclusion is not contradicted by ClinVar, which has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-8.416Likely Pathogenic0.789Likely PathogenicAmbiguous0.347Likely Benign0.14350.25480.93Ambiguous0.10.97Ambiguous0.95Ambiguous0.78Ambiguous-6.92Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.09Tolerated21-0.3-23.04
c.1357C>G
H453D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H453D is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The high‑accuracy consensus methods reinforce a pathogenic interpretation: AlphaMissense‑Optimized predicts pathogenicity, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also indicates pathogenicity. premPS remains uncertain. Overall, the majority of evidence points to a pathogenic effect for H453D, and this conclusion is not contradicted by ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-15.256Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.443Likely Benign0.22250.18153.33Destabilizing0.02.68Destabilizing3.01Destabilizing0.97Ambiguous-8.89Deleterious1.000Probably Damaging0.999Probably Damaging3.48Benign0.09Tolerated1-1-0.3-22.05
c.1357C>T
H453Y
2D
AIThe SynGAP1 missense variant H453Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign calls come from REVEL, premPS, FATHMM, and AlphaMissense‑Optimized; pathogenic calls come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and the SGM‑Consensus. Predictions from FoldX, Rosetta, and Foldetta are uncertain. High‑accuracy methods provide a mixed picture: AlphaMissense‑Optimized predicts benign, SGM‑Consensus predicts likely pathogenic, and Foldetta is inconclusive. Overall, the majority of evidence points toward a pathogenic effect, aligning with the SGM‑Consensus but opposing the benign predictions from several tools. Because ClinVar contains no entry for this variant, there is no conflict with existing clinical annotations.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-12.060Likely Pathogenic0.753Likely PathogenicLikely Benign0.320Likely Benign0.08150.3843-0.52Ambiguous0.7-0.68Ambiguous-0.60Ambiguous0.09Likely Benign-5.93Deleterious0.995Probably Damaging0.961Probably Damaging3.41Benign0.04Affected021.926.03
c.1358A>C
H453P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H453P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL and FATHMM. The majority of tools predict a pathogenic impact: FoldX, Rosetta, Foldetta, premPS (uncertain), PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta outputs, is pathogenic. No predictions are missing or inconclusive. Based on the preponderance of evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-15.704Likely Pathogenic0.987Likely PathogenicLikely Pathogenic0.488Likely Benign0.21150.39383.29Destabilizing0.47.04Destabilizing5.17Destabilizing0.84Ambiguous-9.88Deleterious1.000Probably Damaging1.000Probably Damaging3.40Benign0.04Affected0-21.6-40.02
c.1358A>G
H453R
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant H453R is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, Rosetta, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect comprise SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, yields an inconclusive result because FoldX is uncertain and Rosetta is benign. Overall, the balance of evidence favors a pathogenic interpretation, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-9.239Likely Pathogenic0.573Likely PathogenicLikely Benign0.396Likely Benign0.16460.2031-0.52Ambiguous0.10.37Likely Benign-0.08Likely Benign0.56Ambiguous-7.91Deleterious0.993Probably Damaging0.957Probably Damaging3.53Benign0.39Tolerated20-1.319.05
c.1358A>T
H453L
2D
3DClick to see structure in 3D Viewer
AISynGAP1 H453L is not reported in ClinVar and is absent from gnomAD. Functional prediction tools show mixed results: benign predictions come from REVEL, Rosetta, premPS, SIFT, FATHMM, and the protein‑folding stability method Foldetta; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments indicate that AlphaMissense‑Optimized is uncertain, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta predicts benign. Overall, the predictions are split, with a slight edge toward pathogenicity from the consensus and high‑accuracy tools, but the presence of several benign calls and the uncertainty of AlphaMissense‑Optimized temper this conclusion. Thus, the variant is most likely pathogenic based on the current computational evidence, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.438Likely Pathogenic0.834Likely PathogenicAmbiguous0.413Likely Benign0.08410.4964-0.59Ambiguous0.10.04Likely Benign-0.28Likely Benign0.31Likely Benign-10.87Deleterious0.998Probably Damaging0.973Probably Damaging3.45Benign0.11Tolerated-2-37.0-23.98
c.1359C>A
H453Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H453Q is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, Rosetta, premPS, AlphaMissense‑Optimized, and Foldetta—are treated as unavailable for pathogenicity assessment. High‑accuracy methods specifically show SGM‑Consensus as Likely Pathogenic, AlphaMissense‑Optimized as uncertain, and Foldetta as uncertain. Overall, the preponderance of evidence from consensus and high‑accuracy predictors indicates that H453Q is most likely pathogenic, and this assessment does not contradict the current ClinVar status, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.894Likely Pathogenic0.893Likely PathogenicAmbiguous0.259Likely Benign0.12230.31120.90Ambiguous0.11.55Ambiguous1.23Ambiguous0.92Ambiguous-7.91Deleterious1.000Probably Damaging0.993Probably Damaging3.45Benign0.09Tolerated30-0.3-9.01
c.1359C>G
H453Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant H453Q is not reported in ClinVar (ClinVar ID None) and has no entries in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic outcome: SGM‑Consensus (Likely Pathogenic), PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—are treated as unavailable for pathogenicity assessment. High‑accuracy methods specifically show SGM‑Consensus as Likely Pathogenic, AlphaMissense‑Optimized as Uncertain, and Foldetta as Uncertain. Overall, the preponderance of evidence points to a pathogenic effect for H453Q. This prediction does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.352862Structured0.316097Uncertain0.9460.2000.000-10.894Likely Pathogenic0.893Likely PathogenicAmbiguous0.258Likely Benign0.12230.31120.90Ambiguous0.11.55Ambiguous1.23Ambiguous0.92Ambiguous-7.91Deleterious1.000Probably Damaging0.993Probably Damaging3.45Benign0.09Tolerated30-0.3-9.01
c.181G>A
E61K
2D
AIThe SynGAP1 E61K missense variant has no ClinVar entry and is not reported in gnomAD. Functional prediction tools cluster into two consensus groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus, SGM‑Consensus, classifies the variant as Likely Benign, and AlphaMissense‑Optimized also predicts Benign. Foldetta, a protein‑folding stability method that integrates FoldX‑MD and Rosetta outputs, has no available result for this variant. Based on the aggregate evidence, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125-4.953Likely Benign0.425AmbiguousLikely Benign0.120Likely Benign0.27360.5691-0.22Neutral0.458Possibly Damaging0.678Possibly Damaging4.34Benign0.00Affected01-0.4-0.94
c.181G>C
E61Q
2D
AIThe SynGAP1 missense variant E61Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available. Overall, the majority of evidence points to a benign effect for E61Q, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125-5.443Likely Benign0.267Likely BenignLikely Benign0.058Likely Benign0.13440.5617-0.41Neutral0.659Possibly Damaging0.775Possibly Damaging4.18Benign0.00Affected220.0-0.98
c.182A>C
E61A
2D
AIThe SynGAP1 missense variant E61A is listed in ClinVar (ID 3767543.0) with an *Uncertain* clinical significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT; AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus as likely benign, while Foldetta (a protein‑folding stability method combining FoldX‑MD and Rosetta outputs) has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the current ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125Uncertain 1-5.235Likely Benign0.453AmbiguousLikely Benign0.074Likely Benign0.44990.5878-1.52Neutral0.458Possibly Damaging0.678Possibly Damaging4.12Benign0.00Affected0-15.3-58.04
c.182A>G
E61G
2D
AIThe SynGAP1 missense variant E61G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions arise from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default remains uncertain. The high‑accuracy consensus methods reinforce the benign assessment: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Benign,” and the protein‑folding stability tool Foldetta is not available for this variant. Overall, the majority of evidence points to a benign effect. There is no ClinVar entry to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125-5.574Likely Benign0.469AmbiguousLikely Benign0.072Likely Benign0.35930.4965-1.68Neutral0.659Possibly Damaging0.775Possibly Damaging4.08Benign0.00Affected0-23.1-72.06
c.182A>T
E61V
2D
AIThe SynGAP1 E61V missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the balance of evidence favors a benign classification, and this conclusion does not contradict the ClinVar status, which currently has no record for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125-5.723Likely Benign0.769Likely PathogenicLikely Benign0.115Likely Benign0.08030.6413-1.80Neutral0.824Possibly Damaging0.775Possibly Damaging4.07Benign0.00Affected-2-27.7-29.98
c.183G>C
E61D
2D
AIThe SynGAP1 missense variant E61D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumVar and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. The variant’s predicted benign status does not contradict ClinVar, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125-4.394Likely Benign0.231Likely BenignLikely Benign0.035Likely Benign0.18950.3851-0.29Neutral0.267Benign0.585Possibly Damaging4.11Benign0.00Affected320.0-14.03
c.183G>T
E61D
2D
AIThe SynGAP1 missense variant E61D is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumVar and SIFT. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a Likely Benign classification. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. The variant’s predicted benign status does not contradict ClinVar, as no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.352862Structured0.477329Uncertain0.5180.6990.125-4.394Likely Benign0.231Likely BenignLikely Benign0.035Likely Benign0.18950.3851-0.29Neutral0.267Benign0.585Possibly Damaging4.11Benign0.00Affected320.0-14.03
c.910G>A
D304N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant D304N is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM, while AlphaMissense‑Default remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250Uncertain 1-6.194Likely Benign0.391AmbiguousLikely Benign0.345Likely Benign0.13530.72050.30Likely Benign0.1-0.08Likely Benign0.11Likely Benign0.21Likely Benign-4.18Deleterious0.999Probably Damaging0.997Probably Damaging1.81Pathogenic0.03Affected3.3823120.0-0.98
c.910G>C
D304H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304H missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into three groups: benign predictions come from REVEL, Rosetta, and premPS; pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default; the remaining tools (FoldX, Foldetta, AlphaMissense‑Optimized) give uncertain results. High‑accuracy assessments reinforce this pattern: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the majority of evidence points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which is currently absent. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-8.160Likely Pathogenic0.822Likely PathogenicAmbiguous0.417Likely Benign0.16600.74980.89Ambiguous0.10.16Likely Benign0.53Ambiguous0.45Likely Benign-5.67Deleterious1.000Probably Damaging0.999Probably Damaging1.75Pathogenic0.01Affected1-10.322.05
c.910G>T
D304Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304Y missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, Rosetta, Foldetta, and premPS, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also labeled Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. With the majority of evidence pointing toward pathogenicity, the variant is most likely pathogenic; this assessment does not conflict with ClinVar, which contains no entry for D304Y.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-10.495Likely Pathogenic0.845Likely PathogenicAmbiguous0.468Likely Benign0.06230.65660.60Ambiguous0.20.14Likely Benign0.37Likely Benign0.37Likely Benign-6.29Deleterious1.000Probably Damaging0.999Probably Damaging1.76Pathogenic0.00Affected-4-32.248.09
c.911A>C
D304A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304A variant has no ClinVar entry and is not listed in gnomAD. Prediction tools that classify it as benign include premPS, ESM1b, and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) all predict a pathogenic effect. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact. This prediction does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-6.258Likely Benign0.604Likely PathogenicLikely Benign0.523Likely Pathogenic0.44570.66421.00Ambiguous0.10.54Ambiguous0.77Ambiguous0.39Likely Benign-5.97Deleterious1.000Probably Damaging0.998Probably Damaging1.80Pathogenic0.02Affected0-25.3-44.01
c.911A>G
D304G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. AlphaMissense‑Default, FoldX, Rosetta, and Foldetta are uncertain and are treated as unavailable evidence. High‑accuracy assessments show AlphaMissense‑Optimized predicting benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting pathogenic, and Foldetta remaining uncertain. Overall, the majority of tools (five pathogenic vs. four benign) and the SGM Consensus support a pathogenic classification. Thus, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.713Likely Benign0.546AmbiguousLikely Benign0.380Likely Benign0.45900.64511.02Ambiguous0.20.95Ambiguous0.99Ambiguous0.47Likely Benign-5.32Deleterious0.999Probably Damaging0.997Probably Damaging1.75Pathogenic0.02Affected1-13.1-58.04
c.911A>T
D304V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304V missense variant is not reported in ClinVar (ClinVar status: None) and has no entry in gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include Rosetta and premPS, while the majority of tools predict a pathogenic impact: SGM‑Consensus, REVEL, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the preponderance of evidence points to a pathogenic effect for D304V. This conclusion is not contradicted by ClinVar, which currently has no classification for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.285053Uncertain0.7640.2710.250-8.280Likely Pathogenic0.803Likely PathogenicAmbiguous0.541Likely Pathogenic0.09710.69991.35Ambiguous0.30.14Likely Benign0.75Ambiguous0.35Likely Benign-6.22Deleterious1.000Probably Damaging0.999Probably Damaging1.81Pathogenic0.00Affected-2-37.7-15.96
c.912C>A
D304E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304E missense variant has no ClinVar entry and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; pathogenic predictions arise from PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence supports a benign effect, and this conclusion does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.715Likely Benign0.233Likely BenignLikely Benign0.186Likely Benign0.15040.69980.34Likely Benign0.10.21Likely Benign0.28Likely Benign0.48Likely Benign-3.29Deleterious0.997Probably Damaging0.994Probably Damaging1.77Pathogenic0.04Affected320.014.03
c.912C>G
D304E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D304E missense variant is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus—derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN—yields a tie and is therefore inconclusive. Overall, the balance of evidence favors a benign classification, and this conclusion does not conflict with the absence of a ClinVar assertion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.285053Uncertain0.7640.2710.250-2.715Likely Benign0.233Likely BenignLikely Benign0.186Likely Benign0.15040.69980.34Likely Benign0.10.21Likely Benign0.28Likely Benign0.48Likely Benign-3.29Deleterious0.997Probably Damaging0.994Probably Damaging1.77Pathogenic0.04Affected320.014.03
c.973C>A
L325M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are Rosetta, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and premPS. Two tools give uncertain results: Foldetta and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. No prediction or folding stability result is missing or inconclusive. Overall, the majority of tools (six pathogenic vs five benign) lean toward pathogenicity, but the high‑accuracy methods and several benign predictions introduce uncertainty. Thus, the variant is most likely pathogenic based on the collective evidence, and this assessment is not contradicted by any ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.352862Structured0.424577Uncertain0.9550.4360.000-6.725Likely Benign0.445AmbiguousLikely Benign0.306Likely Benign0.09340.39420.22Likely Benign0.02.04Destabilizing1.13Ambiguous1.05Destabilizing-0.86Neutral0.997Probably Damaging0.939Probably Damaging1.36Pathogenic0.01Affected42-1.918.03
c.973C>G
L325V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L325V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Rosetta and Foldetta give uncertain results. The high‑accuracy consensus from AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely benign, and Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact, and this assessment does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.352862Structured0.424577Uncertain0.9550.4360.000-3.104Likely Benign0.162Likely BenignLikely Benign0.183Likely Benign0.15710.39572.26Destabilizing0.11.27Ambiguous1.77Ambiguous-0.39Likely Benign0.16Neutral0.898Possibly Damaging0.472Possibly Damaging1.68Pathogenic1.00Tolerated210.4-14.03
c.974T>A
L325Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools uniformly classify it as pathogenic. Benign predictions are absent; all evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—return pathogenic or likely pathogenic calls. High‑accuracy assessments corroborate this: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) also reports pathogenic. Consequently, the variant is most likely pathogenic, with no conflict with ClinVar status because no ClinVar assertion exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-17.005Likely Pathogenic0.997Likely PathogenicLikely Pathogenic0.547Likely Pathogenic0.12350.14053.23Destabilizing0.02.68Destabilizing2.96Destabilizing2.02Destabilizing-3.97Deleterious0.999Probably Damaging0.977Probably Damaging1.33Pathogenic0.00Affected-2-2-7.314.97
c.974T>C
L325P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325P is not reported in ClinVar (ClinVar status: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity all agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as pathogenic. No tool predicts a benign outcome. High‑accuracy methods reinforce this consensus: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates pathogenicity; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, reports a pathogenic effect. No predictions or stability results are missing or inconclusive. Based on the unanimous computational evidence, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-16.130Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.607Likely Pathogenic0.33930.19035.49Destabilizing0.37.27Destabilizing6.38Destabilizing1.89Destabilizing-4.37Deleterious0.999Probably Damaging0.977Probably Damaging1.33Pathogenic0.00Affected-3-3-5.4-16.04
c.974T>G
L325R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L325R is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity all converge on a deleterious effect: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic outcome. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is pathogenic. No predictions or stability results are missing or inconclusive. **Based on the collective predictions, the variant is most likely pathogenic, and this assessment does not contradict the ClinVar status (no ClinVar entry).**

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.352862Structured0.424577Uncertain0.9550.4360.000-16.612Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.551Likely Pathogenic0.14050.10474.34Destabilizing0.34.11Destabilizing4.23Destabilizing1.94Destabilizing-4.39Deleterious0.999Probably Damaging0.969Probably Damaging1.33Pathogenic0.00Affected-3-2-8.343.03
c.1021G>A
G341S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G341S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, polyPhen‑2 HumVar, and the SGM‑Consensus (Likely Benign). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and FATHMM. Predictions that are inconclusive or uncertain are Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, the SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of evidence points to a benign impact for G341S, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.431164Uncertain0.7450.4790.250-3.206Likely Benign0.090Likely BenignLikely Benign0.343Likely Benign0.24160.42150.41Likely Benign0.3-1.46Ambiguous-0.53Ambiguous-0.67Ambiguous0.73Neutral0.454Possibly Damaging0.192Benign0.37Pathogenic0.72Tolerated10-0.430.03
c.1021G>C
G341R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant G341R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, polyPhen‑2 HumVar, and Foldetta. Those that predict a pathogenic effect are SGM‑Consensus (Likely Pathogenic), polyPhen‑2 HumDiv, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools give uncertain results: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show that the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts a likely pathogenic outcome, while Foldetta predicts a benign effect; AlphaMissense‑Optimized remains inconclusive. Overall, the majority of predictions lean toward a benign impact, and this does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign, though the evidence is not definitive.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.356642Structured0.431164Uncertain0.7450.4790.250-8.263Likely Pathogenic0.945Likely PathogenicAmbiguous0.379Likely Benign0.08380.36180.28Likely Benign0.2-1.25Ambiguous-0.49Likely Benign0.18Likely Benign-1.03Neutral0.801Possibly Damaging0.417Benign0.34Pathogenic0.17Tolerated-3-2-4.199.14
c.1021G>T
G341C
2D
AIThe SynGAP1 missense variant G341C has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include FoldX, Foldetta, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (likely benign). Tools that predict a pathogenic effect are REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM; Rosetta remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Based on the overall consensus of the available predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status (none is reported).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.431164Uncertain0.7450.4790.250-6.156Likely Benign0.190Likely BenignLikely Benign0.501Likely Pathogenic0.12850.36500.42Likely Benign1.2-0.92Ambiguous-0.25Likely Benign0.24Likely Benign-2.40Neutral0.997Probably Damaging0.870Possibly Damaging0.34Pathogenic0.01Affected-3-32.946.09
c.1022G>A
G341D
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G341D is not reported in ClinVar (ClinVar ID: None) but is present in gnomAD (ID: 6-33437927‑G‑A). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, FATHMM, and AlphaMissense‑Default. The remaining tools—Foldetta, AlphaMissense‑Optimized, ESM1b, and Rosetta—return uncertain or inconclusive results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Considering the majority of standard tools lean benign but the high‑accuracy consensus indicates pathogenicity, the variant is most likely pathogenic based on current predictions, and this assessment does not contradict ClinVar status because the variant is not yet catalogued there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.356642Structured0.431164Uncertain0.7450.4790.2506-33437927-G-A63.72e-6-7.402In-Between0.871Likely PathogenicAmbiguous0.295Likely Benign0.17270.22410.28Likely Benign0.1-1.32Ambiguous-0.52Ambiguous-0.04Likely Benign-0.11Neutral0.454Possibly Damaging0.192Benign0.34Pathogenic0.25Tolerated3.4213-11-3.158.04
c.1022G>C
G341A
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G341A is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Pathogenic predictions come only from polyPhen‑2 HumDiv and FATHMM. Uncertain results are reported by Rosetta and Foldetta. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is likely benign; Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, remains inconclusive. Overall, the preponderance of evidence indicates that G341A is most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.431164Uncertain0.7450.4790.250-3.211Likely Benign0.109Likely BenignLikely Benign0.239Likely Benign0.35620.39790.16Likely Benign0.4-1.23Ambiguous-0.54Ambiguous-0.03Likely Benign-1.13Neutral0.625Possibly Damaging0.192Benign0.43Pathogenic0.15Tolerated102.214.03
c.1022G>T
G341V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant G341V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, Rosetta, PROVEAN, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, polyPhen‑2 HumVar, and the SGM‑Consensus score (derived from a majority of benign calls among AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as benign, and Foldetta (combining FoldX‑MD and Rosetta stability outputs) as uncertain. No evidence from FoldX or premPS is available. Overall, the majority of predictions support a benign classification, and this is consistent with the lack of ClinVar annotation. Therefore, the variant is most likely benign and does not contradict any existing ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.431164Uncertain0.7450.4790.250-5.371Likely Benign0.247Likely BenignLikely Benign0.459Likely Benign0.10190.36490.86Ambiguous0.3-2.24Stabilizing-0.69Ambiguous-0.50Ambiguous-2.29Neutral0.801Possibly Damaging0.192Benign0.42Pathogenic0.05Affected-1-34.642.08
c.898T>A
S300T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300T is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only FATHMM indicates a pathogenic outcome. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is benign; the SGM‑Consensus (3 benign vs. 1 pathogenic) is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also predicts benign. No prediction or stability result is inconclusive. Overall, the evidence overwhelmingly supports a benign classification, and this conclusion does not contradict the absence of a ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.256848Uncertain0.7420.2800.375-4.648Likely Benign0.069Likely BenignLikely Benign0.056Likely Benign0.14090.64280.85Ambiguous0.1-0.30Likely Benign0.28Likely Benign-0.33Likely Benign0.50Neutral0.003Benign0.002Benign1.94Pathogenic0.85Tolerated110.114.03
c.898T>C
S300P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300P is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumVar, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, SIFT, and FATHMM. The remaining tools—FoldX, Foldetta, and ESM1b—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, while Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.356642Structured0.256848Uncertain0.7420.2800.375-7.379In-Between0.110Likely BenignLikely Benign0.086Likely Benign0.21920.55851.24Ambiguous1.00.06Likely Benign0.65Ambiguous0.50Likely Benign-2.46Neutral0.784Possibly Damaging0.390Benign1.54Pathogenic0.02Affected1-1-0.810.04
c.898T>G
S300A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300A is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only FATHMM predicts a pathogenic outcome. Rosetta and Foldetta give uncertain results and are therefore not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is also benign (3 benign vs. 1 pathogenic). Foldetta remains uncertain. Overall, the preponderance of evidence indicates that the variant is most likely benign, and this conclusion does not contradict the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.256848Uncertain0.7420.2800.375-5.420Likely Benign0.060Likely BenignLikely Benign0.031Likely Benign0.51350.4949Weaken0.08Likely Benign0.31.07Ambiguous0.58Ambiguous0.08Likely Benign-1.18Neutral0.139Benign0.060Benign1.56Pathogenic0.20Tolerated112.6-16.00
c.899C>A
S300Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300Y has no ClinVar entry and is not reported in gnomAD. Prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Foldetta, premPS, and AlphaMissense‑Optimized; pathogenic predictions come from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and FATHMM. Two tools (AlphaMissense‑Default and Rosetta) are uncertain and do not influence the consensus. High‑accuracy methods give the following results: AlphaMissense‑Optimized predicts benign; SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic; Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Overall, the majority of evidence points toward a pathogenic effect, and this assessment does not contradict any ClinVar status (none is available). Thus, based on current predictions, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.356642Structured0.256848Uncertain0.7420.2800.375-10.464Likely Pathogenic0.422AmbiguousLikely Benign0.116Likely Benign0.06780.5395-0.08Likely Benign0.40.55Ambiguous0.24Likely Benign0.28Likely Benign-2.52Deleterious0.975Probably Damaging0.686Possibly Damaging1.52Pathogenic0.01Affected-3-2-0.576.10
c.899C>G
S300C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant S300C is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33437804‑C‑G). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Rosetta and Foldetta give uncertain results and are therefore not considered evidence for either side. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign, SGM‑Consensus as Likely Benign, and Foldetta as Uncertain. Overall, the majority of reliable predictions indicate a benign impact, and this is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.356642Structured0.256848Uncertain0.7420.2800.3756-33437804-C-G-6.749Likely Benign0.108Likely BenignLikely Benign0.129Likely Benign0.10050.64930.31Likely Benign0.21.45Ambiguous0.88Ambiguous0.34Likely Benign-2.45Neutral0.975Probably Damaging0.815Possibly Damaging1.55Pathogenic0.01Affected3.4719-103.316.06
c.899C>T
S300F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant S300F is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Functional prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and FATHMM. The remaining tool, AlphaMissense‑Default, gives an uncertain result. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as benign. Overall, the majority of predictions lean toward pathogenicity, while two high‑accuracy methods support a benign effect. Thus, the variant is most likely pathogenic based on the current computational evidence, which does not contradict its ClinVar status of uncertain significance.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.356642Structured0.256848Uncertain0.7420.2800.375Uncertain 1-10.222Likely Pathogenic0.353AmbiguousLikely Benign0.117Likely Benign0.05790.5701-0.29Likely Benign0.40.16Likely Benign-0.07Likely Benign0.04Likely Benign-2.66Deleterious0.975Probably Damaging0.596Possibly Damaging1.52Pathogenic0.01Affected3.4719-3-23.660.10233.6-67.6-0.10.00.40.2XXPotentially PathogenicThe hydroxyl group of the Ser300 side chain, located in a β hairpin loop linking two anti-parallel β sheet strands (res. Met289-Pro298, res. Thr305-Asn315), hydrogen bonds with the guanidinium group of Arg299 and the backbone amide group and side chain of Ser302. Thus, in the WT simulations, it contributes to the β hairpin stability. In the variant simulations, the phenol ring of Phe300 cannot form any side chain-related hydrogen bonds, and Arg299 is moved away from its central hairpin loop position.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.913A>C
T305P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T305P missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), and FATHMM; premPS is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as pathogenic, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of tools (7 pathogenic vs. 5 benign) lean toward a pathogenic impact, and this assessment does not contradict the lack of ClinVar annotation. Thus, the variant is most likely pathogenic based on current predictive evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.359901Structured0.299706Uncertain0.8720.2740.125-5.203Likely Benign0.177Likely BenignLikely Benign0.293Likely Benign0.22060.53333.64Destabilizing1.16.02Destabilizing4.83Destabilizing0.71Ambiguous-2.83Deleterious0.997Probably Damaging0.929Probably Damaging1.72Pathogenic0.06Tolerated0-1-0.9-3.99
c.913A>G
T305A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 T305A variant is listed in ClinVar with an “Uncertain” status and is present in gnomAD (ID 6‑33437818‑A‑G). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports a “Likely Benign” outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar “Uncertain” classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125Conflicting 26-33437818-A-G138.05e-6-4.307Likely Benign0.078Likely BenignLikely Benign0.144Likely Benign0.42770.44031.30Ambiguous0.61.55Ambiguous1.43Ambiguous0.77Ambiguous-2.10Neutral0.939Possibly Damaging0.645Possibly Damaging1.76Pathogenic0.12Tolerated3.4020102.5-30.03177.943.5-0.20.10.40.0UncertainThe hydroxyl group of Thr305, located at the beginning of an anti-parallel β strand (res. Thr305-Asn315), hydrogen bonds with the carboxylate groups of Glu270 and Asp304 in the anti-parallel β strand and the adjacent β hairpin loop, respectively. In the variant simulations, the methyl group of the Ala305 side chain cannot hydrogen bond with either of the acidic residues, which could weaken the integrity of the tertiary structure and the β hairpin loop. Indeed, the guanidinium group of Arg299 does not acquire its central hairpin loop position due to the residue swap.β hairpins are potential nucleation sites during the initial stages of protein folding, so even minor changes in them could be significant. Due to its location near the membrane surface, the residue swap could also affect the C2 loop dynamics and SynGAP-membrane association. However, this is beyond the scope of the solvent-only simulations to unravel.
c.913A>T
T305S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T305S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive or uncertain are provided by Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125-2.899Likely Benign0.107Likely BenignLikely Benign0.135Likely Benign0.35790.44960.45Likely Benign0.41.21Ambiguous0.83Ambiguous0.55Ambiguous-0.60Neutral0.760Possibly Damaging0.484Possibly Damaging1.86Pathogenic0.54Tolerated11-0.1-14.03
c.914C>A
T305N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant T305N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the substitution as tolerated or benign, and the SGM‑Consensus score is “Likely Benign.” Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, and the combined Foldetta) return uncertain or inconclusive results. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is also benign, and Foldetta remains uncertain. Overall, the majority of evidence supports a benign impact for T305N, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125-3.261Likely Benign0.158Likely BenignLikely Benign0.098Likely Benign0.13270.43521.18Ambiguous0.21.65Ambiguous1.42Ambiguous0.09Likely Benign0.71Neutral0.046Benign0.040Benign2.34Pathogenic0.67Tolerated00-2.813.00
c.914C>G
T305S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T305S is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, FoldX, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Predictions that are inconclusive or uncertain are provided by Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates “Likely Benign,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, yields an uncertain result. Overall, the majority of evidence points to a benign effect, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.359901Structured0.299706Uncertain0.8720.2740.125-2.899Likely Benign0.107Likely BenignLikely Benign0.104Likely Benign0.35790.44960.45Likely Benign0.41.21Ambiguous0.83Ambiguous0.55Ambiguous-0.60Neutral0.760Possibly Damaging0.484Possibly Damaging1.86Pathogenic0.54Tolerated11-0.1-14.03
c.914C>T
T305I
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant T305I is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33437819‑C‑T). Functional prediction tools that agree on a benign effect include REVEL, FoldX, premPS, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic outcome are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. The high‑accuracy AlphaMissense‑Optimized score is benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Overall, the balance of evidence from high‑confidence predictors leans toward a benign impact, and this assessment does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.359901Structured0.299706Uncertain0.8720.2740.125Uncertain 16-33437819-C-T16.20e-7-5.222Likely Benign0.305Likely BenignLikely Benign0.224Likely Benign0.09390.56930.37Likely Benign0.20.58Ambiguous0.48Likely Benign0.25Likely Benign-2.90Deleterious0.997Probably Damaging0.929Probably Damaging1.70Pathogenic0.04Affected3.4020-105.212.05
c.1102C>A
P368T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P368T missense variant is not listed in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. FoldX, Rosetta, and Foldetta report uncertain or inconclusive stability changes and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a tie (2 benign, 2 pathogenic) and thus inconclusive, and Foldetta remains uncertain. Overall, the predictions are evenly split between benign and pathogenic, providing no definitive classification. The variant’s status does not contradict ClinVar, which has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.439989Uncertain0.5800.6770.250-5.308Likely Benign0.284Likely BenignLikely Benign0.188Likely Benign0.19830.61551.95Ambiguous0.61.61Ambiguous1.78Ambiguous0.45Likely Benign-5.43Deleterious0.941Possibly Damaging0.527Possibly Damaging1.72Pathogenic0.01Affected0-10.93.99
c.1102C>G
P368A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P368A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, AlphaMissense‑Default, AlphaMissense‑Optimized, ESM1b, and polyPhen‑2 HumVar. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, SIFT, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta (combining FoldX‑MD and Rosetta outputs) is also inconclusive. Overall, the balance of evidence leans toward a benign impact for P368A. This conclusion does not contradict any ClinVar annotation, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.439989Uncertain0.5800.6770.250-4.608Likely Benign0.174Likely BenignLikely Benign0.144Likely Benign0.38610.56351.49Ambiguous0.31.47Ambiguous1.48Ambiguous0.47Likely Benign-5.42Deleterious0.767Possibly Damaging0.344Benign1.74Pathogenic0.02Affected1-13.4-26.04
c.1102C>T
P368S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P368S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN and FATHMM. The remaining methods (FoldX, Rosetta, Foldetta, premPS) yield uncertain results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta is uncertain, so these do not alter the overall interpretation. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict the current ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.439989Uncertain0.5800.6770.250-4.790Likely Benign0.247Likely BenignLikely Benign0.090Likely Benign0.37000.56351.68Ambiguous0.41.60Ambiguous1.64Ambiguous0.52Ambiguous-5.12Deleterious0.384Benign0.113Benign1.80Pathogenic0.10Tolerated1-10.8-10.04
c.1103C>A
P368Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P368Q missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Remaining tools (AlphaMissense‑Default, FoldX, Rosetta, Foldetta, premPS) give uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as uncertain. Overall, the majority of definitive predictions (five pathogenic vs. three benign) indicate that the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.439989Uncertain0.5800.6770.250-6.019Likely Benign0.413AmbiguousLikely Benign0.205Likely Benign0.16940.52831.56Ambiguous0.81.71Ambiguous1.64Ambiguous0.71Ambiguous-5.10Deleterious0.991Probably Damaging0.881Possibly Damaging1.71Pathogenic0.04Affected0-1-1.931.01
c.1103C>G
P368R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 P368R missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Uncertain or inconclusive results come from FoldX, Rosetta, Foldetta, and premPS. High‑accuracy methods give a mixed picture: AlphaMissense‑Optimized predicts benign, whereas the SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts likely pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, is uncertain. Overall, the majority of evidence—including the SGM‑Consensus and several individual high‑accuracy tools—points to a pathogenic effect. This conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.439989Uncertain0.5800.6770.250-9.564Likely Pathogenic0.736Likely PathogenicLikely Benign0.263Likely Benign0.14390.39221.57Ambiguous1.01.54Ambiguous1.56Ambiguous0.58Ambiguous-6.07Deleterious0.991Probably Damaging0.881Possibly Damaging1.78Pathogenic0.00Affected0-2-2.959.07
c.1103C>T
P368L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant P368L is not reported in ClinVar (ClinVar ID None) but is present in gnomAD (ID 6‑33438008‑C‑T). Prediction tools that agree on a benign effect include REVEL, ESM1b, and AlphaMissense‑Optimized. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, and FATHMM. Predictions that are uncertain or inconclusive are FoldX, Rosetta, premPS, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments give AlphaMissense‑Optimized a benign score, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta outputs, is uncertain. Based on the overall distribution of predictions, the variant is most likely pathogenic. This assessment does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.439989Uncertain0.5800.6770.2506-33438008-C-T16.33e-7-6.520Likely Benign0.444AmbiguousLikely Benign0.248Likely Benign0.23360.71251.52Ambiguous0.71.15Ambiguous1.34Ambiguous0.52Ambiguous-6.61Deleterious0.991Probably Damaging0.831Possibly Damaging1.77Pathogenic0.00Affected3.4219-3-35.416.04
c.604G>A
E202K
2D
AIThe SynGAP1 E202K missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Rosetta and Foldetta give uncertain results. High‑accuracy methods give mixed evidence: AlphaMissense‑Optimized predicts benign, SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicts pathogenic, and Foldetta’s stability assessment is uncertain. Overall, more tools (7 vs. 5) predict pathogenicity, and the high‑accuracy consensus leans toward pathogenic. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.429450Uncertain0.7120.4150.125-9.011Likely Pathogenic0.678Likely PathogenicLikely Benign0.231Likely Benign0.19630.6885-0.24Likely Benign0.3-0.76Ambiguous-0.50Ambiguous0.10Likely Benign-2.55Deleterious0.982Probably Damaging0.679Possibly Damaging4.07Benign0.03Affected01-0.4-0.94
c.604G>C
E202Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202Q missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic outcome are polyPhen‑2 (HumDiv and HumVar) and SIFT. Two tools, ESM1b and AlphaMissense‑Default, return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑to‑2 split. Overall, the majority of evidence points to a benign effect. This conclusion is consistent with the lack of ClinVar annotation and gnomAD presence, so there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.429450Uncertain0.7120.4150.125-7.129In-Between0.456AmbiguousLikely Benign0.175Likely Benign0.09490.6792-0.16Likely Benign0.00.23Likely Benign0.04Likely Benign-0.13Likely Benign-1.39Neutral0.995Probably Damaging0.747Possibly Damaging4.07Benign0.02Affected220.0-0.98
c.605A>C
E202A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202A missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. Two tools (AlphaMissense‑Default and ESM1b) return uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive and therefore unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the lack of ClinVar annotation. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.429450Uncertain0.7120.4150.125-7.222In-Between0.538AmbiguousLikely Benign0.220Likely Benign0.39030.64680.13Likely Benign0.00.14Likely Benign0.14Likely Benign0.19Likely Benign-4.05Deleterious0.948Possibly Damaging0.484Possibly Damaging4.02Benign0.02Affected0-15.3-58.04
c.605A>G
E202G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202G missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM. Those that predict a pathogenic impact are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Tools with uncertain or inconclusive results are Rosetta, AlphaMissense‑Default, and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) leans toward pathogenic (2 pathogenic, 1 benign, 1 uncertain). Foldetta remains uncertain. Overall, the majority of standard prediction tools suggest a benign effect, and this conclusion does not contradict the lack of ClinVar reporting. Thus, the variant is most likely benign based on the current computational evidence.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.429450Uncertain0.7120.4150.125-8.310Likely Pathogenic0.495AmbiguousLikely Benign0.259Likely Benign0.30610.54050.37Likely Benign0.00.74Ambiguous0.56Ambiguous0.27Likely Benign-4.70Deleterious0.995Probably Damaging0.829Possibly Damaging4.01Benign0.07Tolerated0-23.1-72.06
c.605A>T
E202V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202V missense variant has no ClinVar record and is not present in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are SIFT, PROVEAN, polyPhen‑2 HumDiv, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Because the majority of tools (8 benign vs. 5 pathogenic) lean toward a benign outcome, the variant is most likely benign, although the SGM Consensus suggests pathogenicity. This conclusion does not contradict ClinVar status, as no ClinVar classification exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.429450Uncertain0.7120.4150.125-8.990Likely Pathogenic0.783Likely PathogenicLikely Benign0.270Likely Benign0.05250.70070.48Likely Benign0.00.34Likely Benign0.41Likely Benign0.12Likely Benign-4.81Deleterious0.649Possibly Damaging0.259Benign3.96Benign0.01Affected-2-27.7-29.98
c.606A>C
E202D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202D missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, and the SGM‑Consensus (majority vote). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The high‑accuracy methods give a consistent benign verdict: AlphaMissense‑Optimized predicts benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also predicts benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts benign. Rosetta alone is uncertain, but this inconclusive result does not alter the overall benign consensus. Based on the aggregate predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.363090Structured0.429450Uncertain0.7120.4150.125-5.646Likely Benign0.169Likely BenignLikely Benign0.065Likely Benign0.16060.40510.35Likely Benign0.10.53Ambiguous0.44Likely Benign0.19Likely Benign-1.82Neutral0.982Probably Damaging0.581Possibly Damaging4.02Benign0.04Affected320.0-14.03
c.606A>T
E202D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 E202D missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, Foldetta, and the SGM‑Consensus score. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized returns a benign prediction; the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also indicates benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, predicts a benign effect. Taken together, the majority of evidence points to a benign impact, and this conclusion does not conflict with the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.363090Structured0.429450Uncertain0.7120.4150.125-5.646Likely Benign0.169Likely BenignLikely Benign0.065Likely Benign0.16060.40510.35Likely Benign0.10.53Ambiguous0.44Likely Benign0.19Likely Benign-1.82Neutral0.982Probably Damaging0.581Possibly Damaging4.02Benign0.04Affected320.0-14.03
c.727A>C
I243L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I243L missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Optimized. No tool predicts a pathogenic outcome; the only inconclusive results come from AlphaMissense‑Default and ESM1b, which are treated as unavailable. High‑accuracy assessments further support a benign classification: AlphaMissense‑Optimized is benign; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields benign; and Foldetta also predicts benign. Overall, the variant is most likely benign, and this conclusion does not contradict any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.344471Uncertain0.8420.3470.000-7.890In-Between0.524AmbiguousLikely Benign0.380Likely Benign0.06260.2891-0.03Likely Benign0.2-0.35Likely Benign-0.19Likely Benign0.32Likely Benign-0.33Neutral0.048Benign0.039Benign5.74Benign0.19Tolerated22-0.70.00
c.727A>G
I243V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243V is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and ESM1b. FoldX and Foldetta give uncertain results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta remains uncertain. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.363090Structured0.344471Uncertain0.8420.3470.000-8.237Likely Pathogenic0.314Likely BenignLikely Benign0.445Likely Benign0.10190.25911.09Ambiguous0.10.19Likely Benign0.64Ambiguous0.39Likely Benign-0.39Neutral0.617Possibly Damaging0.140Benign5.71Benign0.15Tolerated43-0.3-14.03
c.727A>T
I243F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 I243F missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include premPS, PROVEAN, and FATHMM. Tools that agree on a pathogenic effect include REVEL, FoldX, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy methods give inconclusive results: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie and thus unavailable; Foldetta is uncertain. Overall, the majority of available predictions (7 pathogenic vs. 3 benign) indicate a likely pathogenic impact. This assessment does not contradict any ClinVar annotation, as none exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.363090Structured0.344471Uncertain0.8420.3470.000-12.559Likely Pathogenic0.934Likely PathogenicAmbiguous0.793Likely Pathogenic0.04090.22052.92Destabilizing2.50.53Ambiguous1.73Ambiguous0.42Likely Benign-2.21Neutral0.985Probably Damaging0.724Possibly Damaging5.53Benign0.02Affected10-1.734.02
c.728T>A
I243N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant I243N is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into three groups: benign (FATHMM), pathogenic (SGM‑Consensus, REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized), and uncertain (FoldX, Rosetta, Foldetta). High‑accuracy methods give a consistent pathogenic signal: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta remains uncertain. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-14.784Likely Pathogenic0.988Likely PathogenicLikely Pathogenic0.811Likely Pathogenic0.08990.02121.90Ambiguous0.21.43Ambiguous1.67Ambiguous1.76Destabilizing-4.46Deleterious0.995Probably Damaging0.854Possibly Damaging5.49Benign0.00Affected-2-3-8.00.94
c.728T>C
I243T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243T is not reported in ClinVar and is absent from gnomAD. Prediction tools largely agree on a deleterious effect: SGM‑Consensus, REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default all classify the variant as pathogenic. Only FATHMM predicts a benign outcome, while Foldetta, AlphaMissense‑Optimized, and Rosetta return uncertain results, which are treated as unavailable evidence. High‑accuracy assessments further support a pathogenic interpretation: AlphaMissense‑Optimized is uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is Likely Pathogenic, and Foldetta remains uncertain. Overall, the preponderance of evidence indicates that I243T is most likely pathogenic, and this conclusion does not contradict the current ClinVar status, which contains no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-9.102Likely Pathogenic0.922Likely PathogenicAmbiguous0.816Likely Pathogenic0.10270.05412.15Destabilizing0.21.52Ambiguous1.84Ambiguous1.72Destabilizing-3.06Deleterious0.982Probably Damaging0.702Possibly Damaging5.55Benign0.01Affected0-1-5.2-12.05
c.728T>G
I243S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243S is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that assess pathogenicity largely agree: SGM‑Consensus, REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a pathogenic effect. Only FATHMM predicts a benign outcome. High‑accuracy methods reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) is pathogenic. No predictions are missing or inconclusive. Based on the consensus of these tools, the variant is most likely pathogenic, and this assessment does not contradict the absence of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.363090Structured0.344471Uncertain0.8420.3470.000-14.097Likely Pathogenic0.975Likely PathogenicLikely Pathogenic0.802Likely Pathogenic0.26580.06002.52Destabilizing0.22.22Destabilizing2.37Destabilizing1.71Destabilizing-3.55Deleterious0.995Probably Damaging0.795Possibly Damaging5.52Benign0.00Affected-1-2-5.3-26.08
c.729T>G
I243M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant I243M has no ClinVar entry (ClinVar status: not reported) and is absent from gnomAD (gnomAD ID: none). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Only the two polyPhen‑2 implementations (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized scores the variant as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Benign”; and Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, also predicts a benign effect. Overall, the consensus of the majority of tools, including the high‑accuracy methods, indicates that the variant is most likely benign, and this conclusion is consistent with the absence of any ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.363090Structured0.344471Uncertain0.8420.3470.000-4.305Likely Benign0.175Likely BenignLikely Benign0.474Likely Benign0.05530.22000.09Likely Benign0.10.16Likely Benign0.13Likely Benign-0.01Likely Benign0.58Neutral0.985Probably Damaging0.798Possibly Damaging5.61Benign0.94Tolerated21-2.618.03
c.916G>A
V306I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306I is not reported in ClinVar (no ClinVar ID) but is present in gnomAD (variant ID 6-33437821‑G‑A). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. No prediction or stability assessment is missing; all available data are considered. Based on the preponderance of benign predictions and the lack of ClinVar evidence to the contrary, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.363090Structured0.315026Uncertain0.8960.2870.1256-33437821-G-A116.82e-6-5.989Likely Benign0.121Likely BenignLikely Benign0.154Likely Benign0.06030.34611.13Ambiguous0.20.38Likely Benign0.76Ambiguous0.19Likely Benign-0.17Neutral0.999Probably Damaging0.993Probably Damaging1.75Pathogenic0.36Tolerated3.3819340.314.03
c.916G>C
V306L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 V306L missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Uncertain results come from Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely benign, and Foldetta is inconclusive. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.363090Structured0.315026Uncertain0.8960.2870.125-3.633Likely Benign0.267Likely BenignLikely Benign0.161Likely Benign0.08230.41172.14Destabilizing0.21.47Ambiguous1.81Ambiguous0.75Ambiguous-1.01Neutral0.999Probably Damaging0.996Probably Damaging1.76Pathogenic0.21Tolerated21-0.414.03
c.916G>T
V306F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306F is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) labeling it likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting a pathogenic effect. Overall, the majority of evidence supports a pathogenic impact, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125-9.311Likely Pathogenic0.700Likely PathogenicLikely Benign0.336Likely Benign0.05350.331813.59Destabilizing1.46.99Destabilizing10.29Destabilizing0.23Likely Benign-3.28Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.01Affected-1-1-1.448.04
c.917T>A
V306D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306D is listed in ClinVar with an “Uncertain” status and is not reported in gnomAD. All available in‑silico predictors that were evaluated return a pathogenic or likely‑pathogenic assessment: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. No tool in the dataset predicts a benign effect. High‑accuracy methods reinforce this view: AlphaMissense‑Optimized is pathogenic; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic”; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is pathogenic. Based on the unanimous pathogenic predictions, the variant is most likely pathogenic, and this conclusion does not contradict the current ClinVar status of uncertainty.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125Uncertain 1-18.289Likely Pathogenic0.986Likely PathogenicLikely Pathogenic0.530Likely Pathogenic0.13170.07684.40Destabilizing0.34.29Destabilizing4.35Destabilizing2.44Destabilizing-5.44Deleterious1.000Probably Damaging0.999Probably Damaging1.74Pathogenic0.00Affected3.3819-2-3-7.715.96212.3-18.3-0.20.40.00.2XXXPotentially PathogenicThe isopropyl group of Val396, located at the beginning of an anti-parallel β sheet strand (res. Thr305-Asn315), packs against multiple hydrophobic residues (e.g., Leu274, Trp308, Ala271) in the WT simulations. However, in the variant simulations, the negatively charged carboxylate group of the Asp306 side chain is not suitable for this hydrophobic niche. Consequently, the side chain moves out to interact with Ser300 in the β strand (res. Met289-Arg299) and the guanidinium group of Arg299 in the β hairpin loop.In the third simulation, the residue swap disrupts the C2 domain secondary structure and tertiary assembly to a large degree when the amino group of the Lys297 side chain rotates to form a salt bridge with Asp306. This drastic effect could potentially reflect the challenge presented by the residue swap during the C2 domain folding. Because the residue swap affects the C2 domain structure, the SynGAP-membrane association could also be impacted. However, this is beyond the scope of the solvent-only simulations to unravel.
c.917T>C
V306A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and AlphaMissense‑Optimized, whereas the remaining tools (SGM‑Consensus, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default) all predict a pathogenic outcome; ESM1b is uncertain and therefore not counted. High‑accuracy assessments give a benign result from AlphaMissense‑Optimized, a likely pathogenic verdict from the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and a pathogenic prediction from Foldetta. Taken together, the preponderance of evidence indicates that V306A is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.363090Structured0.315026Uncertain0.8960.2870.125-7.924In-Between0.599Likely PathogenicLikely Benign0.300Likely Benign0.26870.19892.76Destabilizing0.13.00Destabilizing2.88Destabilizing2.25Destabilizing-2.94Deleterious0.997Probably Damaging0.992Probably Damaging1.77Pathogenic0.05Affected00-2.4-28.05
c.917T>G
V306G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant V306G is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that assess pathogenicity unanimously classify the variant as pathogenic: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. No tool predicts a benign effect. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized is uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. All available evidence points to a pathogenic effect. Therefore, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.363090Structured0.315026Uncertain0.8960.2870.125-12.313Likely Pathogenic0.795Likely PathogenicAmbiguous0.529Likely Pathogenic0.18740.20354.39Destabilizing0.25.89Destabilizing5.14Destabilizing2.46Destabilizing-5.48Deleterious0.998Probably Damaging1.000Probably Damaging1.78Pathogenic0.00Affected-1-3-4.6-42.08
c.1024T>A
Y342N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342N has no ClinVar entry (ClinVar status: None) and is not reported in gnomAD (gnomAD ID: None). Prediction tools that assess the variant’s effect are overwhelmingly in agreement that it is deleterious: SGM‑Consensus, REVEL, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default all predict a pathogenic outcome. No tool predicts a benign effect. High‑accuracy assessments further support this view: AlphaMissense‑Optimized is inconclusive, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports “Likely Pathogenic,” and Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic impact. Taken together, the variant is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250-9.685Likely Pathogenic0.940Likely PathogenicAmbiguous0.554Likely Pathogenic0.21890.08621.76Ambiguous0.12.89Destabilizing2.33Destabilizing1.02Destabilizing-6.65Deleterious1.000Probably Damaging0.999Probably Damaging1.71Pathogenic0.03Affected-2-2-2.2-49.07
c.1024T>C
Y342H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342H is reported in gnomAD (ID 6‑33437929‑T‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and ESM1b, while pathogenic predictions are made by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. Five tools predict pathogenicity versus three predicting benign, with the remaining five (FoldX, Rosetta, Foldetta, premPS, AlphaMissense‑Optimized) yielding uncertain or inconclusive results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is uncertain, SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is uncertain. Overall, the preponderance of evidence indicates that Y342H is most likely pathogenic, and this conclusion is not contradicted by ClinVar status, which currently contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.2506-33437929-T-C16.20e-7-6.459Likely Benign0.944Likely PathogenicAmbiguous0.453Likely Benign0.24910.08621.63Ambiguous0.11.33Ambiguous1.48Ambiguous0.73Ambiguous-3.61Deleterious1.000Probably Damaging0.999Probably Damaging1.72Pathogenic0.06Tolerated3.372520-1.9-26.03
c.1024T>G
Y342D
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342D is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include premPS and SIFT, whereas the majority of other in silico predictors (SGM‑Consensus, REVEL, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized) predict it to be pathogenic. FoldX reports an uncertain effect, while Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic; and Foldetta is pathogenic. Based on the preponderance of pathogenic predictions and the absence of benign evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250-10.940Likely Pathogenic0.985Likely PathogenicLikely Pathogenic0.668Likely Pathogenic0.39250.08621.60Ambiguous0.12.70Destabilizing2.15Destabilizing0.13Likely Benign-7.19Deleterious1.000Probably Damaging0.999Probably Damaging1.71Pathogenic0.07Tolerated-4-3-2.2-48.09
c.1025A>C
Y342S
2D
3DClick to see structure in 3D Viewer
AISynGAP1 variant Y342S is listed in ClinVar with an uncertain significance and is not reported in gnomAD. Prediction tools that agree on a benign effect include only REVEL, whereas the majority of algorithms predict a pathogenic impact: FoldX, Rosetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, FATHMM, AlphaMissense‑Default, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and the Foldetta stability assessment (combining FoldX‑MD and Rosetta). Uncertain results come from premPS, ESM1b, and AlphaMissense‑Optimized. High‑accuracy methods specifically give AlphaMissense‑Optimized as uncertain, SGM‑Consensus as pathogenic, and Foldetta as pathogenic. Overall, the preponderance of evidence points to a pathogenic effect, which contradicts the ClinVar uncertain classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250Uncertain 2-7.996In-Between0.925Likely PathogenicAmbiguous0.407Likely Benign0.46170.26373.03Destabilizing0.12.87Destabilizing2.95Destabilizing0.93Ambiguous-6.60Deleterious1.000Probably Damaging0.998Probably Damaging1.75Pathogenic0.04Affected3.3725-3-20.5-76.10200.177.80.00.0-0.20.1Potentially PathogenicThe phenol ring of Tyr342, located at the end of an anti-parallel β sheet strand (res. Gly341-Pro349), faces outward in the C2 domain. In the WT simulations, the phenol ring of Tyr342 contributes to a triple tyrosine stack (Tyr342, Tyr328, and Tyr281) that links together three anti-parallel β sheet strands. Additionally, it shields Gly344 from the solvent, reducing its exposure and providing stability for the β-sandwich. This motif also contributes to a twist formation in the β sheet.In the variant simulations, the Ser342 side chain cannot participate in the stack formation. Instead, the hydroxyl group of the Ser342 side chain forms a hydrogen bond with the imidazole ring of His326 in a neighboring β strand (res. Ala322-Asp330). This disrupts the formation of a hydrogen bond between His326 and the carboxylate group of the Glu283 side chain from another β strand (res. Arg279-Cys285). Although these changes in surface interactions could weaken the characteristic twist that strengthens the β sheet fold, no major structural effects are observed in the variant simulations. The residue swap could also affect the SynGAP-membrane association, as the hydroxyl group of Ser342 could form hydrogen bonds with membrane-facing loop residues. However, this phenomenon cannot be addressed using solvent-only simulations.
c.1025A>G
Y342C
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant Y342C is listed in ClinVar as Benign (ClinVar ID 1213078.0) and is observed in gnomAD (ID 6‑33437930‑A‑G). Across general prediction tools, benign calls are made by REVEL and AlphaMissense‑Optimized, whereas pathogenic calls are made by FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, AlphaMissense‑Default, and the SGM‑Consensus score (Likely Pathogenic). Uncertain results are reported by premPS and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized predicting Benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) predicting Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) predicting Pathogenic. Overall, the majority of predictions support a pathogenic effect, contradicting the ClinVar benign classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.366687Structured0.408200Uncertain0.8660.4870.250Benign/Likely benign 26-33437930-A-G211.30e-5-7.596In-Between0.682Likely PathogenicLikely Benign0.404Likely Benign0.28360.28702.48Destabilizing0.12.73Destabilizing2.61Destabilizing0.92Ambiguous-6.67Deleterious1.000Probably Damaging0.999Probably Damaging1.72Pathogenic0.02Affected3.37250-23.8-60.04242.462.80.10.0-0.10.2Potentially PathogenicThe phenol ring of Tyr342, located at the end of an anti-parallel β sheet strand (res. Gly341-Pro349), faces outward in the C2 domain. This phenol ring contributes to a triple tyrosine stack (Tyr342, Tyr328, and Tyr281) that links together three anti-parallel β sheet strands. Additionally, it shields Gly344 from the solvent, reducing its exposure and providing stability for the β-sandwich. This motif also contributes to a twist formation in the β sheet.In the variant simulations, the Cys342 side chain cannot participate in the stack formation. Instead, its thiol group forms a hydrogen bond with the backbone carbonyl group of Leu327. Although these changes in surface interactions could weaken the characteristic twist that strengthens the β sheet fold, no major structural effects are observed in the variant simulations. The residue swap could also affect the SynGAP-membrane association; however, this phenomenon cannot be addressed using solvent-only simulations. Notably, the thiol group of cysteine is not a particularly strong hydrogen-bonding partner, which could mitigate the negative effects of the residue swap.
c.1025A>T
Y342F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant Y342F is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive and therefore treated as unavailable. Overall, the majority of evidence points to a benign impact. This conclusion does not contradict the ClinVar status, which currently has no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.366687Structured0.408200Uncertain0.8660.4870.250-6.987Likely Benign0.145Likely BenignLikely Benign0.160Likely Benign0.26260.3615-0.13Likely Benign0.10.42Likely Benign0.15Likely Benign0.05Likely Benign-2.67Deleterious0.999Probably Damaging0.992Probably Damaging2.03Pathogenic0.26Tolerated734.1-16.00
c.598T>A
L200M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L200M is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign outcome. Only two tools, polyPhen‑2 HumDiv and HumVar, predict pathogenicity. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign; the SGM‑Consensus, derived from the four high‑confidence predictors, is benign; and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, also reports a benign effect. Taken together, the overwhelming majority of evidence supports a benign classification for L200M, and this conclusion is consistent with the absence of a ClinVar entry. Thus, the variant is most likely benign, and this assessment does not contradict ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.366687Structured0.428168Uncertain0.6870.4530.125-4.107Likely Benign0.215Likely BenignLikely Benign0.139Likely Benign0.07510.35110.08Likely Benign0.10.41Likely Benign0.25Likely Benign-0.25Likely Benign0.47Neutral0.997Probably Damaging0.960Probably Damaging4.11Benign0.31Tolerated42-1.918.03
c.598T>G
L200V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L200V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). Tools that predict a pathogenic outcome are FoldX, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and the Foldetta stability assessment. Uncertain results come from Rosetta and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign, and Foldetta as pathogenic. Overall, the majority of evidence points to a benign effect; there is no ClinVar annotation to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.366687Structured0.428168Uncertain0.6870.4530.125-6.917Likely Benign0.213Likely BenignLikely Benign0.098Likely Benign0.15930.36072.15Destabilizing0.21.85Ambiguous2.00Destabilizing0.92Ambiguous-1.07Neutral0.990Probably Damaging0.760Possibly Damaging4.09Benign0.24Tolerated210.4-14.03
c.599T>C
L200S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L200S missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, and FATHMM. Those that predict a pathogenic effect comprise FoldX, Rosetta, Foldetta, premPS, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, and AlphaMissense‑Default. The SGM Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 vs 2). High‑accuracy methods give a pathogenic signal from Foldetta (protein‑folding stability analysis) while AlphaMissense‑Optimized is uncertain and thus not considered evidence. Overall, the majority of available predictions (10 pathogenic vs 4 benign) indicate a pathogenic impact. Therefore, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428168Uncertain0.6870.4530.125-10.755Likely Pathogenic0.807Likely PathogenicAmbiguous0.141Likely Benign0.32790.05752.72Destabilizing0.13.38Destabilizing3.05Destabilizing1.43Destabilizing-1.96Neutral0.970Probably Damaging0.683Possibly Damaging4.05Benign0.06Tolerated-3-2-4.6-26.08
c.599T>G
L200W
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L200W is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL and FATHMM, whereas the majority of tools (SGM‑Consensus, FoldX, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and Foldetta) predict a pathogenic impact. Two tools (AlphaMissense‑Optimized and Rosetta) provide inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus as Likely Pathogenic (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN), and Foldetta as Pathogenic, the latter integrating stability predictions from FoldX‑MD and Rosetta. Overall, the preponderance of evidence indicates that the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.428168Uncertain0.6870.4530.125-11.550Likely Pathogenic0.824Likely PathogenicAmbiguous0.200Likely Benign0.06270.28932.90Destabilizing1.01.95Ambiguous2.43Destabilizing1.20Destabilizing-2.93Deleterious0.999Probably Damaging0.970Probably Damaging3.98Benign0.02Affected-2-2-4.773.05
c.600G>C
L200F
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant L200F is listed in ClinVar with an uncertain significance and is present in gnomAD (ID 6‑33435242‑G‑C). Functional prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Predictions that are inconclusive are FoldX, Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact, which does not contradict the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428168Uncertain0.6870.4530.125Uncertain 16-33435242-G-C21.24e-6-7.606In-Between0.592Likely PathogenicLikely Benign0.094Likely Benign0.06400.31201.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.46920-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.600G>T
L200F
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L200F missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Four tools (FoldX, Rosetta, ESM1b, Foldetta) returned uncertain results and are not considered evidence for either side. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus—derived from a majority vote of AlphaMissense‑Default (pathogenic), ESM1b (uncertain), FATHMM (benign), and PROVEAN (benign)—is benign; Foldetta remains uncertain and is treated as unavailable. Overall, the balance of evidence (six benign vs. three pathogenic predictions, with a benign consensus from high‑accuracy methods) indicates that the variant is most likely benign, and this conclusion does not contradict the ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428168Uncertain0.6870.4530.125-7.606In-Between0.592Likely PathogenicLikely Benign0.094Likely Benign0.06400.31201.00Ambiguous0.51.45Ambiguous1.23Ambiguous0.43Likely Benign-1.97Neutral0.997Probably Damaging0.916Probably Damaging4.02Benign0.17Tolerated3.46920-1.034.02250.4-15.10.60.20.50.0XUncertainLeu200, a hydrophobic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another hydrophobic residue, phenylalanine. Both the phenyl group of Phe200 and the branched iso-butyl hydrocarbon sidechain of Leu200 occupy an inward hydrophobic niche (e.g., Leu246, Val222, Phe231) during the simulations. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.601G>A
D201N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, SIFT, and FATHMM. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The remaining tools—Rosetta, Foldetta, ESM1b, and AlphaMissense‑Default—return uncertain results and are treated as unavailable for pathogenicity inference. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is unavailable because two of the four inputs are uncertain. Foldetta also yields an uncertain result and is unavailable. Overall, the preponderance of evidence points to a benign impact for D201N, and this conclusion does not contradict the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428570Uncertain0.6980.4470.125-7.686In-Between0.525AmbiguousLikely Benign0.160Likely Benign0.09110.54130.31Likely Benign0.01.21Ambiguous0.76Ambiguous-0.10Likely Benign-2.36Neutral0.996Probably Damaging0.877Possibly Damaging4.08Benign0.13Tolerated210.0-0.98
c.601G>C
D201H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201H missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM. Those that agree on a pathogenic effect include SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, and AlphaMissense‑Default. Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, SGM‑Consensus (a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta as uncertain. Overall, the majority of available predictions (seven pathogenic vs. three benign) indicate that the variant is most likely pathogenic. This conclusion is not contradicted by ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.428570Uncertain0.6980.4470.125-8.595Likely Pathogenic0.862Likely PathogenicAmbiguous0.284Likely Benign0.11520.58380.68Ambiguous0.21.43Ambiguous1.06Ambiguous0.44Likely Benign-3.45Deleterious1.000Probably Damaging0.960Probably Damaging4.04Benign0.03Affected1-10.322.05
c.601G>T
D201Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201Y missense variant is not reported in ClinVar (status: None) and has no entry in gnomAD. Prediction tools that indicate a benign effect include REVEL, FoldX, premPS, and FATHMM. Those that predict a pathogenic effect comprise SGM Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and Rosetta. High‑accuracy methods give the following results: AlphaMissense‑Optimized is uncertain; SGM Consensus predicts likely pathogenic; Foldetta is uncertain. Because the majority of consensus and individual predictors (seven pathogenic vs four benign) lean toward a damaging outcome, the variant is most likely pathogenic. This assessment is not contradicted by ClinVar, which contains no classification for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.428570Uncertain0.6980.4470.125-10.916Likely Pathogenic0.892Likely PathogenicAmbiguous0.334Likely Benign0.04310.53710.28Likely Benign0.22.39Destabilizing1.34Ambiguous0.31Likely Benign-4.93Deleterious1.000Probably Damaging0.960Probably Damaging4.02Benign0.02Affected-4-32.248.09
c.602A>C
D201A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201A variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, and FATHMM, whereas a pathogenic consensus is reached by PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. Uncertain or unavailable results come from Rosetta, Foldetta, and ESM1b. High‑accuracy assessments show AlphaMissense‑Optimized predicts a benign outcome, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) leans toward pathogenic, and Foldetta remains inconclusive. Overall, the majority of standard tools favor a benign classification, but the high‑accuracy consensus indicates a pathogenic signal, leaving the variant’s impact uncertain. The predictions do not contradict ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428570Uncertain0.6980.4470.125-7.793In-Between0.769Likely PathogenicLikely Benign0.261Likely Benign0.31770.50500.45Likely Benign0.11.86Ambiguous1.16Ambiguous0.23Likely Benign-3.81Deleterious0.989Probably Damaging0.828Possibly Damaging4.11Benign0.09Tolerated0-25.3-44.01
c.602A>G
D201G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201G missense change is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, SIFT, FATHMM, and AlphaMissense‑Optimized. Those that predict a pathogenic impact are Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), AlphaMissense‑Default, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus as pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the balance of evidence favors a pathogenic interpretation, with no ClinVar annotation to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
PH0.366687Structured0.428570Uncertain0.6980.4470.125-7.744In-Between0.603Likely PathogenicLikely Benign0.289Likely Benign0.32680.50470.71Ambiguous0.02.64Destabilizing1.68Ambiguous0.24Likely Benign-3.03Deleterious0.996Probably Damaging0.877Possibly Damaging4.09Benign0.39Tolerated1-13.1-58.04
c.602A>T
D201V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201V missense variant has no ClinVar entry and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, premPS, and FATHMM, while those that predict a pathogenic impact are SGM‑Consensus (Likely Pathogenic), Rosetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Uncertain. With the majority of tools indicating pathogenicity and no ClinVar record to contradict this, the variant is most likely pathogenic.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.428570Uncertain0.6980.4470.125-10.283Likely Pathogenic0.906Likely PathogenicAmbiguous0.305Likely Benign0.05720.52070.87Ambiguous0.12.18Destabilizing1.53Ambiguous0.31Likely Benign-5.01Deleterious0.999Probably Damaging0.946Probably Damaging4.04Benign0.02Affected-2-37.7-15.96
c.603T>A
D201E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201E missense variant (ClinVar ID 3004688.0) is classified as **Benign** in ClinVar and is not reported in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Only polyPhen‑2 HumDiv predicts a pathogenic outcome, while Rosetta, Foldetta, and AlphaMissense‑Default are uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as **Benign**, the SGM‑Consensus as **Likely Benign**, and Foldetta as **Uncertain**. Taken together, the overwhelming majority of evidence points to a benign impact, and this conclusion aligns with the ClinVar designation. Thus, the variant is most likely benign, with no contradiction to its ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.366687Structured0.428570Uncertain0.6980.4470.125Benign 1-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.10690.55050.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.603T>G
D201E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D201E missense variant (gnomAD ID 6‑33435245‑T‑G) is listed in ClinVar with an uncertain significance. Across a broad panel of in silico predictors, the majority indicate a benign effect: REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized all score benign. Only polyPhen‑2 HumDiv predicts pathogenicity, while Rosetta, Foldetta, and AlphaMissense‑Default remain inconclusive. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, resolves to “likely benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized is benign, SGM‑Consensus is likely benign, and Foldetta is inconclusive. Taken together, the preponderance of evidence points to a benign impact, which does not conflict with the ClinVar uncertain status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.366687Structured0.428570Uncertain0.6980.4470.125Conflicting 26-33435245-T-G201.24e-5-2.640Likely Benign0.406AmbiguousLikely Benign0.165Likely Benign0.10690.55050.42Likely Benign0.21.99Ambiguous1.21Ambiguous0.23Likely Benign-0.69Neutral0.633Possibly Damaging0.108Benign4.30Benign1.00Tolerated3.469320.014.03258.7-24.80.90.1-0.30.2XUncertainAsp201, an acidic residue located in the N-terminal loop before the first anti-parallel β sheet strand (res. Ile205-Pro208), is replaced by another acidic residue, glutamate. The carboxylate groups of both Asp201 and Glu201 side chains form hydrogen bonds with the hydroxyl group of Ser221 in the simulations. Due to its shorter side chain, Asp201 can also hydrogen bond with the backbone amide groups of neighboring loop residues Ser204 and Asp203. However, since the model ends abruptly at the N-terminus, no definite conclusions can be drawn from the simulations.
c.691T>A
F231I
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231I is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include polyPhen‑2 HumVar and FATHMM, whereas the majority of tools predict a pathogenic impact: REVEL, SIFT, PROVEAN, polyPhen‑2 HumDiv, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Pathogenic). High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is Likely Pathogenic, while Foldetta’s stability prediction is uncertain and thus not considered evidence. No other tools provide definitive pathogenic or benign conclusions. Based on the preponderance of pathogenic predictions and the lack of contrary evidence, the variant is most likely pathogenic; this assessment does not contradict any ClinVar status, as none is available.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-13.827Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.894Likely Pathogenic0.21220.28131.16Ambiguous0.41.65Ambiguous1.41Ambiguous0.94Ambiguous-5.01Deleterious0.759Possibly Damaging0.328Benign5.76Benign0.00Affected101.7-34.02
c.691T>C
F231L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that agree on a pathogenic effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact for F231L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-9.482Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.801Likely Pathogenic0.23380.37941.07Ambiguous0.31.26Ambiguous1.17Ambiguous0.85Ambiguous-5.08Deleterious0.390Benign0.142Benign6.04Benign0.01Affected201.0-34.02
c.691T>G
F231V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231V is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect are polyPhen‑2 HumVar and FATHMM. All other evaluated algorithms—REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—classify the change as pathogenic. High‑accuracy assessments further support a deleterious impact: AlphaMissense‑Optimized predicts pathogenicity; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) reports a likely pathogenic status; and Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, also indicates pathogenicity. Taken together, the evidence overwhelmingly points to a pathogenic effect for F231V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-13.201Likely Pathogenic0.999Likely PathogenicLikely Pathogenic0.910Likely Pathogenic0.22120.30302.16Destabilizing0.32.30Destabilizing2.23Destabilizing1.13Destabilizing-5.90Deleterious0.759Possibly Damaging0.328Benign5.72Benign0.00Affected-1-11.4-48.04
c.692T>A
F231Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231Y is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on benign effects include Rosetta, Foldetta, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and FATHMM. Those that predict pathogenicity are REVEL, PROVEAN, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; FoldX and premPS are inconclusive. High‑accuracy methods give AlphaMissense‑Optimized as pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as pathogenic, and Foldetta as benign. Overall, the majority of standard tools lean benign, but the two most accurate predictors and the consensus vote favor pathogenicity. Thus, the variant is most likely pathogenic, and this assessment does not contradict ClinVar status, which currently has no classification for F231Y.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-9.831Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.687Likely Pathogenic0.13550.27320.69Ambiguous0.10.00Likely Benign0.35Likely Benign0.85Ambiguous-2.60Deleterious0.437Benign0.079Benign5.50Benign0.12Tolerated73-4.116.00
c.692T>C
F231S
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231S is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect are polyPhen‑2 HumVar and FATHMM; all other evaluated algorithms—including REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 HumDiv, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized—predict a pathogenic impact. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No prediction or stability result is missing or inconclusive. Based on the collective evidence, the variant is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-14.655Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.909Likely Pathogenic0.42970.05442.89Destabilizing0.44.22Destabilizing3.56Destabilizing2.22Destabilizing-6.92Deleterious0.608Possibly Damaging0.205Benign5.48Benign0.00Affected-3-2-3.6-60.10
c.692T>G
F231C
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231C is not reported in ClinVar and is absent from gnomAD. Prediction tools that assess pathogenicity largely agree: REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict a deleterious effect, while only FATHMM predicts a benign outcome. High‑accuracy assessments reinforce the pathogenic signal: AlphaMissense‑Optimized is pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is pathogenic. No predictions are missing or inconclusive. Based on the overwhelming agreement among the majority of tools and the high‑accuracy methods, the variant is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-13.315Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.937Likely Pathogenic0.25270.16122.26Destabilizing0.32.82Destabilizing2.54Destabilizing2.04Destabilizing-6.89Deleterious0.992Probably Damaging0.707Possibly Damaging5.49Benign0.00Affected-4-2-0.3-44.04
c.693T>A
F231L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231L is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. Tools that agree on a pathogenic effect include REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized; the SGM‑Consensus score is “Likely Pathogenic.” Predictions that are uncertain or inconclusive are FoldX, Rosetta, Foldetta, and premPS. High‑accuracy assessments show AlphaMissense‑Optimized as pathogenic, the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as uncertain. Overall, the majority of evidence points to a pathogenic impact for F231L, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-9.482Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.662Likely Pathogenic0.23380.37941.07Ambiguous0.31.26Ambiguous1.17Ambiguous0.85Ambiguous-5.08Deleterious0.390Benign0.142Benign6.04Benign0.01Affected201.0-34.02
c.693T>G
F231L
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant F231L is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify it as benign include polyPhen‑2 HumDiv, polyPhen‑2 HumVar and FATHMM, whereas REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default and AlphaMissense‑Optimized all predict a pathogenic effect. The SGM‑Consensus score is labeled Likely Pathogenic, and the remaining tools (FoldX, Rosetta, Foldetta, premPS) are inconclusive. High‑accuracy methods give a pathogenic verdict from AlphaMissense‑Optimized, a Likely Pathogenic result from the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), and an uncertain outcome from Foldetta. Overall, the majority of evidence points to a pathogenic impact for F231L, and this assessment does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.366687Structured0.306467Uncertain0.8950.3000.000-9.482Likely Pathogenic1.000Likely PathogenicLikely Pathogenic0.661Likely Pathogenic0.23380.37941.07Ambiguous0.31.26Ambiguous1.17Ambiguous0.85Ambiguous-5.08Deleterious0.390Benign0.142Benign6.04Benign0.01Affected201.0-34.02
c.1099C>A
L367M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L367M variant is not reported in ClinVar and is absent from gnomAD. Prediction tools that uniformly indicate a benign effect include REVEL, FoldX, premPS, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic outcome are polyPhen‑2 HumDiv and FATHMM. The remaining predictions are uncertain: Rosetta and Foldetta. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is also likely benign; Foldetta remains inconclusive. Overall, the majority of evidence supports a benign classification, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.370445Structured0.441805Uncertain0.7900.6570.250-4.968Likely Benign0.111Likely BenignLikely Benign0.078Likely Benign0.14020.39470.22Likely Benign0.10.92Ambiguous0.57Ambiguous-0.04Likely Benign0.12Neutral0.947Possibly Damaging0.360Benign1.63Pathogenic0.13Tolerated42-1.918.03
c.1099C>G
L367V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L367V is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). Only FATHMM predicts a pathogenic outcome. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, so they provide no evidence for or against pathogenicity. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, and Foldetta as uncertain. Overall, the preponderance of evidence points to a benign effect for L367V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.370445Structured0.441805Uncertain0.7900.6570.250-2.383Likely Benign0.066Likely BenignLikely Benign0.040Likely Benign0.23210.32851.48Ambiguous0.21.72Ambiguous1.60Ambiguous0.15Likely Benign0.19Neutral0.410Benign0.104Benign1.67Pathogenic0.13Tolerated210.4-14.03
c.1100T>A
L367Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L367Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that indicate a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, AlphaMissense‑Default, AlphaMissense‑Optimized, and ESM1b. Tools that predict a pathogenic effect are SIFT and FATHMM. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as “Likely Benign.” High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus also as benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) yields an uncertain result. Overall, the majority of evidence points to a benign impact. This conclusion is consistent with the lack of ClinVar annotation; there is no contradiction with existing clinical data.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.370445Structured0.441805Uncertain0.7900.6570.250-3.432Likely Benign0.150Likely BenignLikely Benign0.061Likely Benign0.16150.09731.09Ambiguous0.31.63Ambiguous1.36Ambiguous0.31Likely Benign0.38Neutral0.002Benign0.002Benign1.65Pathogenic0.02Affected-2-2-7.314.97
c.1100T>C
L367P
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant L367P is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD. Functional prediction tools that agree on benign impact include REVEL, PROVEAN, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote). Tools that predict pathogenicity are FoldX, Rosetta, Foldetta, polyPhen‑2 HumDiv, SIFT, and FATHMM; premPS remains uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM‑Consensus as likely benign, while Foldetta (combining FoldX‑MD and Rosetta outputs) predicts a pathogenic effect. Overall, the majority of predictions lean toward a benign effect, and this conclusion does not contradict any ClinVar annotation because no ClinVar status exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignC20.370445Structured0.441805Uncertain0.7900.6570.250-2.418Likely Benign0.160Likely BenignLikely Benign0.212Likely Benign0.39460.18742.13Destabilizing0.44.05Destabilizing3.09Destabilizing0.72Ambiguous-0.50Neutral0.627Possibly Damaging0.196Benign1.72Pathogenic0.02Affected-3-3-5.4-16.04
c.1100T>G
L367R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 L367R missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and ESM1b. Those that predict a pathogenic effect are SIFT, FATHMM, and Rosetta. Tools with uncertain or inconclusive results are FoldX, premPS, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta (combining FoldX‑MD and Rosetta outputs) as pathogenic. Overall, the majority of evidence points to a benign impact, with a minority of pathogenic predictions. The variant’s status is not contradicted by ClinVar, as it is not yet classified there.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.370445Structured0.441805Uncertain0.7900.6570.250-6.527Likely Benign0.515AmbiguousLikely Benign0.196Likely Benign0.16080.11730.68Ambiguous0.46.63Destabilizing3.66Destabilizing0.70Ambiguous-0.39Neutral0.146Benign0.057Benign1.66Pathogenic0.02Affected-3-2-8.343.03
c.2293A>C
S765R
2D
AIThe SynGAP1 missense variant S765R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus (majority vote) as Benign, and Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. There is no ClinVar entry to contradict this conclusion, so the variant is most likely benign based on current predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-5.422Likely Benign0.791Likely PathogenicAmbiguous0.157Likely Benign0.07410.3859-1.57Neutral0.996Probably Damaging0.985Probably Damaging4.16Benign0.07Tolerated3.646-10-3.769.11
c.2293A>G
S765G
2D
AIThe SynGAP1 missense variant S765G is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability result is available, so it does not influence the assessment. Overall, the majority of evidence points to the variant being most likely benign, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-4.658Likely Benign0.152Likely BenignLikely Benign0.048Likely Benign0.28940.4946-0.98Neutral0.963Probably Damaging0.950Probably Damaging4.09Benign0.05Affected100.4-30.03
c.2293A>T
S765C
2D
AIThe SynGAP1 missense variant S765C is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates a likely benign outcome. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic effect. High‑accuracy assessments reinforce the benign consensus: AlphaMissense‑Optimized is benign, and the SGM‑Consensus is likely benign; Foldetta results are unavailable. Overall, the preponderance of evidence supports a benign classification for S765C, and this conclusion does not contradict any existing ClinVar annotation (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-6.875Likely Benign0.256Likely BenignLikely Benign0.173Likely Benign0.08930.6309-2.12Neutral0.999Probably Damaging0.993Probably Damaging4.05Benign0.07Tolerated0-13.316.06
c.2294G>A
S765N
2D
AIThe SynGAP1 missense variant S765N (ClinVar ID 2979632.0) is listed as “Uncertain” in ClinVar and is not reported in gnomAD. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus score (Likely Benign). In contrast, PolyPhen‑2 (HumDiv and HumVar) predict a pathogenic impact. High‑accuracy assessments further support a benign interpretation: AlphaMissense‑Optimized is benign, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is also benign. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect, which is consistent with the ClinVar “Uncertain” classification and does not contradict it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250Uncertain 1-5.098Likely Benign0.378AmbiguousLikely Benign0.094Likely Benign0.11410.4658-0.94Neutral0.985Probably Damaging0.950Probably Damaging4.11Benign0.06Tolerated3.64611-2.727.03
c.2294G>C
S765T
2D
AIThe SynGAP1 missense variant S765T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv and polyPhen‑2 HumVar. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM‑Consensus as Likely Benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact. The predictions do not contradict ClinVar status, as ClinVar contains no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-4.233Likely Benign0.215Likely BenignLikely Benign0.094Likely Benign0.13120.6673-1.12Neutral0.963Probably Damaging0.950Probably Damaging4.13Benign0.37Tolerated110.114.03
c.2294G>T
S765I
2D
AIThe SynGAP1 missense variant S765I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM‑Consensus (derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also resolves to benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the majority of evidence points to a benign impact, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-6.891Likely Benign0.699Likely PathogenicLikely Benign0.187Likely Benign0.07680.5577-1.24Neutral0.996Probably Damaging0.985Probably Damaging4.09Benign0.69Tolerated-1-25.326.08
c.2295C>A
S765R
2D
AIThe SynGAP1 missense variant S765R is reported in gnomAD (ID 6‑33442453‑C‑A) but has no ClinVar entry. Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM. Those that predict a pathogenic impact are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Taken together, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because none is assigned. Thus, the variant is most likely benign.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.2506-33442453-C-A-5.422Likely Benign0.791Likely PathogenicAmbiguous0.155Likely Benign0.07410.3859-1.57Neutral0.996Probably Damaging0.985Probably Damaging4.16Benign0.07Tolerated3.646-10-3.769.11
c.2295C>G
S765R
2D
AIThe SynGAP1 missense variant S765R is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and FATHMM, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence points to a benign impact for S765R, and this conclusion does not contradict any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.370445Structured0.922652Binding0.3350.8650.250-5.422Likely Benign0.791Likely PathogenicAmbiguous0.155Likely Benign0.07410.3859-1.57Neutral0.996Probably Damaging0.985Probably Damaging4.16Benign0.07Tolerated3.646-10-3.769.11
c.2158G>A
D720N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D720N is listed in ClinVar as benign (ClinVar ID 2837618.0) and is present in gnomAD (ID 6‑33441623‑G‑A). Prediction tools that indicate a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus as pathogenic. With seven pathogenic versus six benign predictions overall, the variant is most likely pathogenic according to in‑silico evidence, which contradicts the benign classification in ClinVar.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.374039Structured0.450695Uncertain0.9550.4170.125Likely Benign 16-33441623-G-A53.10e-6-9.135Likely Pathogenic0.654Likely PathogenicLikely Benign0.289Likely Benign0.12160.55130.01Likely Benign0.0-0.20Likely Benign-0.10Likely Benign0.46Likely Benign-3.74Deleterious1.000Probably Damaging0.995Probably Damaging2.18Pathogenic0.01Affected3.509120.0-0.98
c.2158G>C
D720H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D720H missense variant is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, FoldX, Foldetta, and premPS. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus, which is a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN and is labeled Likely Pathogenic. The high‑accuracy AlphaMissense‑Optimized score is Uncertain, while Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta, indicates a Benign effect. Considering the overall distribution of predictions, the variant is most likely pathogenic, and this assessment does not contradict any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.374039Structured0.450695Uncertain0.9550.4170.125-12.355Likely Pathogenic0.947Likely PathogenicAmbiguous0.444Likely Benign0.13630.61980.03Likely Benign0.0-0.87Ambiguous-0.42Likely Benign0.48Likely Benign-5.27Deleterious1.000Probably Damaging0.999Probably Damaging2.13Pathogenic0.01Affected1-10.322.05
c.2158G>T
D720Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D720Y is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL and premPS, while pathogenic predictions are made by SIFT, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are inconclusive. The high‑accuracy consensus (SGM Consensus) classifies the variant as Likely Pathogenic, and Foldetta likewise yields an uncertain stability change. AlphaMissense‑Optimized remains inconclusive. Overall, the majority of evidence points to a pathogenic effect, and this assessment does not conflict with any ClinVar annotation because none exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.374039Structured0.450695Uncertain0.9550.4170.125-14.771Likely Pathogenic0.946Likely PathogenicAmbiguous0.499Likely Benign0.06260.5973-0.74Ambiguous0.1-1.38Ambiguous-1.06Ambiguous0.20Likely Benign-7.05Deleterious1.000Probably Damaging1.000Probably Damaging2.11Pathogenic0.00Affected-4-32.248.09
c.2159A>C
D720A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D720A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, and SIFT, while those that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, FATHMM, and AlphaMissense‑Default; AlphaMissense‑Optimized is uncertain. High‑accuracy assessments show that the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome, whereas Foldetta (combining FoldX‑MD and Rosetta) predicts a benign impact, and AlphaMissense‑Optimized remains uncertain. Overall, the predictions are split, with a slight tilt toward pathogenicity from the consensus and high‑accuracy methods. Thus, the variant is most likely pathogenic based on the available predictions, and this does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.374039Structured0.450695Uncertain0.9550.4170.125-10.999Likely Pathogenic0.871Likely PathogenicAmbiguous0.424Likely Benign0.37260.5551-0.14Likely Benign0.0-0.35Likely Benign-0.25Likely Benign0.40Likely Benign-6.20Deleterious1.000Probably Damaging0.999Probably Damaging2.16Pathogenic0.11Tolerated0-25.3-44.01
c.2159A>G
D720G
2D
AISynGAP1 missense variant D720G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, FoldX, Foldetta, and premPS, whereas pathogenic predictions arise from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two tools remain inconclusive: AlphaMissense‑Optimized and Rosetta. High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as likely pathogenic, and Foldetta (integrating FoldX‑MD and Rosetta outputs) as benign. Overall, the balance of evidence favors a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.374039Structured0.450695Uncertain0.9550.4170.125-11.130Likely Pathogenic0.911Likely PathogenicAmbiguous0.427Likely Benign0.40270.50110.45Likely Benign0.40.53Ambiguous0.49Likely Benign0.46Likely Benign-5.67Deleterious1.000Probably Damaging0.999Probably Damaging2.15Pathogenic0.01Affected1-13.1-58.04
c.2159A>T
D720V
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D720V has no ClinVar entry and is not reported in gnomAD. Prediction tools that classify it as benign include REVEL, FoldX, Foldetta, and premPS, whereas pathogenic predictions come from PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and the SGM Consensus score (Likely Pathogenic). High‑accuracy assessments show AlphaMissense‑Optimized as uncertain, Foldetta as benign, and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) as Likely Pathogenic. Overall, the majority of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicGAP0.374039Structured0.450695Uncertain0.9550.4170.125-12.730Likely Pathogenic0.941Likely PathogenicAmbiguous0.437Likely Benign0.08220.57080.08Likely Benign0.0-0.78Ambiguous-0.35Likely Benign0.20Likely Benign-7.18Deleterious0.999Probably Damaging0.999Probably Damaging2.12Pathogenic0.00Affected-2-37.7-15.96
c.2160C>A
D720E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D720E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority, and Foldetta also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the collective predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.374039Structured0.450695Uncertain0.9550.4170.125-5.527Likely Benign0.391AmbiguousLikely Benign0.131Likely Benign0.13100.5275-0.31Likely Benign0.1-0.41Likely Benign-0.36Likely Benign0.23Likely Benign-2.46Neutral0.975Probably Damaging0.969Probably Damaging2.46Pathogenic0.15Tolerated320.014.03
c.2160C>G
D720E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D720E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, premPS, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; AlphaMissense‑Default remains uncertain. High‑accuracy assessments reinforce the benign interpretation: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) yields a benign majority, and Foldetta also predicts benign stability. No prediction or folding result is missing or inconclusive. Overall, the variant is most likely benign based on the collective predictions, and this assessment does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
GAP0.374039Structured0.450695Uncertain0.9550.4170.125-5.527Likely Benign0.391AmbiguousLikely Benign0.131Likely Benign0.13100.5275-0.31Likely Benign0.1-0.41Likely Benign-0.36Likely Benign0.23Likely Benign-2.46Neutral0.975Probably Damaging0.969Probably Damaging2.46Pathogenic0.15Tolerated320.014.03
c.619A>C
K207Q
2D
3DClick to see structure in 3D Viewer
AISynGAP1 K207Q is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions from REVEL, SIFT, and FATHMM; pathogenic predictions from SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, and AlphaMissense‑Default. High‑accuracy assessments give a mixed picture: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic effect; AlphaMissense‑Optimized is uncertain; Foldetta, which integrates FoldX‑MD and Rosetta outputs, predicts a benign impact. Folding‑stability scores from FoldX and Rosetta are inconclusive, and premPS is unavailable. Overall, the preponderance of evidence points to a pathogenic effect, and this conclusion does not conflict with the absence of a ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-9.544Likely Pathogenic0.874Likely PathogenicAmbiguous0.250Likely Benign0.40100.17970.57Ambiguous0.1-0.57Ambiguous0.00Likely Benign0.61Ambiguous-2.95Deleterious0.995Probably Damaging0.829Possibly Damaging4.00Benign0.10Tolerated110.4-0.04
c.619A>G
K207E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K207E is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a larger group predicts pathogenicity: premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN). High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized is pathogenic, the SGM Consensus is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) is inconclusive. The remaining stability predictions (FoldX and Rosetta) are uncertain. Overall, the majority of evidence points to a pathogenic effect for K207E, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-14.387Likely Pathogenic0.995Likely PathogenicLikely Pathogenic0.265Likely Benign0.35040.15571.39Ambiguous0.11.21Ambiguous1.30Ambiguous1.09Destabilizing-3.00Deleterious0.982Probably Damaging0.679Possibly Damaging4.02Benign0.07Tolerated010.40.94
c.620A>C
K207T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K207T is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: FoldX, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Uncertain predictions come from Rosetta, Foldetta, and premPS. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized is pathogenic; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is also pathogenic; Foldetta’s stability analysis is inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for K207T, and this conclusion is not contradicted by any ClinVar annotation (none exists).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-11.002Likely Pathogenic0.974Likely PathogenicLikely Pathogenic0.239Likely Benign0.16360.40312.15Destabilizing0.80.57Ambiguous1.36Ambiguous0.78Ambiguous-4.57Deleterious0.982Probably Damaging0.747Possibly Damaging3.99Benign0.07Tolerated0-13.2-27.07
c.620A>G
K207R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense change K207R is not listed in ClinVar and has no reported allele in gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, premPS, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) all indicate a benign or likely benign outcome. In contrast, polyPhen‑2 HumDiv and HumVar classify the variant as pathogenic. Stability‑based methods (FoldX, Rosetta, Foldetta) are inconclusive, providing no definitive support for either outcome. High‑accuracy assessments show AlphaMissense‑Optimized as benign, SGM‑Consensus as likely benign, and Foldetta as uncertain. Taken together, the majority of evidence points to a benign effect, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely BenignPH0.374039Structured0.406823Uncertain0.8470.3590.125-5.157Likely Benign0.217Likely BenignLikely Benign0.140Likely Benign0.46400.1704-0.58Ambiguous0.1-1.07Ambiguous-0.83Ambiguous0.37Likely Benign-1.77Neutral0.982Probably Damaging0.679Possibly Damaging4.09Benign0.20Tolerated32-0.628.01
c.620A>T
K207M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K207M missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, and FATHMM, whereas a majority of tools (SGM‑Consensus, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized) predict a pathogenic impact; premPS is uncertain. High‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts pathogenic, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) is likely pathogenic, and Foldetta (combining FoldX‑MD and Rosetta) predicts benign. Overall, the balance of evidence favors a pathogenic classification, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.596Likely Pathogenic0.977Likely PathogenicLikely Pathogenic0.336Likely Benign0.09820.4705-0.22Likely Benign0.0-0.47Likely Benign-0.35Likely Benign0.59Ambiguous-4.67Deleterious0.985Probably Damaging0.832Possibly Damaging3.94Benign0.03Affected0-15.83.02
c.621G>C
K207N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 K207N missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, SIFT, and FATHMM, whereas a majority of tools predict a pathogenic impact: SGM‑Consensus, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. FoldX, Rosetta, and Foldetta provide uncertain or inconclusive results and are treated as unavailable. High‑accuracy assessments show AlphaMissense‑Optimized classifying the variant as pathogenic, the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicating likely pathogenic, while Foldetta’s stability prediction is unavailable. Overall, the preponderance of evidence points to a pathogenic effect for K207N, and this conclusion does not contradict the ClinVar status, which currently has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.881Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.123Likely Benign0.31840.23350.72Ambiguous0.11.48Ambiguous1.10Ambiguous1.00Destabilizing-3.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.98Benign0.07Tolerated100.4-14.07
c.621G>T
K207N
2D
3DClick to see structure in 3D Viewer
AISynGAP1 missense variant K207N is not reported in ClinVar and is absent from gnomAD. Functional prediction tools cluster into two groups: benign predictions come from REVEL, SIFT, and FATHMM, whereas pathogenic predictions arise from premPS, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is classified as Likely Pathogenic. High‑accuracy assessments further support pathogenicity: AlphaMissense‑Optimized predicts Pathogenic, and the SGM Consensus (majority vote) also predicts Pathogenic. Foldetta, which integrates FoldX‑MD and Rosetta stability outputs, is inconclusive. Overall, the preponderance of evidence indicates that K207N is most likely pathogenic, and this conclusion does not conflict with the absence of a ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicPH0.374039Structured0.406823Uncertain0.8470.3590.125-12.881Likely Pathogenic0.998Likely PathogenicLikely Pathogenic0.124Likely Benign0.31840.23350.72Ambiguous0.11.48Ambiguous1.10Ambiguous1.00Destabilizing-3.54Deleterious0.995Probably Damaging0.829Possibly Damaging3.98Benign0.07Tolerated100.4-14.07
c.1000A>C
K334Q
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334Q is not reported in ClinVar and is absent from gnomAD. Prediction tools that classify the variant as benign include REVEL, FoldX, Rosetta, Foldetta, and premPS. Those that predict pathogenicity are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. With seven tools favoring pathogenicity versus five favoring benign, the overall prediction leans toward pathogenic. This conclusion does not contradict ClinVar status, as the variant has no ClinVar entry.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.377384Structured0.325972Uncertain0.5440.4140.500-8.185Likely Pathogenic0.810Likely PathogenicAmbiguous0.357Likely Benign0.45190.10620.08Likely Benign0.00.10Likely Benign0.09Likely Benign0.46Likely Benign-3.67Deleterious1.000Probably Damaging0.998Probably Damaging1.74Pathogenic0.03Affected110.4-0.04
c.1000A>G
K334E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334E is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect comprise PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. High‑accuracy assessments show AlphaMissense‑Optimized as Pathogenic, SGM‑Consensus as Likely Pathogenic, and Foldetta (combining FoldX‑MD and Rosetta outputs) as Benign. Overall, the majority of evidence points toward a pathogenic impact, and this conclusion does not contradict any ClinVar annotation because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.377384Structured0.325972Uncertain0.5440.4140.500-12.770Likely Pathogenic0.991Likely PathogenicLikely Pathogenic0.372Likely Benign0.39290.08820.30Likely Benign0.2-0.07Likely Benign0.12Likely Benign0.42Likely Benign-3.67Deleterious0.999Probably Damaging0.995Probably Damaging1.74Pathogenic0.02Affected010.40.94
c.1001A>C
K334T
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334T is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, Rosetta, and premPS. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Predictions that are inconclusive or uncertain are FoldX, Foldetta, and AlphaMissense‑Optimized. High‑accuracy assessments show that the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) predicts a likely pathogenic outcome, AlphaMissense‑Optimized is uncertain, and Foldetta (combining FoldX‑MD and Rosetta outputs) is also uncertain. Overall, the majority of evidence points to a pathogenic impact. This conclusion is not contradicted by ClinVar status, which is currently unreported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.377384Structured0.325972Uncertain0.5440.4140.500-8.313Likely Pathogenic0.943Likely PathogenicAmbiguous0.320Likely Benign0.20620.29780.78Ambiguous0.30.21Likely Benign0.50Ambiguous0.17Likely Benign-5.51Deleterious1.000Probably Damaging0.998Probably Damaging1.78Pathogenic0.02Affected0-13.2-27.07
c.1001A>G
K334R
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334R is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, premPS, SIFT, ESM1b, AlphaMissense‑Default, AlphaMissense‑Optimized, and Foldetta. Tools that predict a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM; Rosetta is uncertain. High‑accuracy assessments show AlphaMissense‑Optimized as benign, Foldetta as benign, and the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive due to a 2‑vs‑2 split. Overall, the majority of evidence points to a benign impact. Thus, the variant is most likely benign, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.377384Structured0.325972Uncertain0.5440.4140.500-5.384Likely Benign0.162Likely BenignLikely Benign0.247Likely Benign0.46470.0976-0.37Likely Benign0.1-0.53Ambiguous-0.45Likely Benign0.39Likely Benign-2.62Deleterious0.999Probably Damaging0.995Probably Damaging1.76Pathogenic0.07Tolerated32-0.628.01
c.1001A>T
K334M
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334M is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that indicate a benign effect include REVEL, FoldX, and premPS. In contrast, the majority of tools predict a pathogenic outcome: PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all classify the variant as deleterious. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also reports the variant as Likely Pathogenic. Foldetta and Rosetta provide uncertain results. Focusing on high‑accuracy methods, AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus confirms a Likely Pathogenic status, and Foldetta remains inconclusive. Overall, the preponderance of evidence points to a pathogenic effect for K334M, and this assessment does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.377384Structured0.325972Uncertain0.5440.4140.500-10.530Likely Pathogenic0.973Likely PathogenicLikely Pathogenic0.323Likely Benign0.10270.36900.44Likely Benign0.00.56Ambiguous0.50Ambiguous0.14Likely Benign-5.51Deleterious1.000Probably Damaging0.999Probably Damaging1.77Pathogenic0.01Affected0-15.83.02
c.1002G>C
K334N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” Separately, the high‑accuracy AlphaMissense‑Optimized tool predicts pathogenicity, the SGM‑Consensus also predicts pathogenicity, while the Foldetta stability assessment predicts a benign effect. Overall, the majority of predictions (8 pathogenic vs. 5 benign) and the high‑accuracy consensus suggest that K334N is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.377384Structured0.325972Uncertain0.5440.4140.500-9.581Likely Pathogenic0.982Likely PathogenicLikely Pathogenic0.249Likely Benign0.37160.09580.15Likely Benign0.1-0.25Likely Benign-0.05Likely Benign0.18Likely Benign-4.59Deleterious1.000Probably Damaging0.998Probably Damaging1.77Pathogenic0.02Affected100.4-14.07
c.1002G>T
K334N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant K334N is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, FoldX, Rosetta, Foldetta, and premPS. Tools that predict a pathogenic effect include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. The SGM‑Consensus score, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Pathogenic.” Separately, the high‑accuracy AlphaMissense‑Optimized tool predicts pathogenicity, the SGM‑Consensus also predicts pathogenicity, while the Foldetta stability assessment predicts a benign effect. Overall, the majority of predictions (8 pathogenic vs. 5 benign) and the high‑accuracy consensus suggest that K334N is most likely pathogenic, and this conclusion does not contradict any ClinVar status because no ClinVar entry exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.377384Structured0.325972Uncertain0.5440.4140.500-9.581Likely Pathogenic0.982Likely PathogenicLikely Pathogenic0.249Likely Benign0.37160.09580.15Likely Benign0.1-0.25Likely Benign-0.05Likely Benign0.18Likely Benign-4.59Deleterious1.000Probably Damaging0.998Probably Damaging1.77Pathogenic0.02Affected100.4-14.07
c.2326G>A
G776S
2D
AIThe SynGAP1 missense variant G776S is reported in ClinVar as “Not submitted” and is present in gnomAD (variant ID 6-33442484-G-A). Functional prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (both HumDiv and HumVar models) predict a pathogenic impact. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus likewise indicates Likely Benign. No Foldetta stability analysis is available for this variant. Overall, the majority of predictive evidence points to a benign effect, and this conclusion does not contradict the ClinVar status, which currently contains no pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.2506-33442484-G-A11.28e-6-3.334Likely Benign0.147Likely BenignLikely Benign0.163Likely Benign0.25390.5785-1.21Neutral0.997Probably Damaging0.992Probably Damaging4.28Benign0.13Tolerated3.64601-0.430.03
c.2326G>C
G776R
2D
AIThe SynGAP1 missense variant G776R is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN), which collectively suggest a likely benign outcome. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The high‑accuracy AlphaMissense‑Optimized tool returns an uncertain result, and the Foldetta protein‑folding stability assessment is unavailable for this variant. Overall, the balance of evidence leans toward a benign interpretation, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.250-6.209Likely Benign0.886Likely PathogenicAmbiguous0.181Likely Benign0.09320.5115-2.28Neutral0.999Probably Damaging0.998Probably Damaging4.22Benign0.01Affected-3-2-4.199.14
c.2326G>T
G776C
2D
AIThe SynGAP1 missense variant G776C is not reported in ClinVar but is present in gnomAD (ID 6‑33442484‑G‑T). Prediction tools cluster into benign (REVEL, FATHMM, AlphaMissense‑Optimized) and pathogenic (PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT). Two tools (ESM1b, AlphaMissense‑Default) return uncertain results. High‑accuracy assessments are limited: AlphaMissense‑Optimized predicts benign, while the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive, and Foldetta data are unavailable. Overall, the majority of conventional predictors indicate pathogenicity, whereas the single high‑accuracy tool suggests benign. Given the preponderance of pathogenic predictions and the absence of a ClinVar entry, the variant is most likely pathogenic and does not contradict any existing ClinVar classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.377384Structured0.886983Binding0.2960.8880.2506-33442484-G-T-7.974In-Between0.380AmbiguousLikely Benign0.181Likely Benign0.12350.4403-2.59Deleterious1.000Probably Damaging0.998Probably Damaging4.15Benign0.01Affected3.646-3-32.946.09
c.2327G>A
G776D
2D
AIThe SynGAP1 missense variant G776D is catalogued in gnomAD (ID 6‑33442485‑G‑A) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized, while pathogenic predictions come from AlphaMissense‑Default, polyPhen‑2 HumDiv, and polyPhen‑2 HumVar. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is “Likely Benign.” High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized scores benign, and the SGM‑Consensus (majority of the four high‑accuracy tools) also indicates benign. Foldetta stability analysis is unavailable, so it does not influence the assessment. Overall, the preponderance of evidence points to a benign effect for G776D, and this conclusion is consistent with the absence of a ClinVar pathogenic classification.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.2506-33442485-G-A0.388Likely Benign0.566Likely PathogenicLikely Benign0.188Likely Benign0.18350.29710.16Neutral0.999Probably Damaging0.996Probably Damaging4.30Benign0.10Tolerated3.646-11-3.158.04
c.2327G>C
G776A
2D
AIThe SynGAP1 missense variant G776A is not reported in ClinVar and is absent from gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote) which classifies the variant as Likely Benign. In contrast, polyPhen‑2 (HumDiv and HumVar) and SIFT all predict a pathogenic impact. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized returns Benign, and the SGM‑Consensus (derived from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) also indicates Likely Benign. No Foldetta stability prediction is available, so it does not influence the assessment. Overall, the majority of evidence points to a benign effect for G776A, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.250-5.275Likely Benign0.296Likely BenignLikely Benign0.173Likely Benign0.36480.4971-1.82Neutral0.992Probably Damaging0.987Probably Damaging4.26Benign0.03Affected102.214.03
c.2327G>T
G776V
2D
AIThe SynGAP1 missense variant G776V is listed in gnomAD (ID 6‑33442485‑G‑T) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions include REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Optimized, and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN). Pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar) and SIFT. AlphaMissense‑Default is uncertain, and Foldetta (FoldX‑MD/Rosetta stability assessment) has no result for this variant. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus also indicates a likely benign outcome; Foldetta data are unavailable. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar status because none is reported.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.377384Structured0.886983Binding0.2960.8880.2506-33442485-G-T-6.541Likely Benign0.515AmbiguousLikely Benign0.180Likely Benign0.09930.4223-2.25Neutral0.999Probably Damaging0.998Probably Damaging4.19Benign0.01Affected3.646-3-14.642.08
c.2287C>A
L763I
2D
AIThe SynGAP1 missense variant L763I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as likely benign; Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact for this variant, and there is no conflict with ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.918636Binding0.3510.8650.125-4.803Likely Benign0.150Likely BenignLikely Benign0.052Likely Benign0.08700.3367-0.55Neutral0.877Possibly Damaging0.675Possibly Damaging2.48Pathogenic0.31Tolerated220.70.00
c.2287C>G
L763V
2D
AIThe SynGAP1 missense variant L763V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools largely agree on a benign effect: REVEL, PROVEAN, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized all predict benign. Only polyPhen‑2 HumDiv indicates a pathogenic outcome, creating a single discordant signal. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments reinforce this view: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus also reports Likely Benign. Foldetta, a protein‑folding stability method combining FoldX‑MD and Rosetta outputs, has no available result for this variant. Overall, the preponderance of evidence supports a benign classification, and this conclusion is consistent with the lack of ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.918636Binding0.3510.8650.125-5.138Likely Benign0.164Likely BenignLikely Benign0.027Likely Benign0.15480.2817-0.94Neutral0.573Possibly Damaging0.230Benign2.57Benign0.25Tolerated210.4-14.03
c.2287C>T
L763F
2D
AIThe SynGAP1 missense variant L763F is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, AlphaMissense‑Default, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. High‑accuracy assessments show AlphaMissense‑Optimized as benign and the SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also as benign; Foldetta results are not available. Overall, the majority of evidence points to a benign impact for this variant. There is no ClinVar entry to contradict this conclusion.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.918636Binding0.3510.8650.125-4.127Likely Benign0.255Likely BenignLikely Benign0.091Likely Benign0.05840.3140-0.71Neutral0.999Probably Damaging0.977Probably Damaging2.39Pathogenic0.19Tolerated20-1.034.02
c.2288T>A
L763H
2D
AIThe SynGAP1 missense variant L763H is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on benign include REVEL, PROVEAN, ESM1b, and AlphaMissense‑Optimized, while pathogenic predictions come from polyPhen‑2 (HumDiv and HumVar), SIFT, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign; the SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, is inconclusive (2 pathogenic vs. 2 benign), and Foldetta results are unavailable. Overall, the predictions are mixed, with a slight tilt toward pathogenicity (5 pathogenic vs. 4 benign). Thus, the variant is most likely pathogenic according to the aggregate predictions, and this assessment does not contradict ClinVar, which currently has no entry for it.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.918636Binding0.3510.8650.125-6.681Likely Benign0.640Likely PathogenicLikely Benign0.180Likely Benign0.10210.0887-0.79Neutral1.000Probably Damaging0.992Probably Damaging2.36Pathogenic0.03Affected-2-3-7.023.98
c.2288T>C
L763P
2D
AIThe SynGAP1 missense variant L763P is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and FATHMM. AlphaMissense‑Default is uncertain. For high‑accuracy assessment, AlphaMissense‑Optimized predicts benign. The SGM Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, also yields a benign prediction (2 benign vs. 1 pathogenic, with one uncertain). Foldetta results are unavailable. Overall, the majority of evidence points to a benign impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.918636Binding0.3510.8650.125-5.802Likely Benign0.550AmbiguousLikely Benign0.158Likely Benign0.39200.1182-0.89Neutral0.999Probably Damaging0.977Probably Damaging2.36Pathogenic0.12Tolerated-3-3-5.4-16.04
c.2288T>G
L763R
2D
AIThe SynGAP1 missense variant L763R is not reported in ClinVar (ClinVar ID = None) and is absent from gnomAD (gnomAD ID = None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, FATHMM, and AlphaMissense‑Default. High‑accuracy assessments show AlphaMissense‑Optimized as benign, while the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic) and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign impact, and this conclusion does not contradict the ClinVar status, which has no entry for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.918636Binding0.3510.8650.125-5.516Likely Benign0.643Likely PathogenicLikely Benign0.163Likely Benign0.11990.0761-1.66Neutral0.999Probably Damaging0.977Probably Damaging2.38Pathogenic0.07Tolerated-3-2-8.343.03
c.2290A>C
N764H
2D
AIThe SynGAP1 missense variant N764H is reported in gnomAD (ID 6‑33441755‑A‑C) but has no ClinVar entry. Functional prediction tools cluster into two groups: benign predictions come from REVEL, PROVEAN, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, and the SGM‑Consensus (Likely Benign). Pathogenic predictions are made by polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, and the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) also indicates Likely Benign. No Foldetta stability result is available. Overall, the majority of evidence points to a benign effect, and this conclusion does not contradict any ClinVar classification (none is present).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.919527Binding0.3050.8610.2506-33441755-A-C-4.954Likely Benign0.320Likely BenignLikely Benign0.091Likely Benign0.12360.5056-2.09Neutral0.998Probably Damaging0.985Probably Damaging2.59Benign0.02Affected3.646120.323.04
c.2290A>G
N764D
2D
AIThe SynGAP1 missense variant N764D is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, PROVEAN, SIFT, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are PolyPhen‑2 HumDiv, PolyPhen‑2 HumVar, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates the majority vote from AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts benign, SGM‑Consensus also predicts benign, and Foldetta results are unavailable. Based on the collective predictions, the variant is most likely benign, and this assessment does not contradict any ClinVar status because no ClinVar classification exists.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.919527Binding0.3050.8610.250-6.012Likely Benign0.572Likely PathogenicLikely Benign0.057Likely Benign0.17690.2921-1.00Neutral0.992Probably Damaging0.893Possibly Damaging2.85Benign0.07Tolerated210.00.98
c.2290A>T
N764Y
2D
AIThe SynGAP1 missense variant N764Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, FATHMM, and AlphaMissense‑Optimized. Tools that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. High‑accuracy methods give mixed results: AlphaMissense‑Optimized predicts benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is inconclusive (2 benign vs 2 pathogenic), and Foldetta data are unavailable. Overall, the balance of evidence favors a pathogenic interpretation, with no ClinVar entry to contradict this assessment.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.919527Binding0.3050.8610.250-5.914Likely Benign0.680Likely PathogenicLikely Benign0.158Likely Benign0.05520.4175-2.85Deleterious0.998Probably Damaging0.967Probably Damaging2.58Benign0.01Affected-2-22.249.07
c.2291A>C
N764T
2D
AIThe SynGAP1 missense variant N764T is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, FATHMM, and AlphaMissense‑Optimized, while those that predict a pathogenic effect are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, and SIFT. The SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Benign. High‑accuracy assessments further support a benign outcome: AlphaMissense‑Optimized predicts Benign, and the SGM‑Consensus also indicates Likely Benign. No Foldetta stability analysis is available, so it does not influence the assessment. Overall, the majority of computational evidence points to a benign impact, and this is consistent with the lack of any ClinVar pathogenic annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.919527Binding0.3050.8610.250-4.214Likely Benign0.449AmbiguousLikely Benign0.071Likely Benign0.12720.5168-1.57Neutral0.975Probably Damaging0.850Possibly Damaging2.63Benign0.05Affected002.8-13.00
c.2291A>G
N764S
2D
AIThe SynGAP1 missense variant N764S is listed in ClinVar as Benign (ClinVar ID 1948460.0) and is not reported in gnomAD. Prediction tools that agree on a benign effect include SGM‑Consensus (Likely Benign), REVEL, PROVEAN, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized. In contrast, polyPhen‑2 (HumDiv and HumVar) predict a pathogenic outcome. High‑accuracy assessments show AlphaMissense‑Optimized as Benign and the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as Likely Benign; Foldetta stability analysis is unavailable. Overall, the majority of evidence points to a benign effect, consistent with the ClinVar classification, and there is no contradiction between the predictions and the reported ClinVar status.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.919527Binding0.3050.8610.250Benign 1-3.149Likely Benign0.159Likely BenignLikely Benign0.058Likely Benign0.37620.5062-0.84Neutral0.992Probably Damaging0.846Possibly Damaging2.65Benign0.61Tolerated3.646112.7-27.03
c.2291A>T
N764I
2D
AIThe SynGAP1 missense variant N764I is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect include REVEL, ESM1b, and FATHMM. Those that agree on a pathogenic effect are PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. AlphaMissense‑Optimized is uncertain. High‑accuracy assessments are inconclusive: AlphaMissense‑Optimized is uncertain; the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is a 2‑vs‑2 tie, and Foldetta results are unavailable. Overall, more tools predict pathogenicity (five) than benignity (three), and no ClinVar evidence contradicts this assessment. Thus, the variant is most likely pathogenic based on the available predictions.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
0.380708Structured0.919527Binding0.3050.8610.250-6.879Likely Benign0.883Likely PathogenicAmbiguous0.115Likely Benign0.05810.4483-2.58Deleterious0.906Possibly Damaging0.679Possibly Damaging2.58Benign0.00Affected-2-38.0-0.94
c.2292C>A
N764K
2D
AIThe SynGAP1 missense variant N764K is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign classification, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.919527Binding0.3050.8610.250-5.867Likely Benign0.892Likely PathogenicAmbiguous0.073Likely Benign0.20050.3539-1.36Neutral0.992Probably Damaging0.921Probably Damaging2.66Benign0.02Affected10-0.414.07
c.2292C>G
N764K
2D
AIThe SynGAP1 missense variant N764K is not reported in ClinVar and has no entries in gnomAD. Prediction tools that agree on a benign effect include REVEL, PROVEAN, ESM1b, and FATHMM, while those that predict a pathogenic outcome are polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, and AlphaMissense‑Default. The SGM‑Consensus, which aggregates AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, reports the variant as Likely Benign. High‑accuracy assessments show AlphaMissense‑Optimized as Uncertain, SGM‑Consensus as Likely Benign, and Foldetta results are unavailable. Overall, the balance of evidence leans toward a benign classification, and this assessment does not contradict any ClinVar status because no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely Benign0.380708Structured0.919527Binding0.3050.8610.250-5.867Likely Benign0.892Likely PathogenicAmbiguous0.073Likely Benign0.20050.3539-1.36Neutral0.992Probably Damaging0.921Probably Damaging2.66Benign0.02Affected10-0.414.07
c.988G>A
D330N
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330N missense variant is not reported in ClinVar (ClinVar ID None) and has no entry in gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include only REVEL, whereas the remaining tools—PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, and AlphaMissense‑Default—consistently predict a pathogenic impact. High‑accuracy assessments further support a deleterious interpretation: the SGM‑Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN) indicates “Likely Pathogenic,” while AlphaMissense‑Optimized and Foldetta yield uncertain results and are treated as unavailable. No folding‑stability methods (FoldX, Rosetta, premPS) provide decisive evidence. Overall, the preponderance of pathogenic predictions strongly suggests that D330N is most likely pathogenic, and this conclusion does not contradict any existing ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-12.993Likely Pathogenic0.909Likely PathogenicAmbiguous0.350Likely Benign0.12520.42631.61Ambiguous0.20.59Ambiguous1.10Ambiguous0.59Ambiguous-3.46Deleterious0.980Probably Damaging0.721Possibly Damaging1.01Pathogenic0.02Affected210.0-0.98
c.988G>C
D330H
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330H missense variant is not reported in ClinVar and is absent from gnomAD. Prediction tools cluster into three groups: benign predictions are limited to REVEL; pathogenic predictions include PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, AlphaMissense‑Default, AlphaMissense‑Optimized, FoldX, and the SGM‑Consensus (Likely Pathogenic). Uncertain or inconclusive results come from Rosetta, Foldetta, and premPS. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized predicts pathogenicity, the SGM‑Consensus also indicates likely pathogenic, while Foldetta’s stability analysis is inconclusive. Taken together, the overwhelming majority of evidence points to a pathogenic impact for D330H. This conclusion is not contradicted by any ClinVar annotation, as the variant is currently unreported in that database.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.926Likely Pathogenic0.980Likely PathogenicLikely Pathogenic0.425Likely Benign0.16080.48432.29Destabilizing0.61.32Ambiguous1.81Ambiguous0.61Ambiguous-4.67Deleterious0.998Probably Damaging0.961Probably Damaging0.96Pathogenic0.01Affected1-10.322.05
c.988G>T
D330Y
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D330Y is not reported in ClinVar (no ClinVar ID) and is absent from gnomAD (no gnomAD ID). Prediction tools that agree on a benign effect are REVEL and premPS, whereas the remaining tools—including SGM‑Consensus, Foldetta, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, AlphaMissense‑Default, and AlphaMissense‑Optimized—consistently predict a pathogenic impact; FoldX is uncertain and therefore not counted. High‑accuracy methods all support pathogenicity: AlphaMissense‑Optimized is pathogenic, SGM‑Consensus is likely pathogenic, and Foldetta is pathogenic. Taken together, the overwhelming majority of evidence indicates that D330Y is most likely pathogenic, and this conclusion is not contradicted by any ClinVar annotation (none is available).

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-14.200Likely Pathogenic0.956Likely PathogenicLikely Pathogenic0.472Likely Benign0.05390.46891.98Ambiguous0.62.90Destabilizing2.44Destabilizing0.35Likely Benign-6.47Deleterious0.998Probably Damaging0.948Probably Damaging0.89Pathogenic0.00Affected-4-32.248.09
c.989A>C
D330A
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330A missense variant is not reported in ClinVar (ClinVar ID: None) and is absent from gnomAD (gnomAD ID: None). Prediction tools that agree on a benign effect include REVEL and SIFT, while a majority of tools predict a pathogenic impact: SGM‑Consensus, PROVEAN, polyPhen‑2 (HumDiv and HumVar), ESM1b, FATHMM, and AlphaMissense‑Default. Tools with uncertain or inconclusive results—FoldX, Rosetta, Foldetta, premPS, and AlphaMissense‑Optimized—do not provide definitive evidence. High‑accuracy methods give the following: SGM‑Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) indicates a likely pathogenic outcome; AlphaMissense‑Optimized is uncertain; Foldetta is also uncertain. Overall, the preponderance of evidence from multiple independent predictors points to a pathogenic effect for D330A. This conclusion is not contradicted by ClinVar status, as no ClinVar assertion exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-14.051Likely Pathogenic0.929Likely PathogenicAmbiguous0.399Likely Benign0.40870.44761.75Ambiguous0.31.06Ambiguous1.41Ambiguous0.60Ambiguous-5.49Deleterious0.961Probably Damaging0.655Possibly Damaging0.93Pathogenic0.11Tolerated0-25.3-44.01
c.989A>G
D330G
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 missense variant D330G is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL, whereas the majority of algorithms predict a pathogenic impact: FoldX, Rosetta, Foldetta, PROVEAN, polyPhen‑2 HumDiv, polyPhen‑2 HumVar, SIFT, ESM1b, FATHMM, and AlphaMissense‑Default. Two predictors (AlphaMissense‑Optimized and premPS) give uncertain results. High‑accuracy assessments further support a deleterious effect: AlphaMissense‑Optimized is inconclusive, the SGM Consensus (majority vote of AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) is “Likely Pathogenic,” and Foldetta, which integrates FoldX‑MD and Rosetta stability calculations, classifies the variant as pathogenic. Overall, the preponderance of evidence indicates that D330G is most likely pathogenic, and this conclusion does not contradict the ClinVar status, which currently has no entry for the variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.064Likely Pathogenic0.950Likely PathogenicAmbiguous0.373Likely Benign0.39350.50152.69Destabilizing0.22.17Destabilizing2.43Destabilizing0.63Ambiguous-5.03Deleterious0.980Probably Damaging0.782Possibly Damaging0.94Pathogenic0.01Affected1-13.1-58.04
c.989A>T
D330V
2D
3DClick to see structure in 3D Viewer
AISynGAP1 D330V is not reported in ClinVar and is absent from gnomAD. Functional prediction tools that agree on a benign effect include REVEL and premPS, whereas a majority of tools predict a pathogenic impact: polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, FATHMM, PROVEAN, and AlphaMissense‑Default. Uncertain predictions from FoldX, Rosetta, Foldetta, and AlphaMissense‑Optimized are treated as unavailable. High‑accuracy assessments show that the SGM‑Consensus, derived from a majority vote of AlphaMissense‑Default, ESM1b, FATHMM, and PROVEAN, classifies the variant as Likely Pathogenic. AlphaMissense‑Optimized and Foldetta provide inconclusive results and are therefore not considered evidence. Overall, the preponderance of evidence points to a pathogenic effect for D330V, and this conclusion is not contradicted by any ClinVar annotation.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
Likely PathogenicC20.380708Structured0.360008Uncertain0.8050.4880.250-13.176Likely Pathogenic0.950Likely PathogenicAmbiguous0.428Likely Benign0.08620.46332.06Destabilizing0.50.57Ambiguous1.32Ambiguous0.45Likely Benign-6.40Deleterious0.994Probably Damaging0.892Possibly Damaging0.89Pathogenic0.01Affected-2-37.7-15.96
c.990C>A
D330E
2D
3DClick to see structure in 3D Viewer
AIThe SynGAP1 D330E missense variant is not reported in ClinVar (ClinVar ID None) and is absent from gnomAD (gnomAD ID None). Prediction tools that agree on a benign effect include REVEL, premPS, PROVEAN, polyPhen‑2 (HumDiv and HumVar), SIFT, ESM1b, and AlphaMissense‑Optimized. Tools that predict a pathogenic effect are Rosetta and FATHMM. The remaining tools—FoldX, AlphaMissense‑Default, and Foldetta—return uncertain or inconclusive results. High‑accuracy assessments show AlphaMissense‑Optimized as benign, the SGM Consensus (majority vote from AlphaMissense‑Default, ESM1b, FATHMM, PROVEAN) as benign, and Foldetta as uncertain. Overall, the majority of evidence points to a benign impact. This conclusion is not contradicted by any ClinVar annotation, as no ClinVar entry exists for this variant.

Disclaimer: This summary was generated using AI and should be interpreted alongside expert review.
C20.380708Structured0.360008Uncertain0.8050.4880.250-3.427Likely Benign0.407AmbiguousLikely Benign0.073Likely Benign0.14640.44160.98Ambiguous0.22.31Destabilizing1.65Ambiguous0.39Likely Benign-1.38Neutral0.122Benign0.030Benign0.97Pathogenic0.67Tolerated320.014.03

Found 8751 rows. Show 800 rows per page. Page 4/11 « Previous | Next »